
<html lang="en"     class="pb-page"  data-request-id="57b0c677-b43c-4612-8e4d-1ceb83ea0b14"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.9b00309;issue:issue:10.1021/jmcmar.2019.62.issue-10;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Structure-Based Design of Selective β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors: Targeting the Flap to Gain Selectivity over BACE2" /></meta><meta name="dc.Creator" content="Kazuki  Fujimoto" /></meta><meta name="dc.Creator" content="Eriko  Matsuoka" /></meta><meta name="dc.Creator" content="Naoya  Asada" /></meta><meta name="dc.Creator" content="Genta  Tadano" /></meta><meta name="dc.Creator" content="Takahiko  Yamamoto" /></meta><meta name="dc.Creator" content="Kenji  Nakahara" /></meta><meta name="dc.Creator" content="Kouki  Fuchino" /></meta><meta name="dc.Creator" content="Hisanori  Ito" /></meta><meta name="dc.Creator" content="Naoki  Kanegawa" /></meta><meta name="dc.Creator" content="Diederik  Moechars" /></meta><meta name="dc.Creator" content="Harrie J. M.  Gijsen" /></meta><meta name="dc.Creator" content="Ken-ichi  Kusakabe" /></meta><meta name="dc.Description" content="BACE1 inhibitors hold potential as agents in disease-modifying treatment for Alzheimer’s disease. BACE2 cleaves the melanocyte protein PMEL in pigment cells of the skin and eye, generating melanin ..." /></meta><meta name="Description" content="BACE1 inhibitors hold potential as agents in disease-modifying treatment for Alzheimer’s disease. BACE2 cleaves the melanocyte protein PMEL in pigment cells of the skin and eye, generating melanin ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 25, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b00309" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00309" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b00309" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00309" /></link>
        
    
    

<title>Structure-Based Design of Selective β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors: Targeting the Flap to Gain Selectivity over BACE2 | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b00309" /></meta><meta property="og:title" content="Structure-Based Design of Selective β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors: Targeting the Flap to Gain Selectivity over BACE2" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0022.jpeg" /></meta><meta property="og:description" content="BACE1 inhibitors hold potential as agents in disease-modifying treatment for Alzheimer’s disease. BACE2 cleaves the melanocyte protein PMEL in pigment cells of the skin and eye, generating melanin pigments. This role of BACE2 implies that nonselective and chronic inhibition of BACE1 may cause side effects derived from BACE2. Herein, we describe the discovery of potent and selective BACE1 inhibitors using structure-based drug design. We targeted the flap region, where the shape and flexibility differ between these enzymes. Analysis of the cocrystal structures of an initial lead 8 prompted us to incorporate spirocycles followed by its fine-tuning, culminating in highly selective compounds 21 and 22. The structures of 22 bound to BACE1 and BACE2 revealed that a relatively high energetic penalty in the flap of the 22-bound BACE2 structure may cause a loss in BACE2 potency, thereby leading to its high selectivity. These findings and insights should contribute to responding to the challenges in exploring selective BACE1 inhibitors." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b00309"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00309">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b00309&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b00309&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b00309&amp;href=/doi/10.1021/acs.jmedchem.9b00309" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 10</span><span class="cit-fg-pageRange">, 5080-5095</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/10" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b00258" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b00318" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Structure-Based Design of Selective β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors: Targeting the Flap to Gain Selectivity over BACE2</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Kazuki Fujimoto</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kazuki Fujimoto</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratory for Core Therapeutic Areas, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kazuki++Fujimoto">Kazuki Fujimoto</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Eriko Matsuoka</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Eriko Matsuoka</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratory for Core Therapeutic Areas, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Eriko++Matsuoka">Eriko Matsuoka</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Naoya Asada</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Naoya Asada</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratory for Core Therapeutic Areas, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Naoya++Asada">Naoya Asada</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Genta Tadano</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Genta Tadano</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratory for Core Therapeutic Areas, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Genta++Tadano">Genta Tadano</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Takahiko Yamamoto</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Takahiko Yamamoto</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratory for Core Therapeutic Areas, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Takahiko++Yamamoto">Takahiko Yamamoto</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kenji Nakahara</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kenji Nakahara</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratory for Core Therapeutic Areas, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kenji++Nakahara">Kenji Nakahara</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kouki Fuchino</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kouki Fuchino</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratory for Core Therapeutic Areas, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kouki++Fuchino">Kouki Fuchino</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hisanori Ito</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hisanori Ito</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratory for Core Therapeutic Areas, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hisanori++Ito">Hisanori Ito</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Naoki Kanegawa</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Naoki Kanegawa</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research Laboratory for Development, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Naoki++Kanegawa">Naoki Kanegawa</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Diederik Moechars</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Diederik Moechars</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Neuroscience Biology, Janssen Research & Development, Turnhoutseweg 30, Beerse B-2340, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Diederik++Moechars">Diederik Moechars</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Harrie J. M. Gijsen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Harrie J. M. Gijsen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Chemistry, Janssen Research & Development, Turnhoutseweg 30, Beerse B-2340, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Harrie+J.+M.++Gijsen">Harrie J. M. Gijsen</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8020-4828" title="Orcid link">http://orcid.org/0000-0001-8020-4828</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Ken-ichi Kusakabe</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ken-ichi Kusakabe</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratory for Core Therapeutic Areas, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#bbd0ded596d2d8d3d295d0cec8dad0dad9defbc8d3d2d4d5d4dcd295d8d495d1cb"><span class="__cf_email__" data-cfemail="375c52591a5e545f5e195c4244565c56555277445f5e585958505e195458195d47">[email protected]</span></a>. Phone: +81-6-6331-6190. Fax: +81-6-6332-6385.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ken-ichi++Kusakabe">Ken-ichi Kusakabe</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9055-8267" title="Orcid link">http://orcid.org/0000-0001-9055-8267</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00309&amp;href=/doi/10.1021%2Facs.jmedchem.9b00309" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 10</span><span class="cit-pageRange">, 5080–5095</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 25, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>16 February 2019</li><li><span class="item_label"><b>Published</b> online</span>25 April 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 May 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b00309" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00309</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5080%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DKazuki%2BFujimoto%252C%2BEriko%2BMatsuoka%252C%2BNaoya%2BAsada%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D10%26contentID%3Dacs.jmedchem.9b00309%26title%3DStructure-Based%2BDesign%2Bof%2BSelective%2B%25CE%25B2-Site%2BAmyloid%2BPrecursor%2BProtein%2BCleaving%2BEnzyme%2B1%2B%2528BACE1%2529%2BInhibitors%253A%2BTargeting%2Bthe%2BFlap%2Bto%2BGain%2BSelectivity%2Bover%2BBACE2%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5095%26publicationDate%3DMay%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b00309"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2049</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">13</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b00309" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Structure-Based Design of Selective β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors: Targeting the Flap to Gain Selectivity over BACE2&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Kazuki&quot;,&quot;last_name&quot;:&quot;Fujimoto&quot;},{&quot;first_name&quot;:&quot;Eriko&quot;,&quot;last_name&quot;:&quot;Matsuoka&quot;},{&quot;first_name&quot;:&quot;Naoya&quot;,&quot;last_name&quot;:&quot;Asada&quot;},{&quot;first_name&quot;:&quot;Genta&quot;,&quot;last_name&quot;:&quot;Tadano&quot;},{&quot;first_name&quot;:&quot;Takahiko&quot;,&quot;last_name&quot;:&quot;Yamamoto&quot;},{&quot;first_name&quot;:&quot;Kenji&quot;,&quot;last_name&quot;:&quot;Nakahara&quot;},{&quot;first_name&quot;:&quot;Kouki&quot;,&quot;last_name&quot;:&quot;Fuchino&quot;},{&quot;first_name&quot;:&quot;Hisanori&quot;,&quot;last_name&quot;:&quot;Ito&quot;},{&quot;first_name&quot;:&quot;Naoki&quot;,&quot;last_name&quot;:&quot;Kanegawa&quot;},{&quot;first_name&quot;:&quot;Diederik&quot;,&quot;last_name&quot;:&quot;Moechars&quot;},{&quot;first_name&quot;:&quot;Harrie&quot;,&quot;last_name&quot;:&quot;J. M. Gijsen&quot;},{&quot;first_name&quot;:&quot;Ken-ichi&quot;,&quot;last_name&quot;:&quot;Kusakabe&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;25&quot;,&quot;issue&quot;:&quot;10&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;5080-5095&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b00309&quot;},&quot;abstract&quot;:&quot;BACE1 inhibitors hold potential as agents in disease-modifying treatment for Alzheimer’s disease. BACE2 cleaves the melanocyte protein PMEL in pigment cells of the skin and eye, generating melanin pigments. This role of BACE2 implies that nonselective and chronic inhibition of BACE1 may cause side effects derived from BACE2. Herein, we describe the discovery of potent and selective BACE1 inhibitors using structure-based drug design. We targeted the flap region, where the shape and flexibility differ between these enzymes. Analysis of the cocrystal structures of an initial lead 8 prompted us to incorporate spirocycles followed by its fine-tuning, culminating in highly selective compounds 21 and 22. The structures of 22 bound to BACE1 and BACE2 revealed that a relatively high energetic penalty in the flap of the 22-bound BACE2 structure may cause a loss in BACE2 potency, thereby leading to its high selectivity. These findings and insights should contribute to responding to the challenges in exploring selective &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00309&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00309" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00309&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00309" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00309&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00309" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00309&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00309&amp;href=/doi/10.1021/acs.jmedchem.9b00309" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b00309" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b00309" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b00309%26sid%3Dliteratum%253Aachs%26pmid%3D31021626%26genre%3Darticle%26aulast%3DFujimoto%26date%3D2019%26atitle%3DStructure-Based%2BDesign%2Bof%2BSelective%2B%25CE%25B2-Site%2BAmyloid%2BPrecursor%2BProtein%2BCleaving%2BEnzyme%2B1%2B%2528BACE1%2529%2BInhibitors%253A%2BTargeting%2Bthe%2BFlap%2Bto%2BGain%2BSelectivity%2Bover%2BBACE2%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D10%26spage%3D5080%26epage%3D5095%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290723" title="Solutions">Solutions</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292200" title="Layers">Layers</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/10" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/jmcmar.2019.62.issue-10/20190523/jmcmar.2019.62.issue-10.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/medium/jm-2019-00309f_0022.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00309&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">BACE1 inhibitors hold potential as agents in disease-modifying treatment for Alzheimer’s disease. BACE2 cleaves the melanocyte protein PMEL in pigment cells of the skin and eye, generating melanin pigments. This role of BACE2 implies that nonselective and chronic inhibition of BACE1 may cause side effects derived from BACE2. Herein, we describe the discovery of potent and selective BACE1 inhibitors using structure-based drug design. We targeted the flap region, where the shape and flexibility differ between these enzymes. Analysis of the cocrystal structures of an initial lead <b>8</b> prompted us to incorporate spirocycles followed by its fine-tuning, culminating in highly selective compounds <b>21</b> and <b>22</b>. The structures of <b>22</b> bound to BACE1 and BACE2 revealed that a relatively high energetic penalty in the flap of the <b>22</b>-bound BACE2 structure may cause a loss in BACE2 potency, thereby leading to its high selectivity. These findings and insights should contribute to responding to the challenges in exploring selective BACE1 inhibitors.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57862" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57862" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease (AD) is the most common form of dementia. In 2016, an estimated 47 million people were living with dementia.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Of them, 60 to 80% were estimated to have AD, and 10% of people aged 65 and older were suffering from the disease.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> The number of patients with AD will escalate rapidly, as the figure is expected to double every 20 years to reach 131 million by 2050.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> AD ultimately leads to death within 3 to 9 years after diagnosis and is the sixth-leading cause of death in the United States.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Additionally, there is a huge impact on the quality of life for both the AD patients and their family caregivers.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> The current therapeutic agents, such as the acetylcholinesterase inhibitors and the <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate receptor antagonist, only possess modest symptomatic effects and do not halt or slow the disease progression. Also, the treatment gains obtained from the drugs are often lost within a few years. Therefore, there is a great unmet medical need for a disease-modifying drug that can benefit patients and caregivers by improving clinical outcomes.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><div class="NLM_p">The accumulation of extracellular deposits of amyloid plaques composed of amyloid β-peptides (Aβ) with 38 to 43 amino acids is a hallmark of AD. Histopathological and genetic evidence underlies the amyloid cascade hypothesis that AD may be caused by deposition of Aβ.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The β-site amyloid precursor protein cleaving enzyme 1 (BACE1), also known as β-secretase, initiates the production of Aβ and hence is a prime target for AD.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Since the discovery of BACE1 in 1999,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> the pharmaceutical industry and academia have pursued orally available and brain penetrant BACE1 inhibitors with an acceptable safety profile. The initially reported BACE1 inhibitors, such as peptidomimetics and hydroxyethylamines, struggled to achieve balanced in vitro potency and favorable pharmacokinetic profiles because of their large molecular weight and high polar surface area.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> The identification of small-molecule amidine-based inhibitors addressed the issues observed in the peptidomimetic analogues.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8,9)</a> Leveraging structure-based design and tuning physicochemical properties culminated in the discovery of several clinical BACE1 inhibitors, such as verubecestat (<b>1</b>, MK-8931),<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> elenbecestat (<b>2</b>, E-2609),<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> lanabecestat (<b>3</b>, AZD-3293),<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> umibecestat (CNP520),<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and atabecestat (JNJ-54861911) (<a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>).<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Unfortunately, <b>1</b> and <b>3</b> failed due to the lack of efficacy in their phase III clinical trials,<a onclick="showRef(event, 'cit10d cit12b'); return false;" href="javascript:void(0);" class="ref cit10d cit12b">(10d,12b)</a> and the development of atabecestat was stopped because of significant elevation of liver enzymes.<a onclick="showRef(event, 'cit14b'); return false;" href="javascript:void(0);" class="ref cit14b">(14b)</a></div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/medium/jm-2019-00309f_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0001.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Representative BACE1 Inhibitors in Clinical Development</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00309&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The Dominantly Inherited Alzheimer Network (DIAN) study, which enrolled participants at risk for carrying a mutation for autosomal dominant AD, reveals that deposition of Aβ, measured by positron-emission tomography (PET), begins approximately 15 years before the age of expected symptom onset, followed by increased tau protein in the CSF and hippocampal atrophy leading to cognitive and clinical changes.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> As in the DIAN study, a similar trend of Aβ deposition, brain atrophy, and cognitive decline is observed in patients with sporadic AD.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Large phase III studies for <b>1</b> and anti-Aβ antibodies involving patients with prodromal or mild-to-moderate AD failed because of no improvement in clinical outcomes,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> however, this may have been due to the intervention with these anti-Aβ therapies being too late to change the clinical outcomes. Thus, the evidence indicates that anti-Aβ drugs such as BACE1 inhibitors need to be given in the early stage of the disease, most likely at the presymptomatic stages, to prevent the development of AD.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> This consideration points to the need for chronic administration for more than 20 years, thereby requiring safer profiles for these anti-Aβ drugs including BACE1 inhibitors.</div><div class="NLM_p">BACE2 is a close homolog of BACE1 (52% sequence identity and 68% sequence similarity) and is primarily expressed in the peripheral tissues but at low levels in the brain.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> The enzyme cleaves the proproliferative type 1 transmembrane protein TMEM27 involved in the regulation of β cell mass.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> BACE2 was also found to process the pigment cell-specific melanocyte protein (PMEL), which is specifically expressed in pigment cells of the eye and skin. Indeed, BACE2<sup>–/–</sup> mice exhibited a silvery depigmented coat.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Furthermore, chronic administration of BACE1 inhibitors, such as <b>1</b> or NB-360,<a onclick="showRef(event, 'cit9i'); return false;" href="javascript:void(0);" class="ref cit9i">(9i)</a> resulted in depigmentation of the coats of rats and rabbits.<a onclick="showRef(event, 'cit10b ref22'); return false;" href="javascript:void(0);" class="ref cit10b ref22">(10b,22)</a> These findings for BACE2 may indicate its potential safety risk associated with chronic and nonselective inhibition of BACE1 inhibitors.</div><div class="NLM_p">Development of selective BACE1 inhibitors remains a significant challenge, given the homology between BACE1 and BACE2. Indeed, the clinical compounds <b>1</b>, <b>2</b>, and <b>3</b> have suboptimal BACE1 selectivities of 1.0-, 12-, and 3.1-fold over BACE2 in our fluorescence resonance energy transfer (FRET) biochemical assay. Although a number of crystal structures of inhibitor-bound BACE1 have been reported,<a onclick="showRef(event, 'cit7b'); return false;" href="javascript:void(0);" class="ref cit7b">(7b)</a> only a few high-resolution crystal structures are available for BACE2.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Bernard and Gsell et al. paved the way for obtaining high-quality inhibitor-bound BACE2 structures by the use of surface mutagenesis or crystallization helpers such as camelid heavy chain antibody (also known as V<sub>H</sub>H or Nanobody or Xaperone) or human Fyn kinase derived SH3 domain (Fynomer).<a onclick="showRef(event, 'cit23b'); return false;" href="javascript:void(0);" class="ref cit23b">(23b)</a> Comparative analysis of inhibitor-bound BACE1 and BACE2 structures revealed differences in conformational flexibility in the 10s loop and the flap region, where BACE2 stabilized these closed conformations,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> whereas BACE1 could accommodate the open conformation.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Thus, these conformational differences could make a large binding site available in BACE1 relative to that in BACE2, thereby offering the design strategy of fine-tuning the size of substituents occupying the two sites. At the outset of this work, pioneering work from Wyeth had identified a highly selective inhibitor <b>4</b> (<a class="ref internalNav" href="#cht2" aria-label="Chart 2">Chart 2</a>), where one of the ethyl groups engages with the flap (<a class="ref internalNav" href="#cht3" aria-label="Chart 3">Chart 3</a>).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> In parallel with our efforts, several pharmaceutical companies reported selective BACE1 inhibitors, such as compounds <b>5</b> (PF-6751979), <b>6</b>, and <b>7</b>, in patent and scientific literature,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> which appear to utilize the 10s loop or the flap to gain selectivity, given the crystal structures of the analogues bound to BACE1. Herein, we describe our medicinal chemistry efforts of exploring the next-generation BACE1 inhibitors with high selectivity over BACE2, starting from compound J (<b>8</b>) (<a class="ref internalNav" href="#cht3" aria-label="Chart 3">Chart 3</a>).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Leveraging the cocrystal structures of <b>4</b> and <b>8</b> led to a successful strategy of targeting the flap followed by incorporating spirocycles at the 5-position on the thiazine, culminating in the highly selective BACE1 inhibitors <b>21</b> and <b>22</b>. Comparative analysis of the cocrystal structures of <b>22</b> bound to BACE1 and BACE2 provided insight into the selectivity.</div><figure id="cht2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/medium/jm-2019-00309f_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0002.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. Representative Selective BACE1 Inhibitors</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00309&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="cht3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Chart 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/medium/jm-2019-00309f_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0003.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 3. Lead Compounds</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00309&amp;id=cht3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08167" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08167" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Inhibitor Design</h3><div class="NLM_p">As the first step of our efforts, we established the binding mode of compound <b>8</b> by soaking it with apo-BACE1 crystals to facilitate medicinal chemistry design.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a><a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A highlighted nonconserved residues around <b>8</b>, consisting of key residues of BACE1, such as Pro70, Gln12, and Arg128 located in the flap, 10s loop, and S2′ pocket, respectively. At the onset of this study, compound <b>4</b><a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> was known as a selective BACE1 inhibitor with a BACE1 selectivity of >227-fold in our FRET biochemical assay (BACE1 IC<sub>50</sub> = 44 nM, BACE2 IC<sub>50</sub> = >10 μM), though it suffered from suboptimal cellular potency (IC<sub>50</sub> = 138 nM; <a class="ref internalNav" href="#cht3" aria-label="Chart 3">Chart 3</a>). The significant selectivity was rationalized by the favorable interaction of the ethyl group on the pyridine with the flap.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Indeed, a difference in the conformation of the flap was observed between BACE1 and BACE2. As mentioned above, the flap in apo BACE1 tends to adopt an open conformation,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> whereas that in apo BACE2 favors a closed one.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Because one of the nonconserved residues in the flap in BACE1 is Pro70, replaced by Lys86 in BACE2, this proline residue may affect the flexibility.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Unlike the apo BACE1 structures, the crystal structure of <b>8</b> bound to BACE1 adopts a closed conformation in the flap (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B). Further analysis of the cocrystal structure of <b>8</b> suggested that introduction of substituents at the 5-position with the stereochemistry in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B on the thiazine ring could provide a favorable interaction with Tyr71 in the flap. Therefore, we reasoned that targeting the flap using the cellular potent lead <b>8</b> could improve selectivity while retaining cellular potency.</div><figure id="fig1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/medium/jm-2019-00309f_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0004.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Schematic representation of nonconserved residues between BACE1 and BACE2 including key interactions. (B) Crystal structure of <b>8</b> bound to a flap-closed form of BACE1. Substituents projecting from the 5-position to reach the flap.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00309&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The 10s loop also adopts distinct conformations between BACE1 and BACE2, providing a smaller S3 pocket in BACE2 than in BACE1.<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23,24)</a> Thus, utilizing this pocket offers another opportunity to design BACE1 selective inhibitors. Indeed, Hilpert et al. at Roche explored amide substituents in their oxazine series positioned in the S3 pocket.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Whereas incorporation of larger substituents at this position achieved increased selectivity, an enzyme-to-cell potency shift was observed in these compounds, resulting in suboptimal cellular activity.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> With this point in mind, we optimized the amide moiety in <b>8</b> interacting with the 10s loop in the S3 pocket, prior to exploring substituents at the 5-position.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Optimization of the Amide Substituent in <b>8</b></h3><div class="NLM_p">The optimization began with adjusting the size of the chloro group in <b>8</b> to strike a balance between potency and selectivity. Replacement of the chloro with a fluorine (<b>9</b>) reduced both BACE1 and BACE2 potency (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Compound <b>10</b> with a cyano group as a larger substituent had a similar potency to <b>8</b> and improved selectivity over BACE2 (6.6-fold). A variety of pyrazine analogues with different R groups (<b>11–14</b>) was then pursued. The difluoromethyl <b>11</b> displayed a higher BACE2 IC<sub>50</sub> value of 102 nM, although BACE1 potency was diminished as well. Compound <b>12</b>, possessing a methoxy group, imparted an increase in BACE1 potency, whereas the BACE2 activity was retained relative to the difluoro counterpart <b>11</b>, resulting in increased BACE1 selectivity. Introduction of a bulkier trifluoromethoxy group (<b>13</b>) retained BACE1 activity and, as expected, provided further improvement in selectivity (44-fold). However, as observed in the previous work at Roche,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> such modification caused an enzyme-to-cell shift, leading to a moderate cellular IC<sub>50</sub> of 13 nM. A balanced profile of BACE1 selectivity and cellular potency was seen when introducing a fluromethoxy group at the R position, leading to compound <b>14</b>. Although the selectivity of <b>14</b> was still moderate (16-fold), this compound served as a starting point to explore substituents at the 5-position on the thiazine ring targeting the flap.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Potency and Selectivity of the Amide Analogues</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/medium/jm-2019-00309f_0016.gif" alt="" id="GRAPHIC-d7e639-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/medium/jm-2019-00309f_0017.gif" alt="" id="gr16" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Values represent the mean values of at least two independent experiments.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Biochemical FRET assay.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">IC<sub>50</sub> determined by measuring the levels of secreted Aβ42 in a human neuroblastoma SKNBE2 cell line expressing the wild-type amyloid precursor protein (hAPP695) via a sandwich αlisa assay.</p></div></div><div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Initial Exploration of Substituents at the 5-Position of the Thiazine</h3><div class="NLM_p">As discussed above, the cocrystal structure of <b>8</b> in BACE1 prompted the introduction of substituents at the 5-position with the (<i>R</i>) configuration as shown in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B. Addition of a methoxy group provided compound <b>15</b>, which reduced BACE2 potency resulting in an improved selectivity of 30-fold relative to the nonsubstituted <b>14</b> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). The cocrystal structure of the initial lead <b>8</b> suggested that larger substituents, such a phenyl group with (<i>R</i>)-configuration (<b>16</b>), could not be accommodated because of steric hindrance from the flap. To confirm the steric constraint around this region, both (<i>R</i>)- and (<i>S</i>)-phenyl <b>16</b> and <b>17</b> were synthesized. Contrary to our expectation, compound <b>16</b> increased potency in both BACE1 and BACE2, leading to the same level of selectivity as <b>14</b>. The phenyl thiazine <b>17</b> with the opposite configuration had a comparable BACE1 potency to <b>14</b>, whereas selectivity was decreased because of slightly increased BACE2 activity relative to the (<i>R</i>)-phenyl <b>16</b>. To gain insight into this unexpected finding, the cocrystal structures of <b>16</b> and the diastereomer counterpart <b>17</b> bound to BACE1 were solved.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Initial Exploration of the 5-Substituted Thiazines</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/medium/jm-2019-00309f_0018.gif" alt="" id="GRAPHIC-d7e739-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/medium/jm-2019-00309f_0019.gif" alt="" id="gr17" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Values represent the mean values of at least two independent experiments.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Biochemical FRET assay.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">IC<sub>50</sub> determined by measuring the levels of secreted Aβ42 in a human neuroblastoma SKNBE2 cell line expressing the wild-type amyloid precursor protein (hAPP695) via a sandwich αlisa assay.</p></div></div><div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> X-ray Analysis of <b>16</b> and <b>17</b> Leading to the Design of Spiro-Thiazines</h3><div class="NLM_p">The crystal structure of <b>16</b> confirms that the flap adopts an open conformation, unlike that of <b>8</b> bound to BACE1 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A). The hydrogen bond between the flap residues Tyr71 and Trp76 is disrupted, thereby moving away the Tyr71 side chain to generate a new binding pocket that accommodates the phenyl group in <b>16</b>. In contrast, <b>17</b> complexed with BACE1 shows a pseudo flap-closed conformation where the side chain in Tyr71 has a good alignment with that of <b>8</b> bound to BACE1 (close conformation), though the hydrogen bond between Tyr71 and Trp76 is not present (a weak water-mediated hydrogen bond is observed), and the phenyl in <b>17</b> points toward the solvent region (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B), explaining why compound <b>17</b> exhibited slightly reduced potency in BACE1. We postulated that a similar change may have occurred in BACE2. Therefore, using the cocrystal structure of <b>16</b>, we looked for an alternative design of substituents at this position, where the analysis prompted us to incorporate spirocycles that could provide an optimal vector to the flap. Alternatively, replacement of the phenyl in <b>16</b> with bulkier substituents, such as saturated rings, was predicted to form favorable interactions with the flap to gain selectivity.</div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/medium/jm-2019-00309f_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0005.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Crystal structure of <b>16</b> bound to BACE1. (B) <b>17</b> bound to BACE1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00309&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Identification of Selective BACE1 Inhibitors <b>21</b> and <b>22</b></h3><div class="NLM_p">To test the design hypothesis, a saturated ring of a tetrahydro-2<i>H</i>-pyran (<b>18</b>) was introduced at the 5-position (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). The compound <b>18</b> showed a potency comparable to the phenyl-substituted <b>16</b> and improved selectivity over BACE2. To our delight, the corresponding spirocycle <b>19</b> provided a further gain in selectivity. The use of a smaller ring size, as in <b>20</b>, resulted in a decreased selectivity as expected, whereas compound <b>21</b> with a difluorocyclohexyl ring displayed significantly reduced BACE2 potency, achieving a 104-fold selectivity. Further gain in selectivity was realized when the difluoromethylene in <b>21</b> was replaced with a sulfonyl group. The sulfonyl compound <b>22</b> demonstrated a remarkable 550-fold selectivity in the FRET assay, although this change was associated with reduced cellular potency (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). This result was attributed to low lipophilicity (log <i>D</i> = 0.62), resulting in a poor permeability of 1.6 × 10<sup>–6</sup> cm/s (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). On the other hand, compounds <b>19</b> and <b>21</b> with good cellular potency displayed improved permeability (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Optimization of the 5-Substituted Thiazines</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/medium/jm-2019-00309f_0020.gif" alt="" id="GRAPHIC-d7e893-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/medium/jm-2019-00309f_0021.gif" alt="" id="gr18" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Values represent the mean values of at least two independent experiments.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">Biochemical FRET assay.</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">IC<sub>50</sub> determined by measuring the levels of secreted Aβ42 in a human neuroblastoma SKNBE2 cell line expressing the wild-type amyloid precursor protein (hAPP695) via a sandwich αlisa assay.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Binding Affinity, Metabolic Stability, P-gp Efflux, and Physicochemical Profiles of <b>19</b>, <b>21</b>, and <b>22</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="."><i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">BACE1</th><th class="colsep0 rowsep0" align="center" char=".">BACE2</th><th class="colsep0 rowsep0" align="center">binding selectivity (BACE2/BACE1)</th><th class="colsep0 rowsep0" align="center">HLM/MLM<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">P-gp ER<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char="."><i>P</i><sub>app</sub><a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char=".">log <i>D</i><a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="char" char=".">6.5</td><td class="colsep0 rowsep0" align="char" char=".">479</td><td class="colsep0 rowsep0" align="left">74×</td><td class="colsep0 rowsep0" align="left">51/5.0</td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">21</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="char" char=".">4.0</td><td class="colsep0 rowsep0" align="char" char=".">2000</td><td class="colsep0 rowsep0" align="left">500×</td><td class="colsep0 rowsep0" align="left">27/4.5</td><td class="colsep0 rowsep0" align="char" char=".">2.4</td><td class="colsep0 rowsep0" align="char" char=".">7.1</td><td class="colsep0 rowsep0" align="char" char=".">2.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="char" char=".">1.9</td><td class="colsep0 rowsep0" align="char" char=".">1740</td><td class="colsep0 rowsep0" align="left">916×</td><td class="colsep0 rowsep0" align="left">55/17</td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td><td class="colsep0 rowsep0" align="char" char=".">0.62</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">The binding affinity (<i>K</i><sub>i</sub>) was determined in a competitive radioligand binding assay using the tritiated nonselective BACE1/BACE 2 inhibitor [<sup>3</sup>H]-JNJ-962 (JNJ-962: BACE1 <i>K</i><sub>i</sub> = 0.69 nM, BACE2 <i>K</i><sub>i</sub> = 0.29 nM). Values represent the mean values of at least two determinations.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">% remaining after 30 min incubation with human liver (HLM) and mouse liver microsomes (MLM).</p></div><div class="footnote" id="t4fn3"><sup><sup>c</sup></sup><p class="last">ER measured in LLC-PK1 cells transfected with human MDR1.</p></div><div class="footnote" id="t4fn4"><sup><sup>d</sup></sup><p class="last">Permeability coefficient measured in LLC-PK1 cells (×10<sup>–6</sup> cm/s).</p></div><div class="footnote" id="t4fn5"><sup><sup>e</sup></sup><p class="last">log <i>D</i> determined in 1-octanol/phosphate buffer at pH 7.4.</p></div></div></div><div class="NLM_p">To further investigate the BACE1 selectivity over BACE2 observed in compounds <b>19</b>, <b>21</b>, and <b>22</b>, the binding affinities (<i>K</i><sub>i</sub>) to the respective enzymes were determined in a competitive radioligand binding assay using a tritiated nonselective BACE1/BACE2 inhibitor (JNJ-962),<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> which had high affinities for both BACE1 and BACE2 (BACE1 <i>K</i><sub>i</sub> = 0.69 nM, BACE2 <i>K</i><sub>i</sub> = 0.29 nM). As shown in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>, compound <b>19</b> had a binding selectivity of 74-fold, similar to the selectivity observed in the FRET assay. The spiro compounds <b>21</b> and <b>22</b> achieved a pronounced binding selectivity of 500-fold and 916-fold, respectively. On the basis of the outstanding selectivity observed for <b>21</b> and <b>22</b>, these compounds were profiled in mouse pharmacokinetics (PK) and pharmacodynamics (PD) models to investigate their effect on Aβ reduction in the brain.</div><div class="NLM_p last">Prior to the PK/PD study in mouse, metabolic stability and P-gp-mediated efflux were profiled including compound <b>19</b> (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Unfortunately, all the compounds exhibited poor metabolic stability in mouse (<20% remaining after 30 min incubation in microsomes), whereas they were more metabolically stable in human. A high P-gp efflux ratio (ER) of 20 was realized with the sulfonyl compound <b>22</b>, whereas <b>21</b>, possessing the difluoromethylene instead of the sulfonyl, showed improved P-gp efflux; the tetrahydropyran <b>19</b> also had a high P-gp efflux. This result indicated that polar substituents, such as sulfone and ether moieties, could be involved in an interaction with P-gp, resulting in increased P-gp efflux. Although increasing permeability is often a successful strategy for reducing P-gp efflux, it does not account for the P-gp ERs observed in these compounds.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Mouse PK/PD Study of <b>21</b> and <b>22</b></h3><div class="NLM_p">Considering the low metabolic stability observed for <b>21</b> and <b>22</b>, Male ICR (Crlj:CD) mice were orally administered a high dose of 30 mg/kg (<i>n</i> = 4), and the total Aβ levels were measured in the brain at 2, 4, and 6 h postdose. Unfortunately, no significant Aβ reduction was observed for the sulfonyl-substituted <b>22</b>. The poor efficacy was explained by the low brain levels at all the time points derived from its low permeability and high P-gp efflux, and consequently it exhibited a brain-to-plasma ratio (<i>K</i><sub>p</sub>) of 0.010. On the other hand, compound <b>21</b> with improved P-gp efflux and permeability demonstrated robust Aβ reduction at the same dose (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). Maximum total Aβ reduction of 61% was observed at 4 h postdose at a brain level of 626 ng/mL with an improved <i>K</i><sub>p</sub> of 0.55. The improved physicochemical properties and reduced P-gp efflux translated into the significantly improved brain levels, which led to the pronounced central activity.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/medium/jm-2019-00309f_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0006.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Reduction of total Aβ in the brain of male ICR mice (<i>n</i> = 4) after the oral administration of <b>21</b> as a solution of 20% 2-hydroxypropyl-β-cyclodextrin (HPBCD) at 30 mg/kg.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00309&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Crystal Structures of 22 Bound to BACE1 and BACE2</h3><div class="NLM_p">To gain insight into the pronounced BACE1 selectivity over BACE2 observed in <b>22</b>, the cocrystal structures of this compound bound to both the enzymes were determined (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Soaking of apo BACE1 crystals generated the <b>22</b>-bound BACE1 structure with a resolution of 2.6 Å. Like the <b>16</b>-bound BACE1 structure, the flap forms an open conformation, where the hydrogen bond interaction between the phenolic OH in Tyr71 and the indole NH in Trp76 is disrupted (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A). A slight movement of the flap over that in apo BACE1 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1w50">1w50</a>)<a onclick="showRef(event, 'cit24a'); return false;" href="javascript:void(0);" class="ref cit24a">(24a)</a> is observed with a distance of 1.5 Å based on the α carbon in Tyr71 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B), whereas no significant movement is seen between the <b>16</b>- and <b>22</b>-bound BACE1 structures. Unlike the <b>16</b>-bound BACE1 structure, the spirocyle in <b>22</b> interacts well with the side chain in Tyr71, confirming our design hypothesis.</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/medium/jm-2019-00309f_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0007.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Crystal structure of <b>22</b> bound to BACE1 and BACE2. (A) View of the flap region in the <b>22</b>-bound BACE1 structure. (B) Superposition of the flap in the <b>22</b>-bound BACE1 and apo BACE1 structures (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1w50">1w50</a>). The color in the flap indicates B-factors (blue: low B-factors; orange: high B-factors). (C) View of the flap region in the <b>22</b>-bound BACE2 structure. (D) Superposition of the flap in the <b>22</b>-bound BACE2 and apo BACE2 structures (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3zkg">3zkg</a>). The color means the same as B).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00309&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The binary complex of BACE2 and a crystallization helper of Xaperone XA4813 was cocrystallized with <b>22</b> with a resolution of 1.5 Å,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> according to a paper published from Roche.<a onclick="showRef(event, 'cit23b'); return false;" href="javascript:void(0);" class="ref cit23b">(23b)</a> As expected, the <b>22</b>-bound BACE2 structure displays a flap-open conformation, consistent with the corresponding BACE1 structure (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C). Notably, the binding of <b>22</b> to BACE2 causes a significant movement of the flap by 3.2 Å, relative to its position in an apo BACE2 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3zkg">3zkg</a>) (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>D).<a onclick="showRef(event, 'cit23b'); return false;" href="javascript:void(0);" class="ref cit23b">(23b)</a> Thus, a larger movement of the flap over the apo enzyme is confirmed in the BACE2 (3.2 Å vs 1.5 Å). More importantly, the difference in mean B-factors (temperature factor) between all of the complex and the flap of the <b>22</b>-bound BACE2 is up to 18.3 Å<sup>2</sup> (B-factor of the complex = 32.0 Å<sup>2</sup>; B-factor of the flap = 50.3 Å<sup>2</sup>), whereas in the <b>22</b>-bound BACE1, it falls to 2.0 Å<sup>2</sup> (B-factor of the complex = 45.9 Å<sup>2</sup>; B-factor of the flap = 47.9 Å<sup>2</sup>). This indicates that the <b>22</b>-bound BACE2 was destabilized relative to the <b>22</b>-bound BACE1, which may result in decreased potency in BACE2 but a retained BACE1 activity, providing an explanation for the increase in selectivity observed in compound <b>22</b>. We believe that these structural insights as well as the cocrystal structures of <b>22</b> bound to BACE1 and BACE2 could aid the design of novel selective BACE1 inhibitors targeting the flap.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61131" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61131" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The compounds <b>8–14</b> bearing various amide moieties were prepared from aniline intermediate <b>23</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). The aniline <b>23</b> and the carboxylic acids used for synthesis of <b>11</b>, <b>13</b>, and <b>14</b> were prepared according to known procedures.<a onclick="showRef(event, 'ref27 ref28 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref31 ref32">(27,28,31,32)</a> Amide formation was accomplished without protection of the amidine moiety by adding 1.0 equiv of HCl over <b>23</b>, furnishing the thiazines <b>8–14</b>.</div><figure id="sch1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/medium/jm-2019-00309f_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0008.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Thiazines <b>8–14</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00309&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) RCO<sub>2</sub>H, EDC·HCl, aq HCl, THF or MeOH, 0 or 0 °C to rt, 49–100%.</p></p></figure><div class="NLM_p">The synthesis of the methoxy thiazine <b>15</b> started with (<i>R</i>)-<i>tert</i>-butylsulfinylketimine <b>25</b>,<a onclick="showRef(event, 'cit27b ref33'); return false;" href="javascript:void(0);" class="ref cit27b ref33">(27b,33)</a> readily available from the corresponding ketone (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). The lithium enolate of methyl 2-methoxyacetate was transformed to the corresponding titanium enolate using ClTi(O<i>i</i>-Pr)<sub>3</sub>, which was reacted with the sulfinyl ketimine <b>25</b> to give the ester <b>26</b>.<a onclick="showRef(event, 'cit27c'); return false;" href="javascript:void(0);" class="ref cit27c">(27c)</a> The ester group in <b>26</b> was reduced to the corresponding alcohol with LiBH<sub>4</sub> followed by cleavage of the sulfineamide group and subsequent thiourea formation using benzoyl isothiocyanate (BzNCS) to yield the thiourea <b>27</b>. Thiazine cyclization was accomplished with Ghosez’s reagent<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> to give the thiazine <b>28</b>. Following deprotection of the benzoyl group in <b>28</b> with hydrazine monohydrate, thiazine <b>29</b> was nitrated with fuming nitric acid, and subsequent reduction of the nitro group and amide formation provided the desired thiazine <b>15</b>.</div><figure id="sch2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/medium/jm-2019-00309f_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0009.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Thiazine <b>15</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00309&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>n</i>-BuLi, diisopropylamine, methyl 2-methoxyacetate, ClTi(O<i>i</i>-Pr)<sub>3</sub>, THF, −78 °C, 72%; (b) (i) LiBH<sub>4</sub>, MeOH, THF, 0 °C, (ii) 4 M HCl in 1,4-dioxane, MeOH, rt, (iii) BzNCS, DCM, rt, 82% over 3 steps; (c) Ghosez’s reagent, DCM, rt, 90%; (d) hydrazine monohydrate, MeOH, THF, rt, 93%; (e) (i) HNO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>, TFA, −20 °C, (ii) Fe, NH<sub>4</sub>Cl, EtOH, toluene, H<sub>2</sub>O, 80 °C, (iii) 5-(fluoromethoxy)pyrazine-2-carboxylic acid, EDC·HCl, aq HCl, MeOH, 0 °C to rt, 58% over 3 steps.</p></p></figure><div class="NLM_p">As shown in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>, synthesis of thiazines <b>16</b> and <b>17</b> was achieved through a modified route to <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. Reaction of (<i>R</i>)-<i>tert</i>-butylsulfinylketimine <b>30</b><a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> and the titanium enolate of ethyl 2-phenylacetate yielded ester <b>31</b> as an inseparable 2:1 diastereomeric mixture. The <i>tert</i>-butylsulfinamide group in <b>31</b> was removed with HCl, and protection of the amine with the Boc group provided <b>32</b> and <b>33</b>, which were separable by silicagel column chromatography. The ester groups in <b>32</b> and <b>33</b> were reduced to the corresponding alcohols, followed by deprotection of the Boc groups and thiourea formation to afford <b>34</b> and <b>35</b>, respectively. Thiazine formation using Ghosez’s reagent<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> provided <b>36</b> and <b>37</b>, of which the benzoyl groups were deprotected, followed by introduction of an azide group with sodium azide and subsequent reduction of the azide group to provide the corresponding anilines. Finally, amide coupling of the anilines afforded the target compounds <b>16</b> and <b>17</b>. The absolute and relative configurations were assigned based on the crystal structures of <b>16</b> and <b>17</b> bound to BACE1.</div><figure id="sch3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/medium/jm-2019-00309f_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0010.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Thiazines <b>16</b> and <b>17</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00309&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>n</i>-BuLi, diisopropylamine, ethyl 2-phenylacetate, ClTi(O<i>i</i>-Pr)<sub>3</sub>, THF, −78 °C, 91%, dr = 2:1; (b) (i) 4 M HCl in 1,4-dioxane, MeOH, rt, (ii) Boc<sub>2</sub>O, MeOH, 60 °C, 57 and 28% over 2 steps; (c) (i) LiBH<sub>4</sub>, MeOH, THF, 0 °C, (ii) TFA, DCM, rt, (iii) BzNCS, DCM, rt, 78 and 87% over 3 steps; (d) Ghosez’s reagent, 0 °C to rt, 90 and 81%; (e) (i) DBU, MeOH, 60 °C, (ii) NaN<sub>3</sub>, CuI, <i>trans</i>-<i>N</i>,<i>N</i>′-dimethylcyclohexane-1,2-diamine, sodium <span class="smallcaps smallerCapital">l</span>-ascorbate, EtOH, H<sub>2</sub>O, 100 °C, (iii) Fe, NH<sub>4</sub>Cl, EtOH, H<sub>2</sub>O, THF, 60 °C or Fe, NH<sub>4</sub>Cl, EtOH, H<sub>2</sub>O, THF, 60 °C, (iv) 5-(fluoromethoxy)pyrazine-2-carboxylic acid, EDC·HCl, aq HCl, MeOH, 0 °C, 46 and 55% over 4 steps.</p></p></figure><div class="NLM_p">As shown in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>, tetrahydro-2<i>H</i>-pyran-substituted thiazine <b>18</b> was synthesized from the ketimine <b>25</b>. Reaction of <b>25</b> with ethyl 2-(tetrahydro-2<i>H</i>-pyran-4-yl)acetate yielded the ester <b>38</b> as an inseparable diasteromeric mixture. Cleavage of the sulfineamide group and subsequent Boc protection provided <b>39</b>. The ester group in <b>39</b> was reduced to the corresponding alcohol, of which the hydroxyl intramolecularly reacted with the Boc group to give carbamate <b>40</b>. The carbamate <b>40</b> was protected with a Boc group to give <b>41</b>. Ring opening of the carbamate <b>41</b> with K<sub>2</sub>CO<sub>2</sub> in MeOH, deprotection of the Boc group, and subsequent thioureation provided <b>42</b>. Thiazine formation of the thiourea <b>42</b> was accomplished with <i>N</i>,<i>N</i>-diethylaminosulfur trifluoride (DAST) to give <b>43</b>.<a onclick="showRef(event, 'cit27d'); return false;" href="javascript:void(0);" class="ref cit27d">(27d)</a> Boc protection of <b>43</b> allowed isolation of <b>44</b> and <b>45</b> as single isomers by silicagel column chromatography. Removal of the benzoyl group was conducted by hydrolysis using K<sub>2</sub>CO<sub>3</sub> in MeOH. The resulting Boc group was deprotected with TFA to afford <b>46</b>, which was converted into the target compound <b>18</b>, according to the established procedure as described in <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a> and <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. The stereochemistry of <b>18</b> was confirmed by NOESY correlations using the intermediates <b>44</b> and <b>45</b> (Figures S1 and S2, see <a href="/doi/suppl/10.1021/acs.jmedchem.9b00309/suppl_file/jm9b00309_si_001.pdf" class="ext-link">Supporting Information</a>).</div><figure id="sch4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/medium/jm-2019-00309f_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0011.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Thiazines <b>18</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00309&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>n</i>-BuLi, diisopropylamine, ethyl 2-(tetrahydro-2<i>H</i>-pyran-4-yl)acetate, ClTi(O<i>i</i>-Pr)<sub>3</sub>, THF, −78 °C, 43%, dr = 2.9:1; (b) (i) 4 M HCl in 1,4-dioxane, MeOH, rt, (ii) Boc<sub>2</sub>O, THF, 60 °C, 88% over 2 steps; (c) LiBH<sub>4</sub>, MeOH, THF, 50 °C, 24%; (d) Boc<sub>2</sub>O, DCM, THF, 60 °C, 73%; (e) (i) K<sub>2</sub>CO<sub>3</sub>, MeOH, rt, (ii) TFA, DCM, rt, (iii) BzNCS, DCM, rt, 49% over 3 steps; (f) DAST, DCM, 0 °C, 73%; (g) Boc<sub>2</sub>O, THF, rt, 47 and 26%; (h) (i) K<sub>2</sub>CO<sub>3</sub>, MeOH, rt, (ii) TFA, DCM, rt, 91% over 2 steps; (i) (i) HNO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>, TFA, −20 °C, (ii) Fe, NH<sub>4</sub>Cl, toluene, H<sub>2</sub>O, 80 °C, 74% over 2 steps; (j) 5-(fluoromethoxy)pyrazine-2-carboxylic acid, EDC·HCl, aq HCl, MeOH, rt, 76%.</p></p></figure><div class="NLM_p">The synthesis of thiazine <b>19</b> started with sulfinyl ketimine <b>25</b> (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>). Addition of the titanium enolate of ethyl tetrahydro-2<i>H</i>-pyran-4-carboxylate to the ketimine <b>25</b>, cleavage of the sulfinaminde, and subsequent Boc protection afforded <b>49</b>. The subsequent steps to the target <b>19</b> were conducted according to the procedures described in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. Similar to the syntheses of compounds <b>18</b> and <b>19</b>, the spiro thiazines <b>20</b> and <b>21</b> were synthesized according to <a class="ref internalNav" href="#sch4" aria-label="Schemes 4">Schemes 4</a> and <a class="ref internalNav" href="#sch5" aria-label="5">5</a> as shown in <a class="ref internalNav" href="#sch6" aria-label="Schemes 6">Schemes 6</a> and <a class="ref internalNav" href="#sch7" aria-label="7">7</a>, respectively.</div><figure id="sch5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/medium/jm-2019-00309f_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0012.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Thiazines <b>19</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00309&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>n</i>-BuLi, diisopropylamine, ethyl tetrahydro-2<i>H</i>-pyran-4-carboxylate, ClTi(O<i>i</i>-Pr)<sub>3</sub>, THF, −78 °C, 75%; (b) (i) 4 M HCl in 1,4-dioxane, MeOH, rt, (ii) Boc<sub>2</sub>O, MeOH, 60 °C, quant. over 2 steps; (c) LiBH<sub>4</sub>, MeOH, THF, 50 °C, 70%; (d) Boc<sub>2</sub>O, DMAP, THF, 50 °C, 84%; (e) (i) K<sub>2</sub>CO<sub>3</sub>, MeOH, rt, (ii) TFA, DCM, rt, (iii) BzNCS, DCM, 0 °C to rt, 74% over 3 steps; (f) DAST, DCM, 0 °C, 57%; (g) hydrazine monohydrate, MeOH, THF, rt, 71%; (h) (i) HNO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>, TFA, −20 to 0 °C, (ii) Fe, NH<sub>4</sub>Cl, toluene, H<sub>2</sub>O, 80 °C, 78% over 2 steps; (i) 5-(fluoromethoxy)pyrazine-2-carboxylic acid, EDC·HCl, aq HCl, MeOH, 0 °C to rt, 81%.</p></p></figure><figure id="sch6" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/medium/jm-2019-00309f_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0013.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Thiazine <b>20</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00309&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>n</i>-BuLi, diisopropylamine, methyl 3,3-difluorocyclobutane-1-carboxylate, ClTi(O<i>i</i>-Pr)<sub>3</sub>, THF, −78 °C, 39%; (b) (i) LiBH<sub>4</sub>, MeOH, THF, 0 °C, (ii) 4 M HCl in 1,4-dioxane, MeOH, rt, (iii) BzNCS, DCM, rt, (iv) Ghosez’s reagent, DCM, rt, 68% over 4 steps; (c) hydrazine monohydrate, MeOH, THF, rt, 96%; (d) (i) HNO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>, TFA, −20 °C to rt, (ii) Boc<sub>2</sub>O, DMAP, THF, rt, 97% over 2 steps; (e) Fe, NH<sub>4</sub>Cl, EtOH, toluene, H<sub>2</sub>O, 60 °C, 79%; (f) (i) 5-(fluoromethoxy)pyrazine-2-carboxylic acid, HATU, <i>N</i>,<i>N</i>-diisopropylethylamine, MeOH, rt, 83%, (ii) TFA, DCM, rt, 93%.</p></p></figure><figure id="sch7" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/medium/jm-2019-00309f_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0014.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of Thiazine <b>21</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00309&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>n</i>-BuLi, diisopropylamine, benzyl 4,4-difluorocyclohexane-1-carboxylate, ClTi(O<i>i</i>-Pr)<sub>3</sub>, THF, −78 °C, 21%; (b) (i) 4 M HCl in 1,4-dioxane, MeOH, rt, (ii) Boc<sub>2</sub>O, MeOH, 60 °C, 88% over 2 steps; (c) (i) LiBH<sub>4</sub>, MeOH, THF, 0 to 40 °C, (ii) 4 M HCl in 1,4-dioxane, rt, (iii) BzNCS, DCM, 0 °C to rt, 54% over 3 steps; (d) DAST, DCM, 0 °C, 61%; (e) hydrazine hydrate, MeOH/THF, 50 °C, 73%; (f) (i) HNO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>, TFA, −15 °C, (ii) Fe, NH<sub>4</sub>Cl, EtOH, toluene, H<sub>2</sub>O, 80 °C, (iii) 5-(fluoromethoxy)pyrazine-2-carboxylic acid, EDC·HCl, aq HCl, MeOH, 0 °C to rt, 55% over 3 steps.</p></p></figure><div class="NLM_p"><a class="ref internalNav" href="#sch8" aria-label="Scheme 8">Scheme 8</a> describes the synthesis of the spiro thiazine <b>22</b> starting from the ketimine <b>25</b>. Like the other thiazines described above, the titanium enolate prepared from ethyl tetrahydro-2<i>H</i>-thiopyran-4-carboxylate reacted with <b>25</b> to afford ester <b>66</b>. Conversion of the ester <b>66</b> to the thiazine <b>70</b> was conducted via a similar reaction sequence as described in <a class="ref internalNav" href="#sch4" aria-label="Schemes 4">Schemes 4</a>–<a class="ref internalNav" href="#sch7" aria-label="7">7</a>. The thiazine <b>70</b> was oxidized with <i>m</i>-CPBA to give <b>71</b>. Sulfone <b>71</b> was nitrated with fuming nitric acid followed by reduction of the nitro group and amide formation to provide the desired spiro thiazine <b>22</b>.</div><figure id="sch8" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/medium/jm-2019-00309f_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0015.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthesis of Spiro-Thiazine <b>22</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00309&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>n</i>-BuLi, diisopropylamine, methyl tetrahydro-2<i>H</i>-thiopyran-4-carboxylate, ClTi(O<i>i</i>-Pr)<sub>3</sub>, THF, −78 °C, 59%; (b) (i) 4 M HCl in 1,4-dioxane, MeOH, rt, (ii) Boc<sub>2</sub>O, MeOH, 50 °C, 94% over 2 steps; (c) LiBH<sub>4</sub>, MeOH/THF, 0 to 50 °C, 48%; (d) (i) TFA, DCM, rt, (ii) BzNCS, DCM, rt, 70% over 2 steps; (e) (i) DAST, DCM, rt, (ii) hydrazine monohydrate, MeOH, THF, 40 °C, 16% over 2 steps; (f) <i>m</i>-CPBA, DCM, 0 °C, 90%; (g) (i) HNO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>, TFA, −10 to 0 °C, (ii) Fe, NH<sub>4</sub>Cl, toluene, H<sub>2</sub>O, 80 °C, 77% over 2 steps; (h) 5-(fluoromethoxy)pyrazine-2-carboxylic acid, EDC·HCl, aq HCl, MeOH, 0 °C to rt, 66%.</p></p></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65180" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65180" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Utilizing structure-based drug design, a unique thiazine-based selective BACE1 inhibitor was discovered starting with <b>8</b>. It possessed a biochemical BACE1/2 selectivity of 1.9-fold, leading to the discovery of the spirocycle-based inhibitors <b>21</b> and <b>22</b> with more than 100- and 500-fold selectivity over BACE2 in the biochemical and the binding assays, respectively. This improved selectivity was rationalized by interaction of the spirocycle with the flap, where BACE1 was likely to accommodate larger substituents than BACE2 due to the difference in conformational flexibility. The cocrystal structures of <b>22</b> bound to both the enzymes confirmed a higher energetic penalty, as indicated by the B-factors, around the flap in the <b>22</b>-bound BACE2 structure than that in BACE1, resulting in loss of BACE2 potency and thereby increased selectivity. The structural insights, the high-resolution inhibitor-bound structures, and the selective BACE1 inhibitors, such as <b>21</b> and <b>22</b>, should aid structure-based discovery of novel selective BACE1 inhibitors, which eventually could lead to a next generation of safer BACE1 inhibitors.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i28">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28106" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28106" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> General Chemistry</h3><div class="NLM_p last">All commercial chemicals were used as received. Column chromatography was carried out on an automated purification system using Fuji Silysia or Yamazen prepacked silica gel columns. <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra were recorded on Bruker ADVANCE 400 and 100 MHz, respectively. Spectral data are reported as follows: chemical shift (as ppm referenced to tetramethylsilane), integration value, multiplicity (s = singlet, d = doublet, dd = double doublet, ddd = double double doublet, dt = double triplet, t = triplet, q = quartet, m = multiplet, and br = broad peak), and coupling constant. Analytical LC/MS was performed on a Shimadzu UFLC system coupled with a LCMS-2020 mass spectrometer, SPD-M20A photodiode array detector (detection at 254 nm), LC-20AD binary gradient module, and SIL-20AC sample manager, which was operated on a Shimadzu Shim-pack XR-ODS column (C<sub>18</sub>, 2.2 μm, 3.0 × 50 mm) with a linear gradient from 10 to 100% B over 3 min and then 100% B for 1 min (A = H<sub>2</sub>O + 0.1% formic acid, B = MeCN + 0.1% formic acid) at a flow rate of 1.6 mL/min. Purities of all final compounds were determined to be greater than 95%. High-resolution mass spectra were recorded on Thermo Fisher Scientific LTQ Orbitrap with electrospray ionization.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> General Procedure for Condensation with Carboxylic Acids</h3><div class="NLM_p last">To a solution of aniline (1.0 equiv), carboxylic acid (1.0–1.05 equiv), and HCl (2 M in water, 1.0 equiv) in MeOH was added EDC·HCl (1.1 equiv) at 0 °C (or room temperature). The mixture was stirred at room temperature for 1 h and treated with aqueous NaHCO<sub>3</sub> solution. The aqueous layer was separated and extracted with EtOAc. The combined organic layers were washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated. The residue was purified by flash column chromatography and/or crystallization to obtain the target compound.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> (<i>S</i>)-<i>N</i>-(3-(2-Amino-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-4-yl)-4-fluorophenyl)-5-chloropicolinamide (<b>8</b>)</h3><div class="NLM_p last">Compound <b>8</b> was prepared from <b>23</b> (150 mg, 0.627 mmol) according to the general procedure (220 mg, 92%). White solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.80 (1H, s), 8.56 (1H, d, <i>J</i> = 2.4 Hz), 8.24 (1H, d, <i>J</i> = 8.4 Hz), 8.00 (1H, ddd, <i>J</i> = 8.8, 4.0, 2.8 Hz), 7.87 (1H, dd, <i>J</i> = 8.4, 2.4 Hz), 7.41 (1H, dd, <i>J</i> = 7.0, 2.8 Hz), 7.06 (1H, dd, <i>J</i> = 11.7, 8.8 Hz), 4.46 (2H, br s), 2.98 (1H, ddd, <i>J</i> = 12.2, 6.7, 3.6 Hz), 2.74 (1H, ddd, <i>J</i> = 12.2, 10.4, 3.6 Hz), 2.43 (1H, ddd, <i>J</i> = 14.0, 6.7, 3.6 Hz), 1.94 (1H, ddd, <i>J</i> = 14.0, 10.4, 3.6 Hz), 1.63 (3H, d, <i>J</i> = 1.0). MS-ESI (<i>m</i>/<i>z</i>): 379 [M + H]<sup>+</sup>.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> (<i>S</i>)-<i>N</i>-(3-(2-Amino-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-4-yl)-4-fluorophenyl)-5-fluoropicolinamide (<b>9</b>)</h3><div class="NLM_p last">Compound <b>9</b> was prepared from <b>23</b> (50.0 mg, 0.209 mmol) according to the general procedure (37.2 mg, 49%). White solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.78 (1H, s), 8.46 (1H, d, <i>J</i> = 2.6 Hz), 8.33 (1H, dd, <i>J</i> = 8.6, 4.6 Hz), 8.01–7.97 (1H, m), 7.59 (1H, td, <i>J</i> = 8.4, 2.6 Hz), 7.40 (1H, dd, <i>J</i> = 6.9, 2.8 Hz), 7.06 (1H, dd, <i>J</i> = 11.6, 8.7 Hz), 2.98 (1H, ddd, <i>J</i> = 11.5, 6.7, 3.9 Hz), 2.78–2.71 (1H, m), 2.49–2.43 (1H, m), 1.94 (1H, ddd, <i>J</i> = 14.2, 10.8, 3.8 Hz), 1.64 (3H, s). MS-ESI (<i>m</i>/<i>z</i>): 363 [M + H]<sup>+</sup>.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> (<i>S</i>)-<i>N</i>-(3-(2-Amino-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-4-yl)-4-fluorophenyl)-5-cyanopicolinamide (<b>10</b>)</h3><div class="NLM_p last">Compound <b>10</b> was prepared from <b>23</b> (130 mg, 0.543 mmol) according to the general procedure (202 mg, quant.). White solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.83 (1H, s), 8.89 (1H, d, <i>J</i> = 2.0 Hz), 8.43 (1H, d, <i>J</i> = 8.2 Hz), 8.20 (1H, dd, <i>J</i> = 8.2, 2.0 Hz), 7.99 (1H, ddd, <i>J</i> = 8.8, 4.0, 2.8 Hz), 7.45 (1H, dd, <i>J</i> = 7.0, 2.8 Hz), 7.08 (1H, dd, <i>J</i> = 11.5, 8.8 Hz), 4.47 (2H, br s), 2.99 (1H, ddd, <i>J</i> = 12.2, 6.8, 3.6 Hz), 2.74 (1H, ddd, <i>J</i> = 12.2, 10.4, 3.6 Hz), 2.42 (1H, ddd, <i>J</i> = 14.0, 6.8, 3.6 Hz), 1.95 (1H, ddd, <i>J</i> = 14.0, 10.4, 3.6 Hz), 1.63 (3H, d, <i>J</i> = 1.1). MS-ESI (<i>m</i>/<i>z</i>): 370 [M + H]<sup>+</sup>.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> (<i>S</i>)-<i>N</i>-(3-(2-Amino-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-4-yl)-4-fluorophenyl)-5-(difluoromethyl)pyrazine-2-carboxamide (<b>11</b>)</h3><div class="NLM_p last">Compound <b>11</b> was prepared from <b>23</b> (51.0 mg, 0.213 mmol) according to the general procedure (63.8 mg, 78%). Pale yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.64 (1H, br s), 9.53 (1H, s), 8.93 (1H, s), 8.00 (1H, ddd, <i>J</i> = 8.8, 3.9, 2.8 Hz), 7.44 (1H, dd, <i>J</i> = 6.8, 2.8 Hz), 7.09 (1H, dd, <i>J</i> = 11.5, 8.8 Hz), 6.79 (1H, t, <i>J</i> = 54.5 Hz), 3.00 (1H, ddd, <i>J</i> = 12.2, 6.7, 3.5 Hz), 2.75 (1H, ddd, <i>J</i> = 12.2, 10.4, 3.5 Hz), 2.44 (1H, ddd, <i>J</i> = 14.0, 6.7, 3.5 Hz), 1.96 (1H, ddd, <i>J</i> = 14.0, 10.4, 3.5 Hz), 1.66 (3H, s). MS-ESI (<i>m</i>/<i>z</i>): 396 [M + H]<sup>+</sup>.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> (<i>S</i>)-<i>N</i>-(3-(2-Amino-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-4-yl)-4-fluorophenyl)-5-methoxypyrazine-2-carboxamide (<b>12</b>)</h3><div class="NLM_p last">Compound <b>12</b> was prepared from <b>23</b> (130 mg, 0.543 mmol) according to the general procedure (190 mg, 93%). White solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.48 (1H, s), 9.01 (1H, d, <i>J</i> = 1.3 Hz), 8.15 (1H, d, <i>J</i> = 1.3 Hz), 7.99 (1H, ddd, <i>J</i> = 8.9, 3.9, 2.8 Hz), 7.37 (1H, dd, <i>J</i> = 7.0, 2.8 Hz), 7.05 (1H, dd, <i>J</i> = 11.7, 8.9 Hz), 4.44 (2H, br s), 4.07 (3H, s), 2.98 (1H, ddd, <i>J</i> = 12.2, 6.6, 3.7 Hz), 2.74 (1H, ddd, <i>J</i> = 12.2, 10.4, 3.5 Hz), 2.43 (1H, ddd, <i>J</i> = 13.9, 6.6, 3.5 Hz), 1.93 (1H, ddd, <i>J</i> = 13.9, 10.4, 3.7 Hz), 1.62 (3H, d, <i>J</i> = 0.9 Hz). MS-ESI (<i>m</i>/<i>z</i>): 376 [M + H]<sup>+</sup>.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> (<i>S</i>)-<i>N</i>-(3-(2-Amino-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-4-yl)-4-fluorophenyl)-5-(2,2,2-trifluoroethoxy)pyrazine-2-carboxamide (<b>13</b>)</h3><div class="NLM_p last">Compound <b>13</b> was prepared from <b>23</b> according to the general procedure (76.0 mg, 86%). White solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.47 (1H, s), 9.02 (1H, d, <i>J</i> = 1.3 Hz), 8.31 (1H, d, <i>J</i> = 1.3 Hz), 7.98 (1H, ddd, <i>J</i> = 8.7, 3.9, 2.9 Hz), 7.40 (1H, dd, <i>J</i> = 7.0, 2.8 Hz), 7.06 (1H, dd, <i>J</i> = 11.6, 8.7 Hz), 4.86 (2H, q, <i>J</i> = 8.2 Hz), 2.99 (1H, ddd, <i>J</i> = 12.2, 6.6, 3.7 Hz), 2.75 (1H, ddd, <i>J</i> = 12.2, 10.5, 3.5 Hz), 2.43 (1H, ddd, <i>J</i> = 14.0, 6.6, 3.4 Hz), 1.95 (1H, ddd, <i>J</i> = 14.0, 10.5, 3.7 Hz), 1.63 (3H, d, <i>J</i> = 1.0 Hz). MS-ESI (<i>m</i>/<i>z</i>): 444 [M + H]<sup>+</sup>.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> (<i>S</i>)-<i>N</i>-(3-(2-Amino-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-4-yl)-4-fluorophenyl)-5-(fluoromethoxy)pyrazine-2-carboxamide (<b>14</b>)</h3><div class="NLM_p last">Compound <b>14</b> was prepared from <b>23</b> (150 mg, 0.627 mmol) according to the general procedure (219 mg, 89%). White solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.47 (1H, s), 9.08 (1H, d, <i>J</i> = 1.2 Hz), 8.28 (1H, d, <i>J</i> = 1.2 Hz), 7.99 (1H, ddd, <i>J</i> = 8.7, 3.9, 2.9 Hz), 7.39 (1H, dd, <i>J</i> = 7.0, 2.9 Hz), 7.06 (1H, dd, <i>J</i> = 11.7, 8.7 Hz), 6.22–6.08 (2H, m), 4.46 (2H, s), 2.98 (1H, ddd, <i>J</i> = 12.2, 6.7, 3.7 Hz), 2.74 (1H, ddd, <i>J</i> = 12.2, 10.5, 3.5 Hz), 2.42 (1H, ddd, <i>J</i> = 13.9, 6.7, 3.5 Hz), 1.94 (1H, ddd, <i>J</i> = 13.9, 10.5, 3.7 Hz), 1.63 (3H, d, <i>J</i> = 0.9 Hz). MS-ESI (<i>m</i>/<i>z</i>): 394 [M + H]<sup>+</sup>.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> <i>N</i>-(3-((4<i>S</i>,5<i>R</i>)-2-Amino-4-methyl-5-phenyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-4-yl)-4-fluorophenyl)-5-(fluoromethoxy)pyrazine-2-carboxamide (<b>16</b>)</h3><div class="NLM_p last">A mixture of <b>36</b> (267 mg, 0.553 mmol) and DBU (83.0 μL, 0.553 mmol) in MeOH (8.0 mL) was stirred at 60 °C for 6 h. The mixture was cooled to room temperature and treated with HCl solution (2 M in water). The mixture was diluted with Et<sub>2</sub>O, and the organic layers were back extracted with H<sub>2</sub>O. The aqueous layer was basified with K<sub>2</sub>CO<sub>3</sub> and extracted with EtOAc. The organic layers were washed with water and concentrated to give the crude compound (201 mg) as a colorless oil. A mixture of this crude compound (108 mg), CuI (10.8 mg, 0.057 mmol), <i>trans</i>-<i>N</i>,<i>N</i>′-dimethylcyclohexane-1,2-diamine (13.5 μL, 0.085 mmol), NaN<sub>3</sub> (74.0 mg, 1.14 mmol), and sodium <span class="smallcaps smallerCapital">l</span>-ascorbate (5.64 mg, 0.0280 mmol) in EtOH and H<sub>2</sub>O (1.5 mL/0.5 mL) was stirred at 100 °C for 1.5 h. The reaction mixture was quenched with water, and the aqueous layer was extracted with EtOAc. The organic layers were washed with water and evaporated to give the crude compound (77.4 mg) as an orange amorphous substance. A suspension of this crude compound, Fe (101 mg, 1.84 mmol), and NH<sub>4</sub>Cl (146 mg, 2.72 mmol) in EtOH/THF/H<sub>2</sub>O (1.0 mL/0.5 mL/0.5 mL) was stirred at 60 °C for 1.5 h. The mixture was cooled to room temperature, diluted with aqueous K<sub>2</sub>CO<sub>3</sub> solution, and filtered through Celite. The aqueous layer was extracted with EtOAc. The organic layers were washed with water and concentrated to give the crude compound (63.4 mg) as a white amorphous substance. This crude compound was subjected to the amide-coupling reaction conditions according to the general procedure outlined above to give <b>16</b> (35.9 mg, 46% over 4 steps) as a tan solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.43 (1H, br s), 9.08 (1H, d, <i>J</i> = 1.3 Hz), 8.29 (1H, d, <i>J</i> = 1.3 Hz), 7.92–7.88 (1H, m), 7.32 (1H, dd, <i>J</i> = 6.9, 2.6 Hz), 7.25–7.22 (3H, m), 7.18–7.16 (2H, m), 7.02 (1H, dd, <i>J</i> = 11.7, 8.7 Hz), 6.15 (2H, d, <i>J</i> = 51.1 Hz), 3.64 (1H, dd, <i>J</i> = 7.1, 4.5 Hz), 3.30 (1H, dd, <i>J</i> = 12.3, 7.1 Hz), 3.11 (1H, dd, <i>J</i> = 12.3, 4.5 Hz), 1.56 (3H, d, <i>J</i> = 1.6 Hz). MS-ESI (<i>m</i>/<i>z</i>): 470 [M + H]<sup>+</sup>.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> <i>N</i>-(3-((4<i>S</i>,5<i>S</i>)-2-Amino-4-methyl-5-phenyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-4-yl)-4-fluorophenyl)-5-(fluoromethoxy)pyrazine-2-carboxamide (<b>17</b>)</h3><div class="NLM_p last">A mixture of <b>37</b> (179 mg, 0.371 mmol) and DBU (55.9 μL, 0.371 mmol) in MeOH (5.4 mL) was stirred at 60 °C for 11 h. The mixture was cooled to room temperature and treated with HCl solution (2 M in water). The mixture was diluted with Et<sub>2</sub>O, and the organic layers were back extracted with H<sub>2</sub>O. The aqueous layer was basified with K<sub>2</sub>CO<sub>3</sub>, and the aqueous layer was extracted with EtOAc. The organic layers were washed with water and concentrated to give the crude compound (137 mg) as a white amorphous substance. A mixture of this crude compound, CuI (13.8 mg, 0.072 mmol), <i>trans</i>-<i>N</i>,<i>N</i>′-dimethylcyclohexane-1,2-diamine (17.1 μL, 0.108 mmol), NaN<sub>3</sub> (94.0 mg, 1.45 mmol), and sodium <span class="smallcaps smallerCapital">l</span>-ascorbate (7.16 mg, 0.0360 mmol) in EtOH/H<sub>2</sub>O (1.9 mL/0.7 mL) was stirred at 100 °C for 2 h. The reaction mixture was quenched with water, and the aqueous layer was extracted with EtOAc. The organic layers were washed with water and evaporated to give the crude compound (109 mg) as a tan amorphous substance. A suspension of this crude compound, Fe (143 mg, 2.56 mmol), and NH<sub>4</sub>Cl (205 mg, 3.84 mmol) in EtOH/H<sub>2</sub>O (1.5 mL/0.8 mL) was stirred at 60 °C for 5 h. The mixture was cooled to room temperature and diluted with aqueous K<sub>2</sub>CO<sub>3</sub> solution and filtered through Celite. The aqueous layer was extracted with EtOAc. The organic layers were washed with water and concentrated to give the crude compound (95.5 mg) as a tan solid. This crude compound was subjected to the amide-coupling reaction conditions, according to the general procedure outlined above to give <b>17</b> (52.8 mg, 55% over 4 steps) as a tan solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.37 (1H, br s), 9.05 (1H, s), 8.27 (1H, s), 7.91–7.88 (1H, m), 7.59–7.56 (1H, m), 7.06–7.04 (5H, m), 6.92–6.87 (1H, m), 6.14 (3H, d, <i>J</i> = 51.2 Hz), 4.50 (2H, br s), 3.78–3.72 (2H, m), 3.14–3.11 (1H, m), 1.71 (3H, s). MS-ESI (<i>m</i>/<i>z</i>): 470 [M + H]<sup>+</sup>.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> (<i>R</i>)-<i>N</i>-(3-(3-Amino-5-methyl-9,9-dioxido-2,9-dithia-4-azaspiro[5.5]undec-3-en-5-yl)-4-fluorophenyl)-5-(fluoromethoxy)pyrazine-2-carboxamide (<b>22</b>)</h3><div class="NLM_p last">Compound <b>22</b> was prepared from <b>72</b> (48.6 mg, 0.136 mmol) according to the general procedure (45.8 mg, 66%). Pale yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.48 (1H, s), 9.09 (1H, d, <i>J</i> = 1.3 Hz), 8.30 (1H, d, <i>J</i> = 1.3 Hz), 7.77–7.71 (2H, m), 7.06 (1H, dd, <i>J</i> = 12.2, 8.8 Hz), 6.15 (2H, d, <i>J</i> = 51.1 Hz), 3.16 (1H, d, <i>J</i> = 13.4 Hz), 3.07–2.89 (5H, m), 2.38–2.30 (1H, m), 2.24–2.15 (2H, m), 1.94–1.90 (1H, m), 1.73 (3H, d, <i>J</i> = 4.5 Hz). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 160.4, 159.4 (d, <i>J</i> = 2.9 Hz), 157.1 (d, <i>J</i> = 245.8 Hz), 148.4, 141.8, 139.7, 133.2, 133.2 (d, <i>J</i> = 2.9 Hz), 130.9 (d, <i>J</i> = 12.5 Hz), 123.7, 121.1 (d, <i>J</i> = 8.8 Hz), 117.3 (d, <i>J</i> = 27.8 Hz), 95.8 (d, <i>J</i> = 223.7 Hz), 63.1, 47.3, 47.2, 33.3, 29.1 (d, <i>J</i> = 3.7 Hz), 27.2, 26.9, 24.0. HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>24</sub>O<sub>4</sub>N<sub>5</sub>F<sub>2</sub>S<sub>2</sub><sup>+</sup>, 512.1232; found, 512.1231.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Ethyl (3<i>S</i>)-3-(5-Bromo-2-fluorophenyl)-3-(((<i>R</i>)-<i>tert</i>-butylsulfinyl)amino)-2-phenylbutanoate (<b>31</b>)</h3><div class="NLM_p last">To a solution of diisopropylamine (2.40 mL, 17.1 mmol) in THF (16 mL) was added dropwise <i>n</i>-BuLi (1.54 M in hexane; 10.5 mL, 16.2 mmol) at −78 °C. The mixture was allowed to warm to 0 °C and stirred at the same temperature for 20 min. The mixture was again cooled to −78 °C, and a solution of ethyl 2-phenylacetate (2.00 g, 12.2 mmol) in THF (7.8 mL) was added dropwise to the mixture. After being stirred at the same temperature for 40 min, a solution of ClTi(O<i>i</i>-Pr)<sub>3</sub> (4.08 mL, 17.1 mmol) in THF (7.8 mL) was added dropwise at −78 °C. The mixture was stirred at the same temperature for 10 min, and then <b>30</b> (1.30 g, 4.06 mmol) in THF (7.8 mL) was added dropwise. After being stirred for 15 min, the mixture was quenched with aqueous NH<sub>4</sub>Cl solution. The resulting mixture was filtered through Celite and evaporated. The residue was purified by flash column chromatography (silica gel; EtOAc/hexane, gradient: 10–40% EtOAc) to give <b>31</b> (1.78 g, 91%) as a yellow oil. 1.7:1 diastereomeric mixture. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.41–7.34 (2H, m), 7.31–7.20 (4H, m), 7.09–7.06 (1H, m), 6.97–6.90 (1H, m), 5.29 (1H, s), 4.46 (1H, d, <i>J</i> = 1.1 Hz), 4.18–4.02 (2H, m), 1.87 (3H, s), 1.27 (9H, s), 1.13 (3H, t, <i>J</i> = 7.1 Hz).</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Ethyl (2<i>R</i>,3<i>S</i>)-3-(5-Bromo-2-fluorophenyl)-3-((<i>tert</i>-butoxycarbonyl)amino)-2-phenylbutanoate (32) and Ethyl (2<i>S</i>,3<i>S</i>)-3-(5-bromo-2-fluorophenyl)-3-((<i>tert</i>-butoxycarbonyl)amino)-2-phenylbutanoate (<b>33</b>)</h3><div class="NLM_p last">A mixture of <b>31</b> (900 mg, 1.86 mmol) and HCl (4 M in 1,4-dioxane; 697 μL, 2.79 mmol) in MeOH (18 mL) was stirred at room temperature for 1 h. The mixture was diluted with Et<sub>2</sub>O, and then the organic layers were back extracted with H<sub>2</sub>O. The aqueous layer was basified with K<sub>2</sub>CO<sub>3</sub>, which was extracted with EtOAc. The organic layers were washed with water and concentrated to give the crude compound (689 mg) as a colorless oil with a diastereomeric ratio of 2:1. A mixture of this crude compound and Boc<sub>2</sub>O (2.11 mL, 9.08 mmol) was stirred at 60 °C for 6 h. The mixture was cooled to room temperature, and then 1-methylpiperazine (805 μL, 7.26 mmol) was added to this mixture. The resulting mixture was evaporated, and the residue was purified by flash column chromatography (silica gel; 10% EtOAc in hexane) to give <b>32</b> (507 mg, 57% over 2 steps) as a white amorphous substance and <b>33</b> (252 mg, 28 over 2 steps) as a white amorphous substance. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>; major isomer): δ 7.49–7.46 (2H, m), 7.38–7.34 (5H, m), 6.95 (1H, dd, <i>J</i> = 11.3, 8.4 Hz), 6.86 (1H, br s), 4.15 (1H, s), 4.03–3.95 (1H, m), 3.86–3.78 (1H, m), 1.75 (3H, d, <i>J</i> = 2.1 Hz), 1.45 (9H, br s), 0.92 (3H, t, <i>J</i> = 7.1 Hz). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>; minor isomer): δ 7.26–7.20 (4H, m), 7.13–7.11 (2H, m), 7.02 (1H, br s), 6.87 (1H, dd, <i>J</i> = 12.0, 8.7 Hz), 6.12 (1H, br s), 4.22–4.15 (1H, m), 4.11 (1H, s), 4.07–4.01 (1H, m), 1.99 (3H, br s), 1.38 (9H, br s), 1.18 (3H, t, <i>J</i> = 6.8 Hz).</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> <i>N</i>-(((2<i>S</i>,3<i>R</i>)-2-(5-Bromo-2-fluorophenyl)-4-hydroxy-3-phenylbutan-2-yl)carbamothioyl)benzamide (<b>34</b>)</h3><div class="NLM_p last">To a solution of <b>32</b> (455 mg, 0.948 mmol) and MeOH (163 μL, 2.85 mmol) in THF (2.3 mL) was added LiBH<sub>4</sub> (3.0 M in THF; 948 μL, 2.85 mmol) at 0 °C. After stirring for 19 h at room temperature, the mixture was cooled to 0 °C and then diluted with H<sub>2</sub>O and AcOH. The aqueous layer was separated and extracted with EtOAc. The organic layers were washed with water and concentrated to give the crude compound (427 mg) as a white amorphous substance. To a solution of this crude and other batch prepared according to the above method (473 mg) in DCM (4.7 mL) was added TFA (832 μL, 10.8 mmol) at room temperature. After stirring for 1 h at the same temperature, the reaction mixture was quenched with aqueous K<sub>2</sub>CO<sub>3</sub> solution. The aqueous layer was separated and extracted with DCM. The organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to give the crude compound (367 mg) as a white amorphous substance. To a solution of this crude compound in DCM (3.7 mL) was added BzNCS (174 μL, 1.30 mmol) at 0 °C. After stirring at room temperature for 1 h, the reaction mixture was concentrated. The residue was purified by flash column chromatography (silica gel; EtOAc/hexane, gradient: 10–45% EtOAc) to give <b>34</b> (414 mg, 78% over 3 steps) as a white amorphous substance. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 11.91 (1H, s), 8.80 (1H, s), 7.89–7.87 (2H, m), 7.66–7.61 (1H, m), 7.55–7.51 (2H, m), 7.29–7.24 (1H, m), 7.22–7.20 (3H, m), 7.08–7.05 (2H, m), 7.01–6.99 (1H, m), 6.85 (1H, dd, <i>J</i> = 11.9, 8.7 Hz), 4.36–4.29 (1H, m), 4.27–4.21 (1H, m), 3.60 (1H, t, <i>J</i> = 7.0 Hz), 2.17 (3H, s), 1.71–1.69 (1H, m).</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> <i>N</i>-(((2<i>S</i>,3<i>S</i>)-2-(5-Bromo-2-fluorophenyl)-4-hydroxy-3-phenylbutan-2-yl)carbamothioyl)benzamide (<b>35</b>)</h3><div class="NLM_p last">To a solution of <b>33</b> (252 mg, 0.524 mmol) and MeOH (90.0 μL, 1.57 mmol) in THF (2.5 mL) was added LiBH<sub>4</sub> (3.0 M in THF; 524 μL, 1.57 mmol) at 0 °C. After stirring for 1 day at room temperature, the mixture was cooled to 0 °C and diluted with H<sub>2</sub>O and AcOH. The aqueous layer was separated and extracted with EtOAc. The organic layers were washed with water and concentrated to give the crude compound (234 mg) as a white amorphous substance. To a solution of this crude compound in DCM (2.3 mL) was added TFA (404 μL, 5.25 mmol) at room temperature. After stirring for 2 h at the same temperature, the reaction mixture was quenched with aqueous K<sub>2</sub>CO<sub>3</sub> solution. The aqueous layer was separated and extracted with DCM. The organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to give the crude compound (189 mg) as a white amorphous substance. To a solution of this crude compound in DCM (1.9 mL) was added BzNCS (84 μL, 0.628 mmol) at 0 °C. After stirring at room temperature for 1 h, the reaction mixture was concentrated. The residue was treated with IPE and collected on a glass filter to give the target compound as a pale yellow solid. The filtrate was purified by flash column chromatography (silica gel; EtOAc/hexane, gradient: 10–40% EtOAc) to afford the target compound as well. The solid collected and the purified compound were combined to give <b>35</b> (229 mg, 87% over 3 steps) as a yellow amorphous substance. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 11.43 (1H, s), 8.70 (1H, s), 7.82–7.80 (2H, m), 7.62–7.59 (1H, m), 7.52–7.48 (2H, m), 7.43–7.35 (6H, m), 7.31–7.29 (1H, m), 6.93 (1H, dd, <i>J</i> = 11.9, 8.7 Hz), 4.10–4.04 (1H, m), 3.87–3.81 (1H, m), 3.62 (1H, dd, <i>J</i> = 9.2, 4.6 Hz), 2.16 (3H, s).</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> <i>N</i>-((4<i>S</i>,5<i>R</i>)-4-(5-Bromo-2-fluorophenyl)-4-methyl-5-phenyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-yl)benzamide (<b>36</b>)</h3><div class="NLM_p last">To a solution of compound <b>34</b> (310 mg, 0.617 mmol) in DCM (3.1 mL) was added Ghosez’s reagent (245 μL, 1.85 mmol) at 0 °C. After stirring for 1.5 h at room temperature, the reaction mixture was treated with aqueous NaHCO<sub>3</sub> solution. The aqueous layer was extracted with EtOAc. The organic layers were washed with water and evaporated. The residue was purified by flash column chromatography (silica gel; EtOAc/hexane, gradient: 10–30% EtOAc) to give <b>36</b> (267 mg, 90%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.24 (2H, d, <i>J</i> = 7.3 Hz), 7.54–7.50 (1H, m), 7.47–7.43 (3H, m), 7.35 (1H, dd, <i>J</i> = 7.1, 2.3 Hz), 7.31–7.25 (5H, m), 7.02 (1H, dd, <i>J</i> = 11.9, 8.8 Hz), 3.95–3.93 (1H, m), 3.26 (1H, dd, <i>J</i> = 13.1, 5.6 Hz), 3.15 (1H, dd, <i>J</i> = 13.1, 4.6 Hz), 1.61 (3H, s).</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> <i>N</i>-((4<i>S</i>,5<i>S</i>)-4-(5-Bromo-2-fluorophenyl)-4-methyl-5-phenyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-yl)benzamide (<b>37</b>)</h3><div class="NLM_p last">To a solution of compound <b>35</b> (229 mg, 0.458 mmol) in DCM (2.3 mL) was added Ghosez’s reagent (182 μL, 1.37 mmol) at 0 °C. After stirring for 3 h at room temperature, the reaction mixture was treated with aqueous NaHCO<sub>3</sub> solution. The aqueous layer was extracted with EtOAc. The organic layers were washed with water and evaporated. The residue was purified by flash column chromatography (silica gel; EtOAc/hexane, gradient: 0–20% EtOAc) to give <b>37</b> (179 mg, 81%) as a white amorphous substance. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.17–8.15 (2H, m), 7.55–7.51 (1H, m), 7.48–7.44 (2H, m), 7.37–7.33 (2H, m), 7.23–7.16 (3H, m), 6.88 (2H, d, <i>J</i> = 7.2 Hz), 6.80 (1H, dd, <i>J</i> = 11.9, 8.7 Hz), 3.59–3.56 (1H, m), 3.33–3.27 (2H, m), 1.87 (3H, br s).</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> Methyl 4-((<i>S</i>)-1-(((<i>R</i>)-<i>tert</i>-butylsulfinyl)amino)-1-(2-fluorophenyl)ethyl)tetrahydro-2<i>H</i>-thiopyran-4-carboxylate (<b>66</b>)</h3><div class="NLM_p last">To a solution of diisopropylamine (12.1 mL, 86.0 mmol) in THF (80 mL) was added dropwise <i>n</i>-BuLi (1.60 M in hexane; 51.4 mL, 82.0 mmol) at −78 °C. The mixture was allowed to warm to 0 °C and stirred at the same temperature for 20 min. The mixture was cooled to −78 °C, and a solution of methyl tetrahydro-2<i>H</i>-thiopyran-4-carboxylate (9.89 g, 61.7 mmol) in THF (40 mL) was added dropwise to the mixture. After being stirred at the same temperature for 45 min, a solution of ClTi(O<i>i</i>-Pr)<sub>3</sub> (20.7 mL, 86.0 mmol) in THF (40 mL) was added dropwise at −78 °C. The mixture was stirred at the same temperature for 10 min, and then <b>25</b> (9.93 g, 41.1 mmol) in THF (40 mL) was added dropwise. After stirring for 10 min, the mixture was quenched with aqueous NH<sub>4</sub>Cl solution. The resulting mixture was filtered through Celite and evaporated. The residue was purified by flash column chromatography (silica gel; EtOAc/hexane, gradient: 20–70% EtOAc) to give <b>66</b> (9.80 g, 59%) as a yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.36–7.27 (2H, m), 7.12–7.08 (1H, m), 7.03 (1H, ddd, <i>J</i> = 13.3, 8.2, 1.1 Hz), 4.97 (1H, s), 3.77 (3H, s), 2.81–2.74 (1H, m), 2.66–2.62 (1H, m), 2.55–2.47 (4H, m), 1.91 (3H, d, <i>J</i> = 4.1 Hz), 1.71–1.64 (1H, m), 1.39–1.32 (1H, m).</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> Methyl (<i>S</i>)-4-(1-((<i>tert</i>-butoxycarbonyl)amino)-1-(2-fluorophenyl)ethyl)tetrahydro-2<i>H</i>-thiopyran-4-carboxylate (<b>67</b>)</h3><div class="NLM_p last">A mixture of <b>66</b> (9.80 g, 24.4 mmol) and HCl (4 M in 1,4-dioxane; 9.15 mL, 36.6 mmol) in MeOH (98 mL) was stirred at room temperature for 2 h. The mixture was diluted with Et<sub>2</sub>O, and the organic layers were back extracted with H<sub>2</sub>O. The aqueous layer was basified with K<sub>2</sub>CO<sub>3</sub>, and the aqueous layer was extracted with EtOAc. The organic layers were washed with water and concentrated to give the crude compound (9.36 g) as a yellow oil. A mixture of this crude compound and Boc<sub>2</sub>O (22.5 mL, 97.0 mmol) was stirred at 50 °C for 7 h. The mixture was cooled to room temperature and carefully treated with 1-methylpiperazine (8.04 mL, 72.5 mmol). The resulting mixture was evaporated, and the residue was purified by flash column chromatography (silica gel; EtOAc/hexane, gradient: 0–10% EtOAc) to give <b>67</b> (9.03 g, 94% over 2 steps) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.24–7.15 (2H, m), 7.07 (1H, t, <i>J</i> = 7.5 Hz), 6.97 (1H, dd, <i>J</i> = 12.9, 8.0 Hz), 6.08 (1H, br s), 3.72 (3H, s), 2.66–2.60 (2H, m), 2.57–2.45 (3H, m), 2.30–2.25 (1H, m), 1.91 (3H, br s), 1.74–1.66 (2H, m), 1.34 (9H, br s).</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> <i>tert</i>-Butyl (<i>S</i>)-(1-(2-Fluorophenyl)-1-(4-(hydroxymethyl)tetrahydro-2<i>H</i>-thiopyran-4-yl)ethyl)carbamate (<b>68</b>)</h3><div class="NLM_p last">To a solution of <b>67</b> (9.03 g, 22.7 mmol) and MeOH (2.76 mL, 68.2 mmol) in THF (90 mL) was added LiBH<sub>4</sub> (3.0 M in THF; 22.7 mL, 68.2 mmol) at 0 °C. After stirring for 6 h at 50 °C, the mixture was cooled to 0 °C and quenched with aqueous NH<sub>4</sub>Cl solution. The aqueous layer was separated and extracted with EtOAc. The organic layers were washed with water and concentrated. The residue was purified by flash column chromatography (silica gel; EtOAc/hexane, gradient: 10–100% EtOAc) to give <b>68</b> (4.04 g, 48%) as a white amorphous substance. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.31–7.29 (1H, m), 7.24–7.19 (1H, m), 7.09 (1H, t, <i>J</i> = 7.6 Hz), 6.99 (1H, dd, <i>J</i> = 13.1, 8.1 Hz), 3.94 (1H, d, <i>J</i> = 11.7 Hz), 3.74 (1H, d, <i>J</i> = 11.7 Hz), 2.88–2.81 (1H, m), 2.80–2.72 (1H, m), 2.47–2.43 (1H, m), 2.38–2.28 (2H, m), 1.95 (3H, d, <i>J</i> = 3.8 Hz), 1.87–1.80 (2H, m), 1.53–1.47 (1H, m), 1.33 (9H, br s).</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> (<i>S</i>)-<i>N</i>-((1-(2-Fluorophenyl)-1-(4-(hydroxymethyl)tetrahydro-2<i>H</i>-thiopyran-4-yl)ethyl)carbamothioyl)benzamide (<b>69</b>)</h3><div class="NLM_p last">To a solution of <b>68</b> (6.27 g, 17.0 mmol) in DCM (63 mL) was added TFA (13.1 mL, 170 mmol) at room temperature. After stirring for 30 min at the same temperature, the reaction mixture was cooled to 0 °C and quenched with aqueous K<sub>2</sub>CO<sub>3</sub> solution. The aqueous layer was separated and extracted with CHCl<sub>3</sub>. The organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to give the crude compound (4.18 g) as a pale yellow solid. To a solution of this crude compound (3.18 g) in DCM (32 mL) was added BzNCS (2.06 mL, 15.3 mmol) at 0 °C. After stirring for 20 h at room temperature, the reaction mixture was concentrated. The residue was purified by flash column chromatography (silica gel; EtOAc/hexane, gradient: 0–30% EtOAc) to give <b>69</b> (3.90 g, 70% over 2 steps) as a yellow amorphous substance. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 11.84 (1H, s), 8.78 (1H, s), 7.86–7.84 (2H, m), 7.62–7.59 (1H, m), 7.52–7.48 (2H, m), 7.32–7.26 (2H, m), 7.19–7.14 (1H, m), 7.06–6.99 (1H, m), 3.99–3.89 (2H, m), 2.94–2.85 (2H, m), 2.50–2.45 (2H, m), 2.30 (3H, br s), 2.28–2.23 (1H, m), 1.91–1.89 (2H, m), 1.83 (1H, dd, <i>J</i> = 13.3, 3.6 Hz), 1.76–1.73 (1H, m).</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> (<i>R</i>)-5-(2-Fluorophenyl)-5-methyl-2,9-dithia-4-azaspiro[5.5]undec-3-en-3-amine (<b>70</b>)</h3><div class="NLM_p last">To a solution of <b>69</b> (3.90 g, 9.02 mmol) in DCM (156 mL) was added DAST (287 μL, 1.95 mmol) at room temperature. After stirring for 15 min at the same temperature, the reaction mixture was cooled to 0 °C and then poured into aqueous K<sub>2</sub>CO<sub>3</sub> solution. The aqueous layer was extracted with CHCl<sub>3</sub>, and the organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated. The residue was purified by flash column chromatography (silica gel; EtOAc/hexane, gradient: 10–30% EtOAc) to give the compound (1.70 g) as a pale yellow amorphous substance. A mixture of this compound (1.70 g) and hydrazine monohydrate (2.18 mL, 44.8 mmol) in MeOH/THF (9.3 mL/9.3 mL) was heated to 40 °C. After stirring for 2 h at the same temperature, the reaction mixture was concentrated. The residue was purified by flash column chromatography (amino silica gel; EtOAc/hexane, gradient: 10–30% EtOAc) to give <b>70</b> (461 mg, 16% over 2 steps) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.41 (1H, td, <i>J</i> = 8.0, 1.7 Hz), 7.25–7.21 (1H, m), 7.14–7.10 (1H, m), 6.99 (1H, ddd, <i>J</i> = 13.0, 8.1, 1.2 Hz), 3.05 (1H, d, <i>J</i> = 13.0 Hz), 2.98 (1H, d, <i>J</i> = 13.0 Hz), 2.88–2.75 (2H, m), 2.46–2.40 (1H, m), 2.38–2.33 (1H, m), 2.13–2.10 (1H, m), 1.84–1.70 (2H, m), 1.67 (3H, d, <i>J</i> = 4.8 Hz), 1.63–1.61 (1H, m).</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> (<i>R</i>)-3-Amino-5-(2-fluorophenyl)-5-methyl-2,9-dithia-4-azaspiro[5.5]undec-3-ene 9,9-dioxide (<b>71</b>)</h3><div class="NLM_p last">To a solution of <b>70</b> (408 mg, 1.31 mmol) in DCM (12.2 mL) was added <i>m</i>-CPBA (40% water, 743 mg, 3.02 mmol) at 0 °C. After stirring for 1 h at the same temperature, the reaction mixture was quenched with aqueous NaHCO<sub>3</sub> and Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> solution. The aqueous layer was extracted with CHCl<sub>3</sub>, and the organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated. The residue was purified by flash column chromatography (silica gel; EtOAc/hexane, gradient: 40–80% EtOAc) to give <b>71</b> (404 mg, 90%) as a white amorphous substance. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.38 (1H, td, <i>J</i> = 8.1, 1.6 Hz), 7.30–7.24 (1H, m), 7.17–7.13 (1H, m), 7.02 (1H, ddd, <i>J</i> = 13.0, 8.1, 1.2 Hz), 3.09 (1H, d, <i>J</i> = 13.3 Hz), 3.04–2.86 (5H, m), 2.37–2.20 (3H, m), 1.82–1.75 (1H, m), 1.72 (3H, d, <i>J</i> = 4.8 Hz).</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> (<i>R</i>)-3-Amino-5-(5-amino-2-fluorophenyl)-5-methyl-2,9-dithia-4-azaspiro[5.5]undec-3-ene 9,9-dioxide (<b>72</b>)</h3><div class="NLM_p last">To a solution of <b>71</b> (194 mg, 0.567 mmol) in TFA (918 μL) was added sulfuric acid (227 μL, 4.25 mmol) at −10 °C. After being stirred at the same temperature for 10 min, the mixture was added dropwise HNO<sub>3</sub> (38.0 μL, 0.851 mmol). The reaction mixture was stirred at −10 °C for 25 min and then poured into aqueous K<sub>2</sub>CO<sub>3</sub> solution. The aqueous layer was separated and extracted with EtOAc. The organic layers were washed with water and evaporated to give the crude compound (214 mg) as a white amorphous substance. A suspension of this crude compound, Fe (247 mg, 4.42 mmol), and NH<sub>4</sub>Cl (355 mg, 6.64 mmol) in toluene/H<sub>2</sub>O (4.3 mL/4.3 mL) was stirred at 80 °C for 1 h. The mixture was cooled to room temperature and quenched with aqueous K<sub>2</sub>CO<sub>3</sub> solution and filtered through Celite. The aqueous layer was treated with NaCl and extracted with CHCl<sub>3</sub>. The organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated. The residue was purified twice by flash column chromatography (amino silica gel; EtOAc/hexane, gradient: 80–100% EtOAc then 20% MeOH in EtOAc) to give <b>72</b> (156 mg, 77% over 2 steps) as a pale yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 6.81 (1H, dd, <i>J</i> = 12.4, 8.5 Hz), 6.65 (1H, dd, <i>J</i> = 6.7, 2.9 Hz), 6.58–6.54 (1H, m), 3.55 (2H, s), 3.08 (1H, d, <i>J</i> = 13.3 Hz), 3.03–2.88 (5H, m), 2.39–2.16 (3H, m), 1.80 (1H, dd, <i>J</i> = 15.1, 3.1 Hz), 1.68 (3H, d, <i>J</i> = 4.6 Hz).</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> Biochemical BACE1 Assay</h3><div class="NLM_p last">The biochemical BACE1 IC<sub>50</sub> values were determined by FRET assay using an amyloid precursor protein (APP)-derived peptide as described previously.<a onclick="showRef(event, 'cit9h'); return false;" href="javascript:void(0);" class="ref cit9h">(9h)</a></div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> Cellular Aβ Assay</h3><div class="NLM_p last">The cellular Aβ IC<sub>50</sub> values were determined by measuring Aβ42 using a sandwich AlphaLISA assay in SKNBE2 cells expressing the wild-type APP as described previously.<a onclick="showRef(event, 'cit9h'); return false;" href="javascript:void(0);" class="ref cit9h">(9h)</a></div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> Biochemical BACE2 Assay</h3><div class="NLM_p last">BACE2 enzymatic activity was assessed by FRET assay using an (APP)-derived 13-amino acid peptide that contains the “Swedish” Lys-Met/Asn-Leu mutation of the APP β-secretase cleavage site as a substrate (Bachem catalogue no. M-2465) and soluble BACE2 in a final concentration of 0.4 μg/mL. This substrate contains two fluorophores: (7-methoxycoumarin-4-yl) acetic acid (Mca) is a fluorescent donor with excitation wavelength at 320 nm and emission at 405 nm and 2,4-dinitrophenyl (Dnp) is a proprietary quencher acceptor. The increase in fluorescence is linearly related to the rate of proteolysis. In a 384-well format, BACE2 was incubated with the substrate and the inhibitor. The amount of proteolysis was directly measured by fluorescence measurement in a Fluoroskan microplate fluorometer (Thermo Scientific). For the low control, no enzyme was added to the reaction mixture.</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> Biochemical Radioligand Binding Assay for BACE1 and BACE2</h3><div class="NLM_p last">The binding affinity (<i>K</i><sub>i</sub>) of compounds under investigation to either BACE1 or BACE2 was determined in a competitive radioligand binding assay, that is, in competition with the tritiated nonselective BACE1/BACE 2 inhibitor [<sup>3</sup>H]-JNJ-962 (JNJ-962 (CAS#: 1397684-09-1): BACE1 <i>K</i><sub>i</sub> = 0.69 nM, BACE2 <i>K</i><sub>i</sub> = 0.29 nM). Briefly, in test tubes, compounds of interest were combined with the radioligand and the BACE1 or BACE2-expressing HEK293-derived membranes. The competitive binding reaction was performed at pH 6.2 and incubated at room temperature until the equilibrium was reached. Afterward, a free radioligand was separated from the bound radioligand by filtration with a Brandell 96 harvester. The filter was washed, filter sheets were punched into scintillation vials, and Ultima Gold scintillation cocktail was added. The day after, the vials were counted in a Tricarb scintillation counter to obtain the disintegrations per minute (dpm) of the bound radioligand. Calculating the % inhibition = 100 – [(sample – LC)/(HC – LC)) × 100], with HC being the high control, that is, total binding of radioligand and LC representing the nonspecific binding measured in the presence of 10 μM of a known BACE inhibitor allowed fitting of curves through the data points of the different doses of the test compound. The pIC<sub>50</sub> or IC<sub>50</sub> is calculated and can be converted to <i>K</i><sub>i</sub> by the formula <i>K</i><sub>i</sub> = IC<sub>50</sub>/(1 + ([RL]/<i>K</i><sub>d</sub>)), with [RL] being the concentration of the radioligand and <i>K</i><sub>d</sub> being the determined dissociation constant of the radioligand–membrane complex.</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> P-gp Assay</h3><div class="NLM_p last">The P-gp ERs were determined in LLC-PK1 cells transfected with human MDR1, and the permeability coefficients (<i>P</i><sub>app</sub>) were determined in wild-type LLC-PK1 cells as described previously.<a onclick="showRef(event, 'cit27c'); return false;" href="javascript:void(0);" class="ref cit27c">(27c)</a></div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> Metabolic Stability Assay</h3><div class="NLM_p last">The metabolic stability in human and mouse microsomes was determined as described previously.<a onclick="showRef(event, 'cit27b'); return false;" href="javascript:void(0);" class="ref cit27b">(27b)</a></div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> PK/PD Study in Wild-Type Mice</h3><div class="NLM_p last">All animal studies were performed with the approval of the Shionogi Animal Care and Use Committee. Male ICR mice (<i>n</i> = 4) were dosed po with the compound dissolved in 20% HPBCD. The detailed method was described previously.<a onclick="showRef(event, 'cit27c'); return false;" href="javascript:void(0);" class="ref cit27c">(27c)</a></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i61"><a href="/doi/suppl/10.1021/acs.jmedchem.9b00309" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22071" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22071" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b00309" class="ext-link">10.1021/acs.jmedchem.9b00309</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Experimental procedures and characterization data for compounds <b>15</b>, <b>18</b>, <b>19</b>, <b>20</b>, and <b>21</b>, NOE for compounds <b>44</b> and <b>45</b>, synthesis of [<sup>3</sup>H]-JNJ-962, and crystallographic data (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00309/suppl_file/jm9b00309_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">SMILE strings, BACE1 IC<sub>50</sub>, BACE2 IC<sub>50</sub>, and cellular Aβ42 IC<sub>50</sub> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00309/suppl_file/jm9b00309_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00309/suppl_file/jm9b00309_si_001.pdf">jm9b00309_si_001.pdf (1.25 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00309/suppl_file/jm9b00309_si_002.csv">jm9b00309_si_002.csv (1.59 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last"><b>8</b> bound to BACE1: 6JSG; <b>16</b> bound to BACE1: 6JSE; <b>17</b> bound to BACE1: 6JSF; <b>22</b> bound to BACE1: 6JSN; and <b>22</b> bound to BACE2: 6JSZ.</p><div class="testing" data-doi="10.1021/acs.jmedchem.9b00309" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13835" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13835" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ken-ichi Kusakabe</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratory for Core Therapeutic Areas and , Shionogi Pharmaceutical
Research Center, 1-1
Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9055-8267" title="Orcid link">http://orcid.org/0000-0001-9055-8267</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#3d56585310545e55541356484e5c565c5f587d4e55545253525a54135e5213574d"><span class="__cf_email__" data-cfemail="c8a3ada6e5a1aba0a1e6a3bdbba9a3a9aaad88bba0a1a7a6a7afa1e6aba7e6a2b8">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kazuki Fujimoto</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratory for Core Therapeutic Areas and , Shionogi Pharmaceutical
Research Center, 1-1
Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eriko Matsuoka</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratory for Core Therapeutic Areas and , Shionogi Pharmaceutical
Research Center, 1-1
Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Naoya Asada</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratory for Core Therapeutic Areas and , Shionogi Pharmaceutical
Research Center, 1-1
Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Genta Tadano</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratory for Core Therapeutic Areas and , Shionogi Pharmaceutical
Research Center, 1-1
Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Takahiko Yamamoto</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratory for Core Therapeutic Areas and , Shionogi Pharmaceutical
Research Center, 1-1
Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</span>; 
    <span>Present Address:
                        API Process Development Department (Biotechnology), Pharmaceutical Technology Division, Chugai Pharmaceutical Co., Ltd, 5-1, Ukima 5-chome, Kita-ku, Tokyo, 115-8543 Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kenji Nakahara</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratory for Core Therapeutic Areas and , Shionogi Pharmaceutical
Research Center, 1-1
Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kouki Fuchino</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratory for Core Therapeutic Areas and , Shionogi Pharmaceutical
Research Center, 1-1
Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hisanori Ito</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratory for Core Therapeutic Areas and , Shionogi Pharmaceutical
Research Center, 1-1
Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Naoki Kanegawa</span> - <span class="hlFld-Affiliation affiliation">Research Laboratory
for Development and , Shionogi Pharmaceutical
Research Center, 1-1
Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Diederik Moechars</span> - <span class="hlFld-Affiliation affiliation">Neuroscience Biology and , Janssen
Research & Development, Turnhoutseweg 30, Beerse B-2340, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Harrie J. M. Gijsen</span> - <span class="hlFld-Affiliation affiliation">Discovery Chemistry and , Janssen
Research & Development, Turnhoutseweg 30, Beerse B-2340, Belgium</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8020-4828" title="Orcid link">http://orcid.org/0000-0001-8020-4828</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>K.F., E.M., N.A., and G.T. contributed equally to this paper.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i65">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73001" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73001" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Ronghui Lin for the synthesis of [<sup>3</sup>H]-JNJ-962, Stefan Steinbacher (Proteros) for the BACE2 X-ray crystallography, Maki Hattori, Masanori Nakae, and Maito Douma for the biological assays, Hirotoshi Morita for the HRMS analysis, and Yukiko Kan for the NMR analysis. We gratefully thank the members of the Janssen-Shionogi research collaboration for the support of this program. We are grateful to Judy Noguchi for proofreading the manuscript.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">amyloid β</p></td></tr><tr><td class="NLM_term">APP</td><td class="NLM_def"><p class="first last">amyloid precursor protein</p></td></tr><tr><td class="NLM_term">BACE1</td><td class="NLM_def"><p class="first last">β-site amyloid precursor protein cleaving enzyme 1</p></td></tr><tr><td class="NLM_term">BzNCS</td><td class="NLM_def"><p class="first last">benzoyl isothiocyanate</p></td></tr><tr><td class="NLM_term">DAST</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diethylaminosulfur trifluoride</p></td></tr><tr><td class="NLM_term">DIAN</td><td class="NLM_def"><p class="first last">the dominantly inherited Alzheimer network</p></td></tr><tr><td class="NLM_term">EDC</td><td class="NLM_def"><p class="first last">1-ethyl-3-(3-dimethylaminopropyl)carbodiimide</p></td></tr><tr><td class="NLM_term">FRET</td><td class="NLM_def"><p class="first last">fluorescence resonance energy transfer</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last">1-[bis(dimethylamino)methylene]-1<i>H</i>-1,2,3-triazolo[4,5-<i>b</i>]pyridinium 3-oxide hexafluorophosphate</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsome</p></td></tr><tr><td class="NLM_term">HPBCD</td><td class="NLM_def"><p class="first last">2-hydroxypropyl-β-cyclodextrin</p></td></tr><tr><td class="NLM_term"><i>m</i>-CPBA</td><td class="NLM_def"><p class="first last"><i>m</i>-chloroperoxybenzoic acid</p></td></tr><tr><td class="NLM_term">MDR</td><td class="NLM_def"><p class="first last">multidrug resistance</p></td></tr><tr><td class="NLM_term">MLM</td><td class="NLM_def"><p class="first last">mouse liver microsome</p></td></tr><tr><td class="NLM_term">PET</td><td class="NLM_def"><p class="first last">positron-emission tomography</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">pharmacodynamics</p></td></tr><tr><td class="NLM_term">P-gp</td><td class="NLM_def"><p class="first last">P-glycoprotein</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">PMEL</td><td class="NLM_def"><p class="first last">pigment cell-specific melanocyte protein</p></td></tr><tr><td class="NLM_term">TMEM27</td><td class="NLM_def"><p class="first last">transmembrane protein 27</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i67">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25675" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25675" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 35 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prince, M.</span>; <span class="NLM_string-name">Comas-Herrera, A.</span>; <span class="NLM_string-name">Knapp, M.</span>; <span class="NLM_string-name">Guerchet, M.</span>; <span class="NLM_string-name">Karagiannidou, M.</span></span> <span> </span><span class="NLM_article-title">World Alzheimer Report 2016</span>. <a href="https://www.alz.co.uk/research/WorldAlzheimerReport2016.pdf" class="extLink">https://www.alz.co.uk/research/WorldAlzheimerReport2016.pdf</a> (accessed Feb 20, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=M.+Prince&author=A.+Comas-Herrera&author=M.+Knapp&author=M.+Guerchet&author=M.+Karagiannidou&title=World+Alzheimer+Report+2016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3DPrince%26aufirst%3DM.%26atitle%3DWorld%2520Alzheimer%2520Report%25202016%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Alzheimer’s Association</span>. <span> </span><span class="NLM_article-title">2017 Alzheimer’s Disease Facts
and Figures</span>. <a href="https://www.alz.org/documents_custom/2017-facts-and-figures.pdf" class="extLink">https://www.alz.org/documents_custom/2017-facts-and-figures.pdf</a> (accessed Feb 20, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=Alzheimer%E2%80%99s+Association&title=2017+Alzheimer%E2%80%99s+Disease+Facts%0Aand+Figures"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3D2017%2520Alzheimer%25E2%2580%2599s%2520Disease%2520Facts%250Aand%2520Figures%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chancellor, D.</span>; <span class="NLM_string-name">Dube, S.</span>; <span class="NLM_string-name">Huntley, C.</span></span> <i>Alzheimer’s Disease</i>. Ref Code: DMKC4740.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Chancellor%2C+D.%3B+Dube%2C+S.%3B+Huntley%2C+C.+Alzheimer%E2%80%99s+Disease.+Ref+Code%3A+DMKC4740."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26aulast%3DChancellor%26aufirst%3DD.%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Disease" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vassar, R.</span></span> <span> </span><span class="NLM_article-title">Targeting the β secretase BACE1 for Alzheimer’s disease therapy</span>. <i>Lancet Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">319</span>– <span class="NLM_lpage">329</span>, <span class="refDoi"> DOI: 10.1016/s1474-4422(13)70276-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1016%2Fs1474-4422%2813%2970276-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=24556009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC2cXis1Cntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=319-329&author=R.+Yanauthor=R.+Vassar&title=Targeting+the+%CE%B2+secretase+BACE1+for+Alzheimer%E2%80%99s+disease+therapy&doi=10.1016%2Fs1474-4422%2813%2970276-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the β secretase BACE1 for Alzheimer's disease therapy</span></div><div class="casAuthors">Yan, Riqiang; Vassar, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">319-329</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The β secretase, widely known as β-site amyloid precursor protein cleaving enzyme 1 (BACE1), initiates the prodn. of the toxic amyloid β (Aβ) that plays a crucial early part in Alzheimer's disease pathogenesis.  BACE1 is a prime therapeutic target for lowering cerebral Aβ concns. in Alzheimer's disease, and clin. development of BACE1 inhibitors is being intensely pursued.  Although BACE1 inhibitor drug development has proven challenging, several promising BACE1 inhibitors have recently entered human clin. trials.  The safety and efficacy of these drugs are being tested at present in healthy individuals and patients with Alzheimer's disease, and will soon be tested in individuals with presymptomatic Alzheimer's disease.  Although hopes are high that BACE1 inhibitors might be efficacious for the prevention or treatment of Alzheimer's disease, concerns have been raised about potential mechanism-based side-effects of these drugs.  The potential of therapeutic BACE1 inhibition might prove to be a watershed in the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8SsSfCAC6nbVg90H21EOLACvtfcHk0ljvBXL6E83h6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXis1Cntbo%253D&md5=11aeb06fee19cafc0b361e2c43900806</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fs1474-4422%2813%2970276-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs1474-4422%252813%252970276-x%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DR.%26aulast%3DVassar%26aufirst%3DR.%26atitle%3DTargeting%2520the%2520%25CE%25B2%2520secretase%2520BACE1%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520therapy%26jtitle%3DLancet%2520Neurol.%26date%3D2014%26volume%3D13%26spage%3D319%26epage%3D329%26doi%3D10.1016%2Fs1474-4422%2813%2970276-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selkoe, D. J.</span></span> <span> </span><span class="NLM_article-title">The amyloid hypothesis of Alzheimer’s disease: Progress and problems on the road to therapeutics</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>297</i></span>,  <span class="NLM_fpage">353</span>– <span class="NLM_lpage">356</span>, <span class="refDoi"> DOI: 10.1126/science.1072994</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1126%2Fscience.1072994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=12130773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2002&pages=353-356&author=J.+Hardyauthor=D.+J.+Selkoe&title=The+amyloid+hypothesis+of+Alzheimer%E2%80%99s+disease%3A+Progress+and+problems+on+the+road+to+therapeutics&doi=10.1126%2Fscience.1072994"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics</span></div><div class="casAuthors">Hardy, John; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">5580</span>),
    <span class="NLM_cas:pages">353-356</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  It has been more than 10 yr since it was first proposed that the neurodegeneration in Alzheimer's disease (AD) may be caused by deposition of amyloid β-peptide (Aβ) in plaques in brain tissue.  According to the amyloid hypothesis, accumulation of Aβ in the brain is the primary influence driving AD pathogenesis.  The rest of the disease process, including formation of neurofibrillary tangles contg. tau protein, is proposed to result from an imbalance between Aβ prodn. and Aβ clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9G5omTHR6cbVg90H21EOLACvtfcHk0ljvBXL6E83h6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D&md5=f7b8db1bc6f13e85f887b73f3042e86e</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1126%2Fscience.1072994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1072994%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520amyloid%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Progress%2520and%2520problems%2520on%2520the%2520road%2520to%2520therapeutics%26jtitle%3DScience%26date%3D2002%26volume%3D297%26spage%3D353%26epage%3D356%26doi%3D10.1126%2Fscience.1072994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Karran, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercken, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strooper, B. D.</span></span> <span> </span><span class="NLM_article-title">The amyloid cascade hypothesis for Alzheimer’s disease: an appraisal for the development of therapeutics</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">698</span>– <span class="NLM_lpage">712</span>, <span class="refDoi"> DOI: 10.1038/nrd3505</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1038%2Fnrd3505" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=21852788" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVelsL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=698-712&author=E.+Karranauthor=M.+Merckenauthor=B.+D.+Strooper&title=The+amyloid+cascade+hypothesis+for+Alzheimer%E2%80%99s+disease%3A+an+appraisal+for+the+development+of+therapeutics&doi=10.1038%2Fnrd3505"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics</span></div><div class="casAuthors">Karran, Eric; Mercken, Marc; De Strooper, Bart</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">698-712</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The amyloid cascade hypothesis, which posits that the deposition of the amyloid-β peptide in the brain is a central event in Alzheimer's disease pathol., has dominated research for the past twenty years.  Several therapeutics that were purported to reduce amyloid-β prodn. or aggregation have failed in Phase III clin. testing, and many others are in various stages of development.  Therefore, it is timely to review the science underpinning the amyloid cascade hypothesis, consider what type of clin. trials will constitute a valid test of this hypothesis and explore whether amyloid-β-directed therapeutics will provide the medicines that are urgently needed by society for treating this devastating disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_-zjcfHaQ87Vg90H21EOLACvtfcHk0ljvBXL6E83h6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVelsL3L&md5=cf2824a56a4c3df6e265d8788970729d</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1038%2Fnrd3505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3505%26sid%3Dliteratum%253Aachs%26aulast%3DKarran%26aufirst%3DE.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DStrooper%26aufirst%3DB.%2BD.%26atitle%3DThe%2520amyloid%2520cascade%2520hypothesis%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520an%2520appraisal%2520for%2520the%2520development%2520of%2520therapeutics%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D698%26epage%3D712%26doi%3D10.1038%2Fnrd3505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Vassar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu-Khan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendiaz, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teplow, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amarante, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loeloff, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edenson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lile, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarosinski, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biere, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curran, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgess, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louis, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treanor, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Citron, M.</span></span> <span> </span><span class="NLM_article-title">β-Secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">735</span>– <span class="NLM_lpage">741</span>, <span class="refDoi"> DOI: 10.1126/science.286.5440.735</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1126%2Fscience.286.5440.735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10531052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADyaK1MXntFWit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=1999&pages=735-741&author=R.+Vassarauthor=B.+D.+Bennettauthor=S.+Babu-Khanauthor=S.+Kahnauthor=E.+A.+Mendiazauthor=P.+Denisauthor=D.+B.+Teplowauthor=S.+Rossauthor=P.+Amaranteauthor=R.+Loeloffauthor=Y.+Luoauthor=S.+Fisherauthor=J.+Fullerauthor=S.+Edensonauthor=J.+Lileauthor=M.+A.+Jarosinskiauthor=A.+L.+Biereauthor=E.+Curranauthor=T.+Burgessauthor=J.-C.+Louisauthor=F.+Collinsauthor=J.+Treanorauthor=G.+Rogersauthor=M.+Citron&title=%CE%B2-Secretase+cleavage+of+Alzheimer%E2%80%99s+amyloid+precursor+protein+by+the+transmembrane+aspartic+protease+BACE&doi=10.1126%2Fscience.286.5440.735"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">β-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE</span></div><div class="casAuthors">Vassar, Robert; Bennett, Brian D.; Babu-Khan, Safura; Kahn, Steve; Mendiaz, Elizabeth A.; Denis, Paul; Teplow, David B.; Ross, Sandra; Amarante, Patricia; Loeloff, Richard; Luo, Yi; Fisher, Seth; Fuller, Janis; Edenson, Steven; Lile, Jackson; Jarosinski, Mark A.; Biere, Anja Leona; Curran, Eileen; Burgess, Teresa; Louis, Jean-Claude; Collins, Frank; Treanor, James; Rogers, Gary; Citron, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">5440</span>),
    <span class="NLM_cas:pages">735-741</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Cerebral deposition of amyloid β peptide (Aβ) is an early and crit. feature of Alzheimer's disease.  Aβ generation depends on proteolytic cleavage of the amyloid precursor protein (APP) by two unknown proteases: β-secretase and γ-secretase.  These proteases are prime therapeutic targets.  A transmembrane aspartic protease with all the known characteristics of β-secretase was cloned and characterized.  Overexpression of this protease, termed BACE (for beta-site APP-cleaving enzyme) increased the amt. of β-secretase cleavage products, and these were cleaved exactly and only at known β-secretase positions.  Antisense inhibition of endogenous BACE mRNA decreased the amt. of β-secretase cleavage products, and purified BACE protein cleaved APP-derived substrates with the same sequence specificity as β-secretase.  Finally, the expression pattern and subcellular localization of BACE were consistent with that expected for β-secretase.  Future development of BACE inhibitors may prove beneficial for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSx3s1NFyByrVg90H21EOLACvtfcHk0ljvBXL6E83h6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFWit74%253D&md5=3f36e8e5b5e9441c7670ccaeb0d2dd4f</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1126%2Fscience.286.5440.735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.286.5440.735%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DKahn%26aufirst%3DS.%26aulast%3DMendiaz%26aufirst%3DE.%2BA.%26aulast%3DDenis%26aufirst%3DP.%26aulast%3DTeplow%26aufirst%3DD.%2BB.%26aulast%3DRoss%26aufirst%3DS.%26aulast%3DAmarante%26aufirst%3DP.%26aulast%3DLoeloff%26aufirst%3DR.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DFisher%26aufirst%3DS.%26aulast%3DFuller%26aufirst%3DJ.%26aulast%3DEdenson%26aufirst%3DS.%26aulast%3DLile%26aufirst%3DJ.%26aulast%3DJarosinski%26aufirst%3DM.%2BA.%26aulast%3DBiere%26aufirst%3DA.%2BL.%26aulast%3DCurran%26aufirst%3DE.%26aulast%3DBurgess%26aufirst%3DT.%26aulast%3DLouis%26aufirst%3DJ.-C.%26aulast%3DCollins%26aufirst%3DF.%26aulast%3DTreanor%26aufirst%3DJ.%26aulast%3DRogers%26aufirst%3DG.%26aulast%3DCitron%26aufirst%3DM.%26atitle%3D%25CE%25B2-Secretase%2520cleavage%2520of%2520Alzheimer%25E2%2580%2599s%2520amyloid%2520precursor%2520protein%2520by%2520the%2520transmembrane%2520aspartic%2520protease%2520BACE%26jtitle%3DScience%26date%3D1999%26volume%3D286%26spage%3D735%26epage%3D741%26doi%3D10.1126%2Fscience.286.5440.735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sinha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, John P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbour, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basi, Guriqbal S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caccavello, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dovey, Harry F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frigon, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson-Croak, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jewett, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keim, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knops, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieberburg, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Power, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tatsuno, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tung, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seubert, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suomensaari, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McConlogue, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">John, V.</span></span> <span> </span><span class="NLM_article-title">Purification and cloning of amyloid precursor protein β-secretase from human brain</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>402</i></span>,  <span class="NLM_fpage">537</span>– <span class="NLM_lpage">540</span>, <span class="refDoi"> DOI: 10.1038/990114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1038%2F990114" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=402&publication_year=1999&pages=537-540&author=S.+Sinhaauthor=John+P.+Andersonauthor=R.+Barbourauthor=Guriqbal+S.+Basiauthor=R.+Caccavelloauthor=D.+Davisauthor=M.+Doanauthor=Harry+F.+Doveyauthor=N.+Frigonauthor=J.+Hongauthor=K.+Jacobson-Croakauthor=N.+Jewettauthor=P.+Keimauthor=J.+Knopsauthor=I.+Lieberburgauthor=M.+Powerauthor=H.+Tanauthor=G.+Tatsunoauthor=J.+Tungauthor=D.+Schenkauthor=P.+Seubertauthor=S.+M.+Suomensaariauthor=S.+Wangauthor=D.+Walkerauthor=J.+Zhaoauthor=L.+McConlogueauthor=V.+John&title=Purification+and+cloning+of+amyloid+precursor+protein+%CE%B2-secretase+from+human+brain&doi=10.1038%2F990114"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1038%2F990114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F990114%26sid%3Dliteratum%253Aachs%26aulast%3DSinha%26aufirst%3DS.%26aulast%3DAnderson%26aufirst%3DJohn%2BP.%26aulast%3DBarbour%26aufirst%3DR.%26aulast%3DBasi%26aufirst%3DGuriqbal%2BS.%26aulast%3DCaccavello%26aufirst%3DR.%26aulast%3DDavis%26aufirst%3DD.%26aulast%3DDoan%26aufirst%3DM.%26aulast%3DDovey%26aufirst%3DHarry%2BF.%26aulast%3DFrigon%26aufirst%3DN.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DJacobson-Croak%26aufirst%3DK.%26aulast%3DJewett%26aufirst%3DN.%26aulast%3DKeim%26aufirst%3DP.%26aulast%3DKnops%26aufirst%3DJ.%26aulast%3DLieberburg%26aufirst%3DI.%26aulast%3DPower%26aufirst%3DM.%26aulast%3DTan%26aufirst%3DH.%26aulast%3DTatsuno%26aufirst%3DG.%26aulast%3DTung%26aufirst%3DJ.%26aulast%3DSchenk%26aufirst%3DD.%26aulast%3DSeubert%26aufirst%3DP.%26aulast%3DSuomensaari%26aufirst%3DS.%2BM.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWalker%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DMcConlogue%26aufirst%3DL.%26aulast%3DJohn%26aufirst%3DV.%26atitle%3DPurification%2520and%2520cloning%2520of%2520amyloid%2520precursor%2520protein%2520%25CE%25B2-secretase%2520from%2520human%2520brain%26jtitle%3DNature%26date%3D1999%26volume%3D402%26spage%3D537%26epage%3D540%26doi%3D10.1038%2F990114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hussain, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howlett, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tew, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meek, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gloger, I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Southan, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmons, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dingwall, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christie, G.</span></span> <span> </span><span class="NLM_article-title">Identification of a novel aspartic protease (Asp 2) as β-secretase</span>. <i>Mol. Cell. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">419</span>– <span class="NLM_lpage">427</span>, <span class="refDoi"> DOI: 10.1006/mcne.1999.0811</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1006%2Fmcne.1999.0811" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10656250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADyaK1MXnt1Chsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1999&pages=419-427&author=I.+Hussainauthor=D.+Powellauthor=D.+R.+Howlettauthor=D.+G.+Tewauthor=T.+D.+Meekauthor=C.+Chapmanauthor=I.+S.+Glogerauthor=K.+E.+Murphyauthor=C.+D.+Southanauthor=D.+M.+Ryanauthor=T.+S.+Smithauthor=D.+L.+Simmonsauthor=F.+S.+Walshauthor=C.+Dingwallauthor=G.+Christie&title=Identification+of+a+novel+aspartic+protease+%28Asp+2%29+as+%CE%B2-secretase&doi=10.1006%2Fmcne.1999.0811"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Novel Aspartic Protease (Asp 2) as β-Secretase</span></div><div class="casAuthors">Hussain, Ishrut; Powell, David; Howlett, David R.; Tew, David G.; Meek, Thomas D.; Chapman, Conrad; Gloger, Israel S.; Murphy, Kay E.; Southan, Christopher D.; Ryan, Dominic M.; Smith, Trudi S.; Simmons, David L.; Walsh, Frank S.; Dingwall, Colin; Christie, Gary</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Neuroscience</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">419-427</span>CODEN:
                <span class="NLM_cas:coden">MOCNED</span>;
        ISSN:<span class="NLM_cas:issn">1044-7431</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">The Alzheimer's disease β-amyloid peptide (Aβ) is produced by excision from the type 1 integral membrane glycoprotein amyloid precursor protein (APP) by the sequential actions of β- and then γ-secretases.  Here we report that Asp 2, a novel transmembrane aspartic protease, has the key activities expected of β-secretase.  Transient expression of Asp 2 in cells expressing APP causes an increase in the secretion of the N-terminal fragment of APP and an increase in the cell-assocd. C-terminal β-secretase APP fragment.  Mutation of either of the putative catalytic aspartyl residues in Asp 2 abrogates the prodn. of the fragments characteristic of cleavage at the β-secretase site.  The enzyme is present in normal and Alzheimer's disease (AD) brain and is also found in cell lines known to produce Aβ.  Asp 2 localizes to the Golgi/endoplasmic reticulum in transfected cells and shows clear colocalization with APP in cells stably expressing the 751-amino-acid isoform of APP.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDUBbUoO6SgLVg90H21EOLACvtfcHk0lgXXksXJveLUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnt1Chsrs%253D&md5=aba834d907c5dae03f060d94729576e9</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1006%2Fmcne.1999.0811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fmcne.1999.0811%26sid%3Dliteratum%253Aachs%26aulast%3DHussain%26aufirst%3DI.%26aulast%3DPowell%26aufirst%3DD.%26aulast%3DHowlett%26aufirst%3DD.%2BR.%26aulast%3DTew%26aufirst%3DD.%2BG.%26aulast%3DMeek%26aufirst%3DT.%2BD.%26aulast%3DChapman%26aufirst%3DC.%26aulast%3DGloger%26aufirst%3DI.%2BS.%26aulast%3DMurphy%26aufirst%3DK.%2BE.%26aulast%3DSouthan%26aufirst%3DC.%2BD.%26aulast%3DRyan%26aufirst%3DD.%2BM.%26aulast%3DSmith%26aufirst%3DT.%2BS.%26aulast%3DSimmons%26aufirst%3DD.%2BL.%26aulast%3DWalsh%26aufirst%3DF.%2BS.%26aulast%3DDingwall%26aufirst%3DC.%26aulast%3DChristie%26aufirst%3DG.%26atitle%3DIdentification%2520of%2520a%2520novel%2520aspartic%2520protease%2520%2528Asp%25202%2529%2520as%2520%25CE%25B2-secretase%26jtitle%3DMol.%2520Cell.%2520Neurosci.%26date%3D1999%26volume%3D14%26spage%3D419%26epage%3D427%26doi%3D10.1006%2Fmcne.1999.0811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bienkowski, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuck, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tory, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pauley, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brashler, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stratman, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathews, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buhl, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomasselli, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parodi, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinrikson, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurney, M. E.</span></span> <span> </span><span class="NLM_article-title">Membrane-anchored aspartyl protease with Alzheimer’s disease β-secretase activity</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>402</i></span>,  <span class="NLM_fpage">533</span>– <span class="NLM_lpage">537</span>, <span class="refDoi"> DOI: 10.1038/990107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1038%2F990107" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=402&publication_year=1999&pages=533-537&author=R.+Yanauthor=M.+J.+Bienkowskiauthor=M.+E.+Shuckauthor=H.+Miaoauthor=M.+C.+Toryauthor=A.+M.+Pauleyauthor=J.+R.+Brashlerauthor=N.+C.+Stratmanauthor=W.+R.+Mathewsauthor=A.+E.+Buhlauthor=D.+B.+Carterauthor=A.+G.+Tomasselliauthor=L.+A.+Parodiauthor=R.+L.+Heinriksonauthor=M.+E.+Gurney&title=Membrane-anchored+aspartyl+protease+with+Alzheimer%E2%80%99s+disease+%CE%B2-secretase+activity&doi=10.1038%2F990107"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6d&amp;dbid=16384&amp;doi=10.1038%2F990107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F990107%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DR.%26aulast%3DBienkowski%26aufirst%3DM.%2BJ.%26aulast%3DShuck%26aufirst%3DM.%2BE.%26aulast%3DMiao%26aufirst%3DH.%26aulast%3DTory%26aufirst%3DM.%2BC.%26aulast%3DPauley%26aufirst%3DA.%2BM.%26aulast%3DBrashler%26aufirst%3DJ.%2BR.%26aulast%3DStratman%26aufirst%3DN.%2BC.%26aulast%3DMathews%26aufirst%3DW.%2BR.%26aulast%3DBuhl%26aufirst%3DA.%2BE.%26aulast%3DCarter%26aufirst%3DD.%2BB.%26aulast%3DTomasselli%26aufirst%3DA.%2BG.%26aulast%3DParodi%26aufirst%3DL.%2BA.%26aulast%3DHeinrikson%26aufirst%3DR.%2BL.%26aulast%3DGurney%26aufirst%3DM.%2BE.%26atitle%3DMembrane-anchored%2520aspartyl%2520protease%2520with%2520Alzheimer%25E2%2580%2599s%2520disease%2520%25CE%25B2-secretase%2520activity%26jtitle%3DNature%26date%3D1999%26volume%3D402%26spage%3D533%26epage%3D537%26doi%3D10.1038%2F990107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koelsch, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Downs, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dashti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J.</span></span> <span> </span><span class="NLM_article-title">Human aspartic protease memapsin 2 cleaves the β-secretase site of β-amyloid precursor protein</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">456</span>– <span class="NLM_lpage">1460</span>, <span class="refDoi"> DOI: 10.1073/pnas.97.4.1456</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1073%2Fpnas.97.4.1456" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=456-1460&author=X.+Linauthor=G.+Koelschauthor=S.+Wuauthor=D.+Downsauthor=A.+Dashtiauthor=J.+Tang&title=Human+aspartic+protease+memapsin+2+cleaves+the+%CE%B2-secretase+site+of+%CE%B2-amyloid+precursor+protein&doi=10.1073%2Fpnas.97.4.1456"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6e&amp;dbid=16384&amp;doi=10.1073%2Fpnas.97.4.1456&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.97.4.1456%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DX.%26aulast%3DKoelsch%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DDowns%26aufirst%3DD.%26aulast%3DDashti%26aufirst%3DA.%26aulast%3DTang%26aufirst%3DJ.%26atitle%3DHuman%2520aspartic%2520protease%2520memapsin%25202%2520cleaves%2520the%2520%25CE%25B2-secretase%2520site%2520of%2520%25CE%25B2-amyloid%2520precursor%2520protein%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2000%26volume%3D97%26spage%3D456%26epage%3D1460%26doi%3D10.1073%2Fpnas.97.4.1456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osswald, H. L.</span></span> <span> </span><span class="NLM_article-title">BACE1 (β-secretase) inhibitors for the treatment of Alzheimer’s disease</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">6765</span>– <span class="NLM_lpage">6813</span>, <span class="refDoi"> DOI: 10.1039/c3cs60460h</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1039%2Fc3cs60460h" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2014&pages=6765-6813&author=A.+K.+Ghoshauthor=H.+L.+Osswald&title=BACE1+%28%CE%B2-secretase%29+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1039%2Fc3cs60460h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1039%2Fc3cs60460h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3cs60460h%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DOsswald%26aufirst%3DH.%2BL.%26atitle%3DBACE1%2520%2528%25CE%25B2-secretase%2529%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2014%26volume%3D43%26spage%3D6765%26epage%3D6813%26doi%3D10.1039%2Fc3cs60460h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatraman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKeever, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dillard, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. B.</span></span> <span> </span><span class="NLM_article-title">Structure based design of β-site APP cleaving enzyme 1 (BACE) inhibitors for the treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4156</span>– <span class="NLM_lpage">4180</span>, <span class="refDoi"> DOI: 10.1021/jm301659n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301659n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4156-4180&author=J.+Yuanauthor=S.+Venkatramanauthor=Y.+Zhengauthor=B.+M.+McKeeverauthor=L.+W.+Dillardauthor=S.+B.+Singh&title=Structure+based+design+of+%CE%B2-site+APP+cleaving+enzyme+1+%28BACE%29+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm301659n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1021%2Fjm301659n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301659n%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DMcKeever%26aufirst%3DB.%2BM.%26aulast%3DDillard%26aufirst%3DL.%2BW.%26aulast%3DSingh%26aufirst%3DS.%2BB.%26atitle%3DStructure%2520based%2520design%2520of%2520%25CE%25B2-site%2520APP%2520cleaving%2520enzyme%25201%2520%2528BACE%2529%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4156%26epage%3D4180%26doi%3D10.1021%2Fjm301659n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Oehlrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokopcova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J. M.</span></span> <span> </span><span class="NLM_article-title">The evolution of amidine-based brain penetrant BACE1 inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2033</span>– <span class="NLM_lpage">2045</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.03.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1016%2Fj.bmcl.2014.03.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=24704031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlvVSqsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2033-2045&author=D.+Oehlrichauthor=H.+Prokopcovaauthor=H.+J.+M.+Gijsen&title=The+evolution+of+amidine-based+brain+penetrant+BACE1+inhibitors&doi=10.1016%2Fj.bmcl.2014.03.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">The evolution of amidine-based brain penetrant BACE1 inhibitors</span></div><div class="casAuthors">Oehlrich, Daniel; Prokopcova, Hana; Gijsen, Harrie J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2033-2045</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Beta site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors hold great potential as disease modifying anti-Alzheimer's drugs.  This digest provides an overview of the amidine contg. class of BACE1 inhibitors, of which multiple examples are now progressing through clin. trials.  The various structural modifications highlight the struggle to combine potency with the optimal properties for a brain penetrant BACE1 inhibitor, and illustrate the crowded competitive landscape.  This overview concludes with a summary of potential issues including substrate and target selectivity and a synopsis of the status of the current and past clin. assets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-4h1WxzUvbbVg90H21EOLACvtfcHk0lgv-3hZMCPiFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlvVSqsrY%253D&md5=a929f7f1be0c7d2ff1a10fc5853de06b</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.03.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.03.025%26sid%3Dliteratum%253Aachs%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DProkopcova%26aufirst%3DH.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26atitle%3DThe%2520evolution%2520of%2520amidine-based%2520brain%2520penetrant%2520BACE1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D2033%26epage%3D2045%26doi%3D10.1016%2Fj.bmcl.2014.03.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Hall, A.</span>; <span class="NLM_string-name">Gijsen, H. J. M.</span></span> <span> </span><span class="NLM_article-title">Targeting β-secretase (BACE) for the treatment of Alzheimer’s disease</span>. In  <i>Comprehensive Medicinal Chemistry III</i>, <span class="NLM_edition">3</span>rd ed.; <span class="NLM_contrib-group"><span class="NLM_string-name">Chackalamannil, S.</span>, <span class="NLM_string-name">Rotella, D. P.</span>, <span class="NLM_string-name">Ward, S. E.</span></span>, Eds.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">Oxford</span>, <span class="NLM_year">2017</span>; Vol.  <span class="NLM_volume">7</span>, pp  <span class="NLM_fpage">326</span>– <span class="NLM_lpage">383</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1016%2FB978-0-12-409547-2.13809-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=326-383&author=A.+Hall&author=H.+J.+M.+Gijsenauthor=S.+Chackalamannil&author=D.+P.+Rotella&author=S.+E.+Ward&title=Comprehensive+Medicinal+Chemistry+III"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-409547-2.13809-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-409547-2.13809-0%26sid%3Dliteratum%253Aachs%26aulast%3DHall%26aufirst%3DA.%26atitle%3DTargeting%2520%25CE%25B2-secretase%2520%2528BACE%2529%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26btitle%3DComprehensive%2520Medicinal%2520Chemistry%2520III%26aulast%3DChackalamannil%26aufirst%3DS.%26pub%3DElsevier%26date%3D2017%26volume%3D7%26spage%3D326%26epage%3D383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hsiao, C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rombouts, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J. M.</span></span> <span> </span><span class="NLM_article-title">New evolutions in the BACE1 inhibitor field from 2014 to 2018</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">761</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.12.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1016%2Fj.bmcl.2018.12.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=30709653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlCmu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2019&pages=761&author=C.-C.+Hsiaoauthor=F.+Romboutsauthor=H.+J.+M.+Gijsen&title=New+evolutions+in+the+BACE1+inhibitor+field+from+2014+to+2018&doi=10.1016%2Fj.bmcl.2018.12.049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8cR"><div class="casContent"><span class="casTitleNuber">8c</span><div class="casTitle"><span class="NLM_cas:atitle">New evolutions in the BACE1 inhibitor field from 2014 to 2018</span></div><div class="casAuthors">Hsiao, Chien-Chi; Rombouts, Frederik; Gijsen, Harrie J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">761-777</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  β-Site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors offer the potential of disease-modifying treatment for Alzheimer's disease (AD).  Since 2014, major breakthroughs have appeared in the field of BACE1 inhibitors.  This review provides an overview of amidine-based BACE1 inhibitors between 2014 and 2018.  Herein are summarized (i) the structure-activity relationship, (ii) the physiol. results and (iii) the potential risks from a lack of selectivity.  This review also summarizes clin. scope, results and outlook of the compds. that have been or are currently under development in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3OfI_B-BJ-LVg90H21EOLACvtfcHk0lj8Mbt1b0U1sA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlCmu7s%253D&md5=049eda6ce97b31a04b5b579afd3e11e5</span></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.12.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.12.049%26sid%3Dliteratum%253Aachs%26aulast%3DHsiao%26aufirst%3DC.-C.%26aulast%3DRombouts%26aufirst%3DF.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26atitle%3DNew%2520evolutions%2520in%2520the%2520BACE1%2520inhibitor%2520field%2520from%25202014%2520to%25202018%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D29%26spage%3D761%26doi%3D10.1016%2Fj.bmcl.2018.12.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittington, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dineen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epstein, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graceffa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiang, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahl, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R. T.</span></span> <span> </span><span class="NLM_article-title">Structure- and property-based design of aminooxazoline xanthenes as selective, orally efficacious, and CNS penetrable BACE inhibitors for the treatment of alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9156</span>– <span class="NLM_lpage">9169</span>, <span class="refDoi"> DOI: 10.1021/jm300598e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300598e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1yhsLjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9156-9169&author=H.+Huangauthor=D.+S.+Laauthor=A.+C.+Chengauthor=D.+A.+Whittingtonauthor=V.+F.+Patelauthor=K.+Chenauthor=T.+A.+Dineenauthor=O.+Epsteinauthor=R.+Graceffaauthor=D.+Hickmanauthor=Y.-H.+Kiangauthor=S.+Louieauthor=Y.+Luoauthor=R.+C.+Wahlauthor=P.+H.+Wenauthor=S.+Woodauthor=R.+T.+Fremeau&title=Structure-+and+property-based+design+of+aminooxazoline+xanthenes+as+selective%2C+orally+efficacious%2C+and+CNS+penetrable+BACE+inhibitors+for+the+treatment+of+alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm300598e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Structure- and property-based design of aminooxazoline xanthenes as selective, orally efficacious, and CNS penetrable BACE inhibitors for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Huang, Hongbing; La, Daniel S.; Cheng, Alan C.; Whittington, Douglas A.; Patel, Vinod F.; Chen, Kui; Dineen, Thomas A.; Epstein, Oleg; Graceffa, Russell; Hickman, Dean; Kiang, Y.-H.; Louie, Steven; Luo, Yi; Wahl, Robert C.; Wen, Paul H.; Wood, Stephen; Fremeau, Robert T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9156-9169</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A structure- and property-based drug design approach was employed to identify aminooxazoline xanthenes as potent and selective human β-secretase inhibitors.  These compds. exhibited good isolated enzyme, cell potency, and selectivity against the structurally related aspartyl protease cathepsin D.  Our efforts resulted in the identification of a potent, orally bioavailable CNS penetrant compd. that exhibited in vivo efficacy.  A single oral dose of compd. (I) resulted in a significant redn. of CNS Aβ40 in naive rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDEYfU4moxMbVg90H21EOLACvtfcHk0lj8Mbt1b0U1sA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1yhsLjJ&md5=0ecd50ec1ea82a058e499bb712c45272</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1021%2Fjm300598e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300598e%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DCheng%26aufirst%3DA.%2BC.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DEpstein%26aufirst%3DO.%26aulast%3DGraceffa%26aufirst%3DR.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DKiang%26aufirst%3DY.-H.%26aulast%3DLouie%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26atitle%3DStructure-%2520and%2520property-based%2520design%2520of%2520aminooxazoline%2520xanthenes%2520as%2520selective%252C%2520orally%2520efficacious%252C%2520and%2520CNS%2520penetrable%2520BACE%2520inhibitors%2520for%2520the%2520treatment%2520of%2520alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9156%26epage%3D9169%26doi%3D10.1021%2Fjm300598e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Swahn, B.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolmodin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlström, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Berg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Söderman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holenz, Jörg</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindström, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundström, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turek, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kihlström, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slivo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyring, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotticci, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Öhberg, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kers, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Kieseritzky, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, L.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eketjäll, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgievska, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeppsson, F.</span></span> <span> </span><span class="NLM_article-title">Design and Synthesis of β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1) Inhibitors with in Vivo Brain Reduction of β-Amyloid Peptides</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9346</span>– <span class="NLM_lpage">9361</span>, <span class="refDoi"> DOI: 10.1021/jm3009025</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3009025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1OmtL%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9346-9361&author=B.-M.+Swahnauthor=K.+Kolmodinauthor=S.+Karlstr%C3%B6mauthor=S.+von+Bergauthor=P.+S%C3%B6dermanauthor=J%C3%B6rg+Holenzauthor=S.+Bergauthor=J.+Lindstr%C3%B6mauthor=M.+Sundstr%C3%B6mauthor=D.+Turekauthor=J.+Kihlstr%C3%B6mauthor=C.+Slivoauthor=L.+Anderssonauthor=D.+Pyringauthor=D.+Rotticciauthor=L.+%C3%96hbergauthor=A.+Kersauthor=K.+Bogarauthor=F.+von+Kieseritzkyauthor=M.+Berghauthor=L.-L.+Olssonauthor=J.+Jansonauthor=S.+Eketj%C3%A4llauthor=B.+Georgievskaauthor=F.+Jeppsson&title=Design+and+Synthesis+of+%CE%B2-Site+Amyloid+Precursor+Protein+Cleaving+Enzyme+%28BACE1%29+Inhibitors+with+in+Vivo+Brain+Reduction+of+%CE%B2-Amyloid+Peptides&doi=10.1021%2Fjm3009025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1) Inhibitors with in Vivo Brain Reduction of β-Amyloid Peptides</span></div><div class="casAuthors">Swahn, Britt-Marie; Kolmodin, Karin; Karlstroem, Sofia; von Berg, Stefan; Soederman, Peter; Holenz, Joerg; Berg, Stefan; Lindstroem, Johan; Sundstroem, Marie; Turek, Dominika; Kihlstroem, Jacob; Slivo, Can; Andersson, Lars; Pyring, David; Rotticci, Didier; Oehberg, Liselotte; Kers, Annika; Bogar, Krisztian; Bergh, Margareta; Olsson, Lise-Lotte; Janson, Juliette; Eketjaell, Susanna; Georgievska, Biljana; Jeppsson, Fredrik; Faelting, Johanna</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9346-9361</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The evaluation of a series of aminoisoindoles as β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors and the discovery of a clin. candidate drug for Alzheimer's disease, (S)-32 (I, AZD3839), are described.  The improvement in permeability properties by the introduction of fluorine adjacent to the amidine moiety, resulting in in vivo brain redn. of Aβ40, is discussed.  Due to the basic nature of these compds., they displayed affinity for the human ether-a-go-go related gene (hERG) ion channel.  Different ways to reduce hERG inhibition and increase hERG margins for this series are described, culminating in (S)-16 (II) and (R)-41 (III) showing large in vitro margins with BACE1 cell IC50 values of 8.6 and 0.16 nM, resp., and hERG IC50 values of 16 and 2.8 μM, resp.  Several compds. were advanced into pharmacodynamic studies and demonstrated significant redn. of β-amyloid peptides in mouse brain following oral dosing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox062OT8a6ubVg90H21EOLACvtfcHk0lj8Mbt1b0U1sA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1OmtL%252FM&md5=da7685d90f56449caa77b6e6393e0a7d</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1021%2Fjm3009025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3009025%26sid%3Dliteratum%253Aachs%26aulast%3DSwahn%26aufirst%3DB.-M.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DKarlstr%25C3%25B6m%26aufirst%3DS.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3DS%25C3%25B6derman%26aufirst%3DP.%26aulast%3DHolenz%26aufirst%3DJ%25C3%25B6rg%26aulast%3DBerg%26aufirst%3DS.%26aulast%3DLindstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DSundstr%25C3%25B6m%26aufirst%3DM.%26aulast%3DTurek%26aufirst%3DD.%26aulast%3DKihlstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DSlivo%26aufirst%3DC.%26aulast%3DAndersson%26aufirst%3DL.%26aulast%3DPyring%26aufirst%3DD.%26aulast%3DRotticci%26aufirst%3DD.%26aulast%3D%25C3%2596hberg%26aufirst%3DL.%26aulast%3DKers%26aufirst%3DA.%26aulast%3DBogar%26aufirst%3DK.%26aulast%3Dvon%2BKieseritzky%26aufirst%3DF.%26aulast%3DBergh%26aufirst%3DM.%26aulast%3DOlsson%26aufirst%3DL.-L.%26aulast%3DJanson%26aufirst%3DJ.%26aulast%3DEketj%25C3%25A4ll%26aufirst%3DS.%26aulast%3DGeorgievska%26aufirst%3DB.%26aulast%3DJeppsson%26aufirst%3DF.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520%25CE%25B2-Site%2520Amyloid%2520Precursor%2520Protein%2520Cleaving%2520Enzyme%2520%2528BACE1%2529%2520Inhibitors%2520with%2520in%2520Vivo%2520Brain%2520Reduction%2520of%2520%25CE%25B2-Amyloid%2520Peptides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9346%26epage%3D9361%26doi%3D10.1021%2Fjm3009025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit9c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mandal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickland, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzola, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grzelak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terracina, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuvelkar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Favreau, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buevich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voigt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazakevich, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKittrick, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenlee, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamford, A. W.</span></span> <span> </span><span class="NLM_article-title">Design and validation of bicyclic iminopyrimidinones as beta amyloid cleaving enzyme-1 (BACE1) inhibitors: Conformational constraint to favor a bioactive conformation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9331</span>– <span class="NLM_lpage">9345</span>, <span class="refDoi"> DOI: 10.1021/jm301039c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301039c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGktb%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9331-9345&author=M.+Mandalauthor=Z.+Zhuauthor=J.+N.+Cummingauthor=X.+Liuauthor=C.+Stricklandauthor=R.+D.+Mazzolaauthor=J.+P.+Caldwellauthor=P.+Leachauthor=M.+Grzelakauthor=L.+Hydeauthor=Q.+Zhangauthor=G.+Terracinaauthor=L.+Zhangauthor=X.+Chenauthor=R.+Kuvelkarauthor=M.+E.+Kennedyauthor=L.+Favreauauthor=K.+Coxauthor=P.+Orthauthor=A.+Buevichauthor=J.+Voigtauthor=H.+Wangauthor=I.+Kazakevichauthor=B.+A.+McKittrickauthor=W.+Greenleeauthor=E.+M.+Parkerauthor=A.+W.+Stamford&title=Design+and+validation+of+bicyclic+iminopyrimidinones+as+beta+amyloid+cleaving+enzyme-1+%28BACE1%29+inhibitors%3A+Conformational+constraint+to+favor+a+bioactive+conformation&doi=10.1021%2Fjm301039c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9cR"><div class="casContent"><span class="casTitleNuber">9c</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Validation of Bicyclic Iminopyrimidinones As Beta Amyloid Cleaving Enzyme-1 (BACE1) Inhibitors: Conformational Constraint to Favor a Bioactive Conformation</span></div><div class="casAuthors">Mandal, Mihirbaran; Zhu, Zhaoning; Cumming, Jared N.; Liu, Xiaoxiang; Strickland, Corey; Mazzola, Robert D.; Caldwell, John P.; Leach, Prescott; Grzelak, Michael; Hyde, Lynn; Zhang, Qi; Terracina, Giuseppe; Zhang, Lili; Chen, Xia; Kuvelkar, Reshma; Kennedy, Matthew E.; Favreau, Leonard; Cox, Kathleen; Orth, Peter; Buevich, Alexei; Voigt, Johannes; Wang, Hongwu; Kazakevich, Irina; McKittrick, Brian A.; Greenlee, William; Parker, Eric M.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9331-9345</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">On the basis of our observation that the biaryl substituent of iminopyrimidinone 7 must be in a pseudoaxial conformation to occupy the contiguous S1-S3 subsites of BACE1, we have designed a novel fused bicyclic iminopyrimidinone scaffold intended to favor this bioactive conformation.  Strategic incorporation of a nitrogen atom in the new constrained ring allowed us to develop SAR around the S2' binding pocket and ultimately resulted in analogs with low nanomolar potency for BACE1.  In particular, optimization of the prime side substituent led to major improvements in potency by displacement of two conserved water mols. from a region near S2'.  Further optimization of the pharmacokinetic properties of this fused pyrrolidine series, in conjunction with facile access to a rat pharmacodynamic model, led to identification of compd. 43, which is an orally active, brain penetrant inhibitor that reduces Aβ40 in the plasma, CSF, and cortex of rats in a dose-dependent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprlJsgY-3wuLVg90H21EOLACvtfcHk0lguoxVxbyLi3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGktb%252FP&md5=6fd0bc5ac847ded7e235939594d4b20d</span></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=10.1021%2Fjm301039c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301039c%26sid%3Dliteratum%253Aachs%26aulast%3DMandal%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DMazzola%26aufirst%3DR.%2BD.%26aulast%3DCaldwell%26aufirst%3DJ.%2BP.%26aulast%3DLeach%26aufirst%3DP.%26aulast%3DGrzelak%26aufirst%3DM.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DTerracina%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DBuevich%26aufirst%3DA.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DDesign%2520and%2520validation%2520of%2520bicyclic%2520iminopyrimidinones%2520as%2520beta%2520amyloid%2520cleaving%2520enzyme-1%2520%2528BACE1%2529%2520inhibitors%253A%2520Conformational%2520constraint%2520to%2520favor%2520a%2520bioactive%2520conformation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9331%26epage%3D9345%26doi%3D10.1021%2Fjm301039c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit9d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hunt, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watts, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vigers, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metcalf, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunawardana, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burkard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geck Do, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutcher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rana, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallan, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeLisle, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regal, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sammond, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groneberg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Purkey, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyssikatos, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marlow, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, T. P.</span></span> <span> </span><span class="NLM_article-title">Spirocyclic β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors: From hit to lowering of cerebrospinal fluid (CSF) amyloid β in a higher species</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3379</span>– <span class="NLM_lpage">3403</span>, <span class="refDoi"> DOI: 10.1021/jm4002154</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4002154" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC3sXkslagsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3379-3403&author=K.+W.+Huntauthor=A.+W.+Cookauthor=R.+J.+Wattsauthor=C.+T.+Clarkauthor=G.+Vigersauthor=D.+Smithauthor=A.+T.+Metcalfauthor=I.+W.+Gunawardanaauthor=M.+Burkardauthor=A.+A.+Coxauthor=M.+K.+Geck+Doauthor=D.+Dutcherauthor=A.+A.+Thomasauthor=S.+Ranaauthor=N.+C.+Kallanauthor=R.+K.+DeLisleauthor=J.+P.+Rizziauthor=K.+Regalauthor=D.+Sammondauthor=R.+Gronebergauthor=M.+Siuauthor=H.+Purkeyauthor=J.+P.+Lyssikatosauthor=A.+Marlowauthor=X.+Liuauthor=T.+P.+Tangauthor=T.+P.+Tang&title=Spirocyclic+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+1+%28BACE1%29+inhibitors%3A+From+hit+to+lowering+of+cerebrospinal+fluid+%28CSF%29+amyloid+%CE%B2+in+a+higher+species&doi=10.1021%2Fjm4002154"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9dR"><div class="casContent"><span class="casTitleNuber">9d</span><div class="casTitle"><span class="NLM_cas:atitle">Spirocyclic β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors: From Hit to Lowering of Cerebrospinal Fluid (CSF) Amyloid β in a Higher Species</span></div><div class="casAuthors">Hunt, Kevin W.; Cook, Adam W.; Watts, Ryan J.; Clark, Christopher T.; Vigers, Guy; Smith, Darin; Metcalf, Andrew T.; Gunawardana, Indrani W.; Burkard, Michael; Cox, April A.; Geck Do, Mary K.; Dutcher, Darrin; Thomas, Allen A.; Rana, Sumeet; Kallan, Nicholas C.; DeLisle, Robert K.; Rizzi, James P.; Regal, Kelly; Sammond, Douglas; Groneberg, Robert; Siu, Michael; Purkey, Hans; Lyssikatos, Joseph P.; Marlow, Allison; Liu, Xingrong; Tang, Tony P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3379-3403</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A hallmark of Alzheimer's disease is the brain deposition of amyloid beta (Aβ), a peptide of 36-43 amino acids that is likely a primary driver of neurodegeneration.  Aβ is produced by the sequential cleavage of APP by BACE1 and γ-secretase; therefore, inhibition of BACE1 represents an attractive therapeutic target to slow or prevent Alzheimer's disease.  Herein are described BACE1 inhibitors with limited mol. flexibility and mol. wt. that decrease CSF Aβ in vivo, despite efflux.  Starting with spirocycle I, the authors explore structure-activity relationships of core changes, P3 moieties, and Asp binding functional groups in order to optimize BACE1 affinity, cathepsin D selectivity, and blood-brain barrier (BBB) penetration.  Using wild type guinea pig and rat, they demonstrate a PK/PD relationship between free drug concns. in the brain and CSF Aβ lowering.  Optimization of brain exposure led to the discovery of (R)-II which reduced CSF Aβ in rodents and in monkey.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYTaFN1ZrY-bVg90H21EOLACvtfcHk0lguoxVxbyLi3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXkslagsLg%253D&md5=b0f610967870013abee4a4bf4ce28b7f</span></div><a href="/servlet/linkout?suffix=cit9d&amp;dbid=16384&amp;doi=10.1021%2Fjm4002154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4002154%26sid%3Dliteratum%253Aachs%26aulast%3DHunt%26aufirst%3DK.%2BW.%26aulast%3DCook%26aufirst%3DA.%2BW.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DClark%26aufirst%3DC.%2BT.%26aulast%3DVigers%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DMetcalf%26aufirst%3DA.%2BT.%26aulast%3DGunawardana%26aufirst%3DI.%2BW.%26aulast%3DBurkard%26aufirst%3DM.%26aulast%3DCox%26aufirst%3DA.%2BA.%26aulast%3DGeck%2BDo%26aufirst%3DM.%2BK.%26aulast%3DDutcher%26aufirst%3DD.%26aulast%3DThomas%26aufirst%3DA.%2BA.%26aulast%3DRana%26aufirst%3DS.%26aulast%3DKallan%26aufirst%3DN.%2BC.%26aulast%3DDeLisle%26aufirst%3DR.%2BK.%26aulast%3DRizzi%26aufirst%3DJ.%2BP.%26aulast%3DRegal%26aufirst%3DK.%26aulast%3DSammond%26aufirst%3DD.%26aulast%3DGroneberg%26aufirst%3DR.%26aulast%3DSiu%26aufirst%3DM.%26aulast%3DPurkey%26aufirst%3DH.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26aulast%3DMarlow%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DTang%26aufirst%3DT.%2BP.%26aulast%3DTang%26aufirst%3DT.%2BP.%26atitle%3DSpirocyclic%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%2520inhibitors%253A%2520From%2520hit%2520to%2520lowering%2520of%2520cerebrospinal%2520fluid%2520%2528CSF%2529%2520amyloid%2520%25CE%25B2%2520in%2520a%2520higher%2520species%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3379%26epage%3D3403%26doi%3D10.1021%2Fjm4002154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit9e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dineen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derakhchan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epstein, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esmay, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreiman, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahl, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittington, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V. F.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of β-site amyloid precursor protein cleaving enzyme (BACE1): Identification of (<i>S</i>)-7-(2-fluoropyridin-3-yl)-3-((3-methyloxetan-3-yl)ethynyl)-5’H-spiro[chromeno[2,3-b]pyridine-5,4’-oxazol]-2’-amine (AMG-8718)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">9811</span>– <span class="NLM_lpage">9831</span>, <span class="refDoi"> DOI: 10.1021/jm5012676</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5012676" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9811-9831&author=T.+A.+Dineenauthor=K.+Chenauthor=A.+C.+Chengauthor=K.+Derakhchanauthor=O.+Epsteinauthor=J.+Esmayauthor=D.+Hickmanauthor=C.+E.+Kreimanauthor=I.+E.+Marxauthor=R.+C.+Wahlauthor=P.+H.+Wenauthor=M.+M.+Weissauthor=D.+A.+Whittingtonauthor=S.+Woodauthor=R.+T.+Fremeauauthor=R.+D.+Whiteauthor=V.+F.+Patel&title=Inhibitors+of+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+%28BACE1%29%3A+Identification+of+%28S%29-7-%282-fluoropyridin-3-yl%29-3-%28%283-methyloxetan-3-yl%29ethynyl%29-5%E2%80%99H-spiro%5Bchromeno%5B2%2C3-b%5Dpyridine-5%2C4%E2%80%99-oxazol%5D-2%E2%80%99-amine+%28AMG-8718%29&doi=10.1021%2Fjm5012676"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9e&amp;dbid=16384&amp;doi=10.1021%2Fjm5012676&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5012676%26sid%3Dliteratum%253Aachs%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DCheng%26aufirst%3DA.%2BC.%26aulast%3DDerakhchan%26aufirst%3DK.%26aulast%3DEpstein%26aufirst%3DO.%26aulast%3DEsmay%26aufirst%3DJ.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DKreiman%26aufirst%3DC.%2BE.%26aulast%3DMarx%26aufirst%3DI.%2BE.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26aulast%3DWhite%26aufirst%3DR.%2BD.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26atitle%3DInhibitors%2520of%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%2520%2528BACE1%2529%253A%2520Identification%2520of%2520%2528S%2529-7-%25282-fluoropyridin-3-yl%2529-3-%2528%25283-methyloxetan-3-yl%2529ethynyl%2529-5%25E2%2580%2599H-spiro%255Bchromeno%255B2%252C3-b%255Dpyridine-5%252C4%25E2%2580%2599-oxazol%255D-2%25E2%2580%2599-amine%2520%2528AMG-8718%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9811%26epage%3D9831%26doi%3D10.1021%2Fjm5012676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit9f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Brodney, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barreiro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riddell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parris, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolan, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atchison, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robshaw, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doran, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bundesmann, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buzon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutra, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henegar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaChapelle, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandit, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lira, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Alsina, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikochik, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogilvie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakya, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, B. T.</span></span> <span> </span><span class="NLM_article-title">Utilizing structures of CYP2D6 and BACE1 complexes to reduce risk of drug-drug interactions with a novel series of centrally efficacious BACE1 inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3223</span>– <span class="NLM_lpage">3252</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00191</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00191" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC2MXksFynsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3223-3252&author=M.+A.+Brodneyauthor=E.+M.+Beckauthor=C.+R.+Butlerauthor=G.+Barreiroauthor=E.+F.+Johnsonauthor=D.+Riddellauthor=K.+Parrisauthor=C.+E.+Nolanauthor=Y.+Fanauthor=K.+Atchisonauthor=C.+Gonzalesauthor=A.+E.+Robshawauthor=S.+D.+Doranauthor=M.+W.+Bundesmannauthor=L.+Buzonauthor=J.+Dutraauthor=K.+Henegarauthor=E.+LaChapelleauthor=X.+Houauthor=B.+N.+Rogersauthor=J.+Panditauthor=R.+Liraauthor=L.+Martinez-Alsinaauthor=P.+Mikochikauthor=J.+C.+Murrayauthor=K.+Ogilvieauthor=L.+Priceauthor=S.+M.+Sakyaauthor=A.+Yuauthor=Y.+Zhangauthor=B.+T.+O%E2%80%99Neill&title=Utilizing+structures+of+CYP2D6+and+BACE1+complexes+to+reduce+risk+of+drug-drug+interactions+with+a+novel+series+of+centrally+efficacious+BACE1+inhibitors&doi=10.1021%2Facs.jmedchem.5b00191"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9fR"><div class="casContent"><span class="casTitleNuber">9f</span><div class="casTitle"><span class="NLM_cas:atitle">Utilizing Structures of CYP2D6 and BACE1 Complexes To Reduce Risk of Drug-Drug Interactions with a Novel Series of Centrally Efficacious BACE1 Inhibitors</span></div><div class="casAuthors">Brodney, Michael A.; Beck, Elizabeth M.; Butler, Christopher R.; Barreiro, Gabriela; Johnson, Eric F.; Riddell, David; Parris, Kevin; Nolan, Charles E.; Fan, Ying; Atchison, Kevin; Gonzales, Cathleen; Robshaw, Ashley E.; Doran, Shawn D.; Bundesmann, Mark W.; Buzon, Leanne; Dutra, Jason; Henegar, Kevin; LaChapelle, Erik; Hou, Xinjun; Rogers, Bruce N.; Pandit, Jayvardhan; Lira, Ricardo; Martinez-Alsina, Luis; Mikochik, Peter; Murray, John C.; Ogilvie, Kevin; Price, Loren; Sakya, Subas M.; Yu, Aijia; Zhang, Yong; O'Neill, Brian T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3223-3252</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In recent years, the first generation of β-secretase (BACE1) inhibitors advanced into clin. development for the treatment of Alzheimer's disease (AD).  However, the alignment of drug-like properties and selectivity remains a major challenge.  Herein, we describe the discovery of a novel class of potent, low clearance, CNS penetrant BACE1 inhibitors represented by thioamidine 5.  Further profiling suggested that a high fraction of the metab. (>95%) was due to CYP2D6, increasing the potential risk for victim-based drug-drug interactions (DDI) and variable exposure in the clinic due to the polymorphic nature of this enzyme.  To guide future design, we solved crystal structures of CYP2D6 complexes with substrate 5 and its corresponding metabolic product pyrazole 6, which provided insight into the binding mode and movements between substrate/inhibitor complexes.  Guided by the BACE1 and CYP2D6 crystal structures, we designed and synthesized analogs with reduced risk for DDI, central efficacy, and improved hERG therapeutic margins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsRdq_8px-VLVg90H21EOLACvtfcHk0lilEa527j_oLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXksFynsL4%253D&md5=ed44904d0e55c74417a6874c1454683c</span></div><a href="/servlet/linkout?suffix=cit9f&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00191%26sid%3Dliteratum%253Aachs%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DButler%26aufirst%3DC.%2BR.%26aulast%3DBarreiro%26aufirst%3DG.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DRiddell%26aufirst%3DD.%26aulast%3DParris%26aufirst%3DK.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DAtchison%26aufirst%3DK.%26aulast%3DGonzales%26aufirst%3DC.%26aulast%3DRobshaw%26aufirst%3DA.%2BE.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DBundesmann%26aufirst%3DM.%2BW.%26aulast%3DBuzon%26aufirst%3DL.%26aulast%3DDutra%26aufirst%3DJ.%26aulast%3DHenegar%26aufirst%3DK.%26aulast%3DLaChapelle%26aufirst%3DE.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DLira%26aufirst%3DR.%26aulast%3DMartinez-Alsina%26aufirst%3DL.%26aulast%3DMikochik%26aufirst%3DP.%26aulast%3DMurray%26aufirst%3DJ.%2BC.%26aulast%3DOgilvie%26aufirst%3DK.%26aulast%3DPrice%26aufirst%3DL.%26aulast%3DSakya%26aufirst%3DS.%2BM.%26aulast%3DYu%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26atitle%3DUtilizing%2520structures%2520of%2520CYP2D6%2520and%2520BACE1%2520complexes%2520to%2520reduce%2520risk%2520of%2520drug-drug%2520interactions%2520with%2520a%2520novel%2520series%2520of%2520centrally%2520efficacious%2520BACE1%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3223%26epage%3D3252%26doi%3D10.1021%2Facs.jmedchem.5b00191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit9g"><span><span class="NLM_label">(g) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guernon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClure, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajamani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camac, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toyn, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahlijanian, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albright, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macor, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, L. A.</span></span> <span> </span><span class="NLM_article-title">Targeting the BACE1 active site flap leads to a potent inhibitor that elicits robust brain Aβ reduction in rodents</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">271</span>– <span class="NLM_lpage">276</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00432</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00432" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC28XmslensA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=271-276&author=Y.-J.+Wuauthor=J.+Guernonauthor=F.+Yangauthor=L.+Snyderauthor=J.+Shiauthor=A.+McClureauthor=R.+Rajamaniauthor=H.+Parkauthor=A.+Ngauthor=H.+Lewisauthor=C.+Changauthor=D.+Camacauthor=J.+H.+Toynauthor=M.+K.+Ahlijanianauthor=C.+F.+Albrightauthor=J.+E.+Macorauthor=L.+A.+Thompson&title=Targeting+the+BACE1+active+site+flap+leads+to+a+potent+inhibitor+that+elicits+robust+brain+A%CE%B2+reduction+in+rodents&doi=10.1021%2Facsmedchemlett.5b00432"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9gR"><div class="casContent"><span class="casTitleNuber">9g</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the BACE1 Active Site Flap Leads to a Potent Inhibitor That Elicits Robust Brain Aβ Reduction in Rodents</span></div><div class="casAuthors">Wu, Yong-Jin; Guernon, Jason; Yang, Fukang; Snyder, Lawrence; Shi, Jianliang; McClure, Andrea; Rajamani, Ramkumar; Park, Hyunsoo; Ng, Alicia; Lewis, Hal; Chang, Chieh Ying; Camac, Dan; Toyn, Jeremy H.; Ahlijanian, Michael K.; Albright, Charles F.; Macor, John E.; Thompson, Lorin A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">271-276</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">By targeting the flap backbone of the BACE1 active site, the authors discovered 6-dimethylisoxazole-substituted biaryl aminothiazine I with 34-fold improved BACE1 inhibitory activity over the lead compd.  The cocrystal structure of I bound to the active site indicated two hydrogen-bond interactions between the dimethylisoxazole and threonine 72 and glutamine 73 of the flap.  Incorporation of the dimethylisoxazole substitution onto the related aminothiazine carboxamide series led to pyrazine-carboxamide II as a very potent BACE1 inhibitor (IC50 < 1 nM).  This compd. demonstrated robust brain Aβ redn. in rat dose-response studies.  Thus, compd. II may be useful in testing the amyloid hypothesis of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9dTGWVgGmmrVg90H21EOLACvtfcHk0lilEa527j_oLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmslensA%253D%253D&md5=b1bd7b0b6cb22ca8d2f49807b905daa9</span></div><a href="/servlet/linkout?suffix=cit9g&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00432%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.-J.%26aulast%3DGuernon%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DSnyder%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DMcClure%26aufirst%3DA.%26aulast%3DRajamani%26aufirst%3DR.%26aulast%3DPark%26aufirst%3DH.%26aulast%3DNg%26aufirst%3DA.%26aulast%3DLewis%26aufirst%3DH.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DCamac%26aufirst%3DD.%26aulast%3DToyn%26aufirst%3DJ.%2BH.%26aulast%3DAhlijanian%26aufirst%3DM.%2BK.%26aulast%3DAlbright%26aufirst%3DC.%2BF.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26aulast%3DThompson%26aufirst%3DL.%2BA.%26atitle%3DTargeting%2520the%2520BACE1%2520active%2520site%2520flap%2520leads%2520to%2520a%2520potent%2520inhibitor%2520that%2520elicits%2520robust%2520brain%2520A%25CE%25B2%2520reduction%2520in%2520rodents%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D271%26epage%3D276%26doi%3D10.1021%2Facsmedchemlett.5b00432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit9h"><span><span class="NLM_label">(h) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Rombouts, F. J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tresadern, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martínez-Lamenca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Gool, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Molina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso de Diego, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oehlrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokopcova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borghys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Brandt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surkyn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Cleyn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moechars, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trabanco, A. A.</span></span> <span> </span><span class="NLM_article-title">1,4-Oxazine β-secretase 1 (BACE1) inhibitors: From hit generation to orally bioavailable brain penetrant leads</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8216</span>– <span class="NLM_lpage">8235</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01101</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01101" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9h&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFWktL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8216-8235&author=F.+J.+R.+Romboutsauthor=G.+Tresadernauthor=O.+Delgadoauthor=C.+Mart%C3%ADnez-Lamencaauthor=M.+Van+Goolauthor=A.+Garc%C3%ADa-Molinaauthor=S.+A.+Alonso+de+Diegoauthor=D.+Oehlrichauthor=H.+Prokopcovaauthor=J.+M.+Alonsoauthor=N.+Austinauthor=H.+Borghysauthor=S.+Van+Brandtauthor=M.+Surkynauthor=M.+De+Cleynauthor=A.+Vosauthor=R.+Alexanderauthor=G.+Macdonaldauthor=D.+Moecharsauthor=H.+Gijsenauthor=A.+A.+Trabanco&title=1%2C4-Oxazine+%CE%B2-secretase+1+%28BACE1%29+inhibitors%3A+From+hit+generation+to+orally+bioavailable+brain+penetrant+leads&doi=10.1021%2Facs.jmedchem.5b01101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9hR"><div class="casContent"><span class="casTitleNuber">9h</span><div class="casTitle"><span class="NLM_cas:atitle">1,4-Oxazine β-Secretase 1 (BACE1) Inhibitors: From Hit Generation to Orally Bioavailable Brain Penetrant Leads</span></div><div class="casAuthors">Rombouts, Frederik J. R.; Tresadern, Gary; Delgado, Oscar; Martinez-Lamenca, Carolina; Van Gool, Michiel; Garcia-Molina, Aranzazu; Alonso de Diego, Sergio A.; Oehlrich, Daniel; Prokopcova, Hana; Alonso, Jose Manuel; Austin, Nigel; Borghys, Herman; Van Brandt, Sven; Surkyn, Michel; De Cleyn, Michel; Vos, Ann; Alexander, Richard; Macdonald, Gregor; Moechars, Dieder; Gijsen, Harrie; Trabanco, Andres A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8216-8235</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">1,4-Oxazines are presented, which show good in vitro inhibition in enzymic and cellular BACE1 assays.  We describe lead optimization focused on reducing the amidine pKa while optimizing interactions in the BACE1 active site.  Our strategy permitted modulation of properties such as permeation and esp. P-glycoprotein efflux.  This led to compds. which were orally bioavailable, centrally active, and which demonstrated robust lowering of brain and CSF Aβ levels, resp., in mouse and dog models.  The amyloid lowering potential of these mols. makes them valuable leads in the search for new BACE1 inhibitors for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHVm9JF2kNa7Vg90H21EOLACvtfcHk0ljdErRDusj8dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFWktL3L&md5=d3563a26a17a1c86c45a4f99b18be251</span></div><a href="/servlet/linkout?suffix=cit9h&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01101%26sid%3Dliteratum%253Aachs%26aulast%3DRombouts%26aufirst%3DF.%2BJ.%2BR.%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DDelgado%26aufirst%3DO.%26aulast%3DMart%25C3%25ADnez-Lamenca%26aufirst%3DC.%26aulast%3DVan%2BGool%26aufirst%3DM.%26aulast%3DGarc%25C3%25ADa-Molina%26aufirst%3DA.%26aulast%3DAlonso%2Bde%2BDiego%26aufirst%3DS.%2BA.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DProkopcova%26aufirst%3DH.%26aulast%3DAlonso%26aufirst%3DJ.%2BM.%26aulast%3DAustin%26aufirst%3DN.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DVan%2BBrandt%26aufirst%3DS.%26aulast%3DSurkyn%26aufirst%3DM.%26aulast%3DDe%2BCleyn%26aufirst%3DM.%26aulast%3DVos%26aufirst%3DA.%26aulast%3DAlexander%26aufirst%3DR.%26aulast%3DMacdonald%26aufirst%3DG.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DGijsen%26aufirst%3DH.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26atitle%3D1%252C4-Oxazine%2520%25CE%25B2-secretase%25201%2520%2528BACE1%2529%2520inhibitors%253A%2520From%2520hit%2520generation%2520to%2520orally%2520bioavailable%2520brain%2520penetrant%2520leads%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8216%26epage%3D8235%26doi%3D10.1021%2Facs.jmedchem.5b01101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit9i"><span><span class="NLM_label">(i) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimshek, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staufenbiel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rueeger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machauer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veenstra, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lueoend, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tintelnot-Blomley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laue, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frieauff, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staufenbiel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, L. H.</span></span> <span> </span><span class="NLM_article-title">A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-β and neuroinflammation in APP transgenic mice</span>. <i>Mol. Neurodegener.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">44</span>, <span class="refDoi"> DOI: 10.1186/s13024-015-0033-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9i&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1186%2Fs13024-015-0033-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9i&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=26336937" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9i&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC28Xls1Sls7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=44&author=U.+Neumannauthor=P.+Schmidauthor=D.+R.+Shimshekauthor=M.+Staufenbielauthor=L.+H.+Jacobsonauthor=H.+Rueegerauthor=R.+Machauerauthor=S.+J.+Veenstraauthor=R.+M.+Lueoendauthor=M.+Tintelnot-Blomleyauthor=G.+Laueauthor=K.+Beltzauthor=B.+Voggauthor=P.+Schmidauthor=W.+Frieauffauthor=M.+Staufenbielauthor=L.+H.+Jacobson&title=A+novel+BACE+inhibitor+NB-360+shows+a+superior+pharmacological+profile+and+robust+reduction+of+amyloid-%CE%B2+and+neuroinflammation+in+APP+transgenic+mice&doi=10.1186%2Fs13024-015-0033-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9iR"><div class="casContent"><span class="casTitleNuber">9i</span><div class="casTitle"><span class="NLM_cas:atitle">A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-β and neuroinflammation in APP transgenic mice</span></div><div class="casAuthors">Neumann, Ulf; Rueeger, Heinrich; Machauer, Rainer; Veenstra, Siem Jacob; Lueoend, Rainer M.; Tintelnot-Blomley, Marina; Laue, Grit; Beltz, Karen; Vogg, Barbara; Schmid, Peter; Frieauff, Wilfried; Shimshek, Derya R.; Staufenbiel, Matthias; Jacobson, Laura H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurodegeneration</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">44/1-44/15</span>CODEN:
                <span class="NLM_cas:coden">MNOEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1750-1326</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Alzheimer's disease (AD) is the most common form of dementia, the no. of affected individuals is rising, with significant impacts for healthcare systems.  Current symptomatic treatments delay, but do not halt, disease progression.  Genetic evidence points to aggregation and deposition of amyloid-β (Aβ) in the brain being causal for the neurodegeneration and dementia typical of AD.  Approaches to target Aβ via inhibition of γ-secretase or passive antibody therapy have not yet resulted in substantial clin. benefits.  Inhibition of BACE1 (β-secretase) has proven a challenging concept, but recent BACE1inhibitors can enter the brain sufficiently well to lower Aβ.  However, failures with the first clin. BACE1 inhibitors have highlighted the need to generate compds. with appropriate efficacy and safety profiles, since long treatment periods are expected to be necessary in humans.  Results: Treatment with NB-360, a potent and brain penetrable BACE-1 inhibitor can completely block the progression of Aβ deposition in the brains of APP transgenic mice, a model for amyloid pathol.  We furthermore show that almost complete redn. of Aβ was achieved also in rats and in dogs, suggesting that these findings are translational across species and can be extrapolated to humans.  Amyloid pathol. may be an initial step in a complex pathol. cascade; therefore we investigated the effect of BACE-1 inhibition on neuroinflammation, a prominent downstream feature of the disease.  NB-360 stopped accumulation of activated inflammatory cells in the brains of APP transgenic mice.  Upon chronic treatment of APP transgenic mice, patches of gray hairs appeared.  Conclusions: In a rapidly developing field, the data on NB-360 broaden the chem. space and expand knowledge on the properties that are needed to make a BACE-1 inhibitor potent and safe enough for long-term use in patients.  Due to its excellent brain penetration, reasonable oral doses of NB-360 were sufficient to completely block amyloid-β deposition in an APP transgenic mouse model.  Data across species suggest similar treatment effects can possibly be achieved in humans.  The reduced neuroinflammation upon amyloid redn. by NB-360 treatment supports the notion that targeting amyloid-β pathol. can have beneficial downstream effects on the progression of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquJLgu8zl8_LVg90H21EOLACvtfcHk0ljdErRDusj8dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xls1Sls7o%253D&md5=728407859709d7de57d68bfdc374fe85</span></div><a href="/servlet/linkout?suffix=cit9i&amp;dbid=16384&amp;doi=10.1186%2Fs13024-015-0033-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13024-015-0033-8%26sid%3Dliteratum%253Aachs%26aulast%3DNeumann%26aufirst%3DU.%26aulast%3DSchmid%26aufirst%3DP.%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26aulast%3DStaufenbiel%26aufirst%3DM.%26aulast%3DJacobson%26aufirst%3DL.%2BH.%26aulast%3DRueeger%26aufirst%3DH.%26aulast%3DMachauer%26aufirst%3DR.%26aulast%3DVeenstra%26aufirst%3DS.%2BJ.%26aulast%3DLueoend%26aufirst%3DR.%2BM.%26aulast%3DTintelnot-Blomley%26aufirst%3DM.%26aulast%3DLaue%26aufirst%3DG.%26aulast%3DBeltz%26aufirst%3DK.%26aulast%3DVogg%26aufirst%3DB.%26aulast%3DSchmid%26aufirst%3DP.%26aulast%3DFrieauff%26aufirst%3DW.%26aulast%3DStaufenbiel%26aufirst%3DM.%26aulast%3DJacobson%26aufirst%3DL.%2BH.%26atitle%3DA%2520novel%2520BACE%2520inhibitor%2520NB-360%2520shows%2520a%2520superior%2520pharmacological%2520profile%2520and%2520robust%2520reduction%2520of%2520amyloid-%25CE%25B2%2520and%2520neuroinflammation%2520in%2520APP%2520transgenic%2520mice%26jtitle%3DMol.%2520Neurodegener.%26date%3D2015%26volume%3D10%26spage%3D44%26doi%3D10.1186%2Fs13024-015-0033-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunskill, A. P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iserloh, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazakevich, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuvelkar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meredith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misiaszek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossiter, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slater, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stone, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickland, C. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voigt, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenlee, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamford, A. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of the 3-imino-1,2,4-thiadiazinane 1,1-dioxide derivative verubecestat (MK-8931)–A β-site amyloid precursor protein cleaving enzyme 1 inhibitor for the treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10435</span>– <span class="NLM_lpage">10450</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00307</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00307" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVKnsLnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10435-10450&author=J.+D.+Scottauthor=S.+W.+Liauthor=A.+P.+J.+Brunskillauthor=X.+Chenauthor=K.+Coxauthor=J.+N.+Cummingauthor=M.+Formanauthor=E.+J.+Gilbertauthor=R.+A.+Hodgsonauthor=L.+A.+Hydeauthor=Q.+Jiangauthor=U.+Iserlohauthor=I.+Kazakevichauthor=R.+Kuvelkarauthor=H.+Meiauthor=J.+Meredithauthor=J.+Misiaszekauthor=P.+Orthauthor=L.+M.+Rossiterauthor=M.+Slaterauthor=J.+Stoneauthor=C.+O.+Stricklandauthor=J.+H.+Voigtauthor=G.+Wangauthor=H.+Wangauthor=Y.+Wuauthor=W.+J.+Greenleeauthor=E.+M.+Parkerauthor=M.+E.+Kennedyauthor=A.+W.+Stamford&title=Discovery+of+the+3-imino-1%2C2%2C4-thiadiazinane+1%2C1-dioxide+derivative+verubecestat+%28MK-8931%29%E2%80%93A+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+1+inhibitor+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.6b00307"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the 3-Imino-1,2,4-thiadiazinane 1,1-Dioxide Derivative Verubecestat (MK-8931)-A β-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitor for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Scott, Jack D.; Li, Sarah W.; Brunskill, Andrew P. J.; Chen, Xia; Cox, Kathleen; Cumming, Jared N.; Forman, Mark; Gilbert, Eric J.; Hodgson, Robert A.; Hyde, Lynn A.; Jiang, Qin; Iserloh, Ulrich; Kazakevich, Irina; Kuvelkar, Reshma; Mei, Hong; Meredith, John; Misiaszek, Jeffrey; Orth, Peter; Rossiter, Lana M.; Slater, Meagan; Stone, Julie; Strickland, Corey O.; Voigt, Johannes H.; Wang, Ganfeng; Wang, Hongwu; Wu, Yusheng; Greenlee, William J.; Parker, Eric M.; Kennedy, Matthew E.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10435-10450</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Verubecestat (MK-8931), a diaryl amide substituted 3-imino-1,2,4-thiadiazinane 1,1-dioxide deriv., is a high-affinity β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor currently undergoing Phase 3 clin. evaluation for the treatment of mild to moderate and prodromal Alzheimer's disease.  Although not selective over the closely related aspartyl protease BACE2, verubecesat has high selectivity for BACE1 over other key aspartyl proteases, notably cathepsin D, and profoundly lowers CSF and brain Aβ levels in rats and nonhuman primates, and CSF Aβ levels in humans.  In this annotation, the authors describe the discovery of verubecesat, including design, validation, and selected SAR around the novel iminothiadiazinane dioxide core, as well as aspects of its preclin. and Phase 1 clin. characterization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpN5wdoirs8rVg90H21EOLACvtfcHk0lgXnxREAkSGiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVKnsLnI&md5=517155e2d4f186261b1451ff4556a621</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00307%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DJ.%2BD.%26aulast%3DLi%26aufirst%3DS.%2BW.%26aulast%3DBrunskill%26aufirst%3DA.%2BP.%2BJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DForman%26aufirst%3DM.%26aulast%3DGilbert%26aufirst%3DE.%2BJ.%26aulast%3DHodgson%26aufirst%3DR.%2BA.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DJiang%26aufirst%3DQ.%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DMei%26aufirst%3DH.%26aulast%3DMeredith%26aufirst%3DJ.%26aulast%3DMisiaszek%26aufirst%3DJ.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DRossiter%26aufirst%3DL.%2BM.%26aulast%3DSlater%26aufirst%3DM.%26aulast%3DStone%26aufirst%3DJ.%26aulast%3DStrickland%26aufirst%3DC.%2BO.%26aulast%3DVoigt%26aufirst%3DJ.%2BH.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DDiscovery%2520of%2520the%25203-imino-1%252C2%252C4-thiadiazinane%25201%252C1-dioxide%2520derivative%2520verubecestat%2520%2528MK-8931%2529%25E2%2580%2593A%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520inhibitor%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10435%26epage%3D10450%26doi%3D10.1021%2Facs.jmedchem.6b00307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamford, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dockendorf, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ereshefsky, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleijn, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuvelkar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattson, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palcza, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troyer, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stone, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forman, M. S.</span></span> <span> </span><span class="NLM_article-title">The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer’s disease patients</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">363ra150</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.aad9704</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1126%2Fscitranslmed.aad9704" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=27807285" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=363ra150&author=M.+E.+Kennedyauthor=A.+W.+Stamfordauthor=X.+Chenauthor=K.+Coxauthor=J.+N.+Cummingauthor=M.+F.+Dockendorfauthor=M.+Eganauthor=L.+Ereshefskyauthor=R.+A.+Hodgsonauthor=L.+A.+Hydeauthor=S.+Jheeauthor=H.+J.+Kleijnauthor=R.+Kuvelkarauthor=W.+Liauthor=B.+A.+Mattsonauthor=H.+Meiauthor=J.+Palczaauthor=J.+D.+Scottauthor=M.+Tanenauthor=M.+D.+Troyerauthor=J.+L.+Tsengauthor=J.+A.+Stoneauthor=E.+M.+Parkerauthor=M.+S.+Forman&title=The+BACE1+inhibitor+verubecestat+%28MK-8931%29+reduces+CNS+%CE%B2-amyloid+in+animal+models+and+in+Alzheimer%E2%80%99s+disease+patients&doi=10.1126%2Fscitranslmed.aad9704"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aad9704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aad9704%26sid%3Dliteratum%253Aachs%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DDockendorf%26aufirst%3DM.%2BF.%26aulast%3DEgan%26aufirst%3DM.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DHodgson%26aufirst%3DR.%2BA.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DJhee%26aufirst%3DS.%26aulast%3DKleijn%26aufirst%3DH.%2BJ.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DMattson%26aufirst%3DB.%2BA.%26aulast%3DMei%26aufirst%3DH.%26aulast%3DPalcza%26aufirst%3DJ.%26aulast%3DScott%26aufirst%3DJ.%2BD.%26aulast%3DTanen%26aufirst%3DM.%26aulast%3DTroyer%26aufirst%3DM.%2BD.%26aulast%3DTseng%26aufirst%3DJ.%2BL.%26aulast%3DStone%26aufirst%3DJ.%2BA.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DForman%26aufirst%3DM.%2BS.%26atitle%3DThe%2520BACE1%2520inhibitor%2520verubecestat%2520%2528MK-8931%2529%2520reduces%2520CNS%2520%25CE%25B2-amyloid%2520in%2520animal%2520models%2520and%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520patients%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2016%26volume%3D8%26spage%3D363ra150%26doi%3D10.1126%2Fscitranslmed.aad9704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit10c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. N.</span>; <span class="NLM_string-name">Scott, J. D.</span>; <span class="NLM_string-name">Strickland, C. O.</span></span> <span> </span><span class="NLM_article-title">Verubecestat</span>. In  <i>Comprehensive Medicinal Chemistry III</i>, <span class="NLM_edition">3</span>rd ed.; <span class="NLM_contrib-group"><span class="NLM_string-name">Chackalamannil, S.</span>, <span class="NLM_string-name">Rotella, D. P.</span>, <span class="NLM_string-name">Ward, S. E.</span></span>, Eds.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">Oxford</span>, <span class="NLM_year">2017</span>; Vol.  <span class="NLM_volume">8</span>, pp  <span class="NLM_fpage">204</span>– <span class="NLM_lpage">251</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=204-251&author=J.+N.+Cumming&author=J.+D.+Scott&author=C.+O.+Stricklandauthor=S.+Chackalamannil&author=D.+P.+Rotella&author=S.+E.+Ward&title=Comprehensive+Medicinal+Chemistry+III"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26atitle%3DVerubecestat%26btitle%3DComprehensive%2520Medicinal%2520Chemistry%2520III%26aulast%3DChackalamannil%26aufirst%3DS.%26pub%3DElsevier%26date%3D2017%26volume%3D8%26spage%3D204%26epage%3D251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kost, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tariot, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aisen, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vellas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sur, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voss, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furtek, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahoney, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mozley, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenberghe, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michelson, D.</span></span> <span> </span><span class="NLM_article-title">Randomized trial of verubecestat for mild-to-moderate Alzheimer’s disease</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>378</i></span>,  <span class="NLM_fpage">1691</span>– <span class="NLM_lpage">1703</span>, <span class="refDoi"> DOI: 10.1056/nejmoa1706441</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1056%2Fnejmoa1706441" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=29719179" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpsFyqsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=378&publication_year=2018&pages=1691-1703&author=M.+F.+Eganauthor=J.+Kostauthor=P.+N.+Tariotauthor=P.+S.+Aisenauthor=J.+L.+Cummingsauthor=B.+Vellasauthor=C.+Surauthor=Y.+Mukaiauthor=T.+Vossauthor=C.+Furtekauthor=E.+Mahoneyauthor=L.+L.+Mozleyauthor=R.+Vandenbergheauthor=Y.+Moauthor=D.+Michelson&title=Randomized+trial+of+verubecestat+for+mild-to-moderate+Alzheimer%E2%80%99s+disease&doi=10.1056%2Fnejmoa1706441"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10dR"><div class="casContent"><span class="casTitleNuber">10d</span><div class="casTitle"><span class="NLM_cas:atitle">Randomized trial of verubecestat for mild-to-moderate Alzheimer's disease</span></div><div class="casAuthors">Egan, Michael F.; Kost, James; Tariot, Pierre N.; Aisen, Paul S.; Cummings, Jeffrey L.; Vellas, Bruno; Sur, Cyrille; Mukai, Yuki; Voss, Tiffini; Furtek, Christine; Mahoney, Erin; Mozley, Lyn Harper; Vandenberghe, Rik; Mo, Yi; Michelson, David</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">378</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1691-1703</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Alzheimer's disease is characterized by the deposition of amyloid-beta (Aβ) plaques in the brain.  Aβ is produced from the sequential cleavage of amyloid precursor protein by β-site amyloid precursor protein-cleaving enzyme 1 (BACE-1) followed by γ-secretase.  Verubecestat is an oral BACE-1 inhibitor that reduces the Aβ level in the cerebrospinal fluid of patients with Alzheimer's disease.  Methods: We conducted a randomized, double-blind, placebo-controlled, 78-wk trial to evaluate verubecestat at doses of 12 mg and 40 mg per day, as compared with placebo, in patients who had a clin. diagnosis of mild-to-moderate Alzheimer's disease.  The coprimary outcomes were the change from baseline to week 78 in the score on the cognitive subscale of the Alzheimer's disease Assessment Scale (ADAS-cog; scores range from 0 to 70, with higher scores indicating worse dementia) and in the score on the Alzheimer's Disease Cooperative Study Activities of Daily Living Inventory scale (ADCS-ADL; scores range from 0 to 78, with lower scores indicating worse function).  Results: A total of 1958 patients underwent randomization; 653 were randomly assigned to receive verubecestat at a dose of 12 mg per day (the 12-mg group), 652 to receive verubecestat at a dose of 40 mg per day (the 40-mg group), and 653 to receive matching placebo.  The trial was terminated early for futility 50 mo after onset, which was within 5 mo before its scheduled completion, and after enrollment of the planned 1958 patients was complete.  The estd. mean change from baseline to week 78 in the ADAS-cog score was 7.9 in the 12-mg group, 8.0 in the 40-mg group, and 7.7 in the placebo group (P = 0.63 for the comparison between the 12-mg group and the placebo group and P = 0.46 for the comparison between the 40-mg group and the placebo group).  The estd. mean change from baseline to week 78 in the ADCS-ADL score was -8.4 in the 12-mg group, -8.2 in the 40-mg group, and -8.9 in the placebo group (P = 0.49 for the comparison between the 12-mg group and the placebo group and P = 0.32 for the comparison between the 40-mg group and the placebo group).  Adverse events, including rash, falls and injuries, sleep disturbance, suicidal ideation, wt. loss, and hair-color change, were more common in the verubecestat groups than in the placebo group. conclusions Verubecestat did not reduce cognitive or functional decline in patients with mild-to-moderate Alzheimer's disease and was assocd. with treatment-related adverse events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroW5Tf-VIj2LVg90H21EOLACvtfcHk0ljMGEsfsdkxCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpsFyqsbs%253D&md5=e6ecfbd2981616b343468ae8bed1db2d</span></div><a href="/servlet/linkout?suffix=cit10d&amp;dbid=16384&amp;doi=10.1056%2Fnejmoa1706441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252Fnejmoa1706441%26sid%3Dliteratum%253Aachs%26aulast%3DEgan%26aufirst%3DM.%2BF.%26aulast%3DKost%26aufirst%3DJ.%26aulast%3DTariot%26aufirst%3DP.%2BN.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DCummings%26aufirst%3DJ.%2BL.%26aulast%3DVellas%26aufirst%3DB.%26aulast%3DSur%26aufirst%3DC.%26aulast%3DMukai%26aufirst%3DY.%26aulast%3DVoss%26aufirst%3DT.%26aulast%3DFurtek%26aufirst%3DC.%26aulast%3DMahoney%26aufirst%3DE.%26aulast%3DMozley%26aufirst%3DL.%2BL.%26aulast%3DVandenberghe%26aufirst%3DR.%26aulast%3DMo%26aufirst%3DY.%26aulast%3DMichelson%26aufirst%3DD.%26atitle%3DRandomized%2520trial%2520of%2520verubecestat%2520for%2520mild-to-moderate%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2018%26volume%3D378%26spage%3D1691%26epage%3D1703%26doi%3D10.1056%2Fnejmoa1706441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span><span> </span><span class="NLM_article-title">Alzforum</span>. <a href="http://www.alzforum.org/therapeutics/elenbecestat" class="extLink">http://www.alzforum.org/therapeutics/elenbecestat</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Alzforum.+http%3A%2F%2Fwww.alzforum.org%2Ftherapeutics%2Felenbecestat+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DAlzforum%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, Y.</span>; <span class="NLM_string-name">Motoki, T.</span>; <span class="NLM_string-name">Kaneko, T.</span>; <span class="NLM_string-name">Takaishi, M.</span>; <span class="NLM_string-name">Ishida, T.</span>; <span class="NLM_string-name">Takeda, K.</span>; <span class="NLM_string-name">Kita, Y.</span>; <span class="NLM_string-name">Yamamoto, N.</span>; <span class="NLM_string-name">Khan, A.</span>; <span class="NLM_string-name">Dimopoulos, P.</span></span> <span> </span><span class="NLM_article-title">Preparation of Condensed Aminodihydrothiazine Derivatives as Inhibitors of β-Site APP-cleaving Enzyme 1 (BACE1)</span>. <span class="NLM_patent">WO 2009091016 A1</span>, July 23, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=Y.+Suzuki&author=T.+Motoki&author=T.+Kaneko&author=M.+Takaishi&author=T.+Ishida&author=K.+Takeda&author=Y.+Kita&author=N.+Yamamoto&author=A.+Khan&author=P.+Dimopoulos&title=Preparation+of+Condensed+Aminodihydrothiazine+Derivatives+as+Inhibitors+of+%CE%B2-Site+APP-cleaving+Enzyme+1+%28BACE1%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DY.%26atitle%3DPreparation%2520of%2520Condensed%2520Aminodihydrothiazine%2520Derivatives%2520as%2520Inhibitors%2520of%2520%25CE%25B2-Site%2520APP-cleaving%2520Enzyme%25201%2520%2528BACE1%2529%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Eketjaell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaspersson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogstedt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeppsson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faelting, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haeberlein, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kugler, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cebers, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, P.</span></span> <span> </span><span class="NLM_article-title">AZD3293: A novel, orally active BACE1 inhibitor with high potency and permeability and markedly slow off-rate kinetics</span>. <i>J. Alzheimers Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">1109</span>– <span class="NLM_lpage">1123</span>, <span class="refDoi"> DOI: 10.3233/jad-150834</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.3233%2Fjad-150834" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=26890753" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2016&pages=1109-1123&author=S.+Eketjaellauthor=J.+Jansonauthor=K.+Kasperssonauthor=A.+Bogstedtauthor=F.+Jeppssonauthor=J.+Faeltingauthor=S.+B.+Haeberleinauthor=A.+R.+Kuglerauthor=R.+C.+Alexanderauthor=G.+Cebersauthor=P.+Ho&title=AZD3293%3A+A+novel%2C+orally+active+BACE1+inhibitor+with+high+potency+and+permeability+and+markedly+slow+off-rate+kinetics&doi=10.3233%2Fjad-150834"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.3233%2Fjad-150834&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252Fjad-150834%26sid%3Dliteratum%253Aachs%26aulast%3DEketjaell%26aufirst%3DS.%26aulast%3DJanson%26aufirst%3DJ.%26aulast%3DKaspersson%26aufirst%3DK.%26aulast%3DBogstedt%26aufirst%3DA.%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DFaelting%26aufirst%3DJ.%26aulast%3DHaeberlein%26aufirst%3DS.%2BB.%26aulast%3DKugler%26aufirst%3DA.%2BR.%26aulast%3DAlexander%26aufirst%3DR.%2BC.%26aulast%3DCebers%26aufirst%3DG.%26aulast%3DHo%26aufirst%3DP.%26atitle%3DAZD3293%253A%2520A%2520novel%252C%2520orally%2520active%2520BACE1%2520inhibitor%2520with%2520high%2520potency%2520and%2520permeability%2520and%2520markedly%2520slow%2520off-rate%2520kinetics%26jtitle%3DJ.%2520Alzheimers%2520Dis.%26date%3D2016%26volume%3D50%26spage%3D1109%26epage%3D1123%26doi%3D10.3233%2Fjad-150834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span> </span><span class="NLM_article-title">Alzforum</span>. <a href="https://www.alzforum.org/therapeutics/azd3293" class="extLink">https://www.alzforum.org/therapeutics/azd3293</a> (accessed December 23, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Alzforum.+https%3A%2F%2Fwww.alzforum.org%2Ftherapeutics%2Fazd3293+%28accessed+December+23%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DAlzforum%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ufer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouzade-Dominguez, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huledal, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolly, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lüönd, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machauer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veenstra, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurth, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rueeger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tintelnot-Blomley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staufenbiel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimshek, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrot, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frieauff, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubost, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiller, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avrameas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kretz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pezous, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rondeau, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beckmann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vormfelde, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galli, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez Lopez, C.</span></span> <span> </span><span class="NLM_article-title">The BACE-1 inhibitor CNP520 for prevention trials in Alzheimer’s disease</span>. <i>EMBO Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">e9316</span> <span class="refDoi"> DOI: 10.15252/emmm.201809316</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.15252%2Femmm.201809316" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=30224383" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&author=U.+Neumannauthor=M.+Uferauthor=L.+H.+Jacobsonauthor=M.+L.+Rouzade-Dominguezauthor=G.+Huledalauthor=C.+Kollyauthor=R.+M.+L%C3%BC%C3%B6ndauthor=R.+Machauerauthor=S.+J.+Veenstraauthor=K.+Hurthauthor=H.+Rueegerauthor=M.+Tintelnot-Blomleyauthor=M.+Staufenbielauthor=D.+R.+Shimshekauthor=L.+Perrotauthor=W.+Frieauffauthor=V.+Dubostauthor=H.+Schillerauthor=B.+Voggauthor=K.+Beltzauthor=A.+Avrameasauthor=S.+Kretzauthor=N.+Pezousauthor=J.+M.+Rondeauauthor=N.+Beckmannauthor=A.+Hartmannauthor=S.+Vormfeldeauthor=O.+J.+Davidauthor=B.+Galliauthor=R.+Ramosauthor=A.+Grafauthor=C.+Lopez+Lopez&title=The+BACE-1+inhibitor+CNP520+for+prevention+trials+in+Alzheimer%E2%80%99s+disease&doi=10.15252%2Femmm.201809316"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.15252%2Femmm.201809316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15252%252Femmm.201809316%26sid%3Dliteratum%253Aachs%26aulast%3DNeumann%26aufirst%3DU.%26aulast%3DUfer%26aufirst%3DM.%26aulast%3DJacobson%26aufirst%3DL.%2BH.%26aulast%3DRouzade-Dominguez%26aufirst%3DM.%2BL.%26aulast%3DHuledal%26aufirst%3DG.%26aulast%3DKolly%26aufirst%3DC.%26aulast%3DL%25C3%25BC%25C3%25B6nd%26aufirst%3DR.%2BM.%26aulast%3DMachauer%26aufirst%3DR.%26aulast%3DVeenstra%26aufirst%3DS.%2BJ.%26aulast%3DHurth%26aufirst%3DK.%26aulast%3DRueeger%26aufirst%3DH.%26aulast%3DTintelnot-Blomley%26aufirst%3DM.%26aulast%3DStaufenbiel%26aufirst%3DM.%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26aulast%3DPerrot%26aufirst%3DL.%26aulast%3DFrieauff%26aufirst%3DW.%26aulast%3DDubost%26aufirst%3DV.%26aulast%3DSchiller%26aufirst%3DH.%26aulast%3DVogg%26aufirst%3DB.%26aulast%3DBeltz%26aufirst%3DK.%26aulast%3DAvrameas%26aufirst%3DA.%26aulast%3DKretz%26aufirst%3DS.%26aulast%3DPezous%26aufirst%3DN.%26aulast%3DRondeau%26aufirst%3DJ.%2BM.%26aulast%3DBeckmann%26aufirst%3DN.%26aulast%3DHartmann%26aufirst%3DA.%26aulast%3DVormfelde%26aufirst%3DS.%26aulast%3DDavid%26aufirst%3DO.%2BJ.%26aulast%3DGalli%26aufirst%3DB.%26aulast%3DRamos%26aufirst%3DR.%26aulast%3DGraf%26aufirst%3DA.%26aulast%3DLopez%2BLopez%26aufirst%3DC.%26atitle%3DThe%2520BACE-1%2520inhibitor%2520CNP520%2520for%2520prevention%2520trials%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2018%26volume%3D10%26doi%3D10.15252%2Femmm.201809316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Timmers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Broeck, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramael, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slemmon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Waepenaert, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stieltjes, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelborghs, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moechars, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercken, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinha, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemp, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Nueten, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tritsmans, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Streffer, J. R.</span></span> <span> </span><span class="NLM_article-title">Profiling the dynamics of CSF and plasma Aβ reduction after treatment with JNJ-54861911, a potent oral BACE inhibitor</span>. <i>Alzheimer’s Dementia Transl. Res. Clin. Interv.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">201</span>– <span class="NLM_lpage">212</span>, <span class="refDoi"> DOI: 10.1016/j.trci.2016.08.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1016%2Fj.trci.2016.08.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2016&pages=201-212&author=M.+Timmersauthor=B.+Van+Broeckauthor=S.+Ramaelauthor=J.+Slemmonauthor=K.+De+Waepenaertauthor=A.+Russuauthor=J.+Bogertauthor=H.+Stieltjesauthor=L.+M.+Shawauthor=S.+Engelborghsauthor=D.+Moecharsauthor=M.+Merckenauthor=E.+Liuauthor=V.+Sinhaauthor=J.+Kempauthor=L.+Van+Nuetenauthor=L.+Tritsmansauthor=J.+R.+Streffer&title=Profiling+the+dynamics+of+CSF+and+plasma+A%CE%B2+reduction+after+treatment+with+JNJ-54861911%2C+a+potent+oral+BACE+inhibitor&doi=10.1016%2Fj.trci.2016.08.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1016%2Fj.trci.2016.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.trci.2016.08.001%26sid%3Dliteratum%253Aachs%26aulast%3DTimmers%26aufirst%3DM.%26aulast%3DVan%2BBroeck%26aufirst%3DB.%26aulast%3DRamael%26aufirst%3DS.%26aulast%3DSlemmon%26aufirst%3DJ.%26aulast%3DDe%2BWaepenaert%26aufirst%3DK.%26aulast%3DRussu%26aufirst%3DA.%26aulast%3DBogert%26aufirst%3DJ.%26aulast%3DStieltjes%26aufirst%3DH.%26aulast%3DShaw%26aufirst%3DL.%2BM.%26aulast%3DEngelborghs%26aufirst%3DS.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DE.%26aulast%3DSinha%26aufirst%3DV.%26aulast%3DKemp%26aufirst%3DJ.%26aulast%3DVan%2BNueten%26aufirst%3DL.%26aulast%3DTritsmans%26aufirst%3DL.%26aulast%3DStreffer%26aufirst%3DJ.%2BR.%26atitle%3DProfiling%2520the%2520dynamics%2520of%2520CSF%2520and%2520plasma%2520A%25CE%25B2%2520reduction%2520after%2520treatment%2520with%2520JNJ-54861911%252C%2520a%2520potent%2520oral%2520BACE%2520inhibitor%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%2520Transl.%2520Res.%2520Clin.%2520Interv.%26date%3D2016%26volume%3D2%26spage%3D201%26epage%3D212%26doi%3D10.1016%2Fj.trci.2016.08.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">The
Janssen Pharmaceutical Campanies of Johnson & Johnson</span>. <a href="https://www.janssen.com/ja/node/45771" class="extLink">https://www.janssen.com/ja/node/45771</a> (accessed Dec 23, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The%0AJanssen+Pharmaceutical+Campanies+of+Johnson+%26+Johnson.+https%3A%2F%2Fwww.janssen.com%2Fja%2Fnode%2F45771+%28accessed+Dec+23%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bateman, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benzinger, T. L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fagan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goate, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcus, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cairns, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blazey, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holtzman, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santacruz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckles, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliver, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moulder, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aisen, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghetti, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klunk, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDade, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martins, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masters, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayeux, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ringman, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossor, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperling, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salloway, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J. C.</span></span> <span> </span><span class="NLM_article-title">Clinical and biomarker changes in dominantly inherited Alzheimer’s disease</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>367</i></span>,  <span class="NLM_fpage">795</span>– <span class="NLM_lpage">804</span>, <span class="refDoi"> DOI: 10.1056/nejmoa1202753</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1056%2Fnejmoa1202753" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=22784036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGktL7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=2012&pages=795-804&author=R.+J.+Batemanauthor=C.+Xiongauthor=T.+L.+S.+Benzingerauthor=A.+M.+Faganauthor=A.+Goateauthor=N.+C.+Foxauthor=D.+S.+Marcusauthor=N.+J.+Cairnsauthor=X.+Xieauthor=T.+M.+Blazeyauthor=D.+M.+Holtzmanauthor=A.+Santacruzauthor=V.+Bucklesauthor=A.+Oliverauthor=K.+Moulderauthor=P.+S.+Aisenauthor=B.+Ghettiauthor=W.+E.+Klunkauthor=E.+McDadeauthor=R.+N.+Martinsauthor=C.+L.+Mastersauthor=R.+Mayeuxauthor=J.+M.+Ringmanauthor=M.+N.+Rossorauthor=P.+R.+Schofieldauthor=R.+A.+Sperlingauthor=S.+Sallowayauthor=J.+C.+Morris&title=Clinical+and+biomarker+changes+in+dominantly+inherited+Alzheimer%E2%80%99s+disease&doi=10.1056%2Fnejmoa1202753"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical and biomarker changes in dominantly inherited Alzheimer's disease</span></div><div class="casAuthors">Bateman, Randall J.; Xiong, Chengjie; Benzinger, Tammie L. S.; Fagan, Anne M.; Goate, Alison; Fox, Nick C.; Marcus, Daniel S.; Cairns, Nigel J.; Xie, Xianyun; Blazey, Tyler M.; Holtzman, David M.; Santacruz, Anna; Buckles, Virginia; Oliver, Angela; Moulder, Krista; Aisen, Paul S.; Ghetti, Bernardino; Klunk, William E.; McDade, Eric; Martins, Ralph N.; Masters, Colin L.; Mayeux, Richard; Ringman, John M.; Rossor, Martin N.; Schofield, Peter R.; Sperling, Reisa A.; Salloway, Stephen; Morris, John C.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">367</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">795-804</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: The order and magnitude of pathol. processes in Alzheimer's disease are not well understood, partly because the disease develops over many years.  Autosomal dominant Alzheimer's disease has a predictable age at onset and provides an opportunity to det. the sequence and magnitude of pathol. changes that culminate in symptomatic disease.  METHODS: In this prospective, longitudinal study, we analyzed data from 128 participants who underwent baseline clin. and cognitive assessments, brain imaging, and cerebrospinal fluid (CSF) and blood tests.  We used the participant's age at baseline assessment and the parent's age at the onset of symptoms of Alzheimer's disease to calc. the estd. years from expected symptom onset (age of the participant minus parent's age at symptom onset).  We conducted cross-sectional analyses of baseline data in relation to estd. years from expected symptom onset in order to det. the relative order and magnitude of pathophysiol. changes.  RESULTS: Concns. of amyloid-beta (Aβ)42 in the CSF appeared to decline 25 years before expected symptom onset.  Aβ deposition, as measured by positron-emission tomog. with the use of Pittsburgh compd. B, was detected 15 years before expected symptom onset.  Increased concns. of tau protein in the CSF and an increase in brain atrophy were detected 15 years before expected symptom onset.  Cerebral hypometabolism and impaired episodic memory were obsd. 10 years before expected symptom onset.  Global cognitive impairment, as measured by the Mini-Mental State Examn. and the Clin. Dementia Rating scale, was detected 5 years before expected symptom onset, and patients met diagnostic criteria for dementia at an av. of 3 years after expected symptom onset.  CONCLUSIONS: We found that autosomal dominant Alzheimer's disease was assocd. with a series of pathophysiol. changes over decades in CSF biochem. markers of Alzheimer's disease, brain amyloid deposition, and brain metab. as well as progressive cognitive impairment.  Our results require confirmation with the use of longitudinal data and may not apply to patients with sporadic Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptJNV9eDXBCLVg90H21EOLACvtfcHk0liUrgulzw0QGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGktL7J&md5=c4f999ea3401af9651a2770724757bed</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1056%2Fnejmoa1202753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252Fnejmoa1202753%26sid%3Dliteratum%253Aachs%26aulast%3DBateman%26aufirst%3DR.%2BJ.%26aulast%3DXiong%26aufirst%3DC.%26aulast%3DBenzinger%26aufirst%3DT.%2BL.%2BS.%26aulast%3DFagan%26aufirst%3DA.%2BM.%26aulast%3DGoate%26aufirst%3DA.%26aulast%3DFox%26aufirst%3DN.%2BC.%26aulast%3DMarcus%26aufirst%3DD.%2BS.%26aulast%3DCairns%26aufirst%3DN.%2BJ.%26aulast%3DXie%26aufirst%3DX.%26aulast%3DBlazey%26aufirst%3DT.%2BM.%26aulast%3DHoltzman%26aufirst%3DD.%2BM.%26aulast%3DSantacruz%26aufirst%3DA.%26aulast%3DBuckles%26aufirst%3DV.%26aulast%3DOliver%26aufirst%3DA.%26aulast%3DMoulder%26aufirst%3DK.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DGhetti%26aufirst%3DB.%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26aulast%3DMcDade%26aufirst%3DE.%26aulast%3DMartins%26aufirst%3DR.%2BN.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DMayeux%26aufirst%3DR.%26aulast%3DRingman%26aufirst%3DJ.%2BM.%26aulast%3DRossor%26aufirst%3DM.%2BN.%26aulast%3DSchofield%26aufirst%3DP.%2BR.%26aulast%3DSperling%26aufirst%3DR.%2BA.%26aulast%3DSalloway%26aufirst%3DS.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26atitle%3DClinical%2520and%2520biomarker%2520changes%2520in%2520dominantly%2520inherited%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2012%26volume%3D367%26spage%3D795%26epage%3D804%26doi%3D10.1056%2Fnejmoa1202753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Villemagne, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burnham, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourgeat, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvado, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szoeke, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macaulay, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martins, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruff, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ames, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowe, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masters, C. L.</span></span> <span> </span><span class="NLM_article-title">Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer’s disease: a prospective cohort study</span>. <i>Lancet Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">357</span>– <span class="NLM_lpage">367</span>, <span class="refDoi"> DOI: 10.1016/s1474-4422(13)70044-</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1016%2Fs1474-4422%2813%2970044-" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=23477989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC3sXksFejsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=357-367&author=V.+L.+Villemagneauthor=S.+Burnhamauthor=P.+Bourgeatauthor=B.+Brownauthor=K.+A.+Ellisauthor=O.+Salvadoauthor=C.+Szoekeauthor=S.+L.+Macaulayauthor=R.+Martinsauthor=P.+Maruffauthor=D.+Amesauthor=C.+C.+Roweauthor=C.+L.+Masters&title=Amyloid+%CE%B2+deposition%2C+neurodegeneration%2C+and+cognitive+decline+in+sporadic+Alzheimer%E2%80%99s+disease%3A+a+prospective+cohort+study&doi=10.1016%2Fs1474-4422%2813%2970044-"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study</span></div><div class="casAuthors">Villemagne, Victor L.; Burnham, Samantha; Bourgeat, Pierrick; Brown, Belinda; Ellis, Kathryn A.; Salvado, Olivier; Szoeke, Cassandra; Macaulay, S. Lance; Martins, Ralph; Maruff, Paul; Ames, David; Rowe, Christopher C.; Masters, Colin L.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">357-367</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Similar to most chronic diseases, Alzheimer's disease (AD) develops slowly from a preclin. phase into a fully expressed clin. syndrome.  We aimed to use longitudinal data to calc. the rates of amyloid β (Aβ) deposition, cerebral atrophy, and cognitive decline.  In this prospective cohort study, healthy controls, patients with mild cognitive impairment (MCI), and patients with AD were assessed at enrolment and every 18 mo.  At every visit, participants underwent neuropsychol. examn., MRI, and a carbon-11-labeled Pittsburgh compd. B (11C-PiB) PET scan.  We included participants with three or more 11C-PiB PET follow-up assessments.  Aβ burden was expressed as 11C-PiB standardised uptake value ratio (SUVR) with the cerebellar cortex as ref. region.  An SUVR of 1·5 was used to discriminate high from low Aβ burdens.  The slope of the regression plots over 3-5 years was used to est. rates of change for Aβ deposition, MRI volumetrics, and cognition.  We included those participants with a pos. rate of Aβ deposition to calc. the trajectory of each variable over time.200 participants (145 healthy controls, 36 participants with MCI, and 19 participants with AD) were assessed at enrolment and every 18 mo for a mean follow-up of 3·8 (95% CI CI 3·6-3·9) years.  At baseline, significantly higher Aβ burdens were noted in patients with AD (2·27, SD 0·43) and those with MCI (1·94, 0·64) than in healthy controls (1·38, 0·39).  At follow-up, 163 (82%) of the 200 participants showed pos. rates of Aβ accumulation.  Aβ deposition was estd. to take 19·2 (95% CI 16·8-22·5) years in an almost linear fashion-with a mean increase of 0·043 (95% CI 0·037-0·049) SUVR per yr-to go from the threshold of 11C-PiB positivity (1·5 SUVR) to the levels obsd. in AD.  It was estd. to take 12·0 (95% CI 10·1-14·9) years from the levels obsd. in healthy controls with low Aβ deposition (1·2 [SD 0·1] SUVR) to the threshold of 11C-PiB positivity.  As AD progressed, the rate of Aβ deposition slowed towards a plateau.  Our projections suggest a prolonged preclin. phase of AD in which Aβ deposition reaches our threshold of positivity at 17·0 (95% CI 14·9-19·9) years, hippocampal atrophy at 4·2 (3·6-5·1) years, and memory impairment at 3·3 (2·5-4·5) years before the onset of dementia (clin. dementia rating score 1).  Aβ deposition is slow and protracted, likely to extend for more than two decades.  Such predictions of the rate of preclin. changes and the onset of the clin. phase of AD will facilitate the design and timing of therapeutic interventions aimed at modifying the course of this illness.  Science and Industry Endowment Fund (Australia), The Commonwealth Scientific and Industrial Research Organization (Australia), The National Health and Medical Research Council of Australia Program and Project Grants, the Austin Hospital Medical Research Foundation, Victorian State Government, The Alzheimer's Drug Discovery Foundation, and the Alzheimer's Assocn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoH2O2TjFkaAbVg90H21EOLACvtfcHk0lhtHsvly2FRsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXksFejsrw%253D&md5=2e325131e69aea18b4f6a7cc756bcc55</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fs1474-4422%2813%2970044-&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs1474-4422%252813%252970044-%26sid%3Dliteratum%253Aachs%26aulast%3DVillemagne%26aufirst%3DV.%2BL.%26aulast%3DBurnham%26aufirst%3DS.%26aulast%3DBourgeat%26aufirst%3DP.%26aulast%3DBrown%26aufirst%3DB.%26aulast%3DEllis%26aufirst%3DK.%2BA.%26aulast%3DSalvado%26aufirst%3DO.%26aulast%3DSzoeke%26aufirst%3DC.%26aulast%3DMacaulay%26aufirst%3DS.%2BL.%26aulast%3DMartins%26aufirst%3DR.%26aulast%3DMaruff%26aufirst%3DP.%26aulast%3DAmes%26aufirst%3DD.%26aulast%3DRowe%26aufirst%3DC.%2BC.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26atitle%3DAmyloid%2520%25CE%25B2%2520deposition%252C%2520neurodegeneration%252C%2520and%2520cognitive%2520decline%2520in%2520sporadic%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520prospective%2520cohort%2520study%26jtitle%3DLancet%2520Neurol.%26date%3D2013%26volume%3D12%26spage%3D357%26epage%3D367%26doi%3D10.1016%2Fs1474-4422%2813%2970044-" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Salloway, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperling, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blennow, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klunk, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raskind, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabbagh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honig, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porsteinsson, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferris, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ketter, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nejadnik, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guenzler, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miloslavsky, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lull, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tudor, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grundman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brashear, H. R.</span></span> <span> </span><span class="NLM_article-title">Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer’s disease</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>370</i></span>,  <span class="NLM_fpage">322</span>– <span class="NLM_lpage">333</span>, <span class="refDoi"> DOI: 10.1056/nejmoa1304839</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1056%2Fnejmoa1304839" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=24450891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Ggt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=370&publication_year=2014&pages=322-333&author=S.+Sallowayauthor=R.+Sperlingauthor=N.+C.+Foxauthor=K.+Blennowauthor=W.+Klunkauthor=M.+Raskindauthor=M.+Sabbaghauthor=L.+S.+Honigauthor=A.+P.+Porsteinssonauthor=S.+Ferrisauthor=M.+Reichertauthor=N.+Ketterauthor=B.+Nejadnikauthor=V.+Guenzlerauthor=M.+Miloslavskyauthor=D.+Wangauthor=Y.+Luauthor=J.+Lullauthor=I.+C.+Tudorauthor=E.+Liuauthor=M.+Grundmanauthor=E.+Yuenauthor=R.+Blackauthor=H.+R.+Brashear&title=Two+phase+3+trials+of+bapineuzumab+in+mild-to-moderate+Alzheimer%E2%80%99s+disease&doi=10.1056%2Fnejmoa1304839"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17aR"><div class="casContent"><span class="casTitleNuber">17a</span><div class="casTitle"><span class="NLM_cas:atitle">Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease</span></div><div class="casAuthors">Salloway, Stephen; Sperling, Reisa; Fox, Nick C.; Blennow, Kaj; Klunk, William; Raskind, Murray; Sabbagh, Marwan; Honig, Lawrence S.; Porsteinsson, Anton P.; Ferris, Steven; Reichert, Marcel; Ketter, Nzeera; Nejadnik, Bijan; Guenzler, Volkmar; Miloslavsky, Maja; Wang, Daniel; Lu, Yuan; Lull, Julia; Tudor, Iulia Cristina; Liu, Enchi; Grundman, Michael; Yuen, Eric; Black, Ronald; Brashear, H. Robert</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">370</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">322-333</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Bapineuzumab, a humanized anti-amyloid-beta monoclonal antibody, is in clin. development for the treatment of Alzheimer's disease.  METHODS: We conducted two double-blind, randomized, placebo-controlled, phase 3 trials involving patients with mild-to-moderate Alzheimer's disease - one involving 1121 carriers of the apolipoprotein E (APOE) ε4 allele and the other involving 1331 noncarriers.  Bapineuzumab or placebo, with doses varying by study, was administered by i.v. infusion every 13 wk for 78 wk.  The primary outcome measures were scores on the 11-item cognitive subscale of the Alzheimer's Disease Assessment Scale (ADAS-cog11, with scores ranging from 0 to 70 and higher scores indicating greater impairment) and the Disability Assessment for Dementia (DAD, with scores ranging from 0 to 100 and higher scores indicating less impairment).  A total of 1090 carriers and 1114 noncarriers were included in the efficacy anal.  Secondary outcome measures included findings on positron-emission tomog. amyloid imaging with the use of Pittsburgh compd. B (PIB-PET) and cerebrospinal fluid phosphorylated tau (phospho-tau) concns.  RESULTS: There were no significant between-group differences in the primary outcomes.  At week 78, the between-group differences in the change from baseline in the ADAS-cog11 and DAD scores (bapineuzumab group minus placebo group) were -0.2 (P = 0.80) and -1.2 (P = 0.34), resp., in the carrier study; the corresponding differences in the noncarrier study were -0.3 (P = 0.64) and 2.8 (P = 0.07) with the 0.5-mg-per-kilogram dose of bapineuzumab and 0.4 (P = 0.62) and 0.9 (P = 0.55) with the 1.0-mg-per-kilogram dose.  The major safety finding was amyloid-related imaging abnormalities with edema among patients receiving bapineuzumab, which increased with bapineuzumab dose and APOE ε4 allele no. and which led to discontinuation of the 2.0-mg-per-kilogram dose.  Between-group differences were obsd. with respect to PIB-PET and cerebrospinal fluid phospho-tau concns. in APOE ε4 allele carriers but not in noncarriers.  CONCLUSIONS: Bapineuzumab did not improve clin. outcomes in patients with Alzheimer's disease, despite treatment differences in biomarkers obsd. in APOE ε4 carriers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEl0PP_aoc9LVg90H21EOLACvtfcHk0lhtHsvly2FRsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Ggt7o%253D&md5=932fe885aa8d2426379c786620bbd766</span></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1056%2Fnejmoa1304839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252Fnejmoa1304839%26sid%3Dliteratum%253Aachs%26aulast%3DSalloway%26aufirst%3DS.%26aulast%3DSperling%26aufirst%3DR.%26aulast%3DFox%26aufirst%3DN.%2BC.%26aulast%3DBlennow%26aufirst%3DK.%26aulast%3DKlunk%26aufirst%3DW.%26aulast%3DRaskind%26aufirst%3DM.%26aulast%3DSabbagh%26aufirst%3DM.%26aulast%3DHonig%26aufirst%3DL.%2BS.%26aulast%3DPorsteinsson%26aufirst%3DA.%2BP.%26aulast%3DFerris%26aufirst%3DS.%26aulast%3DReichert%26aufirst%3DM.%26aulast%3DKetter%26aufirst%3DN.%26aulast%3DNejadnik%26aufirst%3DB.%26aulast%3DGuenzler%26aufirst%3DV.%26aulast%3DMiloslavsky%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DLull%26aufirst%3DJ.%26aulast%3DTudor%26aufirst%3DI.%2BC.%26aulast%3DLiu%26aufirst%3DE.%26aulast%3DGrundman%26aufirst%3DM.%26aulast%3DYuen%26aufirst%3DE.%26aulast%3DBlack%26aufirst%3DR.%26aulast%3DBrashear%26aufirst%3DH.%2BR.%26atitle%3DTwo%2520phase%25203%2520trials%2520of%2520bapineuzumab%2520in%2520mild-to-moderate%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2014%26volume%3D370%26spage%3D322%26epage%3D333%26doi%3D10.1056%2Fnejmoa1304839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit17b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Doody, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farlow, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwatsubo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vellas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joffe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieburtz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aisen, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siemers, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu-Seifert, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohs, R.</span></span> <span> </span><span class="NLM_article-title">Phase 3 trials of solanezumab for mild-to-moderate Alzheimer’s disease</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>370</i></span>,  <span class="NLM_fpage">311</span>– <span class="NLM_lpage">321</span>, <span class="refDoi"> DOI: 10.1056/nejmoa1312889</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1056%2Fnejmoa1312889" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=24450890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Ggt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=370&publication_year=2014&pages=311-321&author=R.+S.+Doodyauthor=R.+G.+Thomasauthor=M.+Farlowauthor=T.+Iwatsuboauthor=B.+Vellasauthor=S.+Joffeauthor=K.+Kieburtzauthor=R.+Ramanauthor=X.+Sunauthor=P.+S.+Aisenauthor=E.+Siemersauthor=H.+Liu-Seifertauthor=R.+Mohs&title=Phase+3+trials+of+solanezumab+for+mild-to-moderate+Alzheimer%E2%80%99s+disease&doi=10.1056%2Fnejmoa1312889"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17b</span><div class="casTitle"><span class="NLM_cas:atitle">Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease</span></div><div class="casAuthors">Doody, Rachelle S.; Thomas, Ronald G.; Farlow, Martin; Iwatsubo, Takeshi; Vellas, Bruno; Joffe, Steven; Kieburtz, Karl; Raman, Rema; Sun, Xiaoying; Aisen, Paul S.; Siemers, Eric; Liu-Seifert, Hong; Mohs, Richard</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">370</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">311-321</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Alzheimer's disease is characterized by amyloid-beta plaques, neurofibrillary tangles, gliosis, and neuronal loss.  Solanezumab, a humanized monoclonal antibody, preferentially binds sol. forms of amyloid and in preclin. studies promoted its clearance from the brain.  METHODS: In two phase 3, double-blind trials (EXPEDITION 1 and EXPEDITION 2), we randomly assigned 1012 and 1040 patients, resp., with mild-to-moderate Alzheimer's disease to receive placebo or solanezumab (administered i.v. at a dose of 400 mg) every 4 wk for 18 mo.  The primary outcomes were the changes from baseline to week 80 in scores on the 11-item cognitive subscale of the Alzheimer's Disease Assessment Scale (ADAS-cog11; range, 0 to 70, with higher scores indicating greater cognitive impairment) and the Alzheimer's Disease Cooperative Study-Activities of Daily Living scale (ADCS-ADL; range, 0 to 78, with lower scores indicating worse functioning).  After anal. of data from EXPEDITION 1, the primary outcome for EXPEDITION 2 was revised to the change in scores on the 14-item cognitive subscale of the Alzheimer's Disease Assessment Scale (ADAS-cog14; range, 0 to 90, with higher scores indicating greater impairment), in patients with mild Alzheimer's disease.  RESULTS: Neither study showed significant improvement in the primary outcomes.  The modeled difference between groups (solanezumab group minus placebo group) in the change from baseline was -0.8 points for the ADAS-cog11 score (95% confidence interval [CI], -2.1 to 0.5; P = 0.24) and -0.4 points for the ADCS-ADL score (95% CI, -2.3 to 1.4; P = 0.64) in EXPEDITION 1 and -1.3 points (95% CI, -2.5 to 0.3; P = 0.06) and 1.6 points (95% CI, -0.2 to 3.3; P = 0.08), resp., in EXPEDITION 2.  Between-group differences in the changes in the ADAS-cog14 score were -1.7 points in patients with mild Alzheimer's disease (95% CI, -3.5 to 0.1; P = 0.06) and -1.5 in patients with moderate Alzheimer's disease (95% CI, -4.1 to 1.1; P = 0.26).  In the combined safety data set, the incidence of amyloid-related imaging abnormalities with edema or hemorrhage was 0.9% with solanezumab and 0.4% with placebo for edema (P = 0.27) and 4.9% and 5.6%, resp., for hemorrhage (P = 0.49).  CONCLUSIONS: Solanezumab, a humanized monoclonal antibody that binds amyloid, failed to improve cognition or functional ability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3Ej7A_YXNwLVg90H21EOLACvtfcHk0lhtHsvly2FRsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Ggt70%253D&md5=c993836d4f7374cc78f155f9cedbc594</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1056%2Fnejmoa1312889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252Fnejmoa1312889%26sid%3Dliteratum%253Aachs%26aulast%3DDoody%26aufirst%3DR.%2BS.%26aulast%3DThomas%26aufirst%3DR.%2BG.%26aulast%3DFarlow%26aufirst%3DM.%26aulast%3DIwatsubo%26aufirst%3DT.%26aulast%3DVellas%26aufirst%3DB.%26aulast%3DJoffe%26aufirst%3DS.%26aulast%3DKieburtz%26aufirst%3DK.%26aulast%3DRaman%26aufirst%3DR.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DSiemers%26aufirst%3DE.%26aulast%3DLiu-Seifert%26aufirst%3DH.%26aulast%3DMohs%26aufirst%3DR.%26atitle%3DPhase%25203%2520trials%2520of%2520solanezumab%2520for%2520mild-to-moderate%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2014%26volume%3D370%26spage%3D311%26epage%3D321%26doi%3D10.1056%2Fnejmoa1312889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit17c"><span><span class="NLM_label">(c) </span><a href="https://www.alzforum.org/news/research-news/merck-pulls-plug-phase-23-bace-inhibitor-trial" class="extLink">https://www.alzforum.org/news/research-news/merck-pulls-plug-phase-23-bace-inhibitor-trial</a> (accessed Dec 23, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=https%3A%2F%2Fwww.alzforum.org%2Fnews%2Fresearch-news%2Fmerck-pulls-plug-phase-23-bace-inhibitor-trial+%28accessed+Dec+23%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sperling, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mormino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, K.</span></span> <span> </span><span class="NLM_article-title">The evolution of preclinical Alzheimer’s disease: implications for prevention trials</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">608</span>– <span class="NLM_lpage">622</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2014.10.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1016%2Fj.neuron.2014.10.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=25442939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvV2mtrfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2014&pages=608-622&author=R.+Sperlingauthor=E.+Morminoauthor=K.+Johnson&title=The+evolution+of+preclinical+Alzheimer%E2%80%99s+disease%3A+implications+for+prevention+trials&doi=10.1016%2Fj.neuron.2014.10.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18aR"><div class="casContent"><span class="casTitleNuber">18a</span><div class="casTitle"><span class="NLM_cas:atitle">The Evolution of Preclinical Alzheimer's Disease: Implications for Prevention Trials</span></div><div class="casAuthors">Sperling, Reisa; Mormino, Elizabeth; Johnson, Keith</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">608-622</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">As the field begins to test the concept of a "preclin." stage of neurodegenerative disease, when the pathophysiol. process has begun in the brain, but clin. symptoms are not yet manifest, a no. of intriguing questions have already arisen.  In particular, in preclin. Alzheimer's disease (AD), the temporal relationship of amyloid markers to markers of neurodegeneration and their relative utility in the prediction of cognitive decline among clin. normal older individuals remains to be fully elucidated.  Secondary prevention trials in AD have already begun in both genetic at-risk and amyloid at-risk cohorts, with several more trials in the planning stages, and should provide crit. answers about whether intervention at this very early stage of disease can truly bend the curve of clin. progression.  This review will highlight recent progress in cognitive, imaging, and biomarker outcomes in the field of preclin. AD, and the remaining gaps in knowledge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-LC1zcm6IDLVg90H21EOLACvtfcHk0lgskhuRDG0vJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvV2mtrfL&md5=f73caaba195d2e18aeae9dde4151ac4d</span></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2014.10.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2014.10.038%26sid%3Dliteratum%253Aachs%26aulast%3DSperling%26aufirst%3DR.%26aulast%3DMormino%26aufirst%3DE.%26aulast%3DJohnson%26aufirst%3DK.%26atitle%3DThe%2520evolution%2520of%2520preclinical%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520implications%2520for%2520prevention%2520trials%26jtitle%3DNeuron%26date%3D2014%26volume%3D84%26spage%3D608%26epage%3D622%26doi%3D10.1016%2Fj.neuron.2014.10.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit18b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Jack, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knopman, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagust, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiner, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aisen, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vemuri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiste, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weigand, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesnick, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pankratz, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donohue, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trojanowski, J. Q.</span></span> <span> </span><span class="NLM_article-title">Tracking pathophysiological processes in Alzheimer’s disease: an updated hypothetical model of dynamic biomarkers</span>. <i>Lancet Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">207</span>– <span class="NLM_lpage">216</span>, <span class="refDoi"> DOI: 10.1016/s1474-4422(12)70291-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1016%2Fs1474-4422%2812%2970291-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=23332364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslCht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=207-216&author=C.+R.+Jackauthor=D.+S.+Knopmanauthor=W.+J.+Jagustauthor=R.+C.+Petersenauthor=M.+W.+Weinerauthor=P.+S.+Aisenauthor=L.+M.+Shawauthor=P.+Vemuriauthor=H.+J.+Wisteauthor=S.+D.+Weigandauthor=T.+G.+Lesnickauthor=V.+S.+Pankratzauthor=M.+C.+Donohueauthor=J.+Q.+Trojanowski&title=Tracking+pathophysiological+processes+in+Alzheimer%E2%80%99s+disease%3A+an+updated+hypothetical+model+of+dynamic+biomarkers&doi=10.1016%2Fs1474-4422%2812%2970291-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18bR"><div class="casContent"><span class="casTitleNuber">18b</span><div class="casTitle"><span class="NLM_cas:atitle">Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers</span></div><div class="casAuthors">Jack, Clifford R.; Knopman, David S.; Jagust, William J.; Petersen, Ronald C.; Weiner, Michael W.; Aisen, Paul S.; Shaw, Leslie M.; Vemuri, Prashanthi; Wiste, Heather J.; Weigand, Stephen D.; Lesnick, Timothy G.; Pankratz, Vernon S.; Donohue, Michael C.; Trojanowski, John Q.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">207-216</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  In 2010, we put forward a hypothetical model of the major biomarkers of Alzheimer's disease (AD).  The model was received with interest because we described the temporal evolution of AD biomarkers in relation to each other and to the onset and progression of clin. symptoms.  Since then, evidence has accumulated that supports the major assumptions of this model.  Evidence has also appeared that challenges some of our assumptions, which has allowed us to modify our original model.  Refinements to our model include indexing of individuals by time rather than clin. symptom severity; incorporation of interindividual variability in cognitive impairment assocd. with progression of AD pathophysiol.; modifications of the specific temporal ordering of some biomarkers; and recognition that the two major proteinopathies underlying AD biomarker changes, amyloid β (Aβ) and tau, might be initiated independently in sporadic AD, in which we hypothesise that an incident Aβ pathophysiol. can accelerate antecedent limbic and brainstem tauopathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgH6Mv-cXkY7Vg90H21EOLACvtfcHk0lgskhuRDG0vJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslCht7o%253D&md5=0f7a94ec086d5287fef9f7a6995981df</span></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.1016%2Fs1474-4422%2812%2970291-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs1474-4422%252812%252970291-0%26sid%3Dliteratum%253Aachs%26aulast%3DJack%26aufirst%3DC.%2BR.%26aulast%3DKnopman%26aufirst%3DD.%2BS.%26aulast%3DJagust%26aufirst%3DW.%2BJ.%26aulast%3DPetersen%26aufirst%3DR.%2BC.%26aulast%3DWeiner%26aufirst%3DM.%2BW.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DShaw%26aufirst%3DL.%2BM.%26aulast%3DVemuri%26aufirst%3DP.%26aulast%3DWiste%26aufirst%3DH.%2BJ.%26aulast%3DWeigand%26aufirst%3DS.%2BD.%26aulast%3DLesnick%26aufirst%3DT.%2BG.%26aulast%3DPankratz%26aufirst%3DV.%2BS.%26aulast%3DDonohue%26aufirst%3DM.%2BC.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26atitle%3DTracking%2520pathophysiological%2520processes%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520an%2520updated%2520hypothetical%2520model%2520of%2520dynamic%2520biomarkers%26jtitle%3DLancet%2520Neurol.%26date%3D2013%26volume%3D12%26spage%3D207%26epage%3D216%26doi%3D10.1016%2Fs1474-4422%2812%2970291-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Farzan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnitzler, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasilieva, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choe, H.</span></span> <span> </span><span class="NLM_article-title">BACE2, a β-secretase homolog, cleaves at the β site and within the amyloid-β region of the amyloid-β precursor protein</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">9712</span>– <span class="NLM_lpage">9717</span>, <span class="refDoi"> DOI: 10.1073/pnas.160115697</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1073%2Fpnas.160115697" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10931940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmtVentL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=9712-9717&author=M.+Farzanauthor=C.+E.+Schnitzlerauthor=N.+Vasilievaauthor=D.+Leungauthor=H.+Choe&title=BACE2%2C+a+%CE%B2-secretase+homolog%2C+cleaves+at+the+%CE%B2+site+and+within+the+amyloid-%CE%B2+region+of+the+amyloid-%CE%B2+precursor+protein&doi=10.1073%2Fpnas.160115697"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">BACE2, a β-secretase homolog, cleaves at the β site and within the amyloid-β region of the amyloid-β precursor protein</span></div><div class="casAuthors">Farzan, Michael; Schnitzler, Christine E.; Vasilieva, Natalya; Leung, Doris; Choe, Hyeryun</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">9712-9717</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Prodn. of amyloid-β protein (Aβ) is initiated by a β-secretase that cleaves the Aβ precursor protein (APP) at the N terminus of Aβ (the β site).  A recently identified aspartyl protease, BACE, cleaves the β site and at residue 11 within the Aβ region of APP.  Here we show that BACE2, a BACE homolog, cleaves at the β site and more efficiently at a different site within Aβ.  The Flemish missense mutation of APP, implicated in a form of familial Alzheimer's disease, is adjacent to this latter site and markedly increases Aβ prodn. by BACE2 but not by BACE.  BACE and BACE2 respond identically to conservative β-site mutations, and alteration of a common active site Arg inhibits β-site cleavage but not cleavage within Aβ by both enzymes.  These data suggest that BACE2 contributes to Aβ prodn. in individuals bearing the Flemish mutation, and that selective inhibition of these highly similar proteases may be feasible and therapeutically advantageous.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoKuCTBTrzorVg90H21EOLACvtfcHk0lgskhuRDG0vJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmtVentL8%253D&md5=4cafdc5cf3c57bb981323281cc55cbae</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1073%2Fpnas.160115697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.160115697%26sid%3Dliteratum%253Aachs%26aulast%3DFarzan%26aufirst%3DM.%26aulast%3DSchnitzler%26aufirst%3DC.%2BE.%26aulast%3DVasilieva%26aufirst%3DN.%26aulast%3DLeung%26aufirst%3DD.%26aulast%3DChoe%26aufirst%3DH.%26atitle%3DBACE2%252C%2520a%2520%25CE%25B2-secretase%2520homolog%252C%2520cleaves%2520at%2520the%2520%25CE%25B2%2520site%2520and%2520within%2520the%2520amyloid-%25CE%25B2%2520region%2520of%2520the%2520amyloid-%25CE%25B2%2520precursor%2520protein%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2000%26volume%3D97%26spage%3D9712%26epage%3D9717%26doi%3D10.1073%2Fpnas.160115697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Esterházy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stützer, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rechsteiner, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beauchamp, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Döbeli, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilpert, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matile, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prummer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieske, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marselli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosco, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerr-Conte, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aebersold, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spinas, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moch, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Migliorini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoffel, M.</span></span> <span> </span><span class="NLM_article-title">Bace2 ts a β cell-enriched protease that regulates pancreatic β cell function and mass</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">365</span>– <span class="NLM_lpage">377</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2011.06.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1016%2Fj.cmet.2011.06.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=21907142" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFGltbbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2011&pages=365-377&author=D.+Esterh%C3%A1zyauthor=I.+St%C3%BCtzerauthor=H.+Wangauthor=M.+P.+Rechsteinerauthor=J.+Beauchampauthor=H.+D%C3%B6beliauthor=H.+Hilpertauthor=H.+Matileauthor=M.+Prummerauthor=A.+Schmidtauthor=N.+Lieskeauthor=B.+Boehmauthor=L.+Marselliauthor=D.+Boscoauthor=J.+Kerr-Conteauthor=R.+Aebersoldauthor=G.+A.+Spinasauthor=H.+Mochauthor=C.+Miglioriniauthor=M.+Stoffel&title=Bace2+ts+a+%CE%B2+cell-enriched+protease+that+regulates+pancreatic+%CE%B2+cell+function+and+mass&doi=10.1016%2Fj.cmet.2011.06.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Bace2 Is a β Cell-Enriched Protease that Regulates Pancreatic β Cell Function and Mass</span></div><div class="casAuthors">Esterhazy, Daria; Stuetzer, Ina; Wang, Haiyan; Rechsteiner, Markus P.; Beauchamp, Jeremy; Doebeli, Heinz; Hilpert, Hans; Matile, Hugues; Prummer, Michael; Schmidt, Alexander; Lieske, Nora; Boehm, Bernhard; Marselli, Lorella; Bosco, Domenico; Kerr-Conte, Julie; Aebersold, Ruedi; Spinas, Giatgen Andreia; Moch, Holger; Migliorini, Cristiano; Stoffel, Markus</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">365-377</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Decreased β cell mass and function are hallmarks of type 2 diabetes.  Here we identified, through a siRNA screen, beta site amyloid precursor protein cleaving enzyme 2 (Bace2) as the sheddase of the proproliferative plasma membrane protein Tmem27 in murine and human β cells.  Mice with functionally inactive Bace2 and insulin-resistant mice treated with a newly identified Bace2 inhibitor both display augmented β cell mass and improved control of glucose homeostasis due to increased insulin levels.  These results implicate Bace2 in the control of β cell maintenance and provide a rational strategy to inhibit this protease for the expansion of functional pancreatic β cell mass.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNmw-BllVxx7Vg90H21EOLACvtfcHk0ljPtL6h19wT6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFGltbbM&md5=489e20b2d997eb0cbaff195819e35d64</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2011.06.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2011.06.018%26sid%3Dliteratum%253Aachs%26aulast%3DEsterh%25C3%25A1zy%26aufirst%3DD.%26aulast%3DSt%25C3%25BCtzer%26aufirst%3DI.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DRechsteiner%26aufirst%3DM.%2BP.%26aulast%3DBeauchamp%26aufirst%3DJ.%26aulast%3DD%25C3%25B6beli%26aufirst%3DH.%26aulast%3DHilpert%26aufirst%3DH.%26aulast%3DMatile%26aufirst%3DH.%26aulast%3DPrummer%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DA.%26aulast%3DLieske%26aufirst%3DN.%26aulast%3DBoehm%26aufirst%3DB.%26aulast%3DMarselli%26aufirst%3DL.%26aulast%3DBosco%26aufirst%3DD.%26aulast%3DKerr-Conte%26aufirst%3DJ.%26aulast%3DAebersold%26aufirst%3DR.%26aulast%3DSpinas%26aufirst%3DG.%2BA.%26aulast%3DMoch%26aufirst%3DH.%26aulast%3DMigliorini%26aufirst%3DC.%26aulast%3DStoffel%26aufirst%3DM.%26atitle%3DBace2%2520ts%2520a%2520%25CE%25B2%2520cell-enriched%2520protease%2520that%2520regulates%2520pancreatic%2520%25CE%25B2%2520cell%2520function%2520and%2520mass%26jtitle%3DCell%2520Metab.%26date%3D2011%26volume%3D14%26spage%3D365%26epage%3D377%26doi%3D10.1016%2Fj.cmet.2011.06.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rochin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurbain, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serneels, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fort, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leblanc, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Strooper, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raposo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Niel, G.</span></span> <span> </span><span class="NLM_article-title">BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">10658</span>– <span class="NLM_lpage">10663</span>, <span class="refDoi"> DOI: 10.1073/pnas.1220748110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1073%2Fpnas.1220748110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=23754390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFejs7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=10658-10663&author=L.+Rochinauthor=I.+Hurbainauthor=L.+Serneelsauthor=C.+Fortauthor=B.+Wattauthor=P.+Leblancauthor=M.+S.+Marksauthor=B.+De+Strooperauthor=G.+Raposoauthor=G.+van+Niel&title=BACE2+processes+PMEL+to+form+the+melanosome+amyloid+matrix+in+pigment+cells&doi=10.1073%2Fpnas.1220748110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells</span></div><div class="casAuthors">Rochin, Leila; Hurbain, Ilse; Serneels, Lutgarde; Fort, Cecile; Watt, Brenda; Leblanc, Pascal; Marks, Michael S.; De Strooper, Bart; Raposo, Graca; van Niel, Guillaume</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">10658-10663,S10658/1-S10658/7</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Amyloids are often assocd. with pathol. processes such as in Alzheimer's disease (AD), but can also underlie physiol. processes such as pigmentation.  Formation of pathol. and functional amyloidogenic substrates can require precursor processing by proteases, as exemplified by the generation of Aβ peptide from amyloid precursor protein (APP) by beta-site APP cleaving enzyme (BACE)1 and γ-secretase.  Proteolytic processing of the pigment cell-specific Melanocyte Protein (PMEL) is also required to form functional amyloid fibrils during melanogenesis, but the enzymes involved are incompletely characterized.  Here we show that the BACE1 homolog BACE2 processes PMEL to generate functional amyloids.  BACE2 is highly expressed in pigment cells and Bace2-/- but not Bace1-/- mice display coat color defects, implying a specific role for BACE2 during melanogenesis.  By using biochem. and morphol. analyses, combined with RNA silencing, pharmacol. inhibition, and BACE2 overexpression in a human melanocytic cell line, we show that BACE2 cleaves the integral membrane form of PMEL within the juxtamembrane domain, releasing the PMEL luminal domain into endosomal precursors for the formation of amyloid fibrils and downstream melanosome morphogenesis.  These studies identify an amyloidogenic substrate of BACE2, reveal an important physiol. role for BACE2 in pigmentation, and highlight analogies in the generation of PMEL-derived functional amyloids and APP-derived pathol. amyloids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLBEney5KFyLVg90H21EOLACvtfcHk0ljPtL6h19wT6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFejs7rK&md5=3deb3f80dca6a32748aa6fe2e50c2df1</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1220748110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1220748110%26sid%3Dliteratum%253Aachs%26aulast%3DRochin%26aufirst%3DL.%26aulast%3DHurbain%26aufirst%3DI.%26aulast%3DSerneels%26aufirst%3DL.%26aulast%3DFort%26aufirst%3DC.%26aulast%3DWatt%26aufirst%3DB.%26aulast%3DLeblanc%26aufirst%3DP.%26aulast%3DMarks%26aufirst%3DM.%2BS.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26aulast%3DRaposo%26aufirst%3DG.%26aulast%3Dvan%2BNiel%26aufirst%3DG.%26atitle%3DBACE2%2520processes%2520PMEL%2520to%2520form%2520the%2520melanosome%2520amyloid%2520matrix%2520in%2520pigment%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2013%26volume%3D110%26spage%3D10658%26epage%3D10663%26doi%3D10.1073%2Fpnas.1220748110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shimshek, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolly, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamurovic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balavenkatraman, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morawiec, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreutzer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schelle, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jucker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertschi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigot, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machauer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brzak, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrot, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span> <span> </span><span class="NLM_article-title">Pharmacological BACE1 and BACE2 inhibition induces hair depigmentation by inhibiting PMEL17 processing in mice</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">21917</span>, <span class="refDoi"> DOI: 10.1038/srep21917</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1038%2Fsrep21917" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=26912421" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjt1eku7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=21917&author=D.+R.+Shimshekauthor=L.+H.+Jacobsonauthor=C.+Kollyauthor=N.+Zamurovicauthor=K.+K.+Balavenkatramanauthor=L.+Morawiecauthor=R.+Kreutzerauthor=J.+Schelleauthor=M.+Juckerauthor=B.+Bertschiauthor=D.+Theilauthor=A.+Heierauthor=K.+Bigotauthor=K.+Beltzauthor=R.+Machauerauthor=I.+Brzakauthor=L.+Perrotauthor=U.+Neumann&title=Pharmacological+BACE1+and+BACE2+inhibition+induces+hair+depigmentation+by+inhibiting+PMEL17+processing+in+mice&doi=10.1038%2Fsrep21917"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological BACE1 and BACE2 inhibition induces hair depigmentation by inhibiting PMEL17 processing in mice</span></div><div class="casAuthors">Shimshek, Derya R.; Jacobson, Laura H.; Kolly, Carine; Zamurovic, Natasa; Balavenkatraman, Kamal Kumar; Morawiec, Laurent; Kreutzer, Robert; Schelle, Juliane; Jucker, Mathias; Bertschi, Barbara; Theil, Diethilde; Heier, Annabelle; Bigot, Karine; Beltz, Karen; Machauer, Rainer; Brzak, Irena; Perrot, Ludovic; Neumann, Ulf</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">21917</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Melanocytes of the hair follicle produce melanin and are essential in detg. the differences in hair color.  Pigment cell-specific MELanocyte Protein (PMEL17) plays a crucial role in melanogenesis.  One of the crit. steps is the amyloid-like functional oligomerization of PMEL17.  Beta Site APP Cleaving Enzyme-2 (BACE2) and γ-secretase have been shown to be key players in generating the proteolytic fragments of PMEL17.  The β-secretase (BACE1) is responsible for the generation of amyloid-β (Aβ) fragments in the brain and is therefore proposed as a therapeutic target for Alzheimer's disease (AD).  Currently BACE1 inhibitors, most of which lack selectivity over BACE2, have demonstrated efficacious redn. of amyloid-β peptides in animals and the CSF of humans.  BACE2 knock-out mice have a deficiency in PMEL17 proteolytic processing leading to impaired melanin storage and hair depigmentation.  Here, we confirm BACE2-mediated inhibition of PMEL17 proteolytic processing in vitro in mouse and human melanocytes.  Furthermore, we show that wildtype as well as bace2+/- and bace2-/- mice treated with a potent dual BACE1/BACE2 inhibitor NB-360 display dose-dependent appearance of irreversibly depigmented hair.  Retinal pigmented epithelium showed no morphol. changes.  Our data demonstrates that BACE2 as well as addnl. BACE1 inhibition affects melanosome maturation and induces hair depigmentation in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtlQ-3Lxc4CLVg90H21EOLACvtfcHk0lidFtZJ18fJvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjt1eku7Y%253D&md5=e3641d48cc7fcf08c4502b5899a49066</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fsrep21917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep21917%26sid%3Dliteratum%253Aachs%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26aulast%3DJacobson%26aufirst%3DL.%2BH.%26aulast%3DKolly%26aufirst%3DC.%26aulast%3DZamurovic%26aufirst%3DN.%26aulast%3DBalavenkatraman%26aufirst%3DK.%2BK.%26aulast%3DMorawiec%26aufirst%3DL.%26aulast%3DKreutzer%26aufirst%3DR.%26aulast%3DSchelle%26aufirst%3DJ.%26aulast%3DJucker%26aufirst%3DM.%26aulast%3DBertschi%26aufirst%3DB.%26aulast%3DTheil%26aufirst%3DD.%26aulast%3DHeier%26aufirst%3DA.%26aulast%3DBigot%26aufirst%3DK.%26aulast%3DBeltz%26aufirst%3DK.%26aulast%3DMachauer%26aufirst%3DR.%26aulast%3DBrzak%26aufirst%3DI.%26aulast%3DPerrot%26aufirst%3DL.%26aulast%3DNeumann%26aufirst%3DU.%26atitle%3DPharmacological%2520BACE1%2520and%2520BACE2%2520inhibition%2520induces%2520hair%2520depigmentation%2520by%2520inhibiting%2520PMEL17%2520processing%2520in%2520mice%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D21917%26doi%3D10.1038%2Fsrep21917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ostermann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eder, Jörg</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidhoff, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zink, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassiepen, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Worpenberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maibaum, Jürgen</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simic, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hommel, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerhartz, B.</span></span> <span> </span><span class="NLM_article-title">Crystal Structure of Human BACE2 in Complex with a Hydroxyethylamine Transition-state Inhibitor</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>355</i></span>,  <span class="NLM_fpage">249</span>– <span class="NLM_lpage">261</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2005.10.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1016%2Fj.jmb.2005.10.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=16305800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlSjt7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2006&pages=249-261&author=N.+Ostermannauthor=J%C3%B6rg+Ederauthor=U.+Eidhoffauthor=F.+Zinkauthor=U.+Hassiepenauthor=S.+Worpenbergauthor=J%C3%BCrgen+Maibaumauthor=O.+Simicauthor=U.+Hommelauthor=B.+Gerhartz&title=Crystal+Structure+of+Human+BACE2+in+Complex+with+a+Hydroxyethylamine+Transition-state+Inhibitor&doi=10.1016%2Fj.jmb.2005.10.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23aR"><div class="casContent"><span class="casTitleNuber">23a</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of Human BACE2 in Complex with a Hydroxyethylamine Transition-state Inhibitor</span></div><div class="casAuthors">Ostermann, Nils; Eder, Joerg; Eidhoff, Ulf; Zink, Florence; Hassiepen, Ulrich; Worpenberg, Susanne; Maibaum, Juergen; Simic, Oliver; Hommel, Ulrich; Gerhartz, Bernd</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">249-261</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">BACE2 is a membrane-bound aspartic protease of the A1 family with a high level of sequence homol. to BACE1.  While BACE1 is involved in the generation of amyloid plaques in Alzheimer's disease by cleaving Aβ-peptides from the amyloid precursor protein, the physiol. function of BACE2 is not well understood.  BACE2 appears to be assocd. with the early onset of dementia in patients with Down's syndrome, and it has been shown to be highly expressed in breast cancers.  Further, it may participate in the function of normal and abnormal processes of human muscle biol.  Similar to other aspartic proteases, BACE2 is expressed as an inactive zymogen requiring the cleavage of its pro-sequence during the maturation process.  We have produced mature BACE2 by expression of pro-BACE2 in Escherichia coli as inclusion bodies, followed by refolding and autocatalytic activation at pH 3.4.  Using a C and N-terminally truncated BACE2 variant, we were able to crystallize and det. the crystal structure of mature BACE2 in complex with a hydroxyethylamine transition-state mimetic inhibitor at 3.1 Å resoln.  The structure of BACE2 follows the general fold of A1 aspartic proteases.  However, similar to BACE1, its C-terminal domain is significantly larger than that of the other family members.  Furthermore, the structure of BACE2 reveals differences in the S3, S2, S1' and S2' active site substrate pockets as compared to BACE1, and allows, therefore, for a deeper understanding of the structural features that may facilitate the design of selective BACE1 or BACE2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpagbhk8u5oybVg90H21EOLACvtfcHk0lidFtZJ18fJvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlSjt7bO&md5=74ae4bbd058acf333ea11fba486f10b2</span></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2005.10.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2005.10.027%26sid%3Dliteratum%253Aachs%26aulast%3DOstermann%26aufirst%3DN.%26aulast%3DEder%26aufirst%3DJ%25C3%25B6rg%26aulast%3DEidhoff%26aufirst%3DU.%26aulast%3DZink%26aufirst%3DF.%26aulast%3DHassiepen%26aufirst%3DU.%26aulast%3DWorpenberg%26aufirst%3DS.%26aulast%3DMaibaum%26aufirst%3DJ%25C3%25BCrgen%26aulast%3DSimic%26aufirst%3DO.%26aulast%3DHommel%26aufirst%3DU.%26aulast%3DGerhartz%26aufirst%3DB.%26atitle%3DCrystal%2520Structure%2520of%2520Human%2520BACE2%2520in%2520Complex%2520with%2520a%2520Hydroxyethylamine%2520Transition-state%2520Inhibitor%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2006%26volume%3D355%26spage%3D249%26epage%3D261%26doi%3D10.1016%2Fj.jmb.2005.10.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit23b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Banner, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gsell, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertschinger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burger, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brack, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuppuleri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debulpaep, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gast, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grabulovski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennig, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilpert, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuglstatter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusznir, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laeremans, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matile, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miscenic, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rufer, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlatter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steyaert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stihle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thoma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruf, A.</span></span> <span> </span><span class="NLM_article-title">Mapping the conformational space accessible to BACE2 using surface mutants and cocrystals with Fab fragments, Fynomers and Xaperones</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">1124</span>– <span class="NLM_lpage">1137</span>, <span class="refDoi"> DOI: 10.1107/s0907444913006574</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1107%2Fs0907444913006574" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=1124-1137&author=D.+W.+Bannerauthor=B.+Gsellauthor=J.+Benzauthor=J.+Bertschingerauthor=D.+Burgerauthor=S.+Brackauthor=S.+Cuppuleriauthor=M.+Debulpaepauthor=A.+Gastauthor=D.+Grabulovskiauthor=M.+Hennigauthor=H.+Hilpertauthor=W.+Huberauthor=A.+Kuglstatterauthor=E.+Kusznirauthor=T.+Laeremansauthor=H.+Matileauthor=C.+Miscenicauthor=A.+C.+Ruferauthor=D.+Schlatterauthor=J.+Steyaertauthor=M.+Stihleauthor=R.+Thomaauthor=M.+Weberauthor=A.+Ruf&title=Mapping+the+conformational+space+accessible+to+BACE2+using+surface+mutants+and+cocrystals+with+Fab+fragments%2C+Fynomers+and+Xaperones&doi=10.1107%2Fs0907444913006574"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=10.1107%2Fs0907444913006574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252Fs0907444913006574%26sid%3Dliteratum%253Aachs%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DGsell%26aufirst%3DB.%26aulast%3DBenz%26aufirst%3DJ.%26aulast%3DBertschinger%26aufirst%3DJ.%26aulast%3DBurger%26aufirst%3DD.%26aulast%3DBrack%26aufirst%3DS.%26aulast%3DCuppuleri%26aufirst%3DS.%26aulast%3DDebulpaep%26aufirst%3DM.%26aulast%3DGast%26aufirst%3DA.%26aulast%3DGrabulovski%26aufirst%3DD.%26aulast%3DHennig%26aufirst%3DM.%26aulast%3DHilpert%26aufirst%3DH.%26aulast%3DHuber%26aufirst%3DW.%26aulast%3DKuglstatter%26aufirst%3DA.%26aulast%3DKusznir%26aufirst%3DE.%26aulast%3DLaeremans%26aufirst%3DT.%26aulast%3DMatile%26aufirst%3DH.%26aulast%3DMiscenic%26aufirst%3DC.%26aulast%3DRufer%26aufirst%3DA.%2BC.%26aulast%3DSchlatter%26aufirst%3DD.%26aulast%3DSteyaert%26aufirst%3DJ.%26aulast%3DStihle%26aufirst%3DM.%26aulast%3DThoma%26aufirst%3DR.%26aulast%3DWeber%26aufirst%3DM.%26aulast%3DRuf%26aufirst%3DA.%26atitle%3DMapping%2520the%2520conformational%2520space%2520accessible%2520to%2520BACE2%2520using%2520surface%2520mutants%2520and%2520cocrystals%2520with%2520Fab%2520fragments%252C%2520Fynomers%2520and%2520Xaperones%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2013%26volume%3D69%26spage%3D1124%26epage%3D1137%26doi%3D10.1107%2Fs0907444913006574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuillard, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleasby, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, Christopher W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yon, J.</span></span> <span> </span><span class="NLM_article-title">Apo and Inhibitor Complex Structures of BACE (β-secretase)</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>343</i></span>,  <span class="NLM_fpage">407</span>– <span class="NLM_lpage">416</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2004.08.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1016%2Fj.jmb.2004.08.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=15451669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnvVyqt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2004&pages=407-416&author=S.+Patelauthor=L.+Vuillardauthor=A.+Cleasbyauthor=Christopher+W.+Murrayauthor=J.+Yon&title=Apo+and+Inhibitor+Complex+Structures+of+BACE+%28%CE%B2-secretase%29&doi=10.1016%2Fj.jmb.2004.08.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24aR"><div class="casContent"><span class="casTitleNuber">24a</span><div class="casTitle"><span class="NLM_cas:atitle">Apo and Inhibitor Complex Structures of BACE (β-secretase)</span></div><div class="casAuthors">Patel, Sahil; Vuillard, Laurent; Cleasby, Anne; Murray, Christopher W.; Yon, Jeff</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">343</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">407-416</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Human BACE, also known as β-secretase, shows promise as a potential therapeutic target for Alzheimer's disease.  The authors detd. the apo structure of BACE to 1.75 Å, and a structure of a hydroxyethylamine inhibitor complex derived by soaking.  These show significant active-site movements compared to previously described BACE structures.  Addnl., the structures reveal two pockets that could be targeted by structure-based drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH0afg2-ZxjLVg90H21EOLACvtfcHk0lidFtZJ18fJvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnvVyqt7w%253D&md5=b14e17f86a4729fb8ee66d84ee6c1fab</span></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2004.08.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2004.08.018%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DVuillard%26aufirst%3DL.%26aulast%3DCleasby%26aufirst%3DA.%26aulast%3DMurray%26aufirst%3DChristopher%2BW.%26aulast%3DYon%26aufirst%3DJ.%26atitle%3DApo%2520and%2520Inhibitor%2520Complex%2520Structures%2520of%2520BACE%2520%2528%25CE%25B2-secretase%2529%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2004%26volume%3D343%26spage%3D407%26epage%3D416%26doi%3D10.1016%2Fj.jmb.2004.08.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit24b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J.</span></span> <span> </span><span class="NLM_article-title">Flap position of free Memapsin 2 (β-secretase), a model for flap opening in aspartic protease catalysis</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">4689</span>– <span class="NLM_lpage">4695</span>, <span class="refDoi"> DOI: 10.1021/bi0498252</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi0498252" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BD2cXis1CjtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=4689-4695&author=L.+Hongauthor=J.+Tang&title=Flap+position+of+free+Memapsin+2+%28%CE%B2-secretase%29%2C+a+model+for+flap+opening+in+aspartic+protease+catalysis&doi=10.1021%2Fbi0498252"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24bR"><div class="casContent"><span class="casTitleNuber">24b</span><div class="casTitle"><span class="NLM_cas:atitle">Flap Position of Free Memapsin 2 (β-Secretase), a Model for Flap Opening in Aspartic Protease Catalysis</span></div><div class="casAuthors">Hong, Lin; Tang, Jordan</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4689-4695</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The three-dimensional structure of unbound human memapsin 2 (β-secretase) protease domain detd. at 2.0-Å resoln. has revealed a new position of the flap region, which appears to be locked in an "open" position.  While the structure outside of the flap is essentially the same as the structure of memapsin 2 bound to an inhibitor, the flap positions are 4.5 Å different at the tips.  The open position of the flap in the current structure is stabilized by two newly formed intraflap hydrogen bonds and anchored by a new hydrogen bond involving the side chain of Tyr-71 (Tyr-75 in pepsin numbering) in a novel orientation.  In mol. modeling expts., the opening of the flap, 6.5 Å at the narrowest point, permits entrance of substrates into the cleft.  The narrowest point of the opening may function to discriminate among substrates based on sequence and shape.  The obsd. flap opening may also serve as a model for the flap movement in the catalytic mechanism of eukaryotic aspartic proteases and provide insight for the side-chain selection in the design of memapsin 2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHKNx5Pd9E1LVg90H21EOLACvtfcHk0lgcgxaG5A9dIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXis1CjtL4%253D&md5=43617f8ecfd4f38675279b9b6a2e9925</span></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=10.1021%2Fbi0498252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0498252%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DL.%26aulast%3DTang%26aufirst%3DJ.%26atitle%3DFlap%2520position%2520of%2520free%2520Memapsin%25202%2520%2528%25CE%25B2-secretase%2529%252C%2520a%2520model%2520for%2520flap%2520opening%2520in%2520aspartic%2520protease%2520catalysis%26jtitle%3DBiochemistry%26date%3D2004%26volume%3D43%26spage%3D4689%26epage%3D4695%26doi%3D10.1021%2Fbi0498252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malamas, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chopra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pangalos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinhart, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robichaud, A. J.</span></span> <span> </span><span class="NLM_article-title">Di-substituted pyridinyl aminohydantoins as potent and highly selective human β-secretase (BACE1) inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">630</span>– <span class="NLM_lpage">639</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2009.12.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1016%2Fj.bmc.2009.12.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=20045648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC3cXot1yqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=630-639&author=M.+S.+Malamasauthor=K.+Barnesauthor=M.+Johnsonauthor=Y.+Huiauthor=P.+Zhouauthor=J.+Turnerauthor=Y.+Huauthor=E.+Wagnerauthor=K.+Fanauthor=R.+Chopraauthor=A.+Ollandauthor=J.+Bardauthor=M.+Pangalosauthor=P.+Reinhartauthor=A.+J.+Robichaud&title=Di-substituted+pyridinyl+aminohydantoins+as+potent+and+highly+selective+human+%CE%B2-secretase+%28BACE1%29+inhibitors&doi=10.1016%2Fj.bmc.2009.12.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Di-substituted pyridinyl aminohydantoins as potent and highly selective human β-secretase (BACE1) inhibitors</span></div><div class="casAuthors">Malamas, Michael S.; Barnes, Keith; Johnson, Matthew; Hui, Yu; Zhou, Ping; Turner, Jim; Hu, Yun; Wagner, Erik; Fan, Kristi; Chopra, Rajiv; Olland, Andrea; Bard, Jonathan; Pangalos, Menelas; Reinhart, Peter; Robichaud, Albert J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">630-639</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The identification of highly selective small mol. di-substituted pyridinyl aminohydantoins as β-secretase inhibitors is reported.  The more potent and selective analogs demonstrate low nanomolar potency for the BACE1 enzyme as measured in a FRET assay, and exhibit comparable activity in a cell-based (ELISA) assay.  In addn., these pyridine-aminohydantoins are highly selectivity (>500×) against the other structurally related aspartyl proteases BACE2, cathepsin D, pepsin and renin.  Our design strategy followed a traditional SAR approach and was supported by mol. modeling studies based on the previously reported aminohydantoin I.  We have taken advantage of the amino acid difference between the BACE1 and BACE2 at the S2' pocket (BACE1 Pro70 changed to BACE2 Lys86) to build ligands with >500-fold selectivity against BACE2.  The addn. of large substituents on the targeted ligand at the vicinity of this aberration has generated a steric conflict between the ligand and these two proteins, thus impacting the ligand's affinity and selectivity.  These ligands have also shown an exceptional selectivity against cathepsin D (>5000-fold) as well as the other aspartyl proteases mentioned.  One of the more potent compds. (S)-II displayed an IC50 value for BACE1 of 10 nM, and exhibited cellular activity with an EC50 value of 130 nM in the ELISA assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBPjXCZYzfhLVg90H21EOLACvtfcHk0lgcgxaG5A9dIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXot1yqsg%253D%253D&md5=7b509e226d91b162059777507e7f8463</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.12.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.12.007%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DBarnes%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DM.%26aulast%3DHui%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DTurner%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DWagner%26aufirst%3DE.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DOlland%26aufirst%3DA.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DPangalos%26aufirst%3DM.%26aulast%3DReinhart%26aufirst%3DP.%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26atitle%3DDi-substituted%2520pyridinyl%2520aminohydantoins%2520as%2520potent%2520and%2520highly%2520selective%2520human%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D630%26epage%3D639%26doi%3D10.1016%2Fj.bmc.2009.12.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Brodney, M. A.</span>; <span class="NLM_string-name">Beck, E. M.</span>; <span class="NLM_string-name">Butler, C. R.</span>; <span class="NLM_string-name">Zhang, L.</span>; <span class="NLM_string-name">O’Neill, B. T.</span>; <span class="NLM_string-name">Barreiro, G.</span>; <span class="NLM_string-name">Lachapelle, E. A.</span>; <span class="NLM_string-name">Rogers, B. N.</span></span> <span> </span><span class="NLM_article-title">Preparation of <i>N</i>-(2-Amino-6-methyl-4,4<i>a</i>,5,6-tetrahydropyrano[3,4-<i>d</i>][1,3]thiazin-8<i>a</i>(8<i>h</i>)-yl-1,3-thiazol-4-yl) Amides as Inhibitors of Beta-site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1)</span>. <span class="NLM_patent">WO 2015155626 A1</span>, Oct 15, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=M.+A.+Brodney&author=E.+M.+Beck&author=C.+R.+Butler&author=L.+Zhang&author=B.+T.+O%E2%80%99Neill&author=G.+Barreiro&author=E.+A.+Lachapelle&author=B.+N.+Rogers&title=Preparation+of+N-%282-Amino-6-methyl-4%2C4a%2C5%2C6-tetrahydropyrano%5B3%2C4-d%5D%5B1%2C3%5Dthiazin-8a%288h%29-yl-1%2C3-thiazol-4-yl%29+Amides+as+Inhibitors+of+Beta-site+Amyloid+Precursor+Protein+Cleaving+Enzyme+1+%28BACE1%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26atitle%3DPreparation%2520of%2520N-%25282-Amino-6-methyl-4%252C4a%252C5%252C6-tetrahydropyrano%255B3%252C4-d%255D%255B1%252C3%255Dthiazin-8a%25288h%2529-yl-1%252C3-thiazol-4-yl%2529%2520Amides%2520as%2520Inhibitors%2520of%2520Beta-site%2520Amyloid%2520Precursor%2520Protein%2520Cleaving%2520Enzyme%25201%2520%2528BACE1%2529%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit26b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Richards, S. J.</span>; <span class="NLM_string-name">Hembre, E. J.</span>; <span class="NLM_string-name">Lopez, J. E.</span>; <span class="NLM_string-name">Winneroski, L. L.,  Jr.</span>; <span class="NLM_string-name">Woods, T. A.</span>; <span class="NLM_string-name">Mcmahon, J. A.</span></span> <span> </span><span class="NLM_article-title">Preparation of 2-Amino-5-(1,1-difluoroalkyl)-4,4a,5,7-tetrahydrofuro[3,4-d][1,3]thiazin-7a-yl]-4-fluorophenyl]-5-(1,2,4-triazol-1-yl)pyrazine-2-carboxamides as Selective BACE1 Inhibitors</span>. U.S. patent <span class="NLM_patent">0,244,465 A1</span>, Aug 25, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=S.+J.+Richards&author=E.+J.+Hembre&author=J.+E.+Lopez&author=L.+L.+Winneroski&author=T.+A.+Woods&author=J.+A.+Mcmahon&title=Preparation+of+2-Amino-5-%281%2C1-difluoroalkyl%29-4%2C4a%2C5%2C7-tetrahydrofuro%5B3%2C4-d%5D%5B1%2C3%5Dthiazin-7a-yl%5D-4-fluorophenyl%5D-5-%281%2C2%2C4-triazol-1-yl%29pyrazine-2-carboxamides+as+Selective+BACE1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRichards%26aufirst%3DS.%2BJ.%26atitle%3DPreparation%2520of%25202-Amino-5-%25281%252C1-difluoroalkyl%2529-4%252C4a%252C5%252C7-tetrahydrofuro%255B3%252C4-d%255D%255B1%252C3%255Dthiazin-7a-yl%255D-4-fluorophenyl%255D-5-%25281%252C2%252C4-triazol-1-yl%2529pyrazine-2-carboxamides%2520as%2520Selective%2520BACE1%2520Inhibitors%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit26c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, J. R.</span>; <span class="NLM_string-name">Amegadzie, A.</span>; <span class="NLM_string-name">Bourbeau, M. P.</span>; <span class="NLM_string-name">Brown, J. A.</span>; <span class="NLM_string-name">Chen, N.</span>; <span class="NLM_string-name">Frohn, M.
J.</span>; <span class="NLM_string-name">Liu, L.</span>; <span class="NLM_string-name">Liu, Q.</span>; <span class="NLM_string-name">Pettus, L. H.</span>; <span class="NLM_string-name">Qian, W.</span>; <span class="NLM_string-name">Reeves, C. M.</span>; <span class="NLM_string-name">Siegmund, A. C.</span></span> <span> </span><span class="NLM_article-title">Preparation of Vinyl Fluoride Cyclopropyl Fused Thiazin-2-amine Compounds as Beta-secretase Inhibitors and Methods of Use</span>. <span class="NLM_patent">WO 2017024180 A1</span>, Feb 9, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=J.+R.+Allen&author=A.+Amegadzie&author=M.+P.+Bourbeau&author=J.+A.+Brown&author=N.+Chen&author=M.%0AJ.+Frohn&author=L.+Liu&author=Q.+Liu&author=L.+H.+Pettus&author=W.+Qian&author=C.+M.+Reeves&author=A.+C.+Siegmund&title=Preparation+of+Vinyl+Fluoride+Cyclopropyl+Fused+Thiazin-2-amine+Compounds+as+Beta-secretase+Inhibitors+and+Methods+of+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DJ.%2BR.%26atitle%3DPreparation%2520of%2520Vinyl%2520Fluoride%2520Cyclopropyl%2520Fused%2520Thiazin-2-amine%2520Compounds%2520as%2520Beta-secretase%2520Inhibitors%2520and%2520Methods%2520of%2520Use%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit26d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolan, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doran, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lapham, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buzon, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutra, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barreiro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Alsina, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalobos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogilvie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Chapelle, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanyon, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steppan, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robshaw, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hales, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boucher, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandher, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houle, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambroise, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karanian, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riddell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bales, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodney, M. A.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of clinical candidate PF-06751979: A potent, brain penetrant, β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor lacking hypopigmentation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">4476</span>– <span class="NLM_lpage">4504</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00246</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00246" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC1cXntVCmtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=4476-4504&author=B.+T.+O%E2%80%99Neillauthor=E.+M.+Beckauthor=C.+R.+Butlerauthor=C.+E.+Nolanauthor=C.+Gonzalesauthor=L.+Zhangauthor=S.+D.+Doranauthor=K.+Laphamauthor=L.+M.+Buzonauthor=J.+K.+Dutraauthor=G.+Barreiroauthor=X.+Houauthor=L.+A.+Martinez-Alsinaauthor=B.+N.+Rogersauthor=A.+Villalobosauthor=J.+C.+Murrayauthor=K.+Ogilvieauthor=E.+A.+La+Chapelleauthor=C.+Changauthor=L.+F.+Lanyonauthor=C.+M.+Steppanauthor=A.+Robshawauthor=K.+Halesauthor=G.+G.+Boucherauthor=K.+Pandherauthor=C.+Houleauthor=C.+W.+Ambroiseauthor=D.+Karanianauthor=D.+Riddellauthor=K.+R.+Balesauthor=M.+A.+Brodney&title=Design+and+synthesis+of+clinical+candidate+PF-06751979%3A+A+potent%2C+brain+penetrant%2C+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+1+%28BACE1%29+inhibitor+lacking+hypopigmentation&doi=10.1021%2Facs.jmedchem.8b00246"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26dR"><div class="casContent"><span class="casTitleNuber">26d</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Clinical Candidate PF-06751979: A Potent, Brain Penetrant, β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitor Lacking Hypopigmentation</span></div><div class="casAuthors">O'Neill, Brian T.; Beck, Elizabeth M.; Butler, Christopher R.; Nolan, Charles E.; Gonzales, Cathleen; Zhang, Lei; Doran, Shawn D.; Lapham, Kimberly; Buzon, Leanne M.; Dutra, Jason K.; Barreiro, Gabriela; Hou, Xinjun; Martinez-Alsina, Luis A.; Rogers, Bruce N.; Villalobos, Anabella; Murray, John C.; Ogilvie, Kevin; La Chapelle, Erik A.; Chang, Cheng; Lanyon, Lorraine F.; Steppan, Claire M.; Robshaw, Ashley; Hales, Katherine; Boucher, Germaine G.; Pandher, Karamjeet; Houle, Christopher; Ambroise, Claude W.; Karanian, David; Riddell, David; Bales, Kelly R.; Brodney, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4476-4504</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A major challenge in the development of β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors for the treatment of Alzheimer's disease is the alignment of potency, drug-like properties, and selectivity over related aspartyl proteases such as Cathepsin D (CatD) and BACE2.  The potential liabilities of inhibiting BACE2 chronically have only recently begun to emerge as BACE2 impacts the processing of the premelanosome protein (PMEL17) and disrupts melanosome morphol. resulting in a depigmentation phenotype.  Herein, the authors describe the identification of clin. candidate PF-06751979 (I), which displays excellent brain penetration, potent in vivo efficacy, and broad selectivity over related aspartyl proteases including BACE2.  Chronic dosing of I for up to 9 mo in dog did not reveal any observation of hair coat color (pigmentation) changes and suggests a key differentiator over current BACE1 inhibitors that are nonselective against BACE2 in later stage clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs1F61vo0jBbVg90H21EOLACvtfcHk0lgOWggiXfCLjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXntVCmtrs%253D&md5=3d8cae0bb20298e66f6da1c26cf8d5bc</span></div><a href="/servlet/linkout?suffix=cit26d&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00246%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DButler%26aufirst%3DC.%2BR.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DGonzales%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DLapham%26aufirst%3DK.%26aulast%3DBuzon%26aufirst%3DL.%2BM.%26aulast%3DDutra%26aufirst%3DJ.%2BK.%26aulast%3DBarreiro%26aufirst%3DG.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DMartinez-Alsina%26aufirst%3DL.%2BA.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DMurray%26aufirst%3DJ.%2BC.%26aulast%3DOgilvie%26aufirst%3DK.%26aulast%3DLa%2BChapelle%26aufirst%3DE.%2BA.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DLanyon%26aufirst%3DL.%2BF.%26aulast%3DSteppan%26aufirst%3DC.%2BM.%26aulast%3DRobshaw%26aufirst%3DA.%26aulast%3DHales%26aufirst%3DK.%26aulast%3DBoucher%26aufirst%3DG.%2BG.%26aulast%3DPandher%26aufirst%3DK.%26aulast%3DHoule%26aufirst%3DC.%26aulast%3DAmbroise%26aufirst%3DC.%2BW.%26aulast%3DKaranian%26aufirst%3DD.%26aulast%3DRiddell%26aufirst%3DD.%26aulast%3DBales%26aufirst%3DK.%2BR.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520clinical%2520candidate%2520PF-06751979%253A%2520A%2520potent%252C%2520brain%2520penetrant%252C%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%2520inhibitor%2520lacking%2520hypopigmentation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D4476%26epage%3D4504%26doi%3D10.1021%2Facs.jmedchem.8b00246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit26e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaspersson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurrell, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bäck, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eketjäll, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cebers, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorne, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenzie, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaton, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davey, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolmodin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holenz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duggan, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haeberlein, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bürli, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burli, R. W.</span></span> <span> </span><span class="NLM_article-title">Toward β-Secretase-1 Inhibitors with Improved Isoform Selectivity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">3491</span>– <span class="NLM_lpage">3502</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01716</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01716" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC1cXntVCmsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=3491-3502&author=P.+Johanssonauthor=K.+Kasperssonauthor=I.+K.+Gurrellauthor=E.+B%C3%A4ckauthor=S.+Eketj%C3%A4llauthor=C.+W.+Scottauthor=G.+Cebersauthor=P.+Thorneauthor=M.+J.+McKenzieauthor=H.+Beatonauthor=P.+Daveyauthor=K.+Kolmodinauthor=J.+Holenzauthor=M.+E.+Dugganauthor=S.+B.+Haeberleinauthor=R.+W.+B%C3%BCrliauthor=R.+W.+Burli&title=Toward+%CE%B2-Secretase-1+Inhibitors+with+Improved+Isoform+Selectivity&doi=10.1021%2Facs.jmedchem.7b01716"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26eR"><div class="casContent"><span class="casTitleNuber">26e</span><div class="casTitle"><span class="NLM_cas:atitle">Toward β-Secretase-1 Inhibitors with Improved Isoform Selectivity</span></div><div class="casAuthors">Johansson, Patrik; Kaspersson, Karin; Gurrell, Ian K.; Baeck, Elisabeth; Eketjaell, Susanna; Scott, Clay W.; Cebers, Gvido; Thorne, Philip; McKenzie, Michael J.; Beaton, Haydn; Davey, Paul; Kolmodin, Karin; Holenz, Joerg; Duggan, Mark E.; Budd Haeberlein, Samantha; Burli, Roland W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3491-3502</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">BACE1 is responsible for the first step in APP proteolysis, leading to toxic Aβ prodn., and has been indicated to play a key role in the pathogenesis of Alzheimer's disease.  The related isoform BACE2 is thought to be involved in processing of the pigment cell-specific melanocyte protein.  To avoid potential effects on pigmentation, we investigated the feasibility for developing isoform-selective BACE1 inhibitors.  Cocrystal structures of 47 compds. were analyzed and clustered according to their selectivity profiles.  Selective BACE1 inhibitors were found to exhibit two distinct conformational features proximal to the flap and the S3 subpocket.  Several new mols. were designed and tested to make use of this observation.  The combination of a pyrimidinyl C-ring and a methylcyclohexyl element resulted in lead mol. 28, which exhibited ∼50-fold selectivity.  Compared to a nonselective BACE1/2 inhibitor, 28 showed significantly less inhibition of PMEL processing in human melanocytes, indicating good functional selectivity of this inhibitor class.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlCCtmcFz6HrVg90H21EOLACvtfcHk0lgOWggiXfCLjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXntVCmsLk%253D&md5=46ce3d839d3153d848c1ae0209263634</span></div><a href="/servlet/linkout?suffix=cit26e&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01716%26sid%3Dliteratum%253Aachs%26aulast%3DJohansson%26aufirst%3DP.%26aulast%3DKaspersson%26aufirst%3DK.%26aulast%3DGurrell%26aufirst%3DI.%2BK.%26aulast%3DB%25C3%25A4ck%26aufirst%3DE.%26aulast%3DEketj%25C3%25A4ll%26aufirst%3DS.%26aulast%3DScott%26aufirst%3DC.%2BW.%26aulast%3DCebers%26aufirst%3DG.%26aulast%3DThorne%26aufirst%3DP.%26aulast%3DMcKenzie%26aufirst%3DM.%2BJ.%26aulast%3DBeaton%26aufirst%3DH.%26aulast%3DDavey%26aufirst%3DP.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DHolenz%26aufirst%3DJ.%26aulast%3DDuggan%26aufirst%3DM.%2BE.%26aulast%3DHaeberlein%26aufirst%3DS.%2BB.%26aulast%3DB%25C3%25BCrli%26aufirst%3DR.%2BW.%26aulast%3DBurli%26aufirst%3DR.%2BW.%26atitle%3DToward%2520%25CE%25B2-Secretase-1%2520Inhibitors%2520with%2520Improved%2520Isoform%2520Selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D3491%26epage%3D3502%26doi%3D10.1021%2Facs.jmedchem.7b01716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, N.</span>; <span class="NLM_string-name">Ueda, K.</span>; <span class="NLM_string-name">Itoh, N.</span>; <span class="NLM_string-name">Suzuki, S.</span>; <span class="NLM_string-name">Sakaguchi, G.</span>; <span class="NLM_string-name">Kato, A.</span>; <span class="NLM_string-name">Yukimasa, A.</span>; <span class="NLM_string-name">Hori, A.</span>; <span class="NLM_string-name">Koriyama, Y.</span>; <span class="NLM_string-name">Haraguchi, H.</span>; <span class="NLM_string-name">Yasui, K.</span>; <span class="NLM_string-name">Kanda, Y.</span></span> <span> </span><span class="NLM_article-title">Preparation of 2-aminodihydrothiazine derivatives as β-secretase inhibitors</span>. <span class="NLM_patent">WO 2007049532 A1</span>, March 3, <span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=N.+Kobayashi&author=K.+Ueda&author=N.+Itoh&author=S.+Suzuki&author=G.+Sakaguchi&author=A.+Kato&author=A.+Yukimasa&author=A.+Hori&author=Y.+Koriyama&author=H.+Haraguchi&author=K.+Yasui&author=Y.+Kanda&title=Preparation+of+2-aminodihydrothiazine+derivatives+as+%CE%B2-secretase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DN.%26atitle%3DPreparation%2520of%25202-aminodihydrothiazine%2520derivatives%2520as%2520%25CE%25B2-secretase%2520inhibitors%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit27b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchino, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsuoka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masui, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurose, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unemura, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosono, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakaguchi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ando, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohnishi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kido, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukushima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyajima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiroyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyabu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhuyvetter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borghys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, Harrie J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iso, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusakabe, K.-I.</span></span> <span> </span><span class="NLM_article-title">Rational design of novel 1,3-oxazine based β-secretase (BACE1) inhibitors: Incorporation of a double bond to reduce P-gp efflux leading to robust Aβ reduction in the brain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5122</span>– <span class="NLM_lpage">5137</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00002</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC1cXptVWhsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5122-5137&author=K.+Fuchinoauthor=Y.+Mitsuokaauthor=M.+Masuiauthor=N.+Kuroseauthor=S.+Yoshidaauthor=K.+Komanoauthor=T.+Yamamotoauthor=M.+Ogawaauthor=C.+Unemuraauthor=M.+Hosonoauthor=H.+Itoauthor=G.+Sakaguchiauthor=S.+Andoauthor=S.+Ohnishiauthor=Y.+Kidoauthor=T.+Fukushimaauthor=H.+Miyajimaauthor=S.+Hiroyamaauthor=K.+Koyabuauthor=D.+Dhuyvetterauthor=H.+Borghysauthor=Harrie+J.+M.+Gijsenauthor=Y.+Yamanoauthor=Y.+Isoauthor=K.-I.+Kusakabe&title=Rational+design+of+novel+1%2C3-oxazine+based+%CE%B2-secretase+%28BACE1%29+inhibitors%3A+Incorporation+of+a+double+bond+to+reduce+P-gp+efflux+leading+to+robust+A%CE%B2+reduction+in+the+brain&doi=10.1021%2Facs.jmedchem.8b00002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27bR"><div class="casContent"><span class="casTitleNuber">27b</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Design of Novel 1,3-Oxazine Based β-Secretase (BACE1) Inhibitors: Incorporation of a Double Bond To Reduce P-gp Efflux Leading to Robust Aβ Reduction in the Brain</span></div><div class="casAuthors">Fuchino, Kouki; Mitsuoka, Yasunori; Masui, Moriyasu; Kurose, Noriyuki; Yoshida, Shuhei; Komano, Kazuo; Yamamoto, Takahiko; Ogawa, Masayoshi; Unemura, Chie; Hosono, Motoko; Ito, Hisanori; Sakaguchi, Gaku; Ando, Shigeru; Ohnishi, Shuichi; Kido, Yasuto; Fukushima, Tamio; Miyajima, Hirofumi; Hiroyama, Shuichi; Koyabu, Kiyotaka; Dhuyvetter, Deborah; Borghys, Herman; Gijsen, Harrie J. M.; Yamano, Yoshinori; Iso, Yasuyoshi; Kusakabe, Ken-ichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5122-5137</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Accumulation of Aβ peptides is a hallmark of Alzheimer's disease (AD) and is considered a causal factor in the pathogenesis of AD.  β-Secretase (BACE1) is a key enzyme responsible for producing Aβ peptides, and thus agents that inhibit BACE1 should be beneficial for disease-modifying treatment of AD.  Here we describe the discovery and optimization of novel oxazine-based BACE1 inhibitors by lowering amidine basicity with the incorporation of a double bond to improve brain penetration.  Starting from a 1,3-dihydrooxazine lead I identified by a hit-to-lead SAR following HTS, we adopted a pKa lowering strategy to reduce the P-gp efflux and the high hERG potential leading to the discovery of II that produced significant Aβ redn. with long duration in pharmacodynamic models and exhibited wide safety margins in cardiovascular safety models.  This compd. II improved the brain-to-plasma ratio relative to I by reducing P-gp recognition, which was demonstrated by a P-gp knockout mouse model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGPZsGRa22ZLVg90H21EOLACvtfcHk0ljp32Ggy5Y10Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXptVWhsLo%253D&md5=ac366bddfe3492a0a47ce02918b5ea41</span></div><a href="/servlet/linkout?suffix=cit27b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00002%26sid%3Dliteratum%253Aachs%26aulast%3DFuchino%26aufirst%3DK.%26aulast%3DMitsuoka%26aufirst%3DY.%26aulast%3DMasui%26aufirst%3DM.%26aulast%3DKurose%26aufirst%3DN.%26aulast%3DYoshida%26aufirst%3DS.%26aulast%3DKomano%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DOgawa%26aufirst%3DM.%26aulast%3DUnemura%26aufirst%3DC.%26aulast%3DHosono%26aufirst%3DM.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DSakaguchi%26aufirst%3DG.%26aulast%3DAndo%26aufirst%3DS.%26aulast%3DOhnishi%26aufirst%3DS.%26aulast%3DKido%26aufirst%3DY.%26aulast%3DFukushima%26aufirst%3DT.%26aulast%3DMiyajima%26aufirst%3DH.%26aulast%3DHiroyama%26aufirst%3DS.%26aulast%3DKoyabu%26aufirst%3DK.%26aulast%3DDhuyvetter%26aufirst%3DD.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DGijsen%26aufirst%3DHarrie%2BJ.%2BM.%26aulast%3DYamano%26aufirst%3DY.%26aulast%3DIso%26aufirst%3DY.%26aulast%3DKusakabe%26aufirst%3DK.-I.%26atitle%3DRational%2520design%2520of%2520novel%25201%252C3-oxazine%2520based%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%253A%2520Incorporation%2520of%2520a%2520double%2520bond%2520to%2520reduce%2520P-gp%2520efflux%2520leading%2520to%2520robust%2520A%25CE%25B2%2520reduction%2520in%2520the%2520brain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5122%26epage%3D5137%26doi%3D10.1021%2Facs.jmedchem.8b00002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit27c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Nakahara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchino, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asada, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tadano, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sako, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unemura, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosono, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakaguchi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ando, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohnishi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kido, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukushima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhuyvetter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borghys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, Harrie J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iso, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusakabe, K.-I.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent and centrally active 6-substituted 5-fluoro-1,3-dihydro-oxazine β-secretase (BACE1) inhibitors via active conformation stabilization</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5525</span>– <span class="NLM_lpage">5546</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00011</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpvVarsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5525-5546&author=K.+Nakaharaauthor=K.+Fuchinoauthor=K.+Komanoauthor=N.+Asadaauthor=G.+Tadanoauthor=T.+Hasegawaauthor=T.+Yamamotoauthor=Y.+Sakoauthor=M.+Ogawaauthor=C.+Unemuraauthor=M.+Hosonoauthor=H.+Itoauthor=G.+Sakaguchiauthor=S.+Andoauthor=S.+Ohnishiauthor=Y.+Kidoauthor=T.+Fukushimaauthor=D.+Dhuyvetterauthor=H.+Borghysauthor=Harrie+J.+M.+Gijsenauthor=Y.+Yamanoauthor=Y.+Isoauthor=K.-I.+Kusakabe&title=Discovery+of+potent+and+centrally+active+6-substituted+5-fluoro-1%2C3-dihydro-oxazine+%CE%B2-secretase+%28BACE1%29+inhibitors+via+active+conformation+stabilization&doi=10.1021%2Facs.jmedchem.8b00011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27cR"><div class="casContent"><span class="casTitleNuber">27c</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent and Centrally Active 6-Substituted 5-Fluoro-1,3-dihydro-oxazine β-Secretase (BACE1) Inhibitors via Active Conformation Stabilization</span></div><div class="casAuthors">Nakahara, Kenji; Fuchino, Kouki; Komano, Kazuo; Asada, Naoya; Tadano, Genta; Hasegawa, Tsuyoshi; Yamamoto, Takahiko; Sako, Yusuke; Ogawa, Masayoshi; Unemura, Chie; Hosono, Motoko; Ito, Hisanori; Sakaguchi, Gaku; Ando, Shigeru; Ohnishi, Shuichi; Kido, Yasuto; Fukushima, Tamio; Dhuyvetter, Deborah; Borghys, Herman; Gijsen, Harrie J. M.; Yamano, Yoshinori; Iso, Yasuyoshi; Kusakabe, Ken-ichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5525-5546</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">β-Secretase (BACE1) has an essential role in the prodn. of amyloid β peptides that accumulate in patients with Alzheimer's disease (AD).  Thus, inhibition of BACE1 is considered to be a disease-modifying approach for the treatment of AD.  The authors' hit-to-lead efforts led to a cellular potent 1,3-dihydro-oxazine I, which however inhibited hERG and showed high P-gp efflux.  The close analog of 5-fluoro-oxazine II reduced P-gp efflux; further introduction of electron withdrawing groups at the 6-position improved potency and also mitigated P-gp efflux and hERG inhibition.  Changing to a pyrazine followed by optimization of substituents on both the oxazine and the pyrazine culminated in III with robust Aβ redn. in vivo at low doses as well as reduced CYP2D6 inhibition.  On the basis of the X-ray anal. and the QM calcn. of given dihydro-oxazines, it was reasoned that the substituents at the 6-position as well as the 5-fluorine on the oxazine would stabilize a bioactive conformation to increase potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBTrC8rX3RE7Vg90H21EOLACvtfcHk0ljp32Ggy5Y10Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpvVarsLs%253D&md5=e622beaca28e64ea0da30c87d0828086</span></div><a href="/servlet/linkout?suffix=cit27c&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00011%26sid%3Dliteratum%253Aachs%26aulast%3DNakahara%26aufirst%3DK.%26aulast%3DFuchino%26aufirst%3DK.%26aulast%3DKomano%26aufirst%3DK.%26aulast%3DAsada%26aufirst%3DN.%26aulast%3DTadano%26aufirst%3DG.%26aulast%3DHasegawa%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DSako%26aufirst%3DY.%26aulast%3DOgawa%26aufirst%3DM.%26aulast%3DUnemura%26aufirst%3DC.%26aulast%3DHosono%26aufirst%3DM.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DSakaguchi%26aufirst%3DG.%26aulast%3DAndo%26aufirst%3DS.%26aulast%3DOhnishi%26aufirst%3DS.%26aulast%3DKido%26aufirst%3DY.%26aulast%3DFukushima%26aufirst%3DT.%26aulast%3DDhuyvetter%26aufirst%3DD.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DGijsen%26aufirst%3DHarrie%2BJ.%2BM.%26aulast%3DYamano%26aufirst%3DY.%26aulast%3DIso%26aufirst%3DY.%26aulast%3DKusakabe%26aufirst%3DK.-I.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520centrally%2520active%25206-substituted%25205-fluoro-1%252C3-dihydro-oxazine%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%2520via%2520active%2520conformation%2520stabilization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5525%26epage%3D5546%26doi%3D10.1021%2Facs.jmedchem.8b00011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit27d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Oguma, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hisakawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takada, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusakabe, K.-I.</span></span> <span> </span><span class="NLM_article-title">Synthesis of a 6-CF<sub>3</sub>-substituted 2-amino-dihydro-1,3-thiazine b-secretase inhibitor by <i>N,N</i>-diethylsulfur trifluoride-mediated chemoselective cyclization</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">4893</span>– <span class="NLM_lpage">4897</span>, <span class="refDoi"> DOI: 10.1021/acs.joc.8b02179</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.joc.8b02179" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2019&pages=4893-4897&author=T.+Ogumaauthor=K.+Ananauthor=S.+Suzukiauthor=S.+Hisakawaauthor=A.+Takadaauthor=M.+Ogawaauthor=K.-I.+Kusakabe&title=Synthesis+of+a+6-CF3-substituted+2-amino-dihydro-1%2C3-thiazine+b-secretase+inhibitor+by+N%2CN-diethylsulfur+trifluoride-mediated+chemoselective+cyclization&doi=10.1021%2Facs.joc.8b02179"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27d&amp;dbid=16384&amp;doi=10.1021%2Facs.joc.8b02179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.joc.8b02179%26sid%3Dliteratum%253Aachs%26aulast%3DOguma%26aufirst%3DT.%26aulast%3DAnan%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DS.%26aulast%3DHisakawa%26aufirst%3DS.%26aulast%3DTakada%26aufirst%3DA.%26aulast%3DOgawa%26aufirst%3DM.%26aulast%3DKusakabe%26aufirst%3DK.-I.%26atitle%3DSynthesis%2520of%2520a%25206-CF3-substituted%25202-amino-dihydro-1%252C3-thiazine%2520b-secretase%2520inhibitor%2520by%2520N%252CN-diethylsulfur%2520trifluoride-mediated%2520chemoselective%2520cyclization%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2019%26volume%3D84%26spage%3D4893%26epage%3D4897%26doi%3D10.1021%2Facs.joc.8b02179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hilpert, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guba, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woltering, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wostl, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinard, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mauser, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayweg, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers-Evans, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humm, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krummenacher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muser, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnider, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozmen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergadano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banner, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hochstrasser, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuglstatter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David-Pierson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polara, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narquizian, R.</span></span> <span> </span><span class="NLM_article-title">β-Secretase (BACE1) inhibitors with high in vivo efficacy suitable for clinical evaluation in Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3980</span>– <span class="NLM_lpage">3995</span>, <span class="refDoi"> DOI: 10.1021/jm400225m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400225m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtVymuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3980-3995&author=H.+Hilpertauthor=W.+Gubaauthor=T.+J.+Wolteringauthor=W.+Wostlauthor=E.+Pinardauthor=H.+Mauserauthor=A.+V.+Maywegauthor=M.+Rogers-Evansauthor=R.+Hummauthor=D.+Krummenacherauthor=T.+Muserauthor=C.+Schniderauthor=H.+Jacobsenauthor=L.+Ozmenauthor=A.+Bergadanoauthor=D.+W.+Bannerauthor=R.+Hochstrasserauthor=A.+Kuglstatterauthor=P.+David-Piersonauthor=H.+Fischerauthor=A.+Polaraauthor=R.+Narquizian&title=%CE%B2-Secretase+%28BACE1%29+inhibitors+with+high+in+vivo+efficacy+suitable+for+clinical+evaluation+in+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm400225m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">β-Secretase (BACE1) Inhibitors with High in Vivo Efficacy Suitable for Clinical Evaluation in Alzheimer's Disease</span></div><div class="casAuthors">Hilpert, Hans; Guba, Wolfgang; Woltering, Thomas J.; Wostl, Wolfgang; Pinard, Emmanuel; Mauser, Harald; Mayweg, Alexander V.; Rogers-Evans, Mark; Humm, Roland; Krummenacher, Daniela; Muser, Thorsten; Schnider, Christian; Jacobsen, Helmut; Ozmen, Laurence; Bergadano, Alessandra; Banner, David W.; Hochstrasser, Remo; Kuglstatter, Andreas; David-Pierson, Pascale; Fischer, Holger; Polara, Alessandra; Narquizian, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3980-3995</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An extensive fluorine scan of 1,3-oxazines revealed the power of fluorine(s) to lower the pKa and thereby dramatically change the pharmacol. profile of this class of BACE1 inhibitors.  The CF3 substituted oxazine 89, a potent and highly brain penetrant BACE1 inhibitor, was able to reduce significantly CSF Aβ40 and 42 in rats at oral doses as low as 1 mg/kg.  The effect was long lasting, showing a significant redn. of Aβ40 and 42 even after 24 h.  In contrast to 89, compd. 1b lacking the CF3 group was virtually inactive in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmoKRrAxxHErVg90H21EOLACvtfcHk0ljuF7qcEFmqhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtVymuro%253D&md5=e5d311d1c8fecfaed043d3a0bf16c168</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm400225m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400225m%26sid%3Dliteratum%253Aachs%26aulast%3DHilpert%26aufirst%3DH.%26aulast%3DGuba%26aufirst%3DW.%26aulast%3DWoltering%26aufirst%3DT.%2BJ.%26aulast%3DWostl%26aufirst%3DW.%26aulast%3DPinard%26aufirst%3DE.%26aulast%3DMauser%26aufirst%3DH.%26aulast%3DMayweg%26aufirst%3DA.%2BV.%26aulast%3DRogers-Evans%26aufirst%3DM.%26aulast%3DHumm%26aufirst%3DR.%26aulast%3DKrummenacher%26aufirst%3DD.%26aulast%3DMuser%26aufirst%3DT.%26aulast%3DSchnider%26aufirst%3DC.%26aulast%3DJacobsen%26aufirst%3DH.%26aulast%3DOzmen%26aufirst%3DL.%26aulast%3DBergadano%26aufirst%3DA.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DHochstrasser%26aufirst%3DR.%26aulast%3DKuglstatter%26aufirst%3DA.%26aulast%3DDavid-Pierson%26aufirst%3DP.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DPolara%26aufirst%3DA.%26aulast%3DNarquizian%26aufirst%3DR.%26atitle%3D%25CE%25B2-Secretase%2520%2528BACE1%2529%2520inhibitors%2520with%2520high%2520in%2520vivo%2520efficacy%2520suitable%2520for%2520clinical%2520evaluation%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3980%26epage%3D3995%26doi%3D10.1021%2Fjm400225m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trabanco-Suarez, A. A.</span>; <span class="NLM_string-name">Gijsen, H. J. M.</span>; <span class="NLM_string-name">Van Gool, M. L. M.</span>; <span class="NLM_string-name">Ramiro, J. A. V.</span>; <span class="NLM_string-name">Delgado-Jimenez, F.</span></span> <span> </span><span class="NLM_article-title">Preparation of Dihydropyrazolopyrazinylamine Derivatives for Use as β-Secretase Inhibitors</span>. <span class="NLM_patent">WO 2012117027 A1</span>, Sept 7, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=A.+A.+Trabanco-Suarez&author=H.+J.+M.+Gijsen&author=M.+L.+M.+Van+Gool&author=J.+A.+V.+Ramiro&author=F.+Delgado-Jimenez&title=Preparation+of+Dihydropyrazolopyrazinylamine+Derivatives+for+Use+as+%CE%B2-Secretase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTrabanco-Suarez%26aufirst%3DA.%2BA.%26atitle%3DPreparation%2520of%2520Dihydropyrazolopyrazinylamine%2520Derivatives%2520for%2520Use%2520as%2520%25CE%25B2-Secretase%2520Inhibitors%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span> </span><span class="NLM_article-title">The cocrystal structure was obtained at
Proteros</span>. <a href="http://www.proteros.de/" class="extLink">http://www.proteros.de/</a> (accessed
Sept 10, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+cocrystal+structure+was+obtained+at%0AProteros.+http%3A%2F%2Fwww.proteros.de%2F+%28accessed%0ASept+10%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DThe%2520cocrystal%2520structure%2520was%2520obtained%2520at%250AProteros%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, N.</span>; <span class="NLM_string-name">Ueda, K.</span>; <span class="NLM_string-name">Itoh, N.</span>; <span class="NLM_string-name">Suzuki, S.</span>; <span class="NLM_string-name">Sakaguchi, G.</span>; <span class="NLM_string-name">Kato, A.</span>; <span class="NLM_string-name">Yukimasa, A.</span>; <span class="NLM_string-name">Hori, A.</span>; <span class="NLM_string-name">Kooriyama, Y.</span>; <span class="NLM_string-name">Haraguchi, H.</span>; <span class="NLM_string-name">Yasui, K.</span>; <span class="NLM_string-name">Kanda, Y.</span></span> <span> </span><span class="NLM_article-title">Preparation of 2-Amino-4-phenyl-4,5-dihydro-5<i>H</i>-1,3-thiazine Derivatives and Related Compounds for Treatment of Alzheimer’s Disease</span>. <span class="NLM_patent">WO 2008133273 A1</span>, Nov 6, <span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=N.+Kobayashi&author=K.+Ueda&author=N.+Itoh&author=S.+Suzuki&author=G.+Sakaguchi&author=A.+Kato&author=A.+Yukimasa&author=A.+Hori&author=Y.+Kooriyama&author=H.+Haraguchi&author=K.+Yasui&author=Y.+Kanda&title=Preparation+of+2-Amino-4-phenyl-4%2C5-dihydro-5H-1%2C3-thiazine+Derivatives+and+Related+Compounds+for+Treatment+of+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DN.%26atitle%3DPreparation%2520of%25202-Amino-4-phenyl-4%252C5-dihydro-5H-1%252C3-thiazine%2520Derivatives%2520and%2520Related%2520Compounds%2520for%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ellard, J. M.</span>; <span class="NLM_string-name">Farthing, C. N.</span>; <span class="NLM_string-name">Hall, A.</span></span> <span> </span><span class="NLM_article-title">Preparation of Fused Aminodihydrooxazine Derivatives as β-Amyloid Inhibitors and Useful in the Treatment of Neurodegenerative Disease Caused by Aβ in Particular Alzheimer-type Dementia</span>. <span class="NLM_patent">WO 2011009898 A1</span>, Jan 27, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=J.+M.+Ellard&author=C.+N.+Farthing&author=A.+Hall&title=Preparation+of+Fused+Aminodihydrooxazine+Derivatives+as+%CE%B2-Amyloid+Inhibitors+and+Useful+in+the+Treatment+of+Neurodegenerative+Disease+Caused+by+A%CE%B2+in+Particular+Alzheimer-type+Dementia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DEllard%26aufirst%3DJ.%2BM.%26atitle%3DPreparation%2520of%2520Fused%2520Aminodihydrooxazine%2520Derivatives%2520as%2520%25CE%25B2-Amyloid%2520Inhibitors%2520and%2520Useful%2520in%2520the%2520Treatment%2520of%2520Neurodegenerative%2520Disease%2520Caused%2520by%2520A%25CE%25B2%2520in%2520Particular%2520Alzheimer-type%2520Dementia%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robak, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herbage, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellman, J. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Applications oftert-Butanesulfinamide</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">3600</span>– <span class="NLM_lpage">3740</span>, <span class="refDoi"> DOI: 10.1021/cr900382t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr900382t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2010&pages=3600-3740&author=M.+T.+Robakauthor=M.+A.+Herbageauthor=J.+A.+Ellman&title=Synthesis+and+Applications+oftert-Butanesulfinamide&doi=10.1021%2Fcr900382t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fcr900382t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr900382t%26sid%3Dliteratum%253Aachs%26aulast%3DRobak%26aufirst%3DM.%2BT.%26aulast%3DHerbage%26aufirst%3DM.%2BA.%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26atitle%3DSynthesis%2520and%2520Applications%2520oftert-Butanesulfinamide%26jtitle%3DChem.%2520Rev.%26date%3D2010%26volume%3D110%26spage%3D3600%26epage%3D3740%26doi%3D10.1021%2Fcr900382t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haveaux, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dekoker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rens, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sidani, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toye, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosez, L.</span></span> <span> </span><span class="NLM_article-title">α-Chloro enamines, reactive intermediates for synthesis: 1-chloro-<i>N,N</i>,2-trimethylpropenylamine</span>. <i>Org. Synth.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">26</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1002/0471264180.os059.05</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1002%2F0471264180.os059.05" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2003&pages=26-34&author=B.+Haveauxauthor=A.+Dekokerauthor=M.+Rensauthor=A.+R.+Sidaniauthor=J.+Toyeauthor=L.+Ghosez&title=%CE%B1-Chloro+enamines%2C+reactive+intermediates+for+synthesis%3A+1-chloro-N%2CN%2C2-trimethylpropenylamine&doi=10.1002%2F0471264180.os059.05"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2F0471264180.os059.05&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F0471264180.os059.05%26sid%3Dliteratum%253Aachs%26aulast%3DHaveaux%26aufirst%3DB.%26aulast%3DDekoker%26aufirst%3DA.%26aulast%3DRens%26aufirst%3DM.%26aulast%3DSidani%26aufirst%3DA.%2BR.%26aulast%3DToye%26aufirst%3DJ.%26aulast%3DGhosez%26aufirst%3DL.%26atitle%3D%25CE%25B1-Chloro%2520enamines%252C%2520reactive%2520intermediates%2520for%2520synthesis%253A%25201-chloro-N%252CN%252C2-trimethylpropenylamine%26jtitle%3DOrg.%2520Synth.%26date%3D2003%26volume%3D59%26spage%3D26%26epage%3D34%26doi%3D10.1002%2F0471264180.os059.05" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thaisrivongs, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Z. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyons, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldman, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naber, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span> <span> </span><span class="NLM_article-title">A Next generation synthesis of BACE1 inhibitor verubecestat (MK-8931)</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1568</span>– <span class="NLM_lpage">1571</span>, <span class="refDoi"> DOI: 10.1021/acs.orglett.8b00259</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.8b00259" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjt1Smu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2018&pages=1568-1571&author=D.+A.+Thaisrivongsauthor=W.+J.+Morrisauthor=L.+Tanauthor=Z.+J.+Songauthor=T.+W.+Lyonsauthor=J.+H.+Waldmanauthor=J.+R.+Naberauthor=W.+Chenauthor=L.+Chenauthor=B.+Zhangauthor=J.+Yang&title=A+Next+generation+synthesis+of+BACE1+inhibitor+verubecestat+%28MK-8931%29&doi=10.1021%2Facs.orglett.8b00259"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">A Next Generation Synthesis of BACE1 Inhibitor Verubecestat (MK-8931)</span></div><div class="casAuthors">Thaisrivongs, David A.; Morris, William J.; Tan, Lushi; Song, Zhiguo J.; Lyons, Thomas W.; Waldman, Jacob H.; Naber, John R.; Chen, Wenyong; Chen, Lu; Zhang, Baoyun; Yang, Jun</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1568-1571</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of a com. manufg. route to verubecestat (MK-8931) is described, highlights of which include the application of a continuous processing step to outcompete fast proton transfer in a Mannich-type ketimine addn., a copper-catalyzed amidation reaction, and an optimized guanidinylation procedure to form the key iminothiadiazine dioxide core.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobgE6qFUSNV7Vg90H21EOLACvtfcHk0livOed1gDujuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjt1Smu7s%253D&md5=131f38cbe2ed02c9960c28e6fe4aa54d</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.8b00259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.8b00259%26sid%3Dliteratum%253Aachs%26aulast%3DThaisrivongs%26aufirst%3DD.%2BA.%26aulast%3DMorris%26aufirst%3DW.%2BJ.%26aulast%3DTan%26aufirst%3DL.%26aulast%3DSong%26aufirst%3DZ.%2BJ.%26aulast%3DLyons%26aufirst%3DT.%2BW.%26aulast%3DWaldman%26aufirst%3DJ.%2BH.%26aulast%3DNaber%26aufirst%3DJ.%2BR.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DJ.%26atitle%3DA%2520Next%2520generation%2520synthesis%2520of%2520BACE1%2520inhibitor%2520verubecestat%2520%2528MK-8931%2529%26jtitle%3DOrg.%2520Lett.%26date%3D2018%26volume%3D20%26spage%3D1568%26epage%3D1571%26doi%3D10.1021%2Facs.orglett.8b00259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5a','cit5b'],'ref6':['cit6a','cit6b','cit6c','cit6d','cit6e'],'ref7':['cit7a','cit7b'],'ref8':['cit8a','cit8b','cit8c'],'ref9':['cit9a','cit9b','cit9c','cit9d','cit9e','cit9f','cit9g','cit9h','cit9i'],'ref10':['cit10a','cit10b','cit10c','cit10d'],'ref11':['cit11a','cit11b'],'ref12':['cit12a','cit12b'],'ref13':['cit13'],'ref14':['cit14a','cit14b'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17a','cit17b','cit17c'],'ref18':['cit18a','cit18b'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23a','cit23b'],'ref24':['cit24a','cit24b'],'ref25':['cit25'],'ref26':['cit26a','cit26b','cit26c','cit26d','cit26e'],'ref27':['cit27a','cit27b','cit27c','cit27d'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 13 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Jianzhong Chen, Shaolong Zhang, Wei Wang, Haibo Sun, Qinggang Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Xinguo Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Binding of Inhibitors to BACE1 Affected by pH-Dependent Protonation: An Exploration from Multiple Replica Gaussian Accelerated Molecular Dynamics and MM-GBSA Calculations. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2021,</strong> <em>12 </em>
                                    (14)
                                     , 2591-2607. <a href="https://doi.org/10.1021/acschemneuro.0c00813" title="DOI URL">https://doi.org/10.1021/acschemneuro.0c00813</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.0c00813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.0c00813%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DBinding%252Bof%252BInhibitors%252Bto%252BBACE1%252BAffected%252Bby%252BpH-Dependent%252BProtonation%25253A%252BAn%252BExploration%252Bfrom%252BMultiple%252BReplica%252BGaussian%252BAccelerated%252BMolecular%252BDynamics%252Band%252BMM-GBSA%252BCalculations%26aulast%3DChen%26aufirst%3DJianzhong%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D22122020%26date%3D14062021%26date%3D29062021%26volume%3D12%26issue%3D14%26spage%3D2591%26epage%3D2607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kazuki Fujimoto, Shuhei Yoshida, Genta Tadano, Naoya Asada, Kouki Fuchino, Shinji Suzuki, Eriko Matsuoka, Takahiko Yamamoto, Shiho Yamamoto, Shigeru Ando, Naoki Kanegawa, Yutaka Tonomura, Hisanori Ito, Diederik Moechars, Frederik J. R. Rombouts, Harrie J. M. Gijsen, <span class="NLM_string-name hlFld-ContribAuthor">Ken-ichi Kusakabe</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Approaches to Improving Selectivity through Utilizing Explicit Water Molecules: Discovery of Selective β-Secretase (BACE1) Inhibitors over BACE2. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (6)
                                     , 3075-3085. <a href="https://doi.org/10.1021/acs.jmedchem.0c01858" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01858</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01858&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01858%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BApproaches%252Bto%252BImproving%252BSelectivity%252Bthrough%252BUtilizing%252BExplicit%252BWater%252BMolecules%25253A%252BDiscovery%252Bof%252BSelective%252B%2525CE%2525B2-Secretase%252B%252528BACE1%252529%252BInhibitors%252Bover%252BBACE2%26aulast%3DFujimoto%26aufirst%3DKazuki%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D26102020%26date%3D15032021%26volume%3D64%26issue%3D6%26spage%3D3075%26epage%3D3085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yu-Chen Yen, Annalissa M. Kammeyer, Jagannadharao Tirlangi, Arun K. Ghosh, <span class="NLM_string-name hlFld-ContribAuthor">Andrew D. Mesecar</span>. </span><span class="cited-content_cbyCitation_article-title">A Structure-Based Discovery Platform for BACE2 and the Development of Selective BACE Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2021,</strong> <em>12 </em>
                                    (4)
                                     , 581-588. <a href="https://doi.org/10.1021/acschemneuro.0c00629" title="DOI URL">https://doi.org/10.1021/acschemneuro.0c00629</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.0c00629&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.0c00629%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DA%252BStructure-Based%252BDiscovery%252BPlatform%252Bfor%252BBACE2%252Band%252Bthe%252BDevelopment%252Bof%252BSelective%252BBACE%252BInhibitors%26aulast%3DYen%26aufirst%3DYu-Chen%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D30092020%26date%3D22122020%26date%3D05022021%26volume%3D12%26issue%3D4%26spage%3D581%26epage%3D588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Cedric L. Hugelshofer, Jianming Bao, Juana Du, Eric Ashley, Wensheng Yu, Tao Ji, Bin Hu, Dejun Liu, Ramu Rondla, Srinivas Karampuri, Vishal Sharma, Krishna Ethiraj, <span class="NLM_string-name hlFld-ContribAuthor">Yeon-Hee Lim</span>. </span><span class="cited-content_cbyCitation_article-title">Scalable Preparation of 4,4-Disubstituted Six-Membered Cyclic Sulfones. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (3)
                                     , 943-947. <a href="https://doi.org/10.1021/acs.orglett.0c04141" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c04141</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c04141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c04141%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DScalable%252BPreparation%252Bof%252B4%25252C4-Disubstituted%252BSix-Membered%252BCyclic%2525C2%2525A0Sulfones%26aulast%3DHugelshofer%26aufirst%3DCedric%2BL.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D15122020%26date%3D08012021%26volume%3D23%26issue%3D3%26spage%3D943%26epage%3D947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Tanaji T. Talele</span>. </span><span class="cited-content_cbyCitation_article-title">Opportunities for Tapping into Three-Dimensional Chemical Space through a Quaternary Carbon. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (22)
                                     , 13291-13315. <a href="https://doi.org/10.1021/acs.jmedchem.0c00829" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00829</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00829%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOpportunities%252Bfor%252BTapping%252Binto%252BThree-Dimensional%252BChemical%252BSpace%252Bthrough%252Ba%252BQuaternary%252BCarbon%26aulast%3DTalele%26aufirst%3DTanaji%2BT.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D15052020%26date%3D31082020%26date%3D17082020%26volume%3D63%26issue%3D22%26spage%3D13291%26epage%3D13315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mihirbaran Mandal, Alexei Buevich, John P. Caldwell, Lynn Hyde, Xianhai Huang, Xiaoxiang Liu, Brian McKittrick, Robert D. Mazzola, Dmitri Pissarnitski, Anandan Palani, Lili Zhang, Eric Parker, Li Xiao, Diane Rindgen, <span class="NLM_string-name hlFld-ContribAuthor">Zhaoning Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Generation of Leads for γ-Secretase Modulation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (15)
                                     , 8216-8230. <a href="https://doi.org/10.1021/acs.jmedchem.0c00446" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00446</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00446%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DGeneration%252Bof%252BLeads%252Bfor%252B%2525CE%2525B3-Secretase%252BModulation%26aulast%3DMandal%26aufirst%3DMihirbaran%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D16032020%26date%3D04082020%26date%3D27072020%26volume%3D63%26issue%3D15%26spage%3D8216%26epage%3D8230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jianzhong Chen, Baohua Yin, Wei Wang, <span class="NLM_string-name hlFld-ContribAuthor">Haibo Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Effects of Disulfide Bonds on Binding of Inhibitors to β-Amyloid Cleaving Enzyme 1 Decoded by Multiple Replica Accelerated Molecular Dynamics Simulations. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2020,</strong> <em>11 </em>
                                    (12)
                                     , 1811-1826. <a href="https://doi.org/10.1021/acschemneuro.0c00234" title="DOI URL">https://doi.org/10.1021/acschemneuro.0c00234</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.0c00234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.0c00234%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DEffects%252Bof%252BDisulfide%252BBonds%252Bon%252BBinding%252Bof%252BInhibitors%252Bto%252B%2525CE%2525B2-Amyloid%252BCleaving%252BEnzyme%252B1%252BDecoded%252Bby%252BMultiple%252BReplica%252BAccelerated%252BMolecular%252BDynamics%252BSimulations%26aulast%3DChen%26aufirst%3DJianzhong%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D21042020%26date%3D27052020%26date%3D08062020%26date%3D27052020%26volume%3D11%26issue%3D12%26spage%3D1811%26epage%3D1826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Faraz  Shaikh</span>, <span class="hlFld-ContribAuthor ">Hio Kuan  Tai</span>, <span class="hlFld-ContribAuthor ">Nirali  Desai</span>, <span class="hlFld-ContribAuthor ">Shirley W. I.  Siu</span>. </span><span class="cited-content_cbyCitation_article-title">LigTMap: ligand and structure-based target identification and activity prediction for small molecular compounds. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cheminformatics</span><span> <strong>2021,</strong> <em>13 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13321-021-00523-1" title="DOI URL">https://doi.org/10.1186/s13321-021-00523-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13321-021-00523-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13321-021-00523-1%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cheminformatics%26atitle%3DLigTMap%25253A%252Bligand%252Band%252Bstructure-based%252Btarget%252Bidentification%252Band%252Bactivity%252Bprediction%252Bfor%252Bsmall%252Bmolecular%252Bcompounds%26aulast%3DShaikh%26aufirst%3DFaraz%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kenji  Nakahara</span>, <span class="hlFld-ContribAuthor ">Yasunori  Mitsuoka</span>, <span class="hlFld-ContribAuthor ">Satoshi  Kasuya</span>, <span class="hlFld-ContribAuthor ">Takahiko  Yamamoto</span>, <span class="hlFld-ContribAuthor ">Shiho  Yamamoto</span>, <span class="hlFld-ContribAuthor ">Hisanori  Ito</span>, <span class="hlFld-ContribAuthor ">Yasuto  Kido</span>, <span class="hlFld-ContribAuthor ">Ken-ichi  Kusakabe</span>. </span><span class="cited-content_cbyCitation_article-title">Balancing potency and basicity by incorporating fluoropyridine moieties: Discovery of a 1-amino-3,4-dihydro-2,6-naphthyridine BACE1 inhibitor that affords robust and sustained central Aβ reduction. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>216 </em>, 113270. <a href="https://doi.org/10.1016/j.ejmech.2021.113270" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113270</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113270%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBalancing%252Bpotency%252Band%252Bbasicity%252Bby%252Bincorporating%252Bfluoropyridine%252Bmoieties%25253A%252BDiscovery%252Bof%252Ba%252B1-amino-3%25252C4-dihydro-2%25252C6-naphthyridine%252BBACE1%252Binhibitor%252Bthat%252Baffords%252Brobust%252Band%252Bsustained%252Bcentral%252BA%2525CE%2525B2%252Breduction%26aulast%3DNakahara%26aufirst%3DKenji%26date%3D2021%26volume%3D216%26spage%3D113270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haizhou  Zhu</span>, <span class="hlFld-ContribAuthor ">Venkateshwara  Dronamraju</span>, <span class="hlFld-ContribAuthor ">Wei  Xie</span>, <span class="hlFld-ContribAuthor ">Swati S.  More</span>. </span><span class="cited-content_cbyCitation_article-title">Sulfur-containing therapeutics in the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2021,</strong> <em>30 </em>
                                    (2)
                                     , 305-352. <a href="https://doi.org/10.1007/s00044-020-02687-1" title="DOI URL">https://doi.org/10.1007/s00044-020-02687-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-020-02687-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-020-02687-1%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DSulfur-containing%252Btherapeutics%252Bin%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DZhu%26aufirst%3DHaizhou%26date%3D2021%26date%3D2021%26volume%3D30%26issue%3D2%26spage%3D305%26epage%3D352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Frederik  Rombouts</span>, <span class="hlFld-ContribAuthor ">Ken-ichi  Kusakabe</span>, <span class="hlFld-ContribAuthor ">Chien-Chi  Hsiao</span>, <span class="hlFld-ContribAuthor ">Harrie J. M.  Gijsen</span>. </span><span class="cited-content_cbyCitation_article-title">Small-molecule BACE1 inhibitors: a patent literature review (2011 to 2020). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2021,</strong> <em>31 </em>
                                    (1)
                                     , 25-52. <a href="https://doi.org/10.1080/13543776.2021.1832463" title="DOI URL">https://doi.org/10.1080/13543776.2021.1832463</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2021.1832463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2021.1832463%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DSmall-molecule%252BBACE1%252Binhibitors%25253A%252Ba%252Bpatent%252Bliterature%252Breview%252B%2525282011%252Bto%252B2020%252529%26aulast%3DRombouts%26aufirst%3DFrederik%26date%3D2021%26date%3D2020%26volume%3D31%26issue%3D1%26spage%3D25%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Varnavas D.  Mouchlis</span>, <span class="hlFld-ContribAuthor ">Georgia  Melagraki</span>, <span class="hlFld-ContribAuthor ">Lefteris C.  Zacharia</span>, <span class="hlFld-ContribAuthor ">Antreas  Afantitis</span>. </span><span class="cited-content_cbyCitation_article-title">Computer-Aided Drug Design of β-Secretase, γ-Secretase and Anti-Tau Inhibitors for the Discovery of Novel Alzheimer’s Therapeutics. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (3)
                                     , 703. <a href="https://doi.org/10.3390/ijms21030703" title="DOI URL">https://doi.org/10.3390/ijms21030703</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21030703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21030703%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DComputer-Aided%252BDrug%252BDesign%252Bof%252B%2525CE%2525B2-Secretase%25252C%252B%2525CE%2525B3-Secretase%252Band%252BAnti-Tau%252BInhibitors%252Bfor%252Bthe%252BDiscovery%252Bof%252BNovel%252BAlzheimer%2525E2%252580%252599s%252BTherapeutics%26aulast%3DMouchlis%26aufirst%3DVarnavas%2BD.%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D3%26spage%3D703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kosuke  Anan</span>, <span class="hlFld-ContribAuthor ">Yasuyoshi  Iso</span>, <span class="hlFld-ContribAuthor ">Takuya  Oguma</span>, <span class="hlFld-ContribAuthor ">Kenji  Nakahara</span>, <span class="hlFld-ContribAuthor ">Shinji  Suzuki</span>, <span class="hlFld-ContribAuthor ">Takahiko  Yamamoto</span>, <span class="hlFld-ContribAuthor ">Eriko  Matsuoka</span>, <span class="hlFld-ContribAuthor ">Hisanori  Ito</span>, <span class="hlFld-ContribAuthor ">Gaku  Sakaguchi</span>, <span class="hlFld-ContribAuthor ">Shigeru  Ando</span>, <span class="hlFld-ContribAuthor ">Kenji  Morimoto</span>, <span class="hlFld-ContribAuthor ">Naoki  Kanegawa</span>, <span class="hlFld-ContribAuthor ">Yasuto  Kido</span>, <span class="hlFld-ContribAuthor ">Tomoyuki  Kawachi</span>, <span class="hlFld-ContribAuthor ">Tamio  Fukushima</span>, <span class="hlFld-ContribAuthor ">Ard  Teisman</span>, <span class="hlFld-ContribAuthor ">Vijay  Urmaliya</span>, <span class="hlFld-ContribAuthor ">Deborah  Dhuyvetter</span>, <span class="hlFld-ContribAuthor ">Herman  Borghys</span>, <span class="hlFld-ContribAuthor ">Nigel  Austin</span>, <span class="hlFld-ContribAuthor ">An  Van Den Bergh</span>, <span class="hlFld-ContribAuthor ">Peter  Verboven</span>, <span class="hlFld-ContribAuthor ">Francois  Bischoff</span>, <span class="hlFld-ContribAuthor ">Harrie J. M.  Gijsen</span>, <span class="hlFld-ContribAuthor ">Yoshinori  Yamano</span>, <span class="hlFld-ContribAuthor ">Ken-ichi  Kusakabe</span>. </span><span class="cited-content_cbyCitation_article-title">Trifluoromethyl Dihydrothiazine‐Based β‐Secretase (BACE1) Inhibitors with Robust Central β‐Amyloid Reduction and Minimal Covalent Binding Burden. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2019,</strong> <em>14 </em>
                                    (22)
                                     , 1894-1910. <a href="https://doi.org/10.1002/cmdc.201900478" title="DOI URL">https://doi.org/10.1002/cmdc.201900478</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201900478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201900478%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DTrifluoromethyl%252BDihydrothiazine%2525E2%252580%252590Based%252B%2525CE%2525B2%2525E2%252580%252590Secretase%252B%252528BACE1%252529%252BInhibitors%252Bwith%252BRobust%252BCentral%252B%2525CE%2525B2%2525E2%252580%252590Amyloid%252BReduction%252Band%252BMinimal%252BCovalent%252BBinding%252BBurden%26aulast%3DAnan%26aufirst%3DKosuke%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D22%26spage%3D1894%26epage%3D1910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/medium/jm-2019-00309f_0022.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00309&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/medium/jm-2019-00309f_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0001.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Representative BACE1 Inhibitors in Clinical Development</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00309&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/medium/jm-2019-00309f_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0002.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. Representative Selective BACE1 Inhibitors</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00309&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Chart 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/medium/jm-2019-00309f_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0003.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 3. Lead Compounds</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00309&amp;id=cht3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/medium/jm-2019-00309f_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0004.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Schematic representation of nonconserved residues between BACE1 and BACE2 including key interactions. (B) Crystal structure of <b>8</b> bound to a flap-closed form of BACE1. Substituents projecting from the 5-position to reach the flap.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00309&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/medium/jm-2019-00309f_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0005.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Crystal structure of <b>16</b> bound to BACE1. (B) <b>17</b> bound to BACE1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00309&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/medium/jm-2019-00309f_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0006.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Reduction of total Aβ in the brain of male ICR mice (<i>n</i> = 4) after the oral administration of <b>21</b> as a solution of 20% 2-hydroxypropyl-β-cyclodextrin (HPBCD) at 30 mg/kg.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00309&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/medium/jm-2019-00309f_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0007.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Crystal structure of <b>22</b> bound to BACE1 and BACE2. (A) View of the flap region in the <b>22</b>-bound BACE1 structure. (B) Superposition of the flap in the <b>22</b>-bound BACE1 and apo BACE1 structures (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1w50">1w50</a>). The color in the flap indicates B-factors (blue: low B-factors; orange: high B-factors). (C) View of the flap region in the <b>22</b>-bound BACE2 structure. (D) Superposition of the flap in the <b>22</b>-bound BACE2 and apo BACE2 structures (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3zkg">3zkg</a>). The color means the same as B).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00309&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/medium/jm-2019-00309f_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0008.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Thiazines <b>8–14</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00309&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) RCO<sub>2</sub>H, EDC·HCl, aq HCl, THF or MeOH, 0 or 0 °C to rt, 49–100%.</p></p></figure><figure data-id="sch2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/medium/jm-2019-00309f_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0009.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Thiazine <b>15</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00309&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>n</i>-BuLi, diisopropylamine, methyl 2-methoxyacetate, ClTi(O<i>i</i>-Pr)<sub>3</sub>, THF, −78 °C, 72%; (b) (i) LiBH<sub>4</sub>, MeOH, THF, 0 °C, (ii) 4 M HCl in 1,4-dioxane, MeOH, rt, (iii) BzNCS, DCM, rt, 82% over 3 steps; (c) Ghosez’s reagent, DCM, rt, 90%; (d) hydrazine monohydrate, MeOH, THF, rt, 93%; (e) (i) HNO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>, TFA, −20 °C, (ii) Fe, NH<sub>4</sub>Cl, EtOH, toluene, H<sub>2</sub>O, 80 °C, (iii) 5-(fluoromethoxy)pyrazine-2-carboxylic acid, EDC·HCl, aq HCl, MeOH, 0 °C to rt, 58% over 3 steps.</p></p></figure><figure data-id="sch3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/medium/jm-2019-00309f_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0010.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Thiazines <b>16</b> and <b>17</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00309&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>n</i>-BuLi, diisopropylamine, ethyl 2-phenylacetate, ClTi(O<i>i</i>-Pr)<sub>3</sub>, THF, −78 °C, 91%, dr = 2:1; (b) (i) 4 M HCl in 1,4-dioxane, MeOH, rt, (ii) Boc<sub>2</sub>O, MeOH, 60 °C, 57 and 28% over 2 steps; (c) (i) LiBH<sub>4</sub>, MeOH, THF, 0 °C, (ii) TFA, DCM, rt, (iii) BzNCS, DCM, rt, 78 and 87% over 3 steps; (d) Ghosez’s reagent, 0 °C to rt, 90 and 81%; (e) (i) DBU, MeOH, 60 °C, (ii) NaN<sub>3</sub>, CuI, <i>trans</i>-<i>N</i>,<i>N</i>′-dimethylcyclohexane-1,2-diamine, sodium <span class="smallcaps smallerCapital">l</span>-ascorbate, EtOH, H<sub>2</sub>O, 100 °C, (iii) Fe, NH<sub>4</sub>Cl, EtOH, H<sub>2</sub>O, THF, 60 °C or Fe, NH<sub>4</sub>Cl, EtOH, H<sub>2</sub>O, THF, 60 °C, (iv) 5-(fluoromethoxy)pyrazine-2-carboxylic acid, EDC·HCl, aq HCl, MeOH, 0 °C, 46 and 55% over 4 steps.</p></p></figure><figure data-id="sch4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/medium/jm-2019-00309f_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0011.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Thiazines <b>18</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00309&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>n</i>-BuLi, diisopropylamine, ethyl 2-(tetrahydro-2<i>H</i>-pyran-4-yl)acetate, ClTi(O<i>i</i>-Pr)<sub>3</sub>, THF, −78 °C, 43%, dr = 2.9:1; (b) (i) 4 M HCl in 1,4-dioxane, MeOH, rt, (ii) Boc<sub>2</sub>O, THF, 60 °C, 88% over 2 steps; (c) LiBH<sub>4</sub>, MeOH, THF, 50 °C, 24%; (d) Boc<sub>2</sub>O, DCM, THF, 60 °C, 73%; (e) (i) K<sub>2</sub>CO<sub>3</sub>, MeOH, rt, (ii) TFA, DCM, rt, (iii) BzNCS, DCM, rt, 49% over 3 steps; (f) DAST, DCM, 0 °C, 73%; (g) Boc<sub>2</sub>O, THF, rt, 47 and 26%; (h) (i) K<sub>2</sub>CO<sub>3</sub>, MeOH, rt, (ii) TFA, DCM, rt, 91% over 2 steps; (i) (i) HNO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>, TFA, −20 °C, (ii) Fe, NH<sub>4</sub>Cl, toluene, H<sub>2</sub>O, 80 °C, 74% over 2 steps; (j) 5-(fluoromethoxy)pyrazine-2-carboxylic acid, EDC·HCl, aq HCl, MeOH, rt, 76%.</p></p></figure><figure data-id="sch5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/medium/jm-2019-00309f_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0012.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Thiazines <b>19</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00309&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>n</i>-BuLi, diisopropylamine, ethyl tetrahydro-2<i>H</i>-pyran-4-carboxylate, ClTi(O<i>i</i>-Pr)<sub>3</sub>, THF, −78 °C, 75%; (b) (i) 4 M HCl in 1,4-dioxane, MeOH, rt, (ii) Boc<sub>2</sub>O, MeOH, 60 °C, quant. over 2 steps; (c) LiBH<sub>4</sub>, MeOH, THF, 50 °C, 70%; (d) Boc<sub>2</sub>O, DMAP, THF, 50 °C, 84%; (e) (i) K<sub>2</sub>CO<sub>3</sub>, MeOH, rt, (ii) TFA, DCM, rt, (iii) BzNCS, DCM, 0 °C to rt, 74% over 3 steps; (f) DAST, DCM, 0 °C, 57%; (g) hydrazine monohydrate, MeOH, THF, rt, 71%; (h) (i) HNO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>, TFA, −20 to 0 °C, (ii) Fe, NH<sub>4</sub>Cl, toluene, H<sub>2</sub>O, 80 °C, 78% over 2 steps; (i) 5-(fluoromethoxy)pyrazine-2-carboxylic acid, EDC·HCl, aq HCl, MeOH, 0 °C to rt, 81%.</p></p></figure><figure data-id="sch6" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/medium/jm-2019-00309f_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0013.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Thiazine <b>20</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00309&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>n</i>-BuLi, diisopropylamine, methyl 3,3-difluorocyclobutane-1-carboxylate, ClTi(O<i>i</i>-Pr)<sub>3</sub>, THF, −78 °C, 39%; (b) (i) LiBH<sub>4</sub>, MeOH, THF, 0 °C, (ii) 4 M HCl in 1,4-dioxane, MeOH, rt, (iii) BzNCS, DCM, rt, (iv) Ghosez’s reagent, DCM, rt, 68% over 4 steps; (c) hydrazine monohydrate, MeOH, THF, rt, 96%; (d) (i) HNO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>, TFA, −20 °C to rt, (ii) Boc<sub>2</sub>O, DMAP, THF, rt, 97% over 2 steps; (e) Fe, NH<sub>4</sub>Cl, EtOH, toluene, H<sub>2</sub>O, 60 °C, 79%; (f) (i) 5-(fluoromethoxy)pyrazine-2-carboxylic acid, HATU, <i>N</i>,<i>N</i>-diisopropylethylamine, MeOH, rt, 83%, (ii) TFA, DCM, rt, 93%.</p></p></figure><figure data-id="sch7" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/medium/jm-2019-00309f_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0014.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of Thiazine <b>21</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00309&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>n</i>-BuLi, diisopropylamine, benzyl 4,4-difluorocyclohexane-1-carboxylate, ClTi(O<i>i</i>-Pr)<sub>3</sub>, THF, −78 °C, 21%; (b) (i) 4 M HCl in 1,4-dioxane, MeOH, rt, (ii) Boc<sub>2</sub>O, MeOH, 60 °C, 88% over 2 steps; (c) (i) LiBH<sub>4</sub>, MeOH, THF, 0 to 40 °C, (ii) 4 M HCl in 1,4-dioxane, rt, (iii) BzNCS, DCM, 0 °C to rt, 54% over 3 steps; (d) DAST, DCM, 0 °C, 61%; (e) hydrazine hydrate, MeOH/THF, 50 °C, 73%; (f) (i) HNO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>, TFA, −15 °C, (ii) Fe, NH<sub>4</sub>Cl, EtOH, toluene, H<sub>2</sub>O, 80 °C, (iii) 5-(fluoromethoxy)pyrazine-2-carboxylic acid, EDC·HCl, aq HCl, MeOH, 0 °C to rt, 55% over 3 steps.</p></p></figure><figure data-id="sch8" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/medium/jm-2019-00309f_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0015.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthesis of Spiro-Thiazine <b>22</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00309/20190516/images/large/jm-2019-00309f_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00309&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>n</i>-BuLi, diisopropylamine, methyl tetrahydro-2<i>H</i>-thiopyran-4-carboxylate, ClTi(O<i>i</i>-Pr)<sub>3</sub>, THF, −78 °C, 59%; (b) (i) 4 M HCl in 1,4-dioxane, MeOH, rt, (ii) Boc<sub>2</sub>O, MeOH, 50 °C, 94% over 2 steps; (c) LiBH<sub>4</sub>, MeOH/THF, 0 to 50 °C, 48%; (d) (i) TFA, DCM, rt, (ii) BzNCS, DCM, rt, 70% over 2 steps; (e) (i) DAST, DCM, rt, (ii) hydrazine monohydrate, MeOH, THF, 40 °C, 16% over 2 steps; (f) <i>m</i>-CPBA, DCM, 0 °C, 90%; (g) (i) HNO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>, TFA, −10 to 0 °C, (ii) Fe, NH<sub>4</sub>Cl, toluene, H<sub>2</sub>O, 80 °C, 77% over 2 steps; (h) 5-(fluoromethoxy)pyrazine-2-carboxylic acid, EDC·HCl, aq HCl, MeOH, 0 °C to rt, 66%.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i67">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15500" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15500" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 35 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prince, M.</span>; <span class="NLM_string-name">Comas-Herrera, A.</span>; <span class="NLM_string-name">Knapp, M.</span>; <span class="NLM_string-name">Guerchet, M.</span>; <span class="NLM_string-name">Karagiannidou, M.</span></span> <span> </span><span class="NLM_article-title">World Alzheimer Report 2016</span>. <a href="https://www.alz.co.uk/research/WorldAlzheimerReport2016.pdf" class="extLink">https://www.alz.co.uk/research/WorldAlzheimerReport2016.pdf</a> (accessed Feb 20, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=M.+Prince&author=A.+Comas-Herrera&author=M.+Knapp&author=M.+Guerchet&author=M.+Karagiannidou&title=World+Alzheimer+Report+2016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3DPrince%26aufirst%3DM.%26atitle%3DWorld%2520Alzheimer%2520Report%25202016%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Alzheimer’s Association</span>. <span> </span><span class="NLM_article-title">2017 Alzheimer’s Disease Facts
and Figures</span>. <a href="https://www.alz.org/documents_custom/2017-facts-and-figures.pdf" class="extLink">https://www.alz.org/documents_custom/2017-facts-and-figures.pdf</a> (accessed Feb 20, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=Alzheimer%E2%80%99s+Association&title=2017+Alzheimer%E2%80%99s+Disease+Facts%0Aand+Figures"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3D2017%2520Alzheimer%25E2%2580%2599s%2520Disease%2520Facts%250Aand%2520Figures%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chancellor, D.</span>; <span class="NLM_string-name">Dube, S.</span>; <span class="NLM_string-name">Huntley, C.</span></span> <i>Alzheimer’s Disease</i>. Ref Code: DMKC4740.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Chancellor%2C+D.%3B+Dube%2C+S.%3B+Huntley%2C+C.+Alzheimer%E2%80%99s+Disease.+Ref+Code%3A+DMKC4740."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26aulast%3DChancellor%26aufirst%3DD.%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Disease" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vassar, R.</span></span> <span> </span><span class="NLM_article-title">Targeting the β secretase BACE1 for Alzheimer’s disease therapy</span>. <i>Lancet Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">319</span>– <span class="NLM_lpage">329</span>, <span class="refDoi"> DOI: 10.1016/s1474-4422(13)70276-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1016%2Fs1474-4422%2813%2970276-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=24556009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC2cXis1Cntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=319-329&author=R.+Yanauthor=R.+Vassar&title=Targeting+the+%CE%B2+secretase+BACE1+for+Alzheimer%E2%80%99s+disease+therapy&doi=10.1016%2Fs1474-4422%2813%2970276-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the β secretase BACE1 for Alzheimer's disease therapy</span></div><div class="casAuthors">Yan, Riqiang; Vassar, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">319-329</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The β secretase, widely known as β-site amyloid precursor protein cleaving enzyme 1 (BACE1), initiates the prodn. of the toxic amyloid β (Aβ) that plays a crucial early part in Alzheimer's disease pathogenesis.  BACE1 is a prime therapeutic target for lowering cerebral Aβ concns. in Alzheimer's disease, and clin. development of BACE1 inhibitors is being intensely pursued.  Although BACE1 inhibitor drug development has proven challenging, several promising BACE1 inhibitors have recently entered human clin. trials.  The safety and efficacy of these drugs are being tested at present in healthy individuals and patients with Alzheimer's disease, and will soon be tested in individuals with presymptomatic Alzheimer's disease.  Although hopes are high that BACE1 inhibitors might be efficacious for the prevention or treatment of Alzheimer's disease, concerns have been raised about potential mechanism-based side-effects of these drugs.  The potential of therapeutic BACE1 inhibition might prove to be a watershed in the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8SsSfCAC6nbVg90H21EOLACvtfcHk0lgPUOcKkNxMDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXis1Cntbo%253D&md5=11aeb06fee19cafc0b361e2c43900806</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fs1474-4422%2813%2970276-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs1474-4422%252813%252970276-x%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DR.%26aulast%3DVassar%26aufirst%3DR.%26atitle%3DTargeting%2520the%2520%25CE%25B2%2520secretase%2520BACE1%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520therapy%26jtitle%3DLancet%2520Neurol.%26date%3D2014%26volume%3D13%26spage%3D319%26epage%3D329%26doi%3D10.1016%2Fs1474-4422%2813%2970276-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selkoe, D. J.</span></span> <span> </span><span class="NLM_article-title">The amyloid hypothesis of Alzheimer’s disease: Progress and problems on the road to therapeutics</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>297</i></span>,  <span class="NLM_fpage">353</span>– <span class="NLM_lpage">356</span>, <span class="refDoi"> DOI: 10.1126/science.1072994</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1126%2Fscience.1072994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=12130773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2002&pages=353-356&author=J.+Hardyauthor=D.+J.+Selkoe&title=The+amyloid+hypothesis+of+Alzheimer%E2%80%99s+disease%3A+Progress+and+problems+on+the+road+to+therapeutics&doi=10.1126%2Fscience.1072994"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics</span></div><div class="casAuthors">Hardy, John; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">5580</span>),
    <span class="NLM_cas:pages">353-356</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  It has been more than 10 yr since it was first proposed that the neurodegeneration in Alzheimer's disease (AD) may be caused by deposition of amyloid β-peptide (Aβ) in plaques in brain tissue.  According to the amyloid hypothesis, accumulation of Aβ in the brain is the primary influence driving AD pathogenesis.  The rest of the disease process, including formation of neurofibrillary tangles contg. tau protein, is proposed to result from an imbalance between Aβ prodn. and Aβ clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9G5omTHR6cbVg90H21EOLACvtfcHk0lgPUOcKkNxMDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D&md5=f7b8db1bc6f13e85f887b73f3042e86e</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1126%2Fscience.1072994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1072994%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520amyloid%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Progress%2520and%2520problems%2520on%2520the%2520road%2520to%2520therapeutics%26jtitle%3DScience%26date%3D2002%26volume%3D297%26spage%3D353%26epage%3D356%26doi%3D10.1126%2Fscience.1072994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Karran, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercken, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strooper, B. D.</span></span> <span> </span><span class="NLM_article-title">The amyloid cascade hypothesis for Alzheimer’s disease: an appraisal for the development of therapeutics</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">698</span>– <span class="NLM_lpage">712</span>, <span class="refDoi"> DOI: 10.1038/nrd3505</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1038%2Fnrd3505" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=21852788" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVelsL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=698-712&author=E.+Karranauthor=M.+Merckenauthor=B.+D.+Strooper&title=The+amyloid+cascade+hypothesis+for+Alzheimer%E2%80%99s+disease%3A+an+appraisal+for+the+development+of+therapeutics&doi=10.1038%2Fnrd3505"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics</span></div><div class="casAuthors">Karran, Eric; Mercken, Marc; De Strooper, Bart</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">698-712</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The amyloid cascade hypothesis, which posits that the deposition of the amyloid-β peptide in the brain is a central event in Alzheimer's disease pathol., has dominated research for the past twenty years.  Several therapeutics that were purported to reduce amyloid-β prodn. or aggregation have failed in Phase III clin. testing, and many others are in various stages of development.  Therefore, it is timely to review the science underpinning the amyloid cascade hypothesis, consider what type of clin. trials will constitute a valid test of this hypothesis and explore whether amyloid-β-directed therapeutics will provide the medicines that are urgently needed by society for treating this devastating disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_-zjcfHaQ87Vg90H21EOLACvtfcHk0ljNCFISF997aA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVelsL3L&md5=cf2824a56a4c3df6e265d8788970729d</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1038%2Fnrd3505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3505%26sid%3Dliteratum%253Aachs%26aulast%3DKarran%26aufirst%3DE.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DStrooper%26aufirst%3DB.%2BD.%26atitle%3DThe%2520amyloid%2520cascade%2520hypothesis%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520an%2520appraisal%2520for%2520the%2520development%2520of%2520therapeutics%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D698%26epage%3D712%26doi%3D10.1038%2Fnrd3505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Vassar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu-Khan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendiaz, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teplow, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amarante, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loeloff, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edenson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lile, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarosinski, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biere, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curran, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgess, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louis, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treanor, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Citron, M.</span></span> <span> </span><span class="NLM_article-title">β-Secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">735</span>– <span class="NLM_lpage">741</span>, <span class="refDoi"> DOI: 10.1126/science.286.5440.735</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1126%2Fscience.286.5440.735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10531052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADyaK1MXntFWit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=1999&pages=735-741&author=R.+Vassarauthor=B.+D.+Bennettauthor=S.+Babu-Khanauthor=S.+Kahnauthor=E.+A.+Mendiazauthor=P.+Denisauthor=D.+B.+Teplowauthor=S.+Rossauthor=P.+Amaranteauthor=R.+Loeloffauthor=Y.+Luoauthor=S.+Fisherauthor=J.+Fullerauthor=S.+Edensonauthor=J.+Lileauthor=M.+A.+Jarosinskiauthor=A.+L.+Biereauthor=E.+Curranauthor=T.+Burgessauthor=J.-C.+Louisauthor=F.+Collinsauthor=J.+Treanorauthor=G.+Rogersauthor=M.+Citron&title=%CE%B2-Secretase+cleavage+of+Alzheimer%E2%80%99s+amyloid+precursor+protein+by+the+transmembrane+aspartic+protease+BACE&doi=10.1126%2Fscience.286.5440.735"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">β-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE</span></div><div class="casAuthors">Vassar, Robert; Bennett, Brian D.; Babu-Khan, Safura; Kahn, Steve; Mendiaz, Elizabeth A.; Denis, Paul; Teplow, David B.; Ross, Sandra; Amarante, Patricia; Loeloff, Richard; Luo, Yi; Fisher, Seth; Fuller, Janis; Edenson, Steven; Lile, Jackson; Jarosinski, Mark A.; Biere, Anja Leona; Curran, Eileen; Burgess, Teresa; Louis, Jean-Claude; Collins, Frank; Treanor, James; Rogers, Gary; Citron, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">5440</span>),
    <span class="NLM_cas:pages">735-741</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Cerebral deposition of amyloid β peptide (Aβ) is an early and crit. feature of Alzheimer's disease.  Aβ generation depends on proteolytic cleavage of the amyloid precursor protein (APP) by two unknown proteases: β-secretase and γ-secretase.  These proteases are prime therapeutic targets.  A transmembrane aspartic protease with all the known characteristics of β-secretase was cloned and characterized.  Overexpression of this protease, termed BACE (for beta-site APP-cleaving enzyme) increased the amt. of β-secretase cleavage products, and these were cleaved exactly and only at known β-secretase positions.  Antisense inhibition of endogenous BACE mRNA decreased the amt. of β-secretase cleavage products, and purified BACE protein cleaved APP-derived substrates with the same sequence specificity as β-secretase.  Finally, the expression pattern and subcellular localization of BACE were consistent with that expected for β-secretase.  Future development of BACE inhibitors may prove beneficial for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSx3s1NFyByrVg90H21EOLACvtfcHk0ljNCFISF997aA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFWit74%253D&md5=3f36e8e5b5e9441c7670ccaeb0d2dd4f</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1126%2Fscience.286.5440.735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.286.5440.735%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DKahn%26aufirst%3DS.%26aulast%3DMendiaz%26aufirst%3DE.%2BA.%26aulast%3DDenis%26aufirst%3DP.%26aulast%3DTeplow%26aufirst%3DD.%2BB.%26aulast%3DRoss%26aufirst%3DS.%26aulast%3DAmarante%26aufirst%3DP.%26aulast%3DLoeloff%26aufirst%3DR.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DFisher%26aufirst%3DS.%26aulast%3DFuller%26aufirst%3DJ.%26aulast%3DEdenson%26aufirst%3DS.%26aulast%3DLile%26aufirst%3DJ.%26aulast%3DJarosinski%26aufirst%3DM.%2BA.%26aulast%3DBiere%26aufirst%3DA.%2BL.%26aulast%3DCurran%26aufirst%3DE.%26aulast%3DBurgess%26aufirst%3DT.%26aulast%3DLouis%26aufirst%3DJ.-C.%26aulast%3DCollins%26aufirst%3DF.%26aulast%3DTreanor%26aufirst%3DJ.%26aulast%3DRogers%26aufirst%3DG.%26aulast%3DCitron%26aufirst%3DM.%26atitle%3D%25CE%25B2-Secretase%2520cleavage%2520of%2520Alzheimer%25E2%2580%2599s%2520amyloid%2520precursor%2520protein%2520by%2520the%2520transmembrane%2520aspartic%2520protease%2520BACE%26jtitle%3DScience%26date%3D1999%26volume%3D286%26spage%3D735%26epage%3D741%26doi%3D10.1126%2Fscience.286.5440.735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sinha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, John P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbour, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basi, Guriqbal S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caccavello, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dovey, Harry F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frigon, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson-Croak, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jewett, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keim, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knops, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieberburg, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Power, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tatsuno, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tung, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seubert, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suomensaari, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McConlogue, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">John, V.</span></span> <span> </span><span class="NLM_article-title">Purification and cloning of amyloid precursor protein β-secretase from human brain</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>402</i></span>,  <span class="NLM_fpage">537</span>– <span class="NLM_lpage">540</span>, <span class="refDoi"> DOI: 10.1038/990114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1038%2F990114" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=402&publication_year=1999&pages=537-540&author=S.+Sinhaauthor=John+P.+Andersonauthor=R.+Barbourauthor=Guriqbal+S.+Basiauthor=R.+Caccavelloauthor=D.+Davisauthor=M.+Doanauthor=Harry+F.+Doveyauthor=N.+Frigonauthor=J.+Hongauthor=K.+Jacobson-Croakauthor=N.+Jewettauthor=P.+Keimauthor=J.+Knopsauthor=I.+Lieberburgauthor=M.+Powerauthor=H.+Tanauthor=G.+Tatsunoauthor=J.+Tungauthor=D.+Schenkauthor=P.+Seubertauthor=S.+M.+Suomensaariauthor=S.+Wangauthor=D.+Walkerauthor=J.+Zhaoauthor=L.+McConlogueauthor=V.+John&title=Purification+and+cloning+of+amyloid+precursor+protein+%CE%B2-secretase+from+human+brain&doi=10.1038%2F990114"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1038%2F990114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F990114%26sid%3Dliteratum%253Aachs%26aulast%3DSinha%26aufirst%3DS.%26aulast%3DAnderson%26aufirst%3DJohn%2BP.%26aulast%3DBarbour%26aufirst%3DR.%26aulast%3DBasi%26aufirst%3DGuriqbal%2BS.%26aulast%3DCaccavello%26aufirst%3DR.%26aulast%3DDavis%26aufirst%3DD.%26aulast%3DDoan%26aufirst%3DM.%26aulast%3DDovey%26aufirst%3DHarry%2BF.%26aulast%3DFrigon%26aufirst%3DN.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DJacobson-Croak%26aufirst%3DK.%26aulast%3DJewett%26aufirst%3DN.%26aulast%3DKeim%26aufirst%3DP.%26aulast%3DKnops%26aufirst%3DJ.%26aulast%3DLieberburg%26aufirst%3DI.%26aulast%3DPower%26aufirst%3DM.%26aulast%3DTan%26aufirst%3DH.%26aulast%3DTatsuno%26aufirst%3DG.%26aulast%3DTung%26aufirst%3DJ.%26aulast%3DSchenk%26aufirst%3DD.%26aulast%3DSeubert%26aufirst%3DP.%26aulast%3DSuomensaari%26aufirst%3DS.%2BM.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWalker%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DMcConlogue%26aufirst%3DL.%26aulast%3DJohn%26aufirst%3DV.%26atitle%3DPurification%2520and%2520cloning%2520of%2520amyloid%2520precursor%2520protein%2520%25CE%25B2-secretase%2520from%2520human%2520brain%26jtitle%3DNature%26date%3D1999%26volume%3D402%26spage%3D537%26epage%3D540%26doi%3D10.1038%2F990114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hussain, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howlett, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tew, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meek, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gloger, I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Southan, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmons, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dingwall, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christie, G.</span></span> <span> </span><span class="NLM_article-title">Identification of a novel aspartic protease (Asp 2) as β-secretase</span>. <i>Mol. Cell. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">419</span>– <span class="NLM_lpage">427</span>, <span class="refDoi"> DOI: 10.1006/mcne.1999.0811</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1006%2Fmcne.1999.0811" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10656250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADyaK1MXnt1Chsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1999&pages=419-427&author=I.+Hussainauthor=D.+Powellauthor=D.+R.+Howlettauthor=D.+G.+Tewauthor=T.+D.+Meekauthor=C.+Chapmanauthor=I.+S.+Glogerauthor=K.+E.+Murphyauthor=C.+D.+Southanauthor=D.+M.+Ryanauthor=T.+S.+Smithauthor=D.+L.+Simmonsauthor=F.+S.+Walshauthor=C.+Dingwallauthor=G.+Christie&title=Identification+of+a+novel+aspartic+protease+%28Asp+2%29+as+%CE%B2-secretase&doi=10.1006%2Fmcne.1999.0811"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Novel Aspartic Protease (Asp 2) as β-Secretase</span></div><div class="casAuthors">Hussain, Ishrut; Powell, David; Howlett, David R.; Tew, David G.; Meek, Thomas D.; Chapman, Conrad; Gloger, Israel S.; Murphy, Kay E.; Southan, Christopher D.; Ryan, Dominic M.; Smith, Trudi S.; Simmons, David L.; Walsh, Frank S.; Dingwall, Colin; Christie, Gary</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Neuroscience</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">419-427</span>CODEN:
                <span class="NLM_cas:coden">MOCNED</span>;
        ISSN:<span class="NLM_cas:issn">1044-7431</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">The Alzheimer's disease β-amyloid peptide (Aβ) is produced by excision from the type 1 integral membrane glycoprotein amyloid precursor protein (APP) by the sequential actions of β- and then γ-secretases.  Here we report that Asp 2, a novel transmembrane aspartic protease, has the key activities expected of β-secretase.  Transient expression of Asp 2 in cells expressing APP causes an increase in the secretion of the N-terminal fragment of APP and an increase in the cell-assocd. C-terminal β-secretase APP fragment.  Mutation of either of the putative catalytic aspartyl residues in Asp 2 abrogates the prodn. of the fragments characteristic of cleavage at the β-secretase site.  The enzyme is present in normal and Alzheimer's disease (AD) brain and is also found in cell lines known to produce Aβ.  Asp 2 localizes to the Golgi/endoplasmic reticulum in transfected cells and shows clear colocalization with APP in cells stably expressing the 751-amino-acid isoform of APP.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDUBbUoO6SgLVg90H21EOLACvtfcHk0lhYuBtTQSgHTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnt1Chsrs%253D&md5=aba834d907c5dae03f060d94729576e9</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1006%2Fmcne.1999.0811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fmcne.1999.0811%26sid%3Dliteratum%253Aachs%26aulast%3DHussain%26aufirst%3DI.%26aulast%3DPowell%26aufirst%3DD.%26aulast%3DHowlett%26aufirst%3DD.%2BR.%26aulast%3DTew%26aufirst%3DD.%2BG.%26aulast%3DMeek%26aufirst%3DT.%2BD.%26aulast%3DChapman%26aufirst%3DC.%26aulast%3DGloger%26aufirst%3DI.%2BS.%26aulast%3DMurphy%26aufirst%3DK.%2BE.%26aulast%3DSouthan%26aufirst%3DC.%2BD.%26aulast%3DRyan%26aufirst%3DD.%2BM.%26aulast%3DSmith%26aufirst%3DT.%2BS.%26aulast%3DSimmons%26aufirst%3DD.%2BL.%26aulast%3DWalsh%26aufirst%3DF.%2BS.%26aulast%3DDingwall%26aufirst%3DC.%26aulast%3DChristie%26aufirst%3DG.%26atitle%3DIdentification%2520of%2520a%2520novel%2520aspartic%2520protease%2520%2528Asp%25202%2529%2520as%2520%25CE%25B2-secretase%26jtitle%3DMol.%2520Cell.%2520Neurosci.%26date%3D1999%26volume%3D14%26spage%3D419%26epage%3D427%26doi%3D10.1006%2Fmcne.1999.0811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bienkowski, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuck, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tory, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pauley, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brashler, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stratman, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathews, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buhl, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomasselli, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parodi, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinrikson, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurney, M. E.</span></span> <span> </span><span class="NLM_article-title">Membrane-anchored aspartyl protease with Alzheimer’s disease β-secretase activity</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>402</i></span>,  <span class="NLM_fpage">533</span>– <span class="NLM_lpage">537</span>, <span class="refDoi"> DOI: 10.1038/990107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1038%2F990107" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=402&publication_year=1999&pages=533-537&author=R.+Yanauthor=M.+J.+Bienkowskiauthor=M.+E.+Shuckauthor=H.+Miaoauthor=M.+C.+Toryauthor=A.+M.+Pauleyauthor=J.+R.+Brashlerauthor=N.+C.+Stratmanauthor=W.+R.+Mathewsauthor=A.+E.+Buhlauthor=D.+B.+Carterauthor=A.+G.+Tomasselliauthor=L.+A.+Parodiauthor=R.+L.+Heinriksonauthor=M.+E.+Gurney&title=Membrane-anchored+aspartyl+protease+with+Alzheimer%E2%80%99s+disease+%CE%B2-secretase+activity&doi=10.1038%2F990107"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6d&amp;dbid=16384&amp;doi=10.1038%2F990107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F990107%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DR.%26aulast%3DBienkowski%26aufirst%3DM.%2BJ.%26aulast%3DShuck%26aufirst%3DM.%2BE.%26aulast%3DMiao%26aufirst%3DH.%26aulast%3DTory%26aufirst%3DM.%2BC.%26aulast%3DPauley%26aufirst%3DA.%2BM.%26aulast%3DBrashler%26aufirst%3DJ.%2BR.%26aulast%3DStratman%26aufirst%3DN.%2BC.%26aulast%3DMathews%26aufirst%3DW.%2BR.%26aulast%3DBuhl%26aufirst%3DA.%2BE.%26aulast%3DCarter%26aufirst%3DD.%2BB.%26aulast%3DTomasselli%26aufirst%3DA.%2BG.%26aulast%3DParodi%26aufirst%3DL.%2BA.%26aulast%3DHeinrikson%26aufirst%3DR.%2BL.%26aulast%3DGurney%26aufirst%3DM.%2BE.%26atitle%3DMembrane-anchored%2520aspartyl%2520protease%2520with%2520Alzheimer%25E2%2580%2599s%2520disease%2520%25CE%25B2-secretase%2520activity%26jtitle%3DNature%26date%3D1999%26volume%3D402%26spage%3D533%26epage%3D537%26doi%3D10.1038%2F990107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koelsch, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Downs, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dashti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J.</span></span> <span> </span><span class="NLM_article-title">Human aspartic protease memapsin 2 cleaves the β-secretase site of β-amyloid precursor protein</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">456</span>– <span class="NLM_lpage">1460</span>, <span class="refDoi"> DOI: 10.1073/pnas.97.4.1456</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1073%2Fpnas.97.4.1456" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=456-1460&author=X.+Linauthor=G.+Koelschauthor=S.+Wuauthor=D.+Downsauthor=A.+Dashtiauthor=J.+Tang&title=Human+aspartic+protease+memapsin+2+cleaves+the+%CE%B2-secretase+site+of+%CE%B2-amyloid+precursor+protein&doi=10.1073%2Fpnas.97.4.1456"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6e&amp;dbid=16384&amp;doi=10.1073%2Fpnas.97.4.1456&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.97.4.1456%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DX.%26aulast%3DKoelsch%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DDowns%26aufirst%3DD.%26aulast%3DDashti%26aufirst%3DA.%26aulast%3DTang%26aufirst%3DJ.%26atitle%3DHuman%2520aspartic%2520protease%2520memapsin%25202%2520cleaves%2520the%2520%25CE%25B2-secretase%2520site%2520of%2520%25CE%25B2-amyloid%2520precursor%2520protein%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2000%26volume%3D97%26spage%3D456%26epage%3D1460%26doi%3D10.1073%2Fpnas.97.4.1456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osswald, H. L.</span></span> <span> </span><span class="NLM_article-title">BACE1 (β-secretase) inhibitors for the treatment of Alzheimer’s disease</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">6765</span>– <span class="NLM_lpage">6813</span>, <span class="refDoi"> DOI: 10.1039/c3cs60460h</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1039%2Fc3cs60460h" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2014&pages=6765-6813&author=A.+K.+Ghoshauthor=H.+L.+Osswald&title=BACE1+%28%CE%B2-secretase%29+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1039%2Fc3cs60460h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1039%2Fc3cs60460h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3cs60460h%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DOsswald%26aufirst%3DH.%2BL.%26atitle%3DBACE1%2520%2528%25CE%25B2-secretase%2529%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2014%26volume%3D43%26spage%3D6765%26epage%3D6813%26doi%3D10.1039%2Fc3cs60460h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatraman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKeever, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dillard, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. B.</span></span> <span> </span><span class="NLM_article-title">Structure based design of β-site APP cleaving enzyme 1 (BACE) inhibitors for the treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4156</span>– <span class="NLM_lpage">4180</span>, <span class="refDoi"> DOI: 10.1021/jm301659n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301659n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4156-4180&author=J.+Yuanauthor=S.+Venkatramanauthor=Y.+Zhengauthor=B.+M.+McKeeverauthor=L.+W.+Dillardauthor=S.+B.+Singh&title=Structure+based+design+of+%CE%B2-site+APP+cleaving+enzyme+1+%28BACE%29+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm301659n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1021%2Fjm301659n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301659n%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DMcKeever%26aufirst%3DB.%2BM.%26aulast%3DDillard%26aufirst%3DL.%2BW.%26aulast%3DSingh%26aufirst%3DS.%2BB.%26atitle%3DStructure%2520based%2520design%2520of%2520%25CE%25B2-site%2520APP%2520cleaving%2520enzyme%25201%2520%2528BACE%2529%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4156%26epage%3D4180%26doi%3D10.1021%2Fjm301659n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Oehlrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokopcova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J. M.</span></span> <span> </span><span class="NLM_article-title">The evolution of amidine-based brain penetrant BACE1 inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2033</span>– <span class="NLM_lpage">2045</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.03.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1016%2Fj.bmcl.2014.03.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=24704031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlvVSqsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2033-2045&author=D.+Oehlrichauthor=H.+Prokopcovaauthor=H.+J.+M.+Gijsen&title=The+evolution+of+amidine-based+brain+penetrant+BACE1+inhibitors&doi=10.1016%2Fj.bmcl.2014.03.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">The evolution of amidine-based brain penetrant BACE1 inhibitors</span></div><div class="casAuthors">Oehlrich, Daniel; Prokopcova, Hana; Gijsen, Harrie J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2033-2045</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Beta site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors hold great potential as disease modifying anti-Alzheimer's drugs.  This digest provides an overview of the amidine contg. class of BACE1 inhibitors, of which multiple examples are now progressing through clin. trials.  The various structural modifications highlight the struggle to combine potency with the optimal properties for a brain penetrant BACE1 inhibitor, and illustrate the crowded competitive landscape.  This overview concludes with a summary of potential issues including substrate and target selectivity and a synopsis of the status of the current and past clin. assets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-4h1WxzUvbbVg90H21EOLACvtfcHk0liPuBT1CNcIBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlvVSqsrY%253D&md5=a929f7f1be0c7d2ff1a10fc5853de06b</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.03.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.03.025%26sid%3Dliteratum%253Aachs%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DProkopcova%26aufirst%3DH.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26atitle%3DThe%2520evolution%2520of%2520amidine-based%2520brain%2520penetrant%2520BACE1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D2033%26epage%3D2045%26doi%3D10.1016%2Fj.bmcl.2014.03.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Hall, A.</span>; <span class="NLM_string-name">Gijsen, H. J. M.</span></span> <span> </span><span class="NLM_article-title">Targeting β-secretase (BACE) for the treatment of Alzheimer’s disease</span>. In  <i>Comprehensive Medicinal Chemistry III</i>, <span class="NLM_edition">3</span>rd ed.; <span class="NLM_contrib-group"><span class="NLM_string-name">Chackalamannil, S.</span>, <span class="NLM_string-name">Rotella, D. P.</span>, <span class="NLM_string-name">Ward, S. E.</span></span>, Eds.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">Oxford</span>, <span class="NLM_year">2017</span>; Vol.  <span class="NLM_volume">7</span>, pp  <span class="NLM_fpage">326</span>– <span class="NLM_lpage">383</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1016%2FB978-0-12-409547-2.13809-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=326-383&author=A.+Hall&author=H.+J.+M.+Gijsenauthor=S.+Chackalamannil&author=D.+P.+Rotella&author=S.+E.+Ward&title=Comprehensive+Medicinal+Chemistry+III"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-409547-2.13809-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-409547-2.13809-0%26sid%3Dliteratum%253Aachs%26aulast%3DHall%26aufirst%3DA.%26atitle%3DTargeting%2520%25CE%25B2-secretase%2520%2528BACE%2529%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26btitle%3DComprehensive%2520Medicinal%2520Chemistry%2520III%26aulast%3DChackalamannil%26aufirst%3DS.%26pub%3DElsevier%26date%3D2017%26volume%3D7%26spage%3D326%26epage%3D383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hsiao, C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rombouts, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J. M.</span></span> <span> </span><span class="NLM_article-title">New evolutions in the BACE1 inhibitor field from 2014 to 2018</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">761</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.12.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1016%2Fj.bmcl.2018.12.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=30709653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlCmu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2019&pages=761&author=C.-C.+Hsiaoauthor=F.+Romboutsauthor=H.+J.+M.+Gijsen&title=New+evolutions+in+the+BACE1+inhibitor+field+from+2014+to+2018&doi=10.1016%2Fj.bmcl.2018.12.049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8cR"><div class="casContent"><span class="casTitleNuber">8c</span><div class="casTitle"><span class="NLM_cas:atitle">New evolutions in the BACE1 inhibitor field from 2014 to 2018</span></div><div class="casAuthors">Hsiao, Chien-Chi; Rombouts, Frederik; Gijsen, Harrie J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">761-777</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  β-Site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors offer the potential of disease-modifying treatment for Alzheimer's disease (AD).  Since 2014, major breakthroughs have appeared in the field of BACE1 inhibitors.  This review provides an overview of amidine-based BACE1 inhibitors between 2014 and 2018.  Herein are summarized (i) the structure-activity relationship, (ii) the physiol. results and (iii) the potential risks from a lack of selectivity.  This review also summarizes clin. scope, results and outlook of the compds. that have been or are currently under development in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3OfI_B-BJ-LVg90H21EOLACvtfcHk0ljX99TMJ4fo-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlCmu7s%253D&md5=049eda6ce97b31a04b5b579afd3e11e5</span></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.12.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.12.049%26sid%3Dliteratum%253Aachs%26aulast%3DHsiao%26aufirst%3DC.-C.%26aulast%3DRombouts%26aufirst%3DF.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26atitle%3DNew%2520evolutions%2520in%2520the%2520BACE1%2520inhibitor%2520field%2520from%25202014%2520to%25202018%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D29%26spage%3D761%26doi%3D10.1016%2Fj.bmcl.2018.12.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittington, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dineen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epstein, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graceffa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiang, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahl, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R. T.</span></span> <span> </span><span class="NLM_article-title">Structure- and property-based design of aminooxazoline xanthenes as selective, orally efficacious, and CNS penetrable BACE inhibitors for the treatment of alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9156</span>– <span class="NLM_lpage">9169</span>, <span class="refDoi"> DOI: 10.1021/jm300598e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300598e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1yhsLjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9156-9169&author=H.+Huangauthor=D.+S.+Laauthor=A.+C.+Chengauthor=D.+A.+Whittingtonauthor=V.+F.+Patelauthor=K.+Chenauthor=T.+A.+Dineenauthor=O.+Epsteinauthor=R.+Graceffaauthor=D.+Hickmanauthor=Y.-H.+Kiangauthor=S.+Louieauthor=Y.+Luoauthor=R.+C.+Wahlauthor=P.+H.+Wenauthor=S.+Woodauthor=R.+T.+Fremeau&title=Structure-+and+property-based+design+of+aminooxazoline+xanthenes+as+selective%2C+orally+efficacious%2C+and+CNS+penetrable+BACE+inhibitors+for+the+treatment+of+alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm300598e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Structure- and property-based design of aminooxazoline xanthenes as selective, orally efficacious, and CNS penetrable BACE inhibitors for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Huang, Hongbing; La, Daniel S.; Cheng, Alan C.; Whittington, Douglas A.; Patel, Vinod F.; Chen, Kui; Dineen, Thomas A.; Epstein, Oleg; Graceffa, Russell; Hickman, Dean; Kiang, Y.-H.; Louie, Steven; Luo, Yi; Wahl, Robert C.; Wen, Paul H.; Wood, Stephen; Fremeau, Robert T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9156-9169</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A structure- and property-based drug design approach was employed to identify aminooxazoline xanthenes as potent and selective human β-secretase inhibitors.  These compds. exhibited good isolated enzyme, cell potency, and selectivity against the structurally related aspartyl protease cathepsin D.  Our efforts resulted in the identification of a potent, orally bioavailable CNS penetrant compd. that exhibited in vivo efficacy.  A single oral dose of compd. (I) resulted in a significant redn. of CNS Aβ40 in naive rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDEYfU4moxMbVg90H21EOLACvtfcHk0ljX99TMJ4fo-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1yhsLjJ&md5=0ecd50ec1ea82a058e499bb712c45272</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1021%2Fjm300598e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300598e%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DCheng%26aufirst%3DA.%2BC.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DEpstein%26aufirst%3DO.%26aulast%3DGraceffa%26aufirst%3DR.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DKiang%26aufirst%3DY.-H.%26aulast%3DLouie%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26atitle%3DStructure-%2520and%2520property-based%2520design%2520of%2520aminooxazoline%2520xanthenes%2520as%2520selective%252C%2520orally%2520efficacious%252C%2520and%2520CNS%2520penetrable%2520BACE%2520inhibitors%2520for%2520the%2520treatment%2520of%2520alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9156%26epage%3D9169%26doi%3D10.1021%2Fjm300598e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Swahn, B.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolmodin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlström, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Berg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Söderman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holenz, Jörg</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindström, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundström, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turek, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kihlström, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slivo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyring, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotticci, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Öhberg, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kers, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Kieseritzky, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, L.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eketjäll, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgievska, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeppsson, F.</span></span> <span> </span><span class="NLM_article-title">Design and Synthesis of β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1) Inhibitors with in Vivo Brain Reduction of β-Amyloid Peptides</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9346</span>– <span class="NLM_lpage">9361</span>, <span class="refDoi"> DOI: 10.1021/jm3009025</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3009025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1OmtL%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9346-9361&author=B.-M.+Swahnauthor=K.+Kolmodinauthor=S.+Karlstr%C3%B6mauthor=S.+von+Bergauthor=P.+S%C3%B6dermanauthor=J%C3%B6rg+Holenzauthor=S.+Bergauthor=J.+Lindstr%C3%B6mauthor=M.+Sundstr%C3%B6mauthor=D.+Turekauthor=J.+Kihlstr%C3%B6mauthor=C.+Slivoauthor=L.+Anderssonauthor=D.+Pyringauthor=D.+Rotticciauthor=L.+%C3%96hbergauthor=A.+Kersauthor=K.+Bogarauthor=F.+von+Kieseritzkyauthor=M.+Berghauthor=L.-L.+Olssonauthor=J.+Jansonauthor=S.+Eketj%C3%A4llauthor=B.+Georgievskaauthor=F.+Jeppsson&title=Design+and+Synthesis+of+%CE%B2-Site+Amyloid+Precursor+Protein+Cleaving+Enzyme+%28BACE1%29+Inhibitors+with+in+Vivo+Brain+Reduction+of+%CE%B2-Amyloid+Peptides&doi=10.1021%2Fjm3009025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1) Inhibitors with in Vivo Brain Reduction of β-Amyloid Peptides</span></div><div class="casAuthors">Swahn, Britt-Marie; Kolmodin, Karin; Karlstroem, Sofia; von Berg, Stefan; Soederman, Peter; Holenz, Joerg; Berg, Stefan; Lindstroem, Johan; Sundstroem, Marie; Turek, Dominika; Kihlstroem, Jacob; Slivo, Can; Andersson, Lars; Pyring, David; Rotticci, Didier; Oehberg, Liselotte; Kers, Annika; Bogar, Krisztian; Bergh, Margareta; Olsson, Lise-Lotte; Janson, Juliette; Eketjaell, Susanna; Georgievska, Biljana; Jeppsson, Fredrik; Faelting, Johanna</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9346-9361</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The evaluation of a series of aminoisoindoles as β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors and the discovery of a clin. candidate drug for Alzheimer's disease, (S)-32 (I, AZD3839), are described.  The improvement in permeability properties by the introduction of fluorine adjacent to the amidine moiety, resulting in in vivo brain redn. of Aβ40, is discussed.  Due to the basic nature of these compds., they displayed affinity for the human ether-a-go-go related gene (hERG) ion channel.  Different ways to reduce hERG inhibition and increase hERG margins for this series are described, culminating in (S)-16 (II) and (R)-41 (III) showing large in vitro margins with BACE1 cell IC50 values of 8.6 and 0.16 nM, resp., and hERG IC50 values of 16 and 2.8 μM, resp.  Several compds. were advanced into pharmacodynamic studies and demonstrated significant redn. of β-amyloid peptides in mouse brain following oral dosing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox062OT8a6ubVg90H21EOLACvtfcHk0lgDHwnWi9Q_4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1OmtL%252FM&md5=da7685d90f56449caa77b6e6393e0a7d</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1021%2Fjm3009025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3009025%26sid%3Dliteratum%253Aachs%26aulast%3DSwahn%26aufirst%3DB.-M.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DKarlstr%25C3%25B6m%26aufirst%3DS.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3DS%25C3%25B6derman%26aufirst%3DP.%26aulast%3DHolenz%26aufirst%3DJ%25C3%25B6rg%26aulast%3DBerg%26aufirst%3DS.%26aulast%3DLindstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DSundstr%25C3%25B6m%26aufirst%3DM.%26aulast%3DTurek%26aufirst%3DD.%26aulast%3DKihlstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DSlivo%26aufirst%3DC.%26aulast%3DAndersson%26aufirst%3DL.%26aulast%3DPyring%26aufirst%3DD.%26aulast%3DRotticci%26aufirst%3DD.%26aulast%3D%25C3%2596hberg%26aufirst%3DL.%26aulast%3DKers%26aufirst%3DA.%26aulast%3DBogar%26aufirst%3DK.%26aulast%3Dvon%2BKieseritzky%26aufirst%3DF.%26aulast%3DBergh%26aufirst%3DM.%26aulast%3DOlsson%26aufirst%3DL.-L.%26aulast%3DJanson%26aufirst%3DJ.%26aulast%3DEketj%25C3%25A4ll%26aufirst%3DS.%26aulast%3DGeorgievska%26aufirst%3DB.%26aulast%3DJeppsson%26aufirst%3DF.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520%25CE%25B2-Site%2520Amyloid%2520Precursor%2520Protein%2520Cleaving%2520Enzyme%2520%2528BACE1%2529%2520Inhibitors%2520with%2520in%2520Vivo%2520Brain%2520Reduction%2520of%2520%25CE%25B2-Amyloid%2520Peptides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9346%26epage%3D9361%26doi%3D10.1021%2Fjm3009025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit9c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mandal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickland, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzola, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grzelak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terracina, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuvelkar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Favreau, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buevich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voigt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazakevich, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKittrick, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenlee, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamford, A. W.</span></span> <span> </span><span class="NLM_article-title">Design and validation of bicyclic iminopyrimidinones as beta amyloid cleaving enzyme-1 (BACE1) inhibitors: Conformational constraint to favor a bioactive conformation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9331</span>– <span class="NLM_lpage">9345</span>, <span class="refDoi"> DOI: 10.1021/jm301039c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301039c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGktb%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9331-9345&author=M.+Mandalauthor=Z.+Zhuauthor=J.+N.+Cummingauthor=X.+Liuauthor=C.+Stricklandauthor=R.+D.+Mazzolaauthor=J.+P.+Caldwellauthor=P.+Leachauthor=M.+Grzelakauthor=L.+Hydeauthor=Q.+Zhangauthor=G.+Terracinaauthor=L.+Zhangauthor=X.+Chenauthor=R.+Kuvelkarauthor=M.+E.+Kennedyauthor=L.+Favreauauthor=K.+Coxauthor=P.+Orthauthor=A.+Buevichauthor=J.+Voigtauthor=H.+Wangauthor=I.+Kazakevichauthor=B.+A.+McKittrickauthor=W.+Greenleeauthor=E.+M.+Parkerauthor=A.+W.+Stamford&title=Design+and+validation+of+bicyclic+iminopyrimidinones+as+beta+amyloid+cleaving+enzyme-1+%28BACE1%29+inhibitors%3A+Conformational+constraint+to+favor+a+bioactive+conformation&doi=10.1021%2Fjm301039c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9cR"><div class="casContent"><span class="casTitleNuber">9c</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Validation of Bicyclic Iminopyrimidinones As Beta Amyloid Cleaving Enzyme-1 (BACE1) Inhibitors: Conformational Constraint to Favor a Bioactive Conformation</span></div><div class="casAuthors">Mandal, Mihirbaran; Zhu, Zhaoning; Cumming, Jared N.; Liu, Xiaoxiang; Strickland, Corey; Mazzola, Robert D.; Caldwell, John P.; Leach, Prescott; Grzelak, Michael; Hyde, Lynn; Zhang, Qi; Terracina, Giuseppe; Zhang, Lili; Chen, Xia; Kuvelkar, Reshma; Kennedy, Matthew E.; Favreau, Leonard; Cox, Kathleen; Orth, Peter; Buevich, Alexei; Voigt, Johannes; Wang, Hongwu; Kazakevich, Irina; McKittrick, Brian A.; Greenlee, William; Parker, Eric M.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9331-9345</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">On the basis of our observation that the biaryl substituent of iminopyrimidinone 7 must be in a pseudoaxial conformation to occupy the contiguous S1-S3 subsites of BACE1, we have designed a novel fused bicyclic iminopyrimidinone scaffold intended to favor this bioactive conformation.  Strategic incorporation of a nitrogen atom in the new constrained ring allowed us to develop SAR around the S2' binding pocket and ultimately resulted in analogs with low nanomolar potency for BACE1.  In particular, optimization of the prime side substituent led to major improvements in potency by displacement of two conserved water mols. from a region near S2'.  Further optimization of the pharmacokinetic properties of this fused pyrrolidine series, in conjunction with facile access to a rat pharmacodynamic model, led to identification of compd. 43, which is an orally active, brain penetrant inhibitor that reduces Aβ40 in the plasma, CSF, and cortex of rats in a dose-dependent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprlJsgY-3wuLVg90H21EOLACvtfcHk0licSZ6fcdcZug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGktb%252FP&md5=6fd0bc5ac847ded7e235939594d4b20d</span></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=10.1021%2Fjm301039c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301039c%26sid%3Dliteratum%253Aachs%26aulast%3DMandal%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DMazzola%26aufirst%3DR.%2BD.%26aulast%3DCaldwell%26aufirst%3DJ.%2BP.%26aulast%3DLeach%26aufirst%3DP.%26aulast%3DGrzelak%26aufirst%3DM.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DTerracina%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DBuevich%26aufirst%3DA.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DDesign%2520and%2520validation%2520of%2520bicyclic%2520iminopyrimidinones%2520as%2520beta%2520amyloid%2520cleaving%2520enzyme-1%2520%2528BACE1%2529%2520inhibitors%253A%2520Conformational%2520constraint%2520to%2520favor%2520a%2520bioactive%2520conformation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9331%26epage%3D9345%26doi%3D10.1021%2Fjm301039c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit9d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hunt, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watts, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vigers, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metcalf, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunawardana, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burkard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geck Do, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutcher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rana, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallan, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeLisle, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regal, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sammond, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groneberg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Purkey, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyssikatos, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marlow, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, T. P.</span></span> <span> </span><span class="NLM_article-title">Spirocyclic β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors: From hit to lowering of cerebrospinal fluid (CSF) amyloid β in a higher species</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3379</span>– <span class="NLM_lpage">3403</span>, <span class="refDoi"> DOI: 10.1021/jm4002154</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4002154" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC3sXkslagsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3379-3403&author=K.+W.+Huntauthor=A.+W.+Cookauthor=R.+J.+Wattsauthor=C.+T.+Clarkauthor=G.+Vigersauthor=D.+Smithauthor=A.+T.+Metcalfauthor=I.+W.+Gunawardanaauthor=M.+Burkardauthor=A.+A.+Coxauthor=M.+K.+Geck+Doauthor=D.+Dutcherauthor=A.+A.+Thomasauthor=S.+Ranaauthor=N.+C.+Kallanauthor=R.+K.+DeLisleauthor=J.+P.+Rizziauthor=K.+Regalauthor=D.+Sammondauthor=R.+Gronebergauthor=M.+Siuauthor=H.+Purkeyauthor=J.+P.+Lyssikatosauthor=A.+Marlowauthor=X.+Liuauthor=T.+P.+Tangauthor=T.+P.+Tang&title=Spirocyclic+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+1+%28BACE1%29+inhibitors%3A+From+hit+to+lowering+of+cerebrospinal+fluid+%28CSF%29+amyloid+%CE%B2+in+a+higher+species&doi=10.1021%2Fjm4002154"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9dR"><div class="casContent"><span class="casTitleNuber">9d</span><div class="casTitle"><span class="NLM_cas:atitle">Spirocyclic β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors: From Hit to Lowering of Cerebrospinal Fluid (CSF) Amyloid β in a Higher Species</span></div><div class="casAuthors">Hunt, Kevin W.; Cook, Adam W.; Watts, Ryan J.; Clark, Christopher T.; Vigers, Guy; Smith, Darin; Metcalf, Andrew T.; Gunawardana, Indrani W.; Burkard, Michael; Cox, April A.; Geck Do, Mary K.; Dutcher, Darrin; Thomas, Allen A.; Rana, Sumeet; Kallan, Nicholas C.; DeLisle, Robert K.; Rizzi, James P.; Regal, Kelly; Sammond, Douglas; Groneberg, Robert; Siu, Michael; Purkey, Hans; Lyssikatos, Joseph P.; Marlow, Allison; Liu, Xingrong; Tang, Tony P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3379-3403</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A hallmark of Alzheimer's disease is the brain deposition of amyloid beta (Aβ), a peptide of 36-43 amino acids that is likely a primary driver of neurodegeneration.  Aβ is produced by the sequential cleavage of APP by BACE1 and γ-secretase; therefore, inhibition of BACE1 represents an attractive therapeutic target to slow or prevent Alzheimer's disease.  Herein are described BACE1 inhibitors with limited mol. flexibility and mol. wt. that decrease CSF Aβ in vivo, despite efflux.  Starting with spirocycle I, the authors explore structure-activity relationships of core changes, P3 moieties, and Asp binding functional groups in order to optimize BACE1 affinity, cathepsin D selectivity, and blood-brain barrier (BBB) penetration.  Using wild type guinea pig and rat, they demonstrate a PK/PD relationship between free drug concns. in the brain and CSF Aβ lowering.  Optimization of brain exposure led to the discovery of (R)-II which reduced CSF Aβ in rodents and in monkey.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYTaFN1ZrY-bVg90H21EOLACvtfcHk0licSZ6fcdcZug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXkslagsLg%253D&md5=b0f610967870013abee4a4bf4ce28b7f</span></div><a href="/servlet/linkout?suffix=cit9d&amp;dbid=16384&amp;doi=10.1021%2Fjm4002154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4002154%26sid%3Dliteratum%253Aachs%26aulast%3DHunt%26aufirst%3DK.%2BW.%26aulast%3DCook%26aufirst%3DA.%2BW.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DClark%26aufirst%3DC.%2BT.%26aulast%3DVigers%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DMetcalf%26aufirst%3DA.%2BT.%26aulast%3DGunawardana%26aufirst%3DI.%2BW.%26aulast%3DBurkard%26aufirst%3DM.%26aulast%3DCox%26aufirst%3DA.%2BA.%26aulast%3DGeck%2BDo%26aufirst%3DM.%2BK.%26aulast%3DDutcher%26aufirst%3DD.%26aulast%3DThomas%26aufirst%3DA.%2BA.%26aulast%3DRana%26aufirst%3DS.%26aulast%3DKallan%26aufirst%3DN.%2BC.%26aulast%3DDeLisle%26aufirst%3DR.%2BK.%26aulast%3DRizzi%26aufirst%3DJ.%2BP.%26aulast%3DRegal%26aufirst%3DK.%26aulast%3DSammond%26aufirst%3DD.%26aulast%3DGroneberg%26aufirst%3DR.%26aulast%3DSiu%26aufirst%3DM.%26aulast%3DPurkey%26aufirst%3DH.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26aulast%3DMarlow%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DTang%26aufirst%3DT.%2BP.%26aulast%3DTang%26aufirst%3DT.%2BP.%26atitle%3DSpirocyclic%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%2520inhibitors%253A%2520From%2520hit%2520to%2520lowering%2520of%2520cerebrospinal%2520fluid%2520%2528CSF%2529%2520amyloid%2520%25CE%25B2%2520in%2520a%2520higher%2520species%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3379%26epage%3D3403%26doi%3D10.1021%2Fjm4002154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit9e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dineen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derakhchan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epstein, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esmay, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreiman, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahl, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittington, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V. F.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of β-site amyloid precursor protein cleaving enzyme (BACE1): Identification of (<i>S</i>)-7-(2-fluoropyridin-3-yl)-3-((3-methyloxetan-3-yl)ethynyl)-5’H-spiro[chromeno[2,3-b]pyridine-5,4’-oxazol]-2’-amine (AMG-8718)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">9811</span>– <span class="NLM_lpage">9831</span>, <span class="refDoi"> DOI: 10.1021/jm5012676</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5012676" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9811-9831&author=T.+A.+Dineenauthor=K.+Chenauthor=A.+C.+Chengauthor=K.+Derakhchanauthor=O.+Epsteinauthor=J.+Esmayauthor=D.+Hickmanauthor=C.+E.+Kreimanauthor=I.+E.+Marxauthor=R.+C.+Wahlauthor=P.+H.+Wenauthor=M.+M.+Weissauthor=D.+A.+Whittingtonauthor=S.+Woodauthor=R.+T.+Fremeauauthor=R.+D.+Whiteauthor=V.+F.+Patel&title=Inhibitors+of+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+%28BACE1%29%3A+Identification+of+%28S%29-7-%282-fluoropyridin-3-yl%29-3-%28%283-methyloxetan-3-yl%29ethynyl%29-5%E2%80%99H-spiro%5Bchromeno%5B2%2C3-b%5Dpyridine-5%2C4%E2%80%99-oxazol%5D-2%E2%80%99-amine+%28AMG-8718%29&doi=10.1021%2Fjm5012676"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9e&amp;dbid=16384&amp;doi=10.1021%2Fjm5012676&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5012676%26sid%3Dliteratum%253Aachs%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DCheng%26aufirst%3DA.%2BC.%26aulast%3DDerakhchan%26aufirst%3DK.%26aulast%3DEpstein%26aufirst%3DO.%26aulast%3DEsmay%26aufirst%3DJ.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DKreiman%26aufirst%3DC.%2BE.%26aulast%3DMarx%26aufirst%3DI.%2BE.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26aulast%3DWhite%26aufirst%3DR.%2BD.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26atitle%3DInhibitors%2520of%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%2520%2528BACE1%2529%253A%2520Identification%2520of%2520%2528S%2529-7-%25282-fluoropyridin-3-yl%2529-3-%2528%25283-methyloxetan-3-yl%2529ethynyl%2529-5%25E2%2580%2599H-spiro%255Bchromeno%255B2%252C3-b%255Dpyridine-5%252C4%25E2%2580%2599-oxazol%255D-2%25E2%2580%2599-amine%2520%2528AMG-8718%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9811%26epage%3D9831%26doi%3D10.1021%2Fjm5012676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit9f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Brodney, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barreiro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riddell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parris, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolan, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atchison, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robshaw, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doran, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bundesmann, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buzon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutra, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henegar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaChapelle, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandit, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lira, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Alsina, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikochik, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogilvie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakya, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, B. T.</span></span> <span> </span><span class="NLM_article-title">Utilizing structures of CYP2D6 and BACE1 complexes to reduce risk of drug-drug interactions with a novel series of centrally efficacious BACE1 inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3223</span>– <span class="NLM_lpage">3252</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00191</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00191" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC2MXksFynsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3223-3252&author=M.+A.+Brodneyauthor=E.+M.+Beckauthor=C.+R.+Butlerauthor=G.+Barreiroauthor=E.+F.+Johnsonauthor=D.+Riddellauthor=K.+Parrisauthor=C.+E.+Nolanauthor=Y.+Fanauthor=K.+Atchisonauthor=C.+Gonzalesauthor=A.+E.+Robshawauthor=S.+D.+Doranauthor=M.+W.+Bundesmannauthor=L.+Buzonauthor=J.+Dutraauthor=K.+Henegarauthor=E.+LaChapelleauthor=X.+Houauthor=B.+N.+Rogersauthor=J.+Panditauthor=R.+Liraauthor=L.+Martinez-Alsinaauthor=P.+Mikochikauthor=J.+C.+Murrayauthor=K.+Ogilvieauthor=L.+Priceauthor=S.+M.+Sakyaauthor=A.+Yuauthor=Y.+Zhangauthor=B.+T.+O%E2%80%99Neill&title=Utilizing+structures+of+CYP2D6+and+BACE1+complexes+to+reduce+risk+of+drug-drug+interactions+with+a+novel+series+of+centrally+efficacious+BACE1+inhibitors&doi=10.1021%2Facs.jmedchem.5b00191"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9fR"><div class="casContent"><span class="casTitleNuber">9f</span><div class="casTitle"><span class="NLM_cas:atitle">Utilizing Structures of CYP2D6 and BACE1 Complexes To Reduce Risk of Drug-Drug Interactions with a Novel Series of Centrally Efficacious BACE1 Inhibitors</span></div><div class="casAuthors">Brodney, Michael A.; Beck, Elizabeth M.; Butler, Christopher R.; Barreiro, Gabriela; Johnson, Eric F.; Riddell, David; Parris, Kevin; Nolan, Charles E.; Fan, Ying; Atchison, Kevin; Gonzales, Cathleen; Robshaw, Ashley E.; Doran, Shawn D.; Bundesmann, Mark W.; Buzon, Leanne; Dutra, Jason; Henegar, Kevin; LaChapelle, Erik; Hou, Xinjun; Rogers, Bruce N.; Pandit, Jayvardhan; Lira, Ricardo; Martinez-Alsina, Luis; Mikochik, Peter; Murray, John C.; Ogilvie, Kevin; Price, Loren; Sakya, Subas M.; Yu, Aijia; Zhang, Yong; O'Neill, Brian T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3223-3252</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In recent years, the first generation of β-secretase (BACE1) inhibitors advanced into clin. development for the treatment of Alzheimer's disease (AD).  However, the alignment of drug-like properties and selectivity remains a major challenge.  Herein, we describe the discovery of a novel class of potent, low clearance, CNS penetrant BACE1 inhibitors represented by thioamidine 5.  Further profiling suggested that a high fraction of the metab. (>95%) was due to CYP2D6, increasing the potential risk for victim-based drug-drug interactions (DDI) and variable exposure in the clinic due to the polymorphic nature of this enzyme.  To guide future design, we solved crystal structures of CYP2D6 complexes with substrate 5 and its corresponding metabolic product pyrazole 6, which provided insight into the binding mode and movements between substrate/inhibitor complexes.  Guided by the BACE1 and CYP2D6 crystal structures, we designed and synthesized analogs with reduced risk for DDI, central efficacy, and improved hERG therapeutic margins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsRdq_8px-VLVg90H21EOLACvtfcHk0lhcxDWPQSdpJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXksFynsL4%253D&md5=ed44904d0e55c74417a6874c1454683c</span></div><a href="/servlet/linkout?suffix=cit9f&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00191%26sid%3Dliteratum%253Aachs%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DButler%26aufirst%3DC.%2BR.%26aulast%3DBarreiro%26aufirst%3DG.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DRiddell%26aufirst%3DD.%26aulast%3DParris%26aufirst%3DK.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DAtchison%26aufirst%3DK.%26aulast%3DGonzales%26aufirst%3DC.%26aulast%3DRobshaw%26aufirst%3DA.%2BE.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DBundesmann%26aufirst%3DM.%2BW.%26aulast%3DBuzon%26aufirst%3DL.%26aulast%3DDutra%26aufirst%3DJ.%26aulast%3DHenegar%26aufirst%3DK.%26aulast%3DLaChapelle%26aufirst%3DE.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DLira%26aufirst%3DR.%26aulast%3DMartinez-Alsina%26aufirst%3DL.%26aulast%3DMikochik%26aufirst%3DP.%26aulast%3DMurray%26aufirst%3DJ.%2BC.%26aulast%3DOgilvie%26aufirst%3DK.%26aulast%3DPrice%26aufirst%3DL.%26aulast%3DSakya%26aufirst%3DS.%2BM.%26aulast%3DYu%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26atitle%3DUtilizing%2520structures%2520of%2520CYP2D6%2520and%2520BACE1%2520complexes%2520to%2520reduce%2520risk%2520of%2520drug-drug%2520interactions%2520with%2520a%2520novel%2520series%2520of%2520centrally%2520efficacious%2520BACE1%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3223%26epage%3D3252%26doi%3D10.1021%2Facs.jmedchem.5b00191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit9g"><span><span class="NLM_label">(g) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guernon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClure, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajamani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camac, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toyn, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahlijanian, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albright, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macor, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, L. A.</span></span> <span> </span><span class="NLM_article-title">Targeting the BACE1 active site flap leads to a potent inhibitor that elicits robust brain Aβ reduction in rodents</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">271</span>– <span class="NLM_lpage">276</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00432</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00432" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC28XmslensA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=271-276&author=Y.-J.+Wuauthor=J.+Guernonauthor=F.+Yangauthor=L.+Snyderauthor=J.+Shiauthor=A.+McClureauthor=R.+Rajamaniauthor=H.+Parkauthor=A.+Ngauthor=H.+Lewisauthor=C.+Changauthor=D.+Camacauthor=J.+H.+Toynauthor=M.+K.+Ahlijanianauthor=C.+F.+Albrightauthor=J.+E.+Macorauthor=L.+A.+Thompson&title=Targeting+the+BACE1+active+site+flap+leads+to+a+potent+inhibitor+that+elicits+robust+brain+A%CE%B2+reduction+in+rodents&doi=10.1021%2Facsmedchemlett.5b00432"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9gR"><div class="casContent"><span class="casTitleNuber">9g</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the BACE1 Active Site Flap Leads to a Potent Inhibitor That Elicits Robust Brain Aβ Reduction in Rodents</span></div><div class="casAuthors">Wu, Yong-Jin; Guernon, Jason; Yang, Fukang; Snyder, Lawrence; Shi, Jianliang; McClure, Andrea; Rajamani, Ramkumar; Park, Hyunsoo; Ng, Alicia; Lewis, Hal; Chang, Chieh Ying; Camac, Dan; Toyn, Jeremy H.; Ahlijanian, Michael K.; Albright, Charles F.; Macor, John E.; Thompson, Lorin A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">271-276</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">By targeting the flap backbone of the BACE1 active site, the authors discovered 6-dimethylisoxazole-substituted biaryl aminothiazine I with 34-fold improved BACE1 inhibitory activity over the lead compd.  The cocrystal structure of I bound to the active site indicated two hydrogen-bond interactions between the dimethylisoxazole and threonine 72 and glutamine 73 of the flap.  Incorporation of the dimethylisoxazole substitution onto the related aminothiazine carboxamide series led to pyrazine-carboxamide II as a very potent BACE1 inhibitor (IC50 < 1 nM).  This compd. demonstrated robust brain Aβ redn. in rat dose-response studies.  Thus, compd. II may be useful in testing the amyloid hypothesis of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9dTGWVgGmmrVg90H21EOLACvtfcHk0lhSb6cv7l8XRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmslensA%253D%253D&md5=b1bd7b0b6cb22ca8d2f49807b905daa9</span></div><a href="/servlet/linkout?suffix=cit9g&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00432%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.-J.%26aulast%3DGuernon%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DSnyder%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DMcClure%26aufirst%3DA.%26aulast%3DRajamani%26aufirst%3DR.%26aulast%3DPark%26aufirst%3DH.%26aulast%3DNg%26aufirst%3DA.%26aulast%3DLewis%26aufirst%3DH.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DCamac%26aufirst%3DD.%26aulast%3DToyn%26aufirst%3DJ.%2BH.%26aulast%3DAhlijanian%26aufirst%3DM.%2BK.%26aulast%3DAlbright%26aufirst%3DC.%2BF.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26aulast%3DThompson%26aufirst%3DL.%2BA.%26atitle%3DTargeting%2520the%2520BACE1%2520active%2520site%2520flap%2520leads%2520to%2520a%2520potent%2520inhibitor%2520that%2520elicits%2520robust%2520brain%2520A%25CE%25B2%2520reduction%2520in%2520rodents%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D271%26epage%3D276%26doi%3D10.1021%2Facsmedchemlett.5b00432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit9h"><span><span class="NLM_label">(h) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Rombouts, F. J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tresadern, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martínez-Lamenca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Gool, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Molina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso de Diego, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oehlrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokopcova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borghys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Brandt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surkyn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Cleyn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moechars, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trabanco, A. A.</span></span> <span> </span><span class="NLM_article-title">1,4-Oxazine β-secretase 1 (BACE1) inhibitors: From hit generation to orally bioavailable brain penetrant leads</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8216</span>– <span class="NLM_lpage">8235</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01101</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01101" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9h&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFWktL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8216-8235&author=F.+J.+R.+Romboutsauthor=G.+Tresadernauthor=O.+Delgadoauthor=C.+Mart%C3%ADnez-Lamencaauthor=M.+Van+Goolauthor=A.+Garc%C3%ADa-Molinaauthor=S.+A.+Alonso+de+Diegoauthor=D.+Oehlrichauthor=H.+Prokopcovaauthor=J.+M.+Alonsoauthor=N.+Austinauthor=H.+Borghysauthor=S.+Van+Brandtauthor=M.+Surkynauthor=M.+De+Cleynauthor=A.+Vosauthor=R.+Alexanderauthor=G.+Macdonaldauthor=D.+Moecharsauthor=H.+Gijsenauthor=A.+A.+Trabanco&title=1%2C4-Oxazine+%CE%B2-secretase+1+%28BACE1%29+inhibitors%3A+From+hit+generation+to+orally+bioavailable+brain+penetrant+leads&doi=10.1021%2Facs.jmedchem.5b01101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9hR"><div class="casContent"><span class="casTitleNuber">9h</span><div class="casTitle"><span class="NLM_cas:atitle">1,4-Oxazine β-Secretase 1 (BACE1) Inhibitors: From Hit Generation to Orally Bioavailable Brain Penetrant Leads</span></div><div class="casAuthors">Rombouts, Frederik J. R.; Tresadern, Gary; Delgado, Oscar; Martinez-Lamenca, Carolina; Van Gool, Michiel; Garcia-Molina, Aranzazu; Alonso de Diego, Sergio A.; Oehlrich, Daniel; Prokopcova, Hana; Alonso, Jose Manuel; Austin, Nigel; Borghys, Herman; Van Brandt, Sven; Surkyn, Michel; De Cleyn, Michel; Vos, Ann; Alexander, Richard; Macdonald, Gregor; Moechars, Dieder; Gijsen, Harrie; Trabanco, Andres A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8216-8235</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">1,4-Oxazines are presented, which show good in vitro inhibition in enzymic and cellular BACE1 assays.  We describe lead optimization focused on reducing the amidine pKa while optimizing interactions in the BACE1 active site.  Our strategy permitted modulation of properties such as permeation and esp. P-glycoprotein efflux.  This led to compds. which were orally bioavailable, centrally active, and which demonstrated robust lowering of brain and CSF Aβ levels, resp., in mouse and dog models.  The amyloid lowering potential of these mols. makes them valuable leads in the search for new BACE1 inhibitors for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHVm9JF2kNa7Vg90H21EOLACvtfcHk0lgEDNZizZRyGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFWktL3L&md5=d3563a26a17a1c86c45a4f99b18be251</span></div><a href="/servlet/linkout?suffix=cit9h&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01101%26sid%3Dliteratum%253Aachs%26aulast%3DRombouts%26aufirst%3DF.%2BJ.%2BR.%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DDelgado%26aufirst%3DO.%26aulast%3DMart%25C3%25ADnez-Lamenca%26aufirst%3DC.%26aulast%3DVan%2BGool%26aufirst%3DM.%26aulast%3DGarc%25C3%25ADa-Molina%26aufirst%3DA.%26aulast%3DAlonso%2Bde%2BDiego%26aufirst%3DS.%2BA.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DProkopcova%26aufirst%3DH.%26aulast%3DAlonso%26aufirst%3DJ.%2BM.%26aulast%3DAustin%26aufirst%3DN.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DVan%2BBrandt%26aufirst%3DS.%26aulast%3DSurkyn%26aufirst%3DM.%26aulast%3DDe%2BCleyn%26aufirst%3DM.%26aulast%3DVos%26aufirst%3DA.%26aulast%3DAlexander%26aufirst%3DR.%26aulast%3DMacdonald%26aufirst%3DG.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DGijsen%26aufirst%3DH.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26atitle%3D1%252C4-Oxazine%2520%25CE%25B2-secretase%25201%2520%2528BACE1%2529%2520inhibitors%253A%2520From%2520hit%2520generation%2520to%2520orally%2520bioavailable%2520brain%2520penetrant%2520leads%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8216%26epage%3D8235%26doi%3D10.1021%2Facs.jmedchem.5b01101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit9i"><span><span class="NLM_label">(i) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimshek, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staufenbiel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rueeger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machauer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veenstra, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lueoend, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tintelnot-Blomley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laue, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frieauff, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staufenbiel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, L. H.</span></span> <span> </span><span class="NLM_article-title">A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-β and neuroinflammation in APP transgenic mice</span>. <i>Mol. Neurodegener.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">44</span>, <span class="refDoi"> DOI: 10.1186/s13024-015-0033-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9i&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1186%2Fs13024-015-0033-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9i&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=26336937" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9i&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC28Xls1Sls7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=44&author=U.+Neumannauthor=P.+Schmidauthor=D.+R.+Shimshekauthor=M.+Staufenbielauthor=L.+H.+Jacobsonauthor=H.+Rueegerauthor=R.+Machauerauthor=S.+J.+Veenstraauthor=R.+M.+Lueoendauthor=M.+Tintelnot-Blomleyauthor=G.+Laueauthor=K.+Beltzauthor=B.+Voggauthor=P.+Schmidauthor=W.+Frieauffauthor=M.+Staufenbielauthor=L.+H.+Jacobson&title=A+novel+BACE+inhibitor+NB-360+shows+a+superior+pharmacological+profile+and+robust+reduction+of+amyloid-%CE%B2+and+neuroinflammation+in+APP+transgenic+mice&doi=10.1186%2Fs13024-015-0033-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9iR"><div class="casContent"><span class="casTitleNuber">9i</span><div class="casTitle"><span class="NLM_cas:atitle">A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-β and neuroinflammation in APP transgenic mice</span></div><div class="casAuthors">Neumann, Ulf; Rueeger, Heinrich; Machauer, Rainer; Veenstra, Siem Jacob; Lueoend, Rainer M.; Tintelnot-Blomley, Marina; Laue, Grit; Beltz, Karen; Vogg, Barbara; Schmid, Peter; Frieauff, Wilfried; Shimshek, Derya R.; Staufenbiel, Matthias; Jacobson, Laura H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurodegeneration</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">44/1-44/15</span>CODEN:
                <span class="NLM_cas:coden">MNOEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1750-1326</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Alzheimer's disease (AD) is the most common form of dementia, the no. of affected individuals is rising, with significant impacts for healthcare systems.  Current symptomatic treatments delay, but do not halt, disease progression.  Genetic evidence points to aggregation and deposition of amyloid-β (Aβ) in the brain being causal for the neurodegeneration and dementia typical of AD.  Approaches to target Aβ via inhibition of γ-secretase or passive antibody therapy have not yet resulted in substantial clin. benefits.  Inhibition of BACE1 (β-secretase) has proven a challenging concept, but recent BACE1inhibitors can enter the brain sufficiently well to lower Aβ.  However, failures with the first clin. BACE1 inhibitors have highlighted the need to generate compds. with appropriate efficacy and safety profiles, since long treatment periods are expected to be necessary in humans.  Results: Treatment with NB-360, a potent and brain penetrable BACE-1 inhibitor can completely block the progression of Aβ deposition in the brains of APP transgenic mice, a model for amyloid pathol.  We furthermore show that almost complete redn. of Aβ was achieved also in rats and in dogs, suggesting that these findings are translational across species and can be extrapolated to humans.  Amyloid pathol. may be an initial step in a complex pathol. cascade; therefore we investigated the effect of BACE-1 inhibition on neuroinflammation, a prominent downstream feature of the disease.  NB-360 stopped accumulation of activated inflammatory cells in the brains of APP transgenic mice.  Upon chronic treatment of APP transgenic mice, patches of gray hairs appeared.  Conclusions: In a rapidly developing field, the data on NB-360 broaden the chem. space and expand knowledge on the properties that are needed to make a BACE-1 inhibitor potent and safe enough for long-term use in patients.  Due to its excellent brain penetration, reasonable oral doses of NB-360 were sufficient to completely block amyloid-β deposition in an APP transgenic mouse model.  Data across species suggest similar treatment effects can possibly be achieved in humans.  The reduced neuroinflammation upon amyloid redn. by NB-360 treatment supports the notion that targeting amyloid-β pathol. can have beneficial downstream effects on the progression of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquJLgu8zl8_LVg90H21EOLACvtfcHk0lgEDNZizZRyGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xls1Sls7o%253D&md5=728407859709d7de57d68bfdc374fe85</span></div><a href="/servlet/linkout?suffix=cit9i&amp;dbid=16384&amp;doi=10.1186%2Fs13024-015-0033-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13024-015-0033-8%26sid%3Dliteratum%253Aachs%26aulast%3DNeumann%26aufirst%3DU.%26aulast%3DSchmid%26aufirst%3DP.%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26aulast%3DStaufenbiel%26aufirst%3DM.%26aulast%3DJacobson%26aufirst%3DL.%2BH.%26aulast%3DRueeger%26aufirst%3DH.%26aulast%3DMachauer%26aufirst%3DR.%26aulast%3DVeenstra%26aufirst%3DS.%2BJ.%26aulast%3DLueoend%26aufirst%3DR.%2BM.%26aulast%3DTintelnot-Blomley%26aufirst%3DM.%26aulast%3DLaue%26aufirst%3DG.%26aulast%3DBeltz%26aufirst%3DK.%26aulast%3DVogg%26aufirst%3DB.%26aulast%3DSchmid%26aufirst%3DP.%26aulast%3DFrieauff%26aufirst%3DW.%26aulast%3DStaufenbiel%26aufirst%3DM.%26aulast%3DJacobson%26aufirst%3DL.%2BH.%26atitle%3DA%2520novel%2520BACE%2520inhibitor%2520NB-360%2520shows%2520a%2520superior%2520pharmacological%2520profile%2520and%2520robust%2520reduction%2520of%2520amyloid-%25CE%25B2%2520and%2520neuroinflammation%2520in%2520APP%2520transgenic%2520mice%26jtitle%3DMol.%2520Neurodegener.%26date%3D2015%26volume%3D10%26spage%3D44%26doi%3D10.1186%2Fs13024-015-0033-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunskill, A. P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iserloh, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazakevich, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuvelkar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meredith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misiaszek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossiter, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slater, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stone, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickland, C. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voigt, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenlee, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamford, A. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of the 3-imino-1,2,4-thiadiazinane 1,1-dioxide derivative verubecestat (MK-8931)–A β-site amyloid precursor protein cleaving enzyme 1 inhibitor for the treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10435</span>– <span class="NLM_lpage">10450</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00307</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00307" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVKnsLnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10435-10450&author=J.+D.+Scottauthor=S.+W.+Liauthor=A.+P.+J.+Brunskillauthor=X.+Chenauthor=K.+Coxauthor=J.+N.+Cummingauthor=M.+Formanauthor=E.+J.+Gilbertauthor=R.+A.+Hodgsonauthor=L.+A.+Hydeauthor=Q.+Jiangauthor=U.+Iserlohauthor=I.+Kazakevichauthor=R.+Kuvelkarauthor=H.+Meiauthor=J.+Meredithauthor=J.+Misiaszekauthor=P.+Orthauthor=L.+M.+Rossiterauthor=M.+Slaterauthor=J.+Stoneauthor=C.+O.+Stricklandauthor=J.+H.+Voigtauthor=G.+Wangauthor=H.+Wangauthor=Y.+Wuauthor=W.+J.+Greenleeauthor=E.+M.+Parkerauthor=M.+E.+Kennedyauthor=A.+W.+Stamford&title=Discovery+of+the+3-imino-1%2C2%2C4-thiadiazinane+1%2C1-dioxide+derivative+verubecestat+%28MK-8931%29%E2%80%93A+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+1+inhibitor+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.6b00307"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the 3-Imino-1,2,4-thiadiazinane 1,1-Dioxide Derivative Verubecestat (MK-8931)-A β-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitor for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Scott, Jack D.; Li, Sarah W.; Brunskill, Andrew P. J.; Chen, Xia; Cox, Kathleen; Cumming, Jared N.; Forman, Mark; Gilbert, Eric J.; Hodgson, Robert A.; Hyde, Lynn A.; Jiang, Qin; Iserloh, Ulrich; Kazakevich, Irina; Kuvelkar, Reshma; Mei, Hong; Meredith, John; Misiaszek, Jeffrey; Orth, Peter; Rossiter, Lana M.; Slater, Meagan; Stone, Julie; Strickland, Corey O.; Voigt, Johannes H.; Wang, Ganfeng; Wang, Hongwu; Wu, Yusheng; Greenlee, William J.; Parker, Eric M.; Kennedy, Matthew E.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10435-10450</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Verubecestat (MK-8931), a diaryl amide substituted 3-imino-1,2,4-thiadiazinane 1,1-dioxide deriv., is a high-affinity β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor currently undergoing Phase 3 clin. evaluation for the treatment of mild to moderate and prodromal Alzheimer's disease.  Although not selective over the closely related aspartyl protease BACE2, verubecesat has high selectivity for BACE1 over other key aspartyl proteases, notably cathepsin D, and profoundly lowers CSF and brain Aβ levels in rats and nonhuman primates, and CSF Aβ levels in humans.  In this annotation, the authors describe the discovery of verubecesat, including design, validation, and selected SAR around the novel iminothiadiazinane dioxide core, as well as aspects of its preclin. and Phase 1 clin. characterization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpN5wdoirs8rVg90H21EOLACvtfcHk0lhn91GQZrtRpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVKnsLnI&md5=517155e2d4f186261b1451ff4556a621</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00307%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DJ.%2BD.%26aulast%3DLi%26aufirst%3DS.%2BW.%26aulast%3DBrunskill%26aufirst%3DA.%2BP.%2BJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DForman%26aufirst%3DM.%26aulast%3DGilbert%26aufirst%3DE.%2BJ.%26aulast%3DHodgson%26aufirst%3DR.%2BA.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DJiang%26aufirst%3DQ.%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DMei%26aufirst%3DH.%26aulast%3DMeredith%26aufirst%3DJ.%26aulast%3DMisiaszek%26aufirst%3DJ.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DRossiter%26aufirst%3DL.%2BM.%26aulast%3DSlater%26aufirst%3DM.%26aulast%3DStone%26aufirst%3DJ.%26aulast%3DStrickland%26aufirst%3DC.%2BO.%26aulast%3DVoigt%26aufirst%3DJ.%2BH.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DDiscovery%2520of%2520the%25203-imino-1%252C2%252C4-thiadiazinane%25201%252C1-dioxide%2520derivative%2520verubecestat%2520%2528MK-8931%2529%25E2%2580%2593A%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520inhibitor%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10435%26epage%3D10450%26doi%3D10.1021%2Facs.jmedchem.6b00307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamford, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dockendorf, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ereshefsky, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleijn, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuvelkar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattson, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palcza, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troyer, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stone, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forman, M. S.</span></span> <span> </span><span class="NLM_article-title">The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer’s disease patients</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">363ra150</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.aad9704</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1126%2Fscitranslmed.aad9704" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=27807285" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=363ra150&author=M.+E.+Kennedyauthor=A.+W.+Stamfordauthor=X.+Chenauthor=K.+Coxauthor=J.+N.+Cummingauthor=M.+F.+Dockendorfauthor=M.+Eganauthor=L.+Ereshefskyauthor=R.+A.+Hodgsonauthor=L.+A.+Hydeauthor=S.+Jheeauthor=H.+J.+Kleijnauthor=R.+Kuvelkarauthor=W.+Liauthor=B.+A.+Mattsonauthor=H.+Meiauthor=J.+Palczaauthor=J.+D.+Scottauthor=M.+Tanenauthor=M.+D.+Troyerauthor=J.+L.+Tsengauthor=J.+A.+Stoneauthor=E.+M.+Parkerauthor=M.+S.+Forman&title=The+BACE1+inhibitor+verubecestat+%28MK-8931%29+reduces+CNS+%CE%B2-amyloid+in+animal+models+and+in+Alzheimer%E2%80%99s+disease+patients&doi=10.1126%2Fscitranslmed.aad9704"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aad9704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aad9704%26sid%3Dliteratum%253Aachs%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DDockendorf%26aufirst%3DM.%2BF.%26aulast%3DEgan%26aufirst%3DM.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DHodgson%26aufirst%3DR.%2BA.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DJhee%26aufirst%3DS.%26aulast%3DKleijn%26aufirst%3DH.%2BJ.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DMattson%26aufirst%3DB.%2BA.%26aulast%3DMei%26aufirst%3DH.%26aulast%3DPalcza%26aufirst%3DJ.%26aulast%3DScott%26aufirst%3DJ.%2BD.%26aulast%3DTanen%26aufirst%3DM.%26aulast%3DTroyer%26aufirst%3DM.%2BD.%26aulast%3DTseng%26aufirst%3DJ.%2BL.%26aulast%3DStone%26aufirst%3DJ.%2BA.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DForman%26aufirst%3DM.%2BS.%26atitle%3DThe%2520BACE1%2520inhibitor%2520verubecestat%2520%2528MK-8931%2529%2520reduces%2520CNS%2520%25CE%25B2-amyloid%2520in%2520animal%2520models%2520and%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520patients%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2016%26volume%3D8%26spage%3D363ra150%26doi%3D10.1126%2Fscitranslmed.aad9704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit10c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. N.</span>; <span class="NLM_string-name">Scott, J. D.</span>; <span class="NLM_string-name">Strickland, C. O.</span></span> <span> </span><span class="NLM_article-title">Verubecestat</span>. In  <i>Comprehensive Medicinal Chemistry III</i>, <span class="NLM_edition">3</span>rd ed.; <span class="NLM_contrib-group"><span class="NLM_string-name">Chackalamannil, S.</span>, <span class="NLM_string-name">Rotella, D. P.</span>, <span class="NLM_string-name">Ward, S. E.</span></span>, Eds.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">Oxford</span>, <span class="NLM_year">2017</span>; Vol.  <span class="NLM_volume">8</span>, pp  <span class="NLM_fpage">204</span>– <span class="NLM_lpage">251</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=204-251&author=J.+N.+Cumming&author=J.+D.+Scott&author=C.+O.+Stricklandauthor=S.+Chackalamannil&author=D.+P.+Rotella&author=S.+E.+Ward&title=Comprehensive+Medicinal+Chemistry+III"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26atitle%3DVerubecestat%26btitle%3DComprehensive%2520Medicinal%2520Chemistry%2520III%26aulast%3DChackalamannil%26aufirst%3DS.%26pub%3DElsevier%26date%3D2017%26volume%3D8%26spage%3D204%26epage%3D251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kost, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tariot, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aisen, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vellas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sur, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voss, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furtek, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahoney, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mozley, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenberghe, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michelson, D.</span></span> <span> </span><span class="NLM_article-title">Randomized trial of verubecestat for mild-to-moderate Alzheimer’s disease</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>378</i></span>,  <span class="NLM_fpage">1691</span>– <span class="NLM_lpage">1703</span>, <span class="refDoi"> DOI: 10.1056/nejmoa1706441</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1056%2Fnejmoa1706441" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=29719179" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpsFyqsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=378&publication_year=2018&pages=1691-1703&author=M.+F.+Eganauthor=J.+Kostauthor=P.+N.+Tariotauthor=P.+S.+Aisenauthor=J.+L.+Cummingsauthor=B.+Vellasauthor=C.+Surauthor=Y.+Mukaiauthor=T.+Vossauthor=C.+Furtekauthor=E.+Mahoneyauthor=L.+L.+Mozleyauthor=R.+Vandenbergheauthor=Y.+Moauthor=D.+Michelson&title=Randomized+trial+of+verubecestat+for+mild-to-moderate+Alzheimer%E2%80%99s+disease&doi=10.1056%2Fnejmoa1706441"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10dR"><div class="casContent"><span class="casTitleNuber">10d</span><div class="casTitle"><span class="NLM_cas:atitle">Randomized trial of verubecestat for mild-to-moderate Alzheimer's disease</span></div><div class="casAuthors">Egan, Michael F.; Kost, James; Tariot, Pierre N.; Aisen, Paul S.; Cummings, Jeffrey L.; Vellas, Bruno; Sur, Cyrille; Mukai, Yuki; Voss, Tiffini; Furtek, Christine; Mahoney, Erin; Mozley, Lyn Harper; Vandenberghe, Rik; Mo, Yi; Michelson, David</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">378</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1691-1703</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Alzheimer's disease is characterized by the deposition of amyloid-beta (Aβ) plaques in the brain.  Aβ is produced from the sequential cleavage of amyloid precursor protein by β-site amyloid precursor protein-cleaving enzyme 1 (BACE-1) followed by γ-secretase.  Verubecestat is an oral BACE-1 inhibitor that reduces the Aβ level in the cerebrospinal fluid of patients with Alzheimer's disease.  Methods: We conducted a randomized, double-blind, placebo-controlled, 78-wk trial to evaluate verubecestat at doses of 12 mg and 40 mg per day, as compared with placebo, in patients who had a clin. diagnosis of mild-to-moderate Alzheimer's disease.  The coprimary outcomes were the change from baseline to week 78 in the score on the cognitive subscale of the Alzheimer's disease Assessment Scale (ADAS-cog; scores range from 0 to 70, with higher scores indicating worse dementia) and in the score on the Alzheimer's Disease Cooperative Study Activities of Daily Living Inventory scale (ADCS-ADL; scores range from 0 to 78, with lower scores indicating worse function).  Results: A total of 1958 patients underwent randomization; 653 were randomly assigned to receive verubecestat at a dose of 12 mg per day (the 12-mg group), 652 to receive verubecestat at a dose of 40 mg per day (the 40-mg group), and 653 to receive matching placebo.  The trial was terminated early for futility 50 mo after onset, which was within 5 mo before its scheduled completion, and after enrollment of the planned 1958 patients was complete.  The estd. mean change from baseline to week 78 in the ADAS-cog score was 7.9 in the 12-mg group, 8.0 in the 40-mg group, and 7.7 in the placebo group (P = 0.63 for the comparison between the 12-mg group and the placebo group and P = 0.46 for the comparison between the 40-mg group and the placebo group).  The estd. mean change from baseline to week 78 in the ADCS-ADL score was -8.4 in the 12-mg group, -8.2 in the 40-mg group, and -8.9 in the placebo group (P = 0.49 for the comparison between the 12-mg group and the placebo group and P = 0.32 for the comparison between the 40-mg group and the placebo group).  Adverse events, including rash, falls and injuries, sleep disturbance, suicidal ideation, wt. loss, and hair-color change, were more common in the verubecestat groups than in the placebo group. conclusions Verubecestat did not reduce cognitive or functional decline in patients with mild-to-moderate Alzheimer's disease and was assocd. with treatment-related adverse events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroW5Tf-VIj2LVg90H21EOLACvtfcHk0lhn91GQZrtRpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpsFyqsbs%253D&md5=e6ecfbd2981616b343468ae8bed1db2d</span></div><a href="/servlet/linkout?suffix=cit10d&amp;dbid=16384&amp;doi=10.1056%2Fnejmoa1706441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252Fnejmoa1706441%26sid%3Dliteratum%253Aachs%26aulast%3DEgan%26aufirst%3DM.%2BF.%26aulast%3DKost%26aufirst%3DJ.%26aulast%3DTariot%26aufirst%3DP.%2BN.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DCummings%26aufirst%3DJ.%2BL.%26aulast%3DVellas%26aufirst%3DB.%26aulast%3DSur%26aufirst%3DC.%26aulast%3DMukai%26aufirst%3DY.%26aulast%3DVoss%26aufirst%3DT.%26aulast%3DFurtek%26aufirst%3DC.%26aulast%3DMahoney%26aufirst%3DE.%26aulast%3DMozley%26aufirst%3DL.%2BL.%26aulast%3DVandenberghe%26aufirst%3DR.%26aulast%3DMo%26aufirst%3DY.%26aulast%3DMichelson%26aufirst%3DD.%26atitle%3DRandomized%2520trial%2520of%2520verubecestat%2520for%2520mild-to-moderate%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2018%26volume%3D378%26spage%3D1691%26epage%3D1703%26doi%3D10.1056%2Fnejmoa1706441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span><span> </span><span class="NLM_article-title">Alzforum</span>. <a href="http://www.alzforum.org/therapeutics/elenbecestat" class="extLink">http://www.alzforum.org/therapeutics/elenbecestat</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Alzforum.+http%3A%2F%2Fwww.alzforum.org%2Ftherapeutics%2Felenbecestat+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DAlzforum%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, Y.</span>; <span class="NLM_string-name">Motoki, T.</span>; <span class="NLM_string-name">Kaneko, T.</span>; <span class="NLM_string-name">Takaishi, M.</span>; <span class="NLM_string-name">Ishida, T.</span>; <span class="NLM_string-name">Takeda, K.</span>; <span class="NLM_string-name">Kita, Y.</span>; <span class="NLM_string-name">Yamamoto, N.</span>; <span class="NLM_string-name">Khan, A.</span>; <span class="NLM_string-name">Dimopoulos, P.</span></span> <span> </span><span class="NLM_article-title">Preparation of Condensed Aminodihydrothiazine Derivatives as Inhibitors of β-Site APP-cleaving Enzyme 1 (BACE1)</span>. <span class="NLM_patent">WO 2009091016 A1</span>, July 23, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=Y.+Suzuki&author=T.+Motoki&author=T.+Kaneko&author=M.+Takaishi&author=T.+Ishida&author=K.+Takeda&author=Y.+Kita&author=N.+Yamamoto&author=A.+Khan&author=P.+Dimopoulos&title=Preparation+of+Condensed+Aminodihydrothiazine+Derivatives+as+Inhibitors+of+%CE%B2-Site+APP-cleaving+Enzyme+1+%28BACE1%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DY.%26atitle%3DPreparation%2520of%2520Condensed%2520Aminodihydrothiazine%2520Derivatives%2520as%2520Inhibitors%2520of%2520%25CE%25B2-Site%2520APP-cleaving%2520Enzyme%25201%2520%2528BACE1%2529%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Eketjaell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaspersson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogstedt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeppsson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faelting, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haeberlein, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kugler, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cebers, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, P.</span></span> <span> </span><span class="NLM_article-title">AZD3293: A novel, orally active BACE1 inhibitor with high potency and permeability and markedly slow off-rate kinetics</span>. <i>J. Alzheimers Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">1109</span>– <span class="NLM_lpage">1123</span>, <span class="refDoi"> DOI: 10.3233/jad-150834</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.3233%2Fjad-150834" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=26890753" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2016&pages=1109-1123&author=S.+Eketjaellauthor=J.+Jansonauthor=K.+Kasperssonauthor=A.+Bogstedtauthor=F.+Jeppssonauthor=J.+Faeltingauthor=S.+B.+Haeberleinauthor=A.+R.+Kuglerauthor=R.+C.+Alexanderauthor=G.+Cebersauthor=P.+Ho&title=AZD3293%3A+A+novel%2C+orally+active+BACE1+inhibitor+with+high+potency+and+permeability+and+markedly+slow+off-rate+kinetics&doi=10.3233%2Fjad-150834"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.3233%2Fjad-150834&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252Fjad-150834%26sid%3Dliteratum%253Aachs%26aulast%3DEketjaell%26aufirst%3DS.%26aulast%3DJanson%26aufirst%3DJ.%26aulast%3DKaspersson%26aufirst%3DK.%26aulast%3DBogstedt%26aufirst%3DA.%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DFaelting%26aufirst%3DJ.%26aulast%3DHaeberlein%26aufirst%3DS.%2BB.%26aulast%3DKugler%26aufirst%3DA.%2BR.%26aulast%3DAlexander%26aufirst%3DR.%2BC.%26aulast%3DCebers%26aufirst%3DG.%26aulast%3DHo%26aufirst%3DP.%26atitle%3DAZD3293%253A%2520A%2520novel%252C%2520orally%2520active%2520BACE1%2520inhibitor%2520with%2520high%2520potency%2520and%2520permeability%2520and%2520markedly%2520slow%2520off-rate%2520kinetics%26jtitle%3DJ.%2520Alzheimers%2520Dis.%26date%3D2016%26volume%3D50%26spage%3D1109%26epage%3D1123%26doi%3D10.3233%2Fjad-150834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span> </span><span class="NLM_article-title">Alzforum</span>. <a href="https://www.alzforum.org/therapeutics/azd3293" class="extLink">https://www.alzforum.org/therapeutics/azd3293</a> (accessed December 23, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Alzforum.+https%3A%2F%2Fwww.alzforum.org%2Ftherapeutics%2Fazd3293+%28accessed+December+23%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DAlzforum%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ufer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouzade-Dominguez, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huledal, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolly, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lüönd, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machauer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veenstra, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurth, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rueeger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tintelnot-Blomley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staufenbiel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimshek, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrot, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frieauff, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubost, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiller, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avrameas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kretz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pezous, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rondeau, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beckmann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vormfelde, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galli, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez Lopez, C.</span></span> <span> </span><span class="NLM_article-title">The BACE-1 inhibitor CNP520 for prevention trials in Alzheimer’s disease</span>. <i>EMBO Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">e9316</span> <span class="refDoi"> DOI: 10.15252/emmm.201809316</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.15252%2Femmm.201809316" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=30224383" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&author=U.+Neumannauthor=M.+Uferauthor=L.+H.+Jacobsonauthor=M.+L.+Rouzade-Dominguezauthor=G.+Huledalauthor=C.+Kollyauthor=R.+M.+L%C3%BC%C3%B6ndauthor=R.+Machauerauthor=S.+J.+Veenstraauthor=K.+Hurthauthor=H.+Rueegerauthor=M.+Tintelnot-Blomleyauthor=M.+Staufenbielauthor=D.+R.+Shimshekauthor=L.+Perrotauthor=W.+Frieauffauthor=V.+Dubostauthor=H.+Schillerauthor=B.+Voggauthor=K.+Beltzauthor=A.+Avrameasauthor=S.+Kretzauthor=N.+Pezousauthor=J.+M.+Rondeauauthor=N.+Beckmannauthor=A.+Hartmannauthor=S.+Vormfeldeauthor=O.+J.+Davidauthor=B.+Galliauthor=R.+Ramosauthor=A.+Grafauthor=C.+Lopez+Lopez&title=The+BACE-1+inhibitor+CNP520+for+prevention+trials+in+Alzheimer%E2%80%99s+disease&doi=10.15252%2Femmm.201809316"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.15252%2Femmm.201809316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15252%252Femmm.201809316%26sid%3Dliteratum%253Aachs%26aulast%3DNeumann%26aufirst%3DU.%26aulast%3DUfer%26aufirst%3DM.%26aulast%3DJacobson%26aufirst%3DL.%2BH.%26aulast%3DRouzade-Dominguez%26aufirst%3DM.%2BL.%26aulast%3DHuledal%26aufirst%3DG.%26aulast%3DKolly%26aufirst%3DC.%26aulast%3DL%25C3%25BC%25C3%25B6nd%26aufirst%3DR.%2BM.%26aulast%3DMachauer%26aufirst%3DR.%26aulast%3DVeenstra%26aufirst%3DS.%2BJ.%26aulast%3DHurth%26aufirst%3DK.%26aulast%3DRueeger%26aufirst%3DH.%26aulast%3DTintelnot-Blomley%26aufirst%3DM.%26aulast%3DStaufenbiel%26aufirst%3DM.%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26aulast%3DPerrot%26aufirst%3DL.%26aulast%3DFrieauff%26aufirst%3DW.%26aulast%3DDubost%26aufirst%3DV.%26aulast%3DSchiller%26aufirst%3DH.%26aulast%3DVogg%26aufirst%3DB.%26aulast%3DBeltz%26aufirst%3DK.%26aulast%3DAvrameas%26aufirst%3DA.%26aulast%3DKretz%26aufirst%3DS.%26aulast%3DPezous%26aufirst%3DN.%26aulast%3DRondeau%26aufirst%3DJ.%2BM.%26aulast%3DBeckmann%26aufirst%3DN.%26aulast%3DHartmann%26aufirst%3DA.%26aulast%3DVormfelde%26aufirst%3DS.%26aulast%3DDavid%26aufirst%3DO.%2BJ.%26aulast%3DGalli%26aufirst%3DB.%26aulast%3DRamos%26aufirst%3DR.%26aulast%3DGraf%26aufirst%3DA.%26aulast%3DLopez%2BLopez%26aufirst%3DC.%26atitle%3DThe%2520BACE-1%2520inhibitor%2520CNP520%2520for%2520prevention%2520trials%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2018%26volume%3D10%26doi%3D10.15252%2Femmm.201809316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Timmers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Broeck, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramael, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slemmon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Waepenaert, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stieltjes, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelborghs, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moechars, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercken, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinha, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemp, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Nueten, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tritsmans, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Streffer, J. R.</span></span> <span> </span><span class="NLM_article-title">Profiling the dynamics of CSF and plasma Aβ reduction after treatment with JNJ-54861911, a potent oral BACE inhibitor</span>. <i>Alzheimer’s Dementia Transl. Res. Clin. Interv.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">201</span>– <span class="NLM_lpage">212</span>, <span class="refDoi"> DOI: 10.1016/j.trci.2016.08.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1016%2Fj.trci.2016.08.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2016&pages=201-212&author=M.+Timmersauthor=B.+Van+Broeckauthor=S.+Ramaelauthor=J.+Slemmonauthor=K.+De+Waepenaertauthor=A.+Russuauthor=J.+Bogertauthor=H.+Stieltjesauthor=L.+M.+Shawauthor=S.+Engelborghsauthor=D.+Moecharsauthor=M.+Merckenauthor=E.+Liuauthor=V.+Sinhaauthor=J.+Kempauthor=L.+Van+Nuetenauthor=L.+Tritsmansauthor=J.+R.+Streffer&title=Profiling+the+dynamics+of+CSF+and+plasma+A%CE%B2+reduction+after+treatment+with+JNJ-54861911%2C+a+potent+oral+BACE+inhibitor&doi=10.1016%2Fj.trci.2016.08.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1016%2Fj.trci.2016.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.trci.2016.08.001%26sid%3Dliteratum%253Aachs%26aulast%3DTimmers%26aufirst%3DM.%26aulast%3DVan%2BBroeck%26aufirst%3DB.%26aulast%3DRamael%26aufirst%3DS.%26aulast%3DSlemmon%26aufirst%3DJ.%26aulast%3DDe%2BWaepenaert%26aufirst%3DK.%26aulast%3DRussu%26aufirst%3DA.%26aulast%3DBogert%26aufirst%3DJ.%26aulast%3DStieltjes%26aufirst%3DH.%26aulast%3DShaw%26aufirst%3DL.%2BM.%26aulast%3DEngelborghs%26aufirst%3DS.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DE.%26aulast%3DSinha%26aufirst%3DV.%26aulast%3DKemp%26aufirst%3DJ.%26aulast%3DVan%2BNueten%26aufirst%3DL.%26aulast%3DTritsmans%26aufirst%3DL.%26aulast%3DStreffer%26aufirst%3DJ.%2BR.%26atitle%3DProfiling%2520the%2520dynamics%2520of%2520CSF%2520and%2520plasma%2520A%25CE%25B2%2520reduction%2520after%2520treatment%2520with%2520JNJ-54861911%252C%2520a%2520potent%2520oral%2520BACE%2520inhibitor%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%2520Transl.%2520Res.%2520Clin.%2520Interv.%26date%3D2016%26volume%3D2%26spage%3D201%26epage%3D212%26doi%3D10.1016%2Fj.trci.2016.08.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">The
Janssen Pharmaceutical Campanies of Johnson & Johnson</span>. <a href="https://www.janssen.com/ja/node/45771" class="extLink">https://www.janssen.com/ja/node/45771</a> (accessed Dec 23, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The%0AJanssen+Pharmaceutical+Campanies+of+Johnson+%26+Johnson.+https%3A%2F%2Fwww.janssen.com%2Fja%2Fnode%2F45771+%28accessed+Dec+23%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bateman, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benzinger, T. L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fagan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goate, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcus, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cairns, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blazey, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holtzman, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santacruz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckles, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliver, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moulder, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aisen, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghetti, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klunk, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDade, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martins, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masters, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayeux, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ringman, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossor, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperling, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salloway, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J. C.</span></span> <span> </span><span class="NLM_article-title">Clinical and biomarker changes in dominantly inherited Alzheimer’s disease</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>367</i></span>,  <span class="NLM_fpage">795</span>– <span class="NLM_lpage">804</span>, <span class="refDoi"> DOI: 10.1056/nejmoa1202753</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1056%2Fnejmoa1202753" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=22784036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGktL7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=2012&pages=795-804&author=R.+J.+Batemanauthor=C.+Xiongauthor=T.+L.+S.+Benzingerauthor=A.+M.+Faganauthor=A.+Goateauthor=N.+C.+Foxauthor=D.+S.+Marcusauthor=N.+J.+Cairnsauthor=X.+Xieauthor=T.+M.+Blazeyauthor=D.+M.+Holtzmanauthor=A.+Santacruzauthor=V.+Bucklesauthor=A.+Oliverauthor=K.+Moulderauthor=P.+S.+Aisenauthor=B.+Ghettiauthor=W.+E.+Klunkauthor=E.+McDadeauthor=R.+N.+Martinsauthor=C.+L.+Mastersauthor=R.+Mayeuxauthor=J.+M.+Ringmanauthor=M.+N.+Rossorauthor=P.+R.+Schofieldauthor=R.+A.+Sperlingauthor=S.+Sallowayauthor=J.+C.+Morris&title=Clinical+and+biomarker+changes+in+dominantly+inherited+Alzheimer%E2%80%99s+disease&doi=10.1056%2Fnejmoa1202753"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical and biomarker changes in dominantly inherited Alzheimer's disease</span></div><div class="casAuthors">Bateman, Randall J.; Xiong, Chengjie; Benzinger, Tammie L. S.; Fagan, Anne M.; Goate, Alison; Fox, Nick C.; Marcus, Daniel S.; Cairns, Nigel J.; Xie, Xianyun; Blazey, Tyler M.; Holtzman, David M.; Santacruz, Anna; Buckles, Virginia; Oliver, Angela; Moulder, Krista; Aisen, Paul S.; Ghetti, Bernardino; Klunk, William E.; McDade, Eric; Martins, Ralph N.; Masters, Colin L.; Mayeux, Richard; Ringman, John M.; Rossor, Martin N.; Schofield, Peter R.; Sperling, Reisa A.; Salloway, Stephen; Morris, John C.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">367</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">795-804</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: The order and magnitude of pathol. processes in Alzheimer's disease are not well understood, partly because the disease develops over many years.  Autosomal dominant Alzheimer's disease has a predictable age at onset and provides an opportunity to det. the sequence and magnitude of pathol. changes that culminate in symptomatic disease.  METHODS: In this prospective, longitudinal study, we analyzed data from 128 participants who underwent baseline clin. and cognitive assessments, brain imaging, and cerebrospinal fluid (CSF) and blood tests.  We used the participant's age at baseline assessment and the parent's age at the onset of symptoms of Alzheimer's disease to calc. the estd. years from expected symptom onset (age of the participant minus parent's age at symptom onset).  We conducted cross-sectional analyses of baseline data in relation to estd. years from expected symptom onset in order to det. the relative order and magnitude of pathophysiol. changes.  RESULTS: Concns. of amyloid-beta (Aβ)42 in the CSF appeared to decline 25 years before expected symptom onset.  Aβ deposition, as measured by positron-emission tomog. with the use of Pittsburgh compd. B, was detected 15 years before expected symptom onset.  Increased concns. of tau protein in the CSF and an increase in brain atrophy were detected 15 years before expected symptom onset.  Cerebral hypometabolism and impaired episodic memory were obsd. 10 years before expected symptom onset.  Global cognitive impairment, as measured by the Mini-Mental State Examn. and the Clin. Dementia Rating scale, was detected 5 years before expected symptom onset, and patients met diagnostic criteria for dementia at an av. of 3 years after expected symptom onset.  CONCLUSIONS: We found that autosomal dominant Alzheimer's disease was assocd. with a series of pathophysiol. changes over decades in CSF biochem. markers of Alzheimer's disease, brain amyloid deposition, and brain metab. as well as progressive cognitive impairment.  Our results require confirmation with the use of longitudinal data and may not apply to patients with sporadic Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptJNV9eDXBCLVg90H21EOLACvtfcHk0lgeQCbR609nZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGktL7J&md5=c4f999ea3401af9651a2770724757bed</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1056%2Fnejmoa1202753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252Fnejmoa1202753%26sid%3Dliteratum%253Aachs%26aulast%3DBateman%26aufirst%3DR.%2BJ.%26aulast%3DXiong%26aufirst%3DC.%26aulast%3DBenzinger%26aufirst%3DT.%2BL.%2BS.%26aulast%3DFagan%26aufirst%3DA.%2BM.%26aulast%3DGoate%26aufirst%3DA.%26aulast%3DFox%26aufirst%3DN.%2BC.%26aulast%3DMarcus%26aufirst%3DD.%2BS.%26aulast%3DCairns%26aufirst%3DN.%2BJ.%26aulast%3DXie%26aufirst%3DX.%26aulast%3DBlazey%26aufirst%3DT.%2BM.%26aulast%3DHoltzman%26aufirst%3DD.%2BM.%26aulast%3DSantacruz%26aufirst%3DA.%26aulast%3DBuckles%26aufirst%3DV.%26aulast%3DOliver%26aufirst%3DA.%26aulast%3DMoulder%26aufirst%3DK.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DGhetti%26aufirst%3DB.%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26aulast%3DMcDade%26aufirst%3DE.%26aulast%3DMartins%26aufirst%3DR.%2BN.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DMayeux%26aufirst%3DR.%26aulast%3DRingman%26aufirst%3DJ.%2BM.%26aulast%3DRossor%26aufirst%3DM.%2BN.%26aulast%3DSchofield%26aufirst%3DP.%2BR.%26aulast%3DSperling%26aufirst%3DR.%2BA.%26aulast%3DSalloway%26aufirst%3DS.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26atitle%3DClinical%2520and%2520biomarker%2520changes%2520in%2520dominantly%2520inherited%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2012%26volume%3D367%26spage%3D795%26epage%3D804%26doi%3D10.1056%2Fnejmoa1202753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Villemagne, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burnham, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourgeat, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvado, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szoeke, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macaulay, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martins, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruff, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ames, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowe, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masters, C. L.</span></span> <span> </span><span class="NLM_article-title">Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer’s disease: a prospective cohort study</span>. <i>Lancet Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">357</span>– <span class="NLM_lpage">367</span>, <span class="refDoi"> DOI: 10.1016/s1474-4422(13)70044-</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1016%2Fs1474-4422%2813%2970044-" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=23477989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC3sXksFejsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=357-367&author=V.+L.+Villemagneauthor=S.+Burnhamauthor=P.+Bourgeatauthor=B.+Brownauthor=K.+A.+Ellisauthor=O.+Salvadoauthor=C.+Szoekeauthor=S.+L.+Macaulayauthor=R.+Martinsauthor=P.+Maruffauthor=D.+Amesauthor=C.+C.+Roweauthor=C.+L.+Masters&title=Amyloid+%CE%B2+deposition%2C+neurodegeneration%2C+and+cognitive+decline+in+sporadic+Alzheimer%E2%80%99s+disease%3A+a+prospective+cohort+study&doi=10.1016%2Fs1474-4422%2813%2970044-"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study</span></div><div class="casAuthors">Villemagne, Victor L.; Burnham, Samantha; Bourgeat, Pierrick; Brown, Belinda; Ellis, Kathryn A.; Salvado, Olivier; Szoeke, Cassandra; Macaulay, S. Lance; Martins, Ralph; Maruff, Paul; Ames, David; Rowe, Christopher C.; Masters, Colin L.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">357-367</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Similar to most chronic diseases, Alzheimer's disease (AD) develops slowly from a preclin. phase into a fully expressed clin. syndrome.  We aimed to use longitudinal data to calc. the rates of amyloid β (Aβ) deposition, cerebral atrophy, and cognitive decline.  In this prospective cohort study, healthy controls, patients with mild cognitive impairment (MCI), and patients with AD were assessed at enrolment and every 18 mo.  At every visit, participants underwent neuropsychol. examn., MRI, and a carbon-11-labeled Pittsburgh compd. B (11C-PiB) PET scan.  We included participants with three or more 11C-PiB PET follow-up assessments.  Aβ burden was expressed as 11C-PiB standardised uptake value ratio (SUVR) with the cerebellar cortex as ref. region.  An SUVR of 1·5 was used to discriminate high from low Aβ burdens.  The slope of the regression plots over 3-5 years was used to est. rates of change for Aβ deposition, MRI volumetrics, and cognition.  We included those participants with a pos. rate of Aβ deposition to calc. the trajectory of each variable over time.200 participants (145 healthy controls, 36 participants with MCI, and 19 participants with AD) were assessed at enrolment and every 18 mo for a mean follow-up of 3·8 (95% CI CI 3·6-3·9) years.  At baseline, significantly higher Aβ burdens were noted in patients with AD (2·27, SD 0·43) and those with MCI (1·94, 0·64) than in healthy controls (1·38, 0·39).  At follow-up, 163 (82%) of the 200 participants showed pos. rates of Aβ accumulation.  Aβ deposition was estd. to take 19·2 (95% CI 16·8-22·5) years in an almost linear fashion-with a mean increase of 0·043 (95% CI 0·037-0·049) SUVR per yr-to go from the threshold of 11C-PiB positivity (1·5 SUVR) to the levels obsd. in AD.  It was estd. to take 12·0 (95% CI 10·1-14·9) years from the levels obsd. in healthy controls with low Aβ deposition (1·2 [SD 0·1] SUVR) to the threshold of 11C-PiB positivity.  As AD progressed, the rate of Aβ deposition slowed towards a plateau.  Our projections suggest a prolonged preclin. phase of AD in which Aβ deposition reaches our threshold of positivity at 17·0 (95% CI 14·9-19·9) years, hippocampal atrophy at 4·2 (3·6-5·1) years, and memory impairment at 3·3 (2·5-4·5) years before the onset of dementia (clin. dementia rating score 1).  Aβ deposition is slow and protracted, likely to extend for more than two decades.  Such predictions of the rate of preclin. changes and the onset of the clin. phase of AD will facilitate the design and timing of therapeutic interventions aimed at modifying the course of this illness.  Science and Industry Endowment Fund (Australia), The Commonwealth Scientific and Industrial Research Organization (Australia), The National Health and Medical Research Council of Australia Program and Project Grants, the Austin Hospital Medical Research Foundation, Victorian State Government, The Alzheimer's Drug Discovery Foundation, and the Alzheimer's Assocn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoH2O2TjFkaAbVg90H21EOLACvtfcHk0lgeQCbR609nZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXksFejsrw%253D&md5=2e325131e69aea18b4f6a7cc756bcc55</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fs1474-4422%2813%2970044-&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs1474-4422%252813%252970044-%26sid%3Dliteratum%253Aachs%26aulast%3DVillemagne%26aufirst%3DV.%2BL.%26aulast%3DBurnham%26aufirst%3DS.%26aulast%3DBourgeat%26aufirst%3DP.%26aulast%3DBrown%26aufirst%3DB.%26aulast%3DEllis%26aufirst%3DK.%2BA.%26aulast%3DSalvado%26aufirst%3DO.%26aulast%3DSzoeke%26aufirst%3DC.%26aulast%3DMacaulay%26aufirst%3DS.%2BL.%26aulast%3DMartins%26aufirst%3DR.%26aulast%3DMaruff%26aufirst%3DP.%26aulast%3DAmes%26aufirst%3DD.%26aulast%3DRowe%26aufirst%3DC.%2BC.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26atitle%3DAmyloid%2520%25CE%25B2%2520deposition%252C%2520neurodegeneration%252C%2520and%2520cognitive%2520decline%2520in%2520sporadic%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520prospective%2520cohort%2520study%26jtitle%3DLancet%2520Neurol.%26date%3D2013%26volume%3D12%26spage%3D357%26epage%3D367%26doi%3D10.1016%2Fs1474-4422%2813%2970044-" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Salloway, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperling, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blennow, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klunk, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raskind, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabbagh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honig, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porsteinsson, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferris, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ketter, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nejadnik, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guenzler, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miloslavsky, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lull, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tudor, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grundman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brashear, H. R.</span></span> <span> </span><span class="NLM_article-title">Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer’s disease</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>370</i></span>,  <span class="NLM_fpage">322</span>– <span class="NLM_lpage">333</span>, <span class="refDoi"> DOI: 10.1056/nejmoa1304839</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1056%2Fnejmoa1304839" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=24450891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Ggt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=370&publication_year=2014&pages=322-333&author=S.+Sallowayauthor=R.+Sperlingauthor=N.+C.+Foxauthor=K.+Blennowauthor=W.+Klunkauthor=M.+Raskindauthor=M.+Sabbaghauthor=L.+S.+Honigauthor=A.+P.+Porsteinssonauthor=S.+Ferrisauthor=M.+Reichertauthor=N.+Ketterauthor=B.+Nejadnikauthor=V.+Guenzlerauthor=M.+Miloslavskyauthor=D.+Wangauthor=Y.+Luauthor=J.+Lullauthor=I.+C.+Tudorauthor=E.+Liuauthor=M.+Grundmanauthor=E.+Yuenauthor=R.+Blackauthor=H.+R.+Brashear&title=Two+phase+3+trials+of+bapineuzumab+in+mild-to-moderate+Alzheimer%E2%80%99s+disease&doi=10.1056%2Fnejmoa1304839"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17aR"><div class="casContent"><span class="casTitleNuber">17a</span><div class="casTitle"><span class="NLM_cas:atitle">Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease</span></div><div class="casAuthors">Salloway, Stephen; Sperling, Reisa; Fox, Nick C.; Blennow, Kaj; Klunk, William; Raskind, Murray; Sabbagh, Marwan; Honig, Lawrence S.; Porsteinsson, Anton P.; Ferris, Steven; Reichert, Marcel; Ketter, Nzeera; Nejadnik, Bijan; Guenzler, Volkmar; Miloslavsky, Maja; Wang, Daniel; Lu, Yuan; Lull, Julia; Tudor, Iulia Cristina; Liu, Enchi; Grundman, Michael; Yuen, Eric; Black, Ronald; Brashear, H. Robert</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">370</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">322-333</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Bapineuzumab, a humanized anti-amyloid-beta monoclonal antibody, is in clin. development for the treatment of Alzheimer's disease.  METHODS: We conducted two double-blind, randomized, placebo-controlled, phase 3 trials involving patients with mild-to-moderate Alzheimer's disease - one involving 1121 carriers of the apolipoprotein E (APOE) ε4 allele and the other involving 1331 noncarriers.  Bapineuzumab or placebo, with doses varying by study, was administered by i.v. infusion every 13 wk for 78 wk.  The primary outcome measures were scores on the 11-item cognitive subscale of the Alzheimer's Disease Assessment Scale (ADAS-cog11, with scores ranging from 0 to 70 and higher scores indicating greater impairment) and the Disability Assessment for Dementia (DAD, with scores ranging from 0 to 100 and higher scores indicating less impairment).  A total of 1090 carriers and 1114 noncarriers were included in the efficacy anal.  Secondary outcome measures included findings on positron-emission tomog. amyloid imaging with the use of Pittsburgh compd. B (PIB-PET) and cerebrospinal fluid phosphorylated tau (phospho-tau) concns.  RESULTS: There were no significant between-group differences in the primary outcomes.  At week 78, the between-group differences in the change from baseline in the ADAS-cog11 and DAD scores (bapineuzumab group minus placebo group) were -0.2 (P = 0.80) and -1.2 (P = 0.34), resp., in the carrier study; the corresponding differences in the noncarrier study were -0.3 (P = 0.64) and 2.8 (P = 0.07) with the 0.5-mg-per-kilogram dose of bapineuzumab and 0.4 (P = 0.62) and 0.9 (P = 0.55) with the 1.0-mg-per-kilogram dose.  The major safety finding was amyloid-related imaging abnormalities with edema among patients receiving bapineuzumab, which increased with bapineuzumab dose and APOE ε4 allele no. and which led to discontinuation of the 2.0-mg-per-kilogram dose.  Between-group differences were obsd. with respect to PIB-PET and cerebrospinal fluid phospho-tau concns. in APOE ε4 allele carriers but not in noncarriers.  CONCLUSIONS: Bapineuzumab did not improve clin. outcomes in patients with Alzheimer's disease, despite treatment differences in biomarkers obsd. in APOE ε4 carriers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEl0PP_aoc9LVg90H21EOLACvtfcHk0liuqhCx1IBQTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Ggt7o%253D&md5=932fe885aa8d2426379c786620bbd766</span></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1056%2Fnejmoa1304839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252Fnejmoa1304839%26sid%3Dliteratum%253Aachs%26aulast%3DSalloway%26aufirst%3DS.%26aulast%3DSperling%26aufirst%3DR.%26aulast%3DFox%26aufirst%3DN.%2BC.%26aulast%3DBlennow%26aufirst%3DK.%26aulast%3DKlunk%26aufirst%3DW.%26aulast%3DRaskind%26aufirst%3DM.%26aulast%3DSabbagh%26aufirst%3DM.%26aulast%3DHonig%26aufirst%3DL.%2BS.%26aulast%3DPorsteinsson%26aufirst%3DA.%2BP.%26aulast%3DFerris%26aufirst%3DS.%26aulast%3DReichert%26aufirst%3DM.%26aulast%3DKetter%26aufirst%3DN.%26aulast%3DNejadnik%26aufirst%3DB.%26aulast%3DGuenzler%26aufirst%3DV.%26aulast%3DMiloslavsky%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DLull%26aufirst%3DJ.%26aulast%3DTudor%26aufirst%3DI.%2BC.%26aulast%3DLiu%26aufirst%3DE.%26aulast%3DGrundman%26aufirst%3DM.%26aulast%3DYuen%26aufirst%3DE.%26aulast%3DBlack%26aufirst%3DR.%26aulast%3DBrashear%26aufirst%3DH.%2BR.%26atitle%3DTwo%2520phase%25203%2520trials%2520of%2520bapineuzumab%2520in%2520mild-to-moderate%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2014%26volume%3D370%26spage%3D322%26epage%3D333%26doi%3D10.1056%2Fnejmoa1304839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit17b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Doody, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farlow, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwatsubo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vellas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joffe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieburtz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aisen, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siemers, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu-Seifert, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohs, R.</span></span> <span> </span><span class="NLM_article-title">Phase 3 trials of solanezumab for mild-to-moderate Alzheimer’s disease</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>370</i></span>,  <span class="NLM_fpage">311</span>– <span class="NLM_lpage">321</span>, <span class="refDoi"> DOI: 10.1056/nejmoa1312889</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1056%2Fnejmoa1312889" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=24450890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Ggt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=370&publication_year=2014&pages=311-321&author=R.+S.+Doodyauthor=R.+G.+Thomasauthor=M.+Farlowauthor=T.+Iwatsuboauthor=B.+Vellasauthor=S.+Joffeauthor=K.+Kieburtzauthor=R.+Ramanauthor=X.+Sunauthor=P.+S.+Aisenauthor=E.+Siemersauthor=H.+Liu-Seifertauthor=R.+Mohs&title=Phase+3+trials+of+solanezumab+for+mild-to-moderate+Alzheimer%E2%80%99s+disease&doi=10.1056%2Fnejmoa1312889"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17b</span><div class="casTitle"><span class="NLM_cas:atitle">Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease</span></div><div class="casAuthors">Doody, Rachelle S.; Thomas, Ronald G.; Farlow, Martin; Iwatsubo, Takeshi; Vellas, Bruno; Joffe, Steven; Kieburtz, Karl; Raman, Rema; Sun, Xiaoying; Aisen, Paul S.; Siemers, Eric; Liu-Seifert, Hong; Mohs, Richard</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">370</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">311-321</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Alzheimer's disease is characterized by amyloid-beta plaques, neurofibrillary tangles, gliosis, and neuronal loss.  Solanezumab, a humanized monoclonal antibody, preferentially binds sol. forms of amyloid and in preclin. studies promoted its clearance from the brain.  METHODS: In two phase 3, double-blind trials (EXPEDITION 1 and EXPEDITION 2), we randomly assigned 1012 and 1040 patients, resp., with mild-to-moderate Alzheimer's disease to receive placebo or solanezumab (administered i.v. at a dose of 400 mg) every 4 wk for 18 mo.  The primary outcomes were the changes from baseline to week 80 in scores on the 11-item cognitive subscale of the Alzheimer's Disease Assessment Scale (ADAS-cog11; range, 0 to 70, with higher scores indicating greater cognitive impairment) and the Alzheimer's Disease Cooperative Study-Activities of Daily Living scale (ADCS-ADL; range, 0 to 78, with lower scores indicating worse functioning).  After anal. of data from EXPEDITION 1, the primary outcome for EXPEDITION 2 was revised to the change in scores on the 14-item cognitive subscale of the Alzheimer's Disease Assessment Scale (ADAS-cog14; range, 0 to 90, with higher scores indicating greater impairment), in patients with mild Alzheimer's disease.  RESULTS: Neither study showed significant improvement in the primary outcomes.  The modeled difference between groups (solanezumab group minus placebo group) in the change from baseline was -0.8 points for the ADAS-cog11 score (95% confidence interval [CI], -2.1 to 0.5; P = 0.24) and -0.4 points for the ADCS-ADL score (95% CI, -2.3 to 1.4; P = 0.64) in EXPEDITION 1 and -1.3 points (95% CI, -2.5 to 0.3; P = 0.06) and 1.6 points (95% CI, -0.2 to 3.3; P = 0.08), resp., in EXPEDITION 2.  Between-group differences in the changes in the ADAS-cog14 score were -1.7 points in patients with mild Alzheimer's disease (95% CI, -3.5 to 0.1; P = 0.06) and -1.5 in patients with moderate Alzheimer's disease (95% CI, -4.1 to 1.1; P = 0.26).  In the combined safety data set, the incidence of amyloid-related imaging abnormalities with edema or hemorrhage was 0.9% with solanezumab and 0.4% with placebo for edema (P = 0.27) and 4.9% and 5.6%, resp., for hemorrhage (P = 0.49).  CONCLUSIONS: Solanezumab, a humanized monoclonal antibody that binds amyloid, failed to improve cognition or functional ability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3Ej7A_YXNwLVg90H21EOLACvtfcHk0liuqhCx1IBQTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Ggt70%253D&md5=c993836d4f7374cc78f155f9cedbc594</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1056%2Fnejmoa1312889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252Fnejmoa1312889%26sid%3Dliteratum%253Aachs%26aulast%3DDoody%26aufirst%3DR.%2BS.%26aulast%3DThomas%26aufirst%3DR.%2BG.%26aulast%3DFarlow%26aufirst%3DM.%26aulast%3DIwatsubo%26aufirst%3DT.%26aulast%3DVellas%26aufirst%3DB.%26aulast%3DJoffe%26aufirst%3DS.%26aulast%3DKieburtz%26aufirst%3DK.%26aulast%3DRaman%26aufirst%3DR.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DSiemers%26aufirst%3DE.%26aulast%3DLiu-Seifert%26aufirst%3DH.%26aulast%3DMohs%26aufirst%3DR.%26atitle%3DPhase%25203%2520trials%2520of%2520solanezumab%2520for%2520mild-to-moderate%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2014%26volume%3D370%26spage%3D311%26epage%3D321%26doi%3D10.1056%2Fnejmoa1312889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit17c"><span><span class="NLM_label">(c) </span><a href="https://www.alzforum.org/news/research-news/merck-pulls-plug-phase-23-bace-inhibitor-trial" class="extLink">https://www.alzforum.org/news/research-news/merck-pulls-plug-phase-23-bace-inhibitor-trial</a> (accessed Dec 23, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=https%3A%2F%2Fwww.alzforum.org%2Fnews%2Fresearch-news%2Fmerck-pulls-plug-phase-23-bace-inhibitor-trial+%28accessed+Dec+23%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sperling, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mormino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, K.</span></span> <span> </span><span class="NLM_article-title">The evolution of preclinical Alzheimer’s disease: implications for prevention trials</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">608</span>– <span class="NLM_lpage">622</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2014.10.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1016%2Fj.neuron.2014.10.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=25442939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvV2mtrfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2014&pages=608-622&author=R.+Sperlingauthor=E.+Morminoauthor=K.+Johnson&title=The+evolution+of+preclinical+Alzheimer%E2%80%99s+disease%3A+implications+for+prevention+trials&doi=10.1016%2Fj.neuron.2014.10.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18aR"><div class="casContent"><span class="casTitleNuber">18a</span><div class="casTitle"><span class="NLM_cas:atitle">The Evolution of Preclinical Alzheimer's Disease: Implications for Prevention Trials</span></div><div class="casAuthors">Sperling, Reisa; Mormino, Elizabeth; Johnson, Keith</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">608-622</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">As the field begins to test the concept of a "preclin." stage of neurodegenerative disease, when the pathophysiol. process has begun in the brain, but clin. symptoms are not yet manifest, a no. of intriguing questions have already arisen.  In particular, in preclin. Alzheimer's disease (AD), the temporal relationship of amyloid markers to markers of neurodegeneration and their relative utility in the prediction of cognitive decline among clin. normal older individuals remains to be fully elucidated.  Secondary prevention trials in AD have already begun in both genetic at-risk and amyloid at-risk cohorts, with several more trials in the planning stages, and should provide crit. answers about whether intervention at this very early stage of disease can truly bend the curve of clin. progression.  This review will highlight recent progress in cognitive, imaging, and biomarker outcomes in the field of preclin. AD, and the remaining gaps in knowledge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-LC1zcm6IDLVg90H21EOLACvtfcHk0liHGCi1klOLqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvV2mtrfL&md5=f73caaba195d2e18aeae9dde4151ac4d</span></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2014.10.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2014.10.038%26sid%3Dliteratum%253Aachs%26aulast%3DSperling%26aufirst%3DR.%26aulast%3DMormino%26aufirst%3DE.%26aulast%3DJohnson%26aufirst%3DK.%26atitle%3DThe%2520evolution%2520of%2520preclinical%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520implications%2520for%2520prevention%2520trials%26jtitle%3DNeuron%26date%3D2014%26volume%3D84%26spage%3D608%26epage%3D622%26doi%3D10.1016%2Fj.neuron.2014.10.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit18b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Jack, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knopman, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagust, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiner, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aisen, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vemuri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiste, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weigand, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesnick, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pankratz, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donohue, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trojanowski, J. Q.</span></span> <span> </span><span class="NLM_article-title">Tracking pathophysiological processes in Alzheimer’s disease: an updated hypothetical model of dynamic biomarkers</span>. <i>Lancet Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">207</span>– <span class="NLM_lpage">216</span>, <span class="refDoi"> DOI: 10.1016/s1474-4422(12)70291-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1016%2Fs1474-4422%2812%2970291-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=23332364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslCht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=207-216&author=C.+R.+Jackauthor=D.+S.+Knopmanauthor=W.+J.+Jagustauthor=R.+C.+Petersenauthor=M.+W.+Weinerauthor=P.+S.+Aisenauthor=L.+M.+Shawauthor=P.+Vemuriauthor=H.+J.+Wisteauthor=S.+D.+Weigandauthor=T.+G.+Lesnickauthor=V.+S.+Pankratzauthor=M.+C.+Donohueauthor=J.+Q.+Trojanowski&title=Tracking+pathophysiological+processes+in+Alzheimer%E2%80%99s+disease%3A+an+updated+hypothetical+model+of+dynamic+biomarkers&doi=10.1016%2Fs1474-4422%2812%2970291-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18bR"><div class="casContent"><span class="casTitleNuber">18b</span><div class="casTitle"><span class="NLM_cas:atitle">Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers</span></div><div class="casAuthors">Jack, Clifford R.; Knopman, David S.; Jagust, William J.; Petersen, Ronald C.; Weiner, Michael W.; Aisen, Paul S.; Shaw, Leslie M.; Vemuri, Prashanthi; Wiste, Heather J.; Weigand, Stephen D.; Lesnick, Timothy G.; Pankratz, Vernon S.; Donohue, Michael C.; Trojanowski, John Q.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">207-216</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  In 2010, we put forward a hypothetical model of the major biomarkers of Alzheimer's disease (AD).  The model was received with interest because we described the temporal evolution of AD biomarkers in relation to each other and to the onset and progression of clin. symptoms.  Since then, evidence has accumulated that supports the major assumptions of this model.  Evidence has also appeared that challenges some of our assumptions, which has allowed us to modify our original model.  Refinements to our model include indexing of individuals by time rather than clin. symptom severity; incorporation of interindividual variability in cognitive impairment assocd. with progression of AD pathophysiol.; modifications of the specific temporal ordering of some biomarkers; and recognition that the two major proteinopathies underlying AD biomarker changes, amyloid β (Aβ) and tau, might be initiated independently in sporadic AD, in which we hypothesise that an incident Aβ pathophysiol. can accelerate antecedent limbic and brainstem tauopathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgH6Mv-cXkY7Vg90H21EOLACvtfcHk0liHGCi1klOLqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslCht7o%253D&md5=0f7a94ec086d5287fef9f7a6995981df</span></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.1016%2Fs1474-4422%2812%2970291-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs1474-4422%252812%252970291-0%26sid%3Dliteratum%253Aachs%26aulast%3DJack%26aufirst%3DC.%2BR.%26aulast%3DKnopman%26aufirst%3DD.%2BS.%26aulast%3DJagust%26aufirst%3DW.%2BJ.%26aulast%3DPetersen%26aufirst%3DR.%2BC.%26aulast%3DWeiner%26aufirst%3DM.%2BW.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DShaw%26aufirst%3DL.%2BM.%26aulast%3DVemuri%26aufirst%3DP.%26aulast%3DWiste%26aufirst%3DH.%2BJ.%26aulast%3DWeigand%26aufirst%3DS.%2BD.%26aulast%3DLesnick%26aufirst%3DT.%2BG.%26aulast%3DPankratz%26aufirst%3DV.%2BS.%26aulast%3DDonohue%26aufirst%3DM.%2BC.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26atitle%3DTracking%2520pathophysiological%2520processes%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520an%2520updated%2520hypothetical%2520model%2520of%2520dynamic%2520biomarkers%26jtitle%3DLancet%2520Neurol.%26date%3D2013%26volume%3D12%26spage%3D207%26epage%3D216%26doi%3D10.1016%2Fs1474-4422%2812%2970291-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Farzan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnitzler, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasilieva, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choe, H.</span></span> <span> </span><span class="NLM_article-title">BACE2, a β-secretase homolog, cleaves at the β site and within the amyloid-β region of the amyloid-β precursor protein</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">9712</span>– <span class="NLM_lpage">9717</span>, <span class="refDoi"> DOI: 10.1073/pnas.160115697</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1073%2Fpnas.160115697" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10931940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmtVentL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=9712-9717&author=M.+Farzanauthor=C.+E.+Schnitzlerauthor=N.+Vasilievaauthor=D.+Leungauthor=H.+Choe&title=BACE2%2C+a+%CE%B2-secretase+homolog%2C+cleaves+at+the+%CE%B2+site+and+within+the+amyloid-%CE%B2+region+of+the+amyloid-%CE%B2+precursor+protein&doi=10.1073%2Fpnas.160115697"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">BACE2, a β-secretase homolog, cleaves at the β site and within the amyloid-β region of the amyloid-β precursor protein</span></div><div class="casAuthors">Farzan, Michael; Schnitzler, Christine E.; Vasilieva, Natalya; Leung, Doris; Choe, Hyeryun</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">9712-9717</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Prodn. of amyloid-β protein (Aβ) is initiated by a β-secretase that cleaves the Aβ precursor protein (APP) at the N terminus of Aβ (the β site).  A recently identified aspartyl protease, BACE, cleaves the β site and at residue 11 within the Aβ region of APP.  Here we show that BACE2, a BACE homolog, cleaves at the β site and more efficiently at a different site within Aβ.  The Flemish missense mutation of APP, implicated in a form of familial Alzheimer's disease, is adjacent to this latter site and markedly increases Aβ prodn. by BACE2 but not by BACE.  BACE and BACE2 respond identically to conservative β-site mutations, and alteration of a common active site Arg inhibits β-site cleavage but not cleavage within Aβ by both enzymes.  These data suggest that BACE2 contributes to Aβ prodn. in individuals bearing the Flemish mutation, and that selective inhibition of these highly similar proteases may be feasible and therapeutically advantageous.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoKuCTBTrzorVg90H21EOLACvtfcHk0liHGCi1klOLqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmtVentL8%253D&md5=4cafdc5cf3c57bb981323281cc55cbae</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1073%2Fpnas.160115697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.160115697%26sid%3Dliteratum%253Aachs%26aulast%3DFarzan%26aufirst%3DM.%26aulast%3DSchnitzler%26aufirst%3DC.%2BE.%26aulast%3DVasilieva%26aufirst%3DN.%26aulast%3DLeung%26aufirst%3DD.%26aulast%3DChoe%26aufirst%3DH.%26atitle%3DBACE2%252C%2520a%2520%25CE%25B2-secretase%2520homolog%252C%2520cleaves%2520at%2520the%2520%25CE%25B2%2520site%2520and%2520within%2520the%2520amyloid-%25CE%25B2%2520region%2520of%2520the%2520amyloid-%25CE%25B2%2520precursor%2520protein%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2000%26volume%3D97%26spage%3D9712%26epage%3D9717%26doi%3D10.1073%2Fpnas.160115697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Esterházy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stützer, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rechsteiner, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beauchamp, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Döbeli, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilpert, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matile, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prummer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieske, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marselli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosco, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerr-Conte, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aebersold, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spinas, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moch, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Migliorini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoffel, M.</span></span> <span> </span><span class="NLM_article-title">Bace2 ts a β cell-enriched protease that regulates pancreatic β cell function and mass</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">365</span>– <span class="NLM_lpage">377</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2011.06.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1016%2Fj.cmet.2011.06.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=21907142" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFGltbbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2011&pages=365-377&author=D.+Esterh%C3%A1zyauthor=I.+St%C3%BCtzerauthor=H.+Wangauthor=M.+P.+Rechsteinerauthor=J.+Beauchampauthor=H.+D%C3%B6beliauthor=H.+Hilpertauthor=H.+Matileauthor=M.+Prummerauthor=A.+Schmidtauthor=N.+Lieskeauthor=B.+Boehmauthor=L.+Marselliauthor=D.+Boscoauthor=J.+Kerr-Conteauthor=R.+Aebersoldauthor=G.+A.+Spinasauthor=H.+Mochauthor=C.+Miglioriniauthor=M.+Stoffel&title=Bace2+ts+a+%CE%B2+cell-enriched+protease+that+regulates+pancreatic+%CE%B2+cell+function+and+mass&doi=10.1016%2Fj.cmet.2011.06.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Bace2 Is a β Cell-Enriched Protease that Regulates Pancreatic β Cell Function and Mass</span></div><div class="casAuthors">Esterhazy, Daria; Stuetzer, Ina; Wang, Haiyan; Rechsteiner, Markus P.; Beauchamp, Jeremy; Doebeli, Heinz; Hilpert, Hans; Matile, Hugues; Prummer, Michael; Schmidt, Alexander; Lieske, Nora; Boehm, Bernhard; Marselli, Lorella; Bosco, Domenico; Kerr-Conte, Julie; Aebersold, Ruedi; Spinas, Giatgen Andreia; Moch, Holger; Migliorini, Cristiano; Stoffel, Markus</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">365-377</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Decreased β cell mass and function are hallmarks of type 2 diabetes.  Here we identified, through a siRNA screen, beta site amyloid precursor protein cleaving enzyme 2 (Bace2) as the sheddase of the proproliferative plasma membrane protein Tmem27 in murine and human β cells.  Mice with functionally inactive Bace2 and insulin-resistant mice treated with a newly identified Bace2 inhibitor both display augmented β cell mass and improved control of glucose homeostasis due to increased insulin levels.  These results implicate Bace2 in the control of β cell maintenance and provide a rational strategy to inhibit this protease for the expansion of functional pancreatic β cell mass.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNmw-BllVxx7Vg90H21EOLACvtfcHk0ljvPLqBnLn5zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFGltbbM&md5=489e20b2d997eb0cbaff195819e35d64</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2011.06.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2011.06.018%26sid%3Dliteratum%253Aachs%26aulast%3DEsterh%25C3%25A1zy%26aufirst%3DD.%26aulast%3DSt%25C3%25BCtzer%26aufirst%3DI.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DRechsteiner%26aufirst%3DM.%2BP.%26aulast%3DBeauchamp%26aufirst%3DJ.%26aulast%3DD%25C3%25B6beli%26aufirst%3DH.%26aulast%3DHilpert%26aufirst%3DH.%26aulast%3DMatile%26aufirst%3DH.%26aulast%3DPrummer%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DA.%26aulast%3DLieske%26aufirst%3DN.%26aulast%3DBoehm%26aufirst%3DB.%26aulast%3DMarselli%26aufirst%3DL.%26aulast%3DBosco%26aufirst%3DD.%26aulast%3DKerr-Conte%26aufirst%3DJ.%26aulast%3DAebersold%26aufirst%3DR.%26aulast%3DSpinas%26aufirst%3DG.%2BA.%26aulast%3DMoch%26aufirst%3DH.%26aulast%3DMigliorini%26aufirst%3DC.%26aulast%3DStoffel%26aufirst%3DM.%26atitle%3DBace2%2520ts%2520a%2520%25CE%25B2%2520cell-enriched%2520protease%2520that%2520regulates%2520pancreatic%2520%25CE%25B2%2520cell%2520function%2520and%2520mass%26jtitle%3DCell%2520Metab.%26date%3D2011%26volume%3D14%26spage%3D365%26epage%3D377%26doi%3D10.1016%2Fj.cmet.2011.06.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rochin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurbain, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serneels, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fort, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leblanc, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Strooper, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raposo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Niel, G.</span></span> <span> </span><span class="NLM_article-title">BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">10658</span>– <span class="NLM_lpage">10663</span>, <span class="refDoi"> DOI: 10.1073/pnas.1220748110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1073%2Fpnas.1220748110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=23754390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFejs7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=10658-10663&author=L.+Rochinauthor=I.+Hurbainauthor=L.+Serneelsauthor=C.+Fortauthor=B.+Wattauthor=P.+Leblancauthor=M.+S.+Marksauthor=B.+De+Strooperauthor=G.+Raposoauthor=G.+van+Niel&title=BACE2+processes+PMEL+to+form+the+melanosome+amyloid+matrix+in+pigment+cells&doi=10.1073%2Fpnas.1220748110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells</span></div><div class="casAuthors">Rochin, Leila; Hurbain, Ilse; Serneels, Lutgarde; Fort, Cecile; Watt, Brenda; Leblanc, Pascal; Marks, Michael S.; De Strooper, Bart; Raposo, Graca; van Niel, Guillaume</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">10658-10663,S10658/1-S10658/7</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Amyloids are often assocd. with pathol. processes such as in Alzheimer's disease (AD), but can also underlie physiol. processes such as pigmentation.  Formation of pathol. and functional amyloidogenic substrates can require precursor processing by proteases, as exemplified by the generation of Aβ peptide from amyloid precursor protein (APP) by beta-site APP cleaving enzyme (BACE)1 and γ-secretase.  Proteolytic processing of the pigment cell-specific Melanocyte Protein (PMEL) is also required to form functional amyloid fibrils during melanogenesis, but the enzymes involved are incompletely characterized.  Here we show that the BACE1 homolog BACE2 processes PMEL to generate functional amyloids.  BACE2 is highly expressed in pigment cells and Bace2-/- but not Bace1-/- mice display coat color defects, implying a specific role for BACE2 during melanogenesis.  By using biochem. and morphol. analyses, combined with RNA silencing, pharmacol. inhibition, and BACE2 overexpression in a human melanocytic cell line, we show that BACE2 cleaves the integral membrane form of PMEL within the juxtamembrane domain, releasing the PMEL luminal domain into endosomal precursors for the formation of amyloid fibrils and downstream melanosome morphogenesis.  These studies identify an amyloidogenic substrate of BACE2, reveal an important physiol. role for BACE2 in pigmentation, and highlight analogies in the generation of PMEL-derived functional amyloids and APP-derived pathol. amyloids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLBEney5KFyLVg90H21EOLACvtfcHk0ljvPLqBnLn5zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFejs7rK&md5=3deb3f80dca6a32748aa6fe2e50c2df1</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1220748110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1220748110%26sid%3Dliteratum%253Aachs%26aulast%3DRochin%26aufirst%3DL.%26aulast%3DHurbain%26aufirst%3DI.%26aulast%3DSerneels%26aufirst%3DL.%26aulast%3DFort%26aufirst%3DC.%26aulast%3DWatt%26aufirst%3DB.%26aulast%3DLeblanc%26aufirst%3DP.%26aulast%3DMarks%26aufirst%3DM.%2BS.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26aulast%3DRaposo%26aufirst%3DG.%26aulast%3Dvan%2BNiel%26aufirst%3DG.%26atitle%3DBACE2%2520processes%2520PMEL%2520to%2520form%2520the%2520melanosome%2520amyloid%2520matrix%2520in%2520pigment%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2013%26volume%3D110%26spage%3D10658%26epage%3D10663%26doi%3D10.1073%2Fpnas.1220748110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shimshek, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolly, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamurovic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balavenkatraman, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morawiec, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreutzer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schelle, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jucker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertschi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigot, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machauer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brzak, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrot, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span> <span> </span><span class="NLM_article-title">Pharmacological BACE1 and BACE2 inhibition induces hair depigmentation by inhibiting PMEL17 processing in mice</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">21917</span>, <span class="refDoi"> DOI: 10.1038/srep21917</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1038%2Fsrep21917" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=26912421" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjt1eku7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=21917&author=D.+R.+Shimshekauthor=L.+H.+Jacobsonauthor=C.+Kollyauthor=N.+Zamurovicauthor=K.+K.+Balavenkatramanauthor=L.+Morawiecauthor=R.+Kreutzerauthor=J.+Schelleauthor=M.+Juckerauthor=B.+Bertschiauthor=D.+Theilauthor=A.+Heierauthor=K.+Bigotauthor=K.+Beltzauthor=R.+Machauerauthor=I.+Brzakauthor=L.+Perrotauthor=U.+Neumann&title=Pharmacological+BACE1+and+BACE2+inhibition+induces+hair+depigmentation+by+inhibiting+PMEL17+processing+in+mice&doi=10.1038%2Fsrep21917"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological BACE1 and BACE2 inhibition induces hair depigmentation by inhibiting PMEL17 processing in mice</span></div><div class="casAuthors">Shimshek, Derya R.; Jacobson, Laura H.; Kolly, Carine; Zamurovic, Natasa; Balavenkatraman, Kamal Kumar; Morawiec, Laurent; Kreutzer, Robert; Schelle, Juliane; Jucker, Mathias; Bertschi, Barbara; Theil, Diethilde; Heier, Annabelle; Bigot, Karine; Beltz, Karen; Machauer, Rainer; Brzak, Irena; Perrot, Ludovic; Neumann, Ulf</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">21917</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Melanocytes of the hair follicle produce melanin and are essential in detg. the differences in hair color.  Pigment cell-specific MELanocyte Protein (PMEL17) plays a crucial role in melanogenesis.  One of the crit. steps is the amyloid-like functional oligomerization of PMEL17.  Beta Site APP Cleaving Enzyme-2 (BACE2) and γ-secretase have been shown to be key players in generating the proteolytic fragments of PMEL17.  The β-secretase (BACE1) is responsible for the generation of amyloid-β (Aβ) fragments in the brain and is therefore proposed as a therapeutic target for Alzheimer's disease (AD).  Currently BACE1 inhibitors, most of which lack selectivity over BACE2, have demonstrated efficacious redn. of amyloid-β peptides in animals and the CSF of humans.  BACE2 knock-out mice have a deficiency in PMEL17 proteolytic processing leading to impaired melanin storage and hair depigmentation.  Here, we confirm BACE2-mediated inhibition of PMEL17 proteolytic processing in vitro in mouse and human melanocytes.  Furthermore, we show that wildtype as well as bace2+/- and bace2-/- mice treated with a potent dual BACE1/BACE2 inhibitor NB-360 display dose-dependent appearance of irreversibly depigmented hair.  Retinal pigmented epithelium showed no morphol. changes.  Our data demonstrates that BACE2 as well as addnl. BACE1 inhibition affects melanosome maturation and induces hair depigmentation in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtlQ-3Lxc4CLVg90H21EOLACvtfcHk0li2Wss3A1Q41A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjt1eku7Y%253D&md5=e3641d48cc7fcf08c4502b5899a49066</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fsrep21917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep21917%26sid%3Dliteratum%253Aachs%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26aulast%3DJacobson%26aufirst%3DL.%2BH.%26aulast%3DKolly%26aufirst%3DC.%26aulast%3DZamurovic%26aufirst%3DN.%26aulast%3DBalavenkatraman%26aufirst%3DK.%2BK.%26aulast%3DMorawiec%26aufirst%3DL.%26aulast%3DKreutzer%26aufirst%3DR.%26aulast%3DSchelle%26aufirst%3DJ.%26aulast%3DJucker%26aufirst%3DM.%26aulast%3DBertschi%26aufirst%3DB.%26aulast%3DTheil%26aufirst%3DD.%26aulast%3DHeier%26aufirst%3DA.%26aulast%3DBigot%26aufirst%3DK.%26aulast%3DBeltz%26aufirst%3DK.%26aulast%3DMachauer%26aufirst%3DR.%26aulast%3DBrzak%26aufirst%3DI.%26aulast%3DPerrot%26aufirst%3DL.%26aulast%3DNeumann%26aufirst%3DU.%26atitle%3DPharmacological%2520BACE1%2520and%2520BACE2%2520inhibition%2520induces%2520hair%2520depigmentation%2520by%2520inhibiting%2520PMEL17%2520processing%2520in%2520mice%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D21917%26doi%3D10.1038%2Fsrep21917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ostermann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eder, Jörg</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidhoff, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zink, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassiepen, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Worpenberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maibaum, Jürgen</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simic, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hommel, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerhartz, B.</span></span> <span> </span><span class="NLM_article-title">Crystal Structure of Human BACE2 in Complex with a Hydroxyethylamine Transition-state Inhibitor</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>355</i></span>,  <span class="NLM_fpage">249</span>– <span class="NLM_lpage">261</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2005.10.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1016%2Fj.jmb.2005.10.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=16305800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlSjt7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2006&pages=249-261&author=N.+Ostermannauthor=J%C3%B6rg+Ederauthor=U.+Eidhoffauthor=F.+Zinkauthor=U.+Hassiepenauthor=S.+Worpenbergauthor=J%C3%BCrgen+Maibaumauthor=O.+Simicauthor=U.+Hommelauthor=B.+Gerhartz&title=Crystal+Structure+of+Human+BACE2+in+Complex+with+a+Hydroxyethylamine+Transition-state+Inhibitor&doi=10.1016%2Fj.jmb.2005.10.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23aR"><div class="casContent"><span class="casTitleNuber">23a</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of Human BACE2 in Complex with a Hydroxyethylamine Transition-state Inhibitor</span></div><div class="casAuthors">Ostermann, Nils; Eder, Joerg; Eidhoff, Ulf; Zink, Florence; Hassiepen, Ulrich; Worpenberg, Susanne; Maibaum, Juergen; Simic, Oliver; Hommel, Ulrich; Gerhartz, Bernd</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">249-261</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">BACE2 is a membrane-bound aspartic protease of the A1 family with a high level of sequence homol. to BACE1.  While BACE1 is involved in the generation of amyloid plaques in Alzheimer's disease by cleaving Aβ-peptides from the amyloid precursor protein, the physiol. function of BACE2 is not well understood.  BACE2 appears to be assocd. with the early onset of dementia in patients with Down's syndrome, and it has been shown to be highly expressed in breast cancers.  Further, it may participate in the function of normal and abnormal processes of human muscle biol.  Similar to other aspartic proteases, BACE2 is expressed as an inactive zymogen requiring the cleavage of its pro-sequence during the maturation process.  We have produced mature BACE2 by expression of pro-BACE2 in Escherichia coli as inclusion bodies, followed by refolding and autocatalytic activation at pH 3.4.  Using a C and N-terminally truncated BACE2 variant, we were able to crystallize and det. the crystal structure of mature BACE2 in complex with a hydroxyethylamine transition-state mimetic inhibitor at 3.1 Å resoln.  The structure of BACE2 follows the general fold of A1 aspartic proteases.  However, similar to BACE1, its C-terminal domain is significantly larger than that of the other family members.  Furthermore, the structure of BACE2 reveals differences in the S3, S2, S1' and S2' active site substrate pockets as compared to BACE1, and allows, therefore, for a deeper understanding of the structural features that may facilitate the design of selective BACE1 or BACE2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpagbhk8u5oybVg90H21EOLACvtfcHk0li2Wss3A1Q41A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlSjt7bO&md5=74ae4bbd058acf333ea11fba486f10b2</span></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2005.10.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2005.10.027%26sid%3Dliteratum%253Aachs%26aulast%3DOstermann%26aufirst%3DN.%26aulast%3DEder%26aufirst%3DJ%25C3%25B6rg%26aulast%3DEidhoff%26aufirst%3DU.%26aulast%3DZink%26aufirst%3DF.%26aulast%3DHassiepen%26aufirst%3DU.%26aulast%3DWorpenberg%26aufirst%3DS.%26aulast%3DMaibaum%26aufirst%3DJ%25C3%25BCrgen%26aulast%3DSimic%26aufirst%3DO.%26aulast%3DHommel%26aufirst%3DU.%26aulast%3DGerhartz%26aufirst%3DB.%26atitle%3DCrystal%2520Structure%2520of%2520Human%2520BACE2%2520in%2520Complex%2520with%2520a%2520Hydroxyethylamine%2520Transition-state%2520Inhibitor%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2006%26volume%3D355%26spage%3D249%26epage%3D261%26doi%3D10.1016%2Fj.jmb.2005.10.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit23b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Banner, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gsell, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertschinger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burger, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brack, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuppuleri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debulpaep, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gast, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grabulovski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennig, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilpert, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuglstatter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusznir, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laeremans, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matile, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miscenic, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rufer, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlatter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steyaert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stihle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thoma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruf, A.</span></span> <span> </span><span class="NLM_article-title">Mapping the conformational space accessible to BACE2 using surface mutants and cocrystals with Fab fragments, Fynomers and Xaperones</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">1124</span>– <span class="NLM_lpage">1137</span>, <span class="refDoi"> DOI: 10.1107/s0907444913006574</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1107%2Fs0907444913006574" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=1124-1137&author=D.+W.+Bannerauthor=B.+Gsellauthor=J.+Benzauthor=J.+Bertschingerauthor=D.+Burgerauthor=S.+Brackauthor=S.+Cuppuleriauthor=M.+Debulpaepauthor=A.+Gastauthor=D.+Grabulovskiauthor=M.+Hennigauthor=H.+Hilpertauthor=W.+Huberauthor=A.+Kuglstatterauthor=E.+Kusznirauthor=T.+Laeremansauthor=H.+Matileauthor=C.+Miscenicauthor=A.+C.+Ruferauthor=D.+Schlatterauthor=J.+Steyaertauthor=M.+Stihleauthor=R.+Thomaauthor=M.+Weberauthor=A.+Ruf&title=Mapping+the+conformational+space+accessible+to+BACE2+using+surface+mutants+and+cocrystals+with+Fab+fragments%2C+Fynomers+and+Xaperones&doi=10.1107%2Fs0907444913006574"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=10.1107%2Fs0907444913006574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252Fs0907444913006574%26sid%3Dliteratum%253Aachs%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DGsell%26aufirst%3DB.%26aulast%3DBenz%26aufirst%3DJ.%26aulast%3DBertschinger%26aufirst%3DJ.%26aulast%3DBurger%26aufirst%3DD.%26aulast%3DBrack%26aufirst%3DS.%26aulast%3DCuppuleri%26aufirst%3DS.%26aulast%3DDebulpaep%26aufirst%3DM.%26aulast%3DGast%26aufirst%3DA.%26aulast%3DGrabulovski%26aufirst%3DD.%26aulast%3DHennig%26aufirst%3DM.%26aulast%3DHilpert%26aufirst%3DH.%26aulast%3DHuber%26aufirst%3DW.%26aulast%3DKuglstatter%26aufirst%3DA.%26aulast%3DKusznir%26aufirst%3DE.%26aulast%3DLaeremans%26aufirst%3DT.%26aulast%3DMatile%26aufirst%3DH.%26aulast%3DMiscenic%26aufirst%3DC.%26aulast%3DRufer%26aufirst%3DA.%2BC.%26aulast%3DSchlatter%26aufirst%3DD.%26aulast%3DSteyaert%26aufirst%3DJ.%26aulast%3DStihle%26aufirst%3DM.%26aulast%3DThoma%26aufirst%3DR.%26aulast%3DWeber%26aufirst%3DM.%26aulast%3DRuf%26aufirst%3DA.%26atitle%3DMapping%2520the%2520conformational%2520space%2520accessible%2520to%2520BACE2%2520using%2520surface%2520mutants%2520and%2520cocrystals%2520with%2520Fab%2520fragments%252C%2520Fynomers%2520and%2520Xaperones%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2013%26volume%3D69%26spage%3D1124%26epage%3D1137%26doi%3D10.1107%2Fs0907444913006574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuillard, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleasby, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, Christopher W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yon, J.</span></span> <span> </span><span class="NLM_article-title">Apo and Inhibitor Complex Structures of BACE (β-secretase)</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>343</i></span>,  <span class="NLM_fpage">407</span>– <span class="NLM_lpage">416</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2004.08.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1016%2Fj.jmb.2004.08.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=15451669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnvVyqt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2004&pages=407-416&author=S.+Patelauthor=L.+Vuillardauthor=A.+Cleasbyauthor=Christopher+W.+Murrayauthor=J.+Yon&title=Apo+and+Inhibitor+Complex+Structures+of+BACE+%28%CE%B2-secretase%29&doi=10.1016%2Fj.jmb.2004.08.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24aR"><div class="casContent"><span class="casTitleNuber">24a</span><div class="casTitle"><span class="NLM_cas:atitle">Apo and Inhibitor Complex Structures of BACE (β-secretase)</span></div><div class="casAuthors">Patel, Sahil; Vuillard, Laurent; Cleasby, Anne; Murray, Christopher W.; Yon, Jeff</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">343</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">407-416</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Human BACE, also known as β-secretase, shows promise as a potential therapeutic target for Alzheimer's disease.  The authors detd. the apo structure of BACE to 1.75 Å, and a structure of a hydroxyethylamine inhibitor complex derived by soaking.  These show significant active-site movements compared to previously described BACE structures.  Addnl., the structures reveal two pockets that could be targeted by structure-based drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH0afg2-ZxjLVg90H21EOLACvtfcHk0lhB2m6lffqjFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnvVyqt7w%253D&md5=b14e17f86a4729fb8ee66d84ee6c1fab</span></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2004.08.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2004.08.018%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DVuillard%26aufirst%3DL.%26aulast%3DCleasby%26aufirst%3DA.%26aulast%3DMurray%26aufirst%3DChristopher%2BW.%26aulast%3DYon%26aufirst%3DJ.%26atitle%3DApo%2520and%2520Inhibitor%2520Complex%2520Structures%2520of%2520BACE%2520%2528%25CE%25B2-secretase%2529%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2004%26volume%3D343%26spage%3D407%26epage%3D416%26doi%3D10.1016%2Fj.jmb.2004.08.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit24b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J.</span></span> <span> </span><span class="NLM_article-title">Flap position of free Memapsin 2 (β-secretase), a model for flap opening in aspartic protease catalysis</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">4689</span>– <span class="NLM_lpage">4695</span>, <span class="refDoi"> DOI: 10.1021/bi0498252</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi0498252" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BD2cXis1CjtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=4689-4695&author=L.+Hongauthor=J.+Tang&title=Flap+position+of+free+Memapsin+2+%28%CE%B2-secretase%29%2C+a+model+for+flap+opening+in+aspartic+protease+catalysis&doi=10.1021%2Fbi0498252"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24bR"><div class="casContent"><span class="casTitleNuber">24b</span><div class="casTitle"><span class="NLM_cas:atitle">Flap Position of Free Memapsin 2 (β-Secretase), a Model for Flap Opening in Aspartic Protease Catalysis</span></div><div class="casAuthors">Hong, Lin; Tang, Jordan</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4689-4695</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The three-dimensional structure of unbound human memapsin 2 (β-secretase) protease domain detd. at 2.0-Å resoln. has revealed a new position of the flap region, which appears to be locked in an "open" position.  While the structure outside of the flap is essentially the same as the structure of memapsin 2 bound to an inhibitor, the flap positions are 4.5 Å different at the tips.  The open position of the flap in the current structure is stabilized by two newly formed intraflap hydrogen bonds and anchored by a new hydrogen bond involving the side chain of Tyr-71 (Tyr-75 in pepsin numbering) in a novel orientation.  In mol. modeling expts., the opening of the flap, 6.5 Å at the narrowest point, permits entrance of substrates into the cleft.  The narrowest point of the opening may function to discriminate among substrates based on sequence and shape.  The obsd. flap opening may also serve as a model for the flap movement in the catalytic mechanism of eukaryotic aspartic proteases and provide insight for the side-chain selection in the design of memapsin 2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHKNx5Pd9E1LVg90H21EOLACvtfcHk0lhB2m6lffqjFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXis1CjtL4%253D&md5=43617f8ecfd4f38675279b9b6a2e9925</span></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=10.1021%2Fbi0498252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0498252%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DL.%26aulast%3DTang%26aufirst%3DJ.%26atitle%3DFlap%2520position%2520of%2520free%2520Memapsin%25202%2520%2528%25CE%25B2-secretase%2529%252C%2520a%2520model%2520for%2520flap%2520opening%2520in%2520aspartic%2520protease%2520catalysis%26jtitle%3DBiochemistry%26date%3D2004%26volume%3D43%26spage%3D4689%26epage%3D4695%26doi%3D10.1021%2Fbi0498252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malamas, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chopra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pangalos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinhart, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robichaud, A. J.</span></span> <span> </span><span class="NLM_article-title">Di-substituted pyridinyl aminohydantoins as potent and highly selective human β-secretase (BACE1) inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">630</span>– <span class="NLM_lpage">639</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2009.12.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1016%2Fj.bmc.2009.12.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=20045648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC3cXot1yqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=630-639&author=M.+S.+Malamasauthor=K.+Barnesauthor=M.+Johnsonauthor=Y.+Huiauthor=P.+Zhouauthor=J.+Turnerauthor=Y.+Huauthor=E.+Wagnerauthor=K.+Fanauthor=R.+Chopraauthor=A.+Ollandauthor=J.+Bardauthor=M.+Pangalosauthor=P.+Reinhartauthor=A.+J.+Robichaud&title=Di-substituted+pyridinyl+aminohydantoins+as+potent+and+highly+selective+human+%CE%B2-secretase+%28BACE1%29+inhibitors&doi=10.1016%2Fj.bmc.2009.12.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Di-substituted pyridinyl aminohydantoins as potent and highly selective human β-secretase (BACE1) inhibitors</span></div><div class="casAuthors">Malamas, Michael S.; Barnes, Keith; Johnson, Matthew; Hui, Yu; Zhou, Ping; Turner, Jim; Hu, Yun; Wagner, Erik; Fan, Kristi; Chopra, Rajiv; Olland, Andrea; Bard, Jonathan; Pangalos, Menelas; Reinhart, Peter; Robichaud, Albert J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">630-639</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The identification of highly selective small mol. di-substituted pyridinyl aminohydantoins as β-secretase inhibitors is reported.  The more potent and selective analogs demonstrate low nanomolar potency for the BACE1 enzyme as measured in a FRET assay, and exhibit comparable activity in a cell-based (ELISA) assay.  In addn., these pyridine-aminohydantoins are highly selectivity (>500×) against the other structurally related aspartyl proteases BACE2, cathepsin D, pepsin and renin.  Our design strategy followed a traditional SAR approach and was supported by mol. modeling studies based on the previously reported aminohydantoin I.  We have taken advantage of the amino acid difference between the BACE1 and BACE2 at the S2' pocket (BACE1 Pro70 changed to BACE2 Lys86) to build ligands with >500-fold selectivity against BACE2.  The addn. of large substituents on the targeted ligand at the vicinity of this aberration has generated a steric conflict between the ligand and these two proteins, thus impacting the ligand's affinity and selectivity.  These ligands have also shown an exceptional selectivity against cathepsin D (>5000-fold) as well as the other aspartyl proteases mentioned.  One of the more potent compds. (S)-II displayed an IC50 value for BACE1 of 10 nM, and exhibited cellular activity with an EC50 value of 130 nM in the ELISA assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBPjXCZYzfhLVg90H21EOLACvtfcHk0lhB2m6lffqjFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXot1yqsg%253D%253D&md5=7b509e226d91b162059777507e7f8463</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.12.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.12.007%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DBarnes%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DM.%26aulast%3DHui%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DTurner%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DWagner%26aufirst%3DE.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DOlland%26aufirst%3DA.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DPangalos%26aufirst%3DM.%26aulast%3DReinhart%26aufirst%3DP.%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26atitle%3DDi-substituted%2520pyridinyl%2520aminohydantoins%2520as%2520potent%2520and%2520highly%2520selective%2520human%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D630%26epage%3D639%26doi%3D10.1016%2Fj.bmc.2009.12.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Brodney, M. A.</span>; <span class="NLM_string-name">Beck, E. M.</span>; <span class="NLM_string-name">Butler, C. R.</span>; <span class="NLM_string-name">Zhang, L.</span>; <span class="NLM_string-name">O’Neill, B. T.</span>; <span class="NLM_string-name">Barreiro, G.</span>; <span class="NLM_string-name">Lachapelle, E. A.</span>; <span class="NLM_string-name">Rogers, B. N.</span></span> <span> </span><span class="NLM_article-title">Preparation of <i>N</i>-(2-Amino-6-methyl-4,4<i>a</i>,5,6-tetrahydropyrano[3,4-<i>d</i>][1,3]thiazin-8<i>a</i>(8<i>h</i>)-yl-1,3-thiazol-4-yl) Amides as Inhibitors of Beta-site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1)</span>. <span class="NLM_patent">WO 2015155626 A1</span>, Oct 15, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=M.+A.+Brodney&author=E.+M.+Beck&author=C.+R.+Butler&author=L.+Zhang&author=B.+T.+O%E2%80%99Neill&author=G.+Barreiro&author=E.+A.+Lachapelle&author=B.+N.+Rogers&title=Preparation+of+N-%282-Amino-6-methyl-4%2C4a%2C5%2C6-tetrahydropyrano%5B3%2C4-d%5D%5B1%2C3%5Dthiazin-8a%288h%29-yl-1%2C3-thiazol-4-yl%29+Amides+as+Inhibitors+of+Beta-site+Amyloid+Precursor+Protein+Cleaving+Enzyme+1+%28BACE1%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26atitle%3DPreparation%2520of%2520N-%25282-Amino-6-methyl-4%252C4a%252C5%252C6-tetrahydropyrano%255B3%252C4-d%255D%255B1%252C3%255Dthiazin-8a%25288h%2529-yl-1%252C3-thiazol-4-yl%2529%2520Amides%2520as%2520Inhibitors%2520of%2520Beta-site%2520Amyloid%2520Precursor%2520Protein%2520Cleaving%2520Enzyme%25201%2520%2528BACE1%2529%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit26b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Richards, S. J.</span>; <span class="NLM_string-name">Hembre, E. J.</span>; <span class="NLM_string-name">Lopez, J. E.</span>; <span class="NLM_string-name">Winneroski, L. L.,  Jr.</span>; <span class="NLM_string-name">Woods, T. A.</span>; <span class="NLM_string-name">Mcmahon, J. A.</span></span> <span> </span><span class="NLM_article-title">Preparation of 2-Amino-5-(1,1-difluoroalkyl)-4,4a,5,7-tetrahydrofuro[3,4-d][1,3]thiazin-7a-yl]-4-fluorophenyl]-5-(1,2,4-triazol-1-yl)pyrazine-2-carboxamides as Selective BACE1 Inhibitors</span>. U.S. patent <span class="NLM_patent">0,244,465 A1</span>, Aug 25, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=S.+J.+Richards&author=E.+J.+Hembre&author=J.+E.+Lopez&author=L.+L.+Winneroski&author=T.+A.+Woods&author=J.+A.+Mcmahon&title=Preparation+of+2-Amino-5-%281%2C1-difluoroalkyl%29-4%2C4a%2C5%2C7-tetrahydrofuro%5B3%2C4-d%5D%5B1%2C3%5Dthiazin-7a-yl%5D-4-fluorophenyl%5D-5-%281%2C2%2C4-triazol-1-yl%29pyrazine-2-carboxamides+as+Selective+BACE1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRichards%26aufirst%3DS.%2BJ.%26atitle%3DPreparation%2520of%25202-Amino-5-%25281%252C1-difluoroalkyl%2529-4%252C4a%252C5%252C7-tetrahydrofuro%255B3%252C4-d%255D%255B1%252C3%255Dthiazin-7a-yl%255D-4-fluorophenyl%255D-5-%25281%252C2%252C4-triazol-1-yl%2529pyrazine-2-carboxamides%2520as%2520Selective%2520BACE1%2520Inhibitors%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit26c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, J. R.</span>; <span class="NLM_string-name">Amegadzie, A.</span>; <span class="NLM_string-name">Bourbeau, M. P.</span>; <span class="NLM_string-name">Brown, J. A.</span>; <span class="NLM_string-name">Chen, N.</span>; <span class="NLM_string-name">Frohn, M.
J.</span>; <span class="NLM_string-name">Liu, L.</span>; <span class="NLM_string-name">Liu, Q.</span>; <span class="NLM_string-name">Pettus, L. H.</span>; <span class="NLM_string-name">Qian, W.</span>; <span class="NLM_string-name">Reeves, C. M.</span>; <span class="NLM_string-name">Siegmund, A. C.</span></span> <span> </span><span class="NLM_article-title">Preparation of Vinyl Fluoride Cyclopropyl Fused Thiazin-2-amine Compounds as Beta-secretase Inhibitors and Methods of Use</span>. <span class="NLM_patent">WO 2017024180 A1</span>, Feb 9, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=J.+R.+Allen&author=A.+Amegadzie&author=M.+P.+Bourbeau&author=J.+A.+Brown&author=N.+Chen&author=M.%0AJ.+Frohn&author=L.+Liu&author=Q.+Liu&author=L.+H.+Pettus&author=W.+Qian&author=C.+M.+Reeves&author=A.+C.+Siegmund&title=Preparation+of+Vinyl+Fluoride+Cyclopropyl+Fused+Thiazin-2-amine+Compounds+as+Beta-secretase+Inhibitors+and+Methods+of+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DJ.%2BR.%26atitle%3DPreparation%2520of%2520Vinyl%2520Fluoride%2520Cyclopropyl%2520Fused%2520Thiazin-2-amine%2520Compounds%2520as%2520Beta-secretase%2520Inhibitors%2520and%2520Methods%2520of%2520Use%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit26d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolan, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doran, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lapham, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buzon, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutra, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barreiro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Alsina, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalobos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogilvie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Chapelle, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanyon, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steppan, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robshaw, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hales, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boucher, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandher, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houle, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambroise, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karanian, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riddell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bales, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodney, M. A.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of clinical candidate PF-06751979: A potent, brain penetrant, β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor lacking hypopigmentation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">4476</span>– <span class="NLM_lpage">4504</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00246</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00246" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC1cXntVCmtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=4476-4504&author=B.+T.+O%E2%80%99Neillauthor=E.+M.+Beckauthor=C.+R.+Butlerauthor=C.+E.+Nolanauthor=C.+Gonzalesauthor=L.+Zhangauthor=S.+D.+Doranauthor=K.+Laphamauthor=L.+M.+Buzonauthor=J.+K.+Dutraauthor=G.+Barreiroauthor=X.+Houauthor=L.+A.+Martinez-Alsinaauthor=B.+N.+Rogersauthor=A.+Villalobosauthor=J.+C.+Murrayauthor=K.+Ogilvieauthor=E.+A.+La+Chapelleauthor=C.+Changauthor=L.+F.+Lanyonauthor=C.+M.+Steppanauthor=A.+Robshawauthor=K.+Halesauthor=G.+G.+Boucherauthor=K.+Pandherauthor=C.+Houleauthor=C.+W.+Ambroiseauthor=D.+Karanianauthor=D.+Riddellauthor=K.+R.+Balesauthor=M.+A.+Brodney&title=Design+and+synthesis+of+clinical+candidate+PF-06751979%3A+A+potent%2C+brain+penetrant%2C+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+1+%28BACE1%29+inhibitor+lacking+hypopigmentation&doi=10.1021%2Facs.jmedchem.8b00246"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26dR"><div class="casContent"><span class="casTitleNuber">26d</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Clinical Candidate PF-06751979: A Potent, Brain Penetrant, β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitor Lacking Hypopigmentation</span></div><div class="casAuthors">O'Neill, Brian T.; Beck, Elizabeth M.; Butler, Christopher R.; Nolan, Charles E.; Gonzales, Cathleen; Zhang, Lei; Doran, Shawn D.; Lapham, Kimberly; Buzon, Leanne M.; Dutra, Jason K.; Barreiro, Gabriela; Hou, Xinjun; Martinez-Alsina, Luis A.; Rogers, Bruce N.; Villalobos, Anabella; Murray, John C.; Ogilvie, Kevin; La Chapelle, Erik A.; Chang, Cheng; Lanyon, Lorraine F.; Steppan, Claire M.; Robshaw, Ashley; Hales, Katherine; Boucher, Germaine G.; Pandher, Karamjeet; Houle, Christopher; Ambroise, Claude W.; Karanian, David; Riddell, David; Bales, Kelly R.; Brodney, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4476-4504</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A major challenge in the development of β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors for the treatment of Alzheimer's disease is the alignment of potency, drug-like properties, and selectivity over related aspartyl proteases such as Cathepsin D (CatD) and BACE2.  The potential liabilities of inhibiting BACE2 chronically have only recently begun to emerge as BACE2 impacts the processing of the premelanosome protein (PMEL17) and disrupts melanosome morphol. resulting in a depigmentation phenotype.  Herein, the authors describe the identification of clin. candidate PF-06751979 (I), which displays excellent brain penetration, potent in vivo efficacy, and broad selectivity over related aspartyl proteases including BACE2.  Chronic dosing of I for up to 9 mo in dog did not reveal any observation of hair coat color (pigmentation) changes and suggests a key differentiator over current BACE1 inhibitors that are nonselective against BACE2 in later stage clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs1F61vo0jBbVg90H21EOLACvtfcHk0ljhFfwATRhvBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXntVCmtrs%253D&md5=3d8cae0bb20298e66f6da1c26cf8d5bc</span></div><a href="/servlet/linkout?suffix=cit26d&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00246%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DButler%26aufirst%3DC.%2BR.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DGonzales%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DLapham%26aufirst%3DK.%26aulast%3DBuzon%26aufirst%3DL.%2BM.%26aulast%3DDutra%26aufirst%3DJ.%2BK.%26aulast%3DBarreiro%26aufirst%3DG.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DMartinez-Alsina%26aufirst%3DL.%2BA.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DMurray%26aufirst%3DJ.%2BC.%26aulast%3DOgilvie%26aufirst%3DK.%26aulast%3DLa%2BChapelle%26aufirst%3DE.%2BA.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DLanyon%26aufirst%3DL.%2BF.%26aulast%3DSteppan%26aufirst%3DC.%2BM.%26aulast%3DRobshaw%26aufirst%3DA.%26aulast%3DHales%26aufirst%3DK.%26aulast%3DBoucher%26aufirst%3DG.%2BG.%26aulast%3DPandher%26aufirst%3DK.%26aulast%3DHoule%26aufirst%3DC.%26aulast%3DAmbroise%26aufirst%3DC.%2BW.%26aulast%3DKaranian%26aufirst%3DD.%26aulast%3DRiddell%26aufirst%3DD.%26aulast%3DBales%26aufirst%3DK.%2BR.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520clinical%2520candidate%2520PF-06751979%253A%2520A%2520potent%252C%2520brain%2520penetrant%252C%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%2520inhibitor%2520lacking%2520hypopigmentation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D4476%26epage%3D4504%26doi%3D10.1021%2Facs.jmedchem.8b00246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit26e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaspersson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurrell, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bäck, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eketjäll, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cebers, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorne, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenzie, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaton, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davey, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolmodin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holenz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duggan, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haeberlein, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bürli, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burli, R. W.</span></span> <span> </span><span class="NLM_article-title">Toward β-Secretase-1 Inhibitors with Improved Isoform Selectivity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">3491</span>– <span class="NLM_lpage">3502</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01716</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01716" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC1cXntVCmsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=3491-3502&author=P.+Johanssonauthor=K.+Kasperssonauthor=I.+K.+Gurrellauthor=E.+B%C3%A4ckauthor=S.+Eketj%C3%A4llauthor=C.+W.+Scottauthor=G.+Cebersauthor=P.+Thorneauthor=M.+J.+McKenzieauthor=H.+Beatonauthor=P.+Daveyauthor=K.+Kolmodinauthor=J.+Holenzauthor=M.+E.+Dugganauthor=S.+B.+Haeberleinauthor=R.+W.+B%C3%BCrliauthor=R.+W.+Burli&title=Toward+%CE%B2-Secretase-1+Inhibitors+with+Improved+Isoform+Selectivity&doi=10.1021%2Facs.jmedchem.7b01716"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26eR"><div class="casContent"><span class="casTitleNuber">26e</span><div class="casTitle"><span class="NLM_cas:atitle">Toward β-Secretase-1 Inhibitors with Improved Isoform Selectivity</span></div><div class="casAuthors">Johansson, Patrik; Kaspersson, Karin; Gurrell, Ian K.; Baeck, Elisabeth; Eketjaell, Susanna; Scott, Clay W.; Cebers, Gvido; Thorne, Philip; McKenzie, Michael J.; Beaton, Haydn; Davey, Paul; Kolmodin, Karin; Holenz, Joerg; Duggan, Mark E.; Budd Haeberlein, Samantha; Burli, Roland W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3491-3502</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">BACE1 is responsible for the first step in APP proteolysis, leading to toxic Aβ prodn., and has been indicated to play a key role in the pathogenesis of Alzheimer's disease.  The related isoform BACE2 is thought to be involved in processing of the pigment cell-specific melanocyte protein.  To avoid potential effects on pigmentation, we investigated the feasibility for developing isoform-selective BACE1 inhibitors.  Cocrystal structures of 47 compds. were analyzed and clustered according to their selectivity profiles.  Selective BACE1 inhibitors were found to exhibit two distinct conformational features proximal to the flap and the S3 subpocket.  Several new mols. were designed and tested to make use of this observation.  The combination of a pyrimidinyl C-ring and a methylcyclohexyl element resulted in lead mol. 28, which exhibited ∼50-fold selectivity.  Compared to a nonselective BACE1/2 inhibitor, 28 showed significantly less inhibition of PMEL processing in human melanocytes, indicating good functional selectivity of this inhibitor class.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlCCtmcFz6HrVg90H21EOLACvtfcHk0ljm7WVa8HOCqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXntVCmsLk%253D&md5=46ce3d839d3153d848c1ae0209263634</span></div><a href="/servlet/linkout?suffix=cit26e&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01716%26sid%3Dliteratum%253Aachs%26aulast%3DJohansson%26aufirst%3DP.%26aulast%3DKaspersson%26aufirst%3DK.%26aulast%3DGurrell%26aufirst%3DI.%2BK.%26aulast%3DB%25C3%25A4ck%26aufirst%3DE.%26aulast%3DEketj%25C3%25A4ll%26aufirst%3DS.%26aulast%3DScott%26aufirst%3DC.%2BW.%26aulast%3DCebers%26aufirst%3DG.%26aulast%3DThorne%26aufirst%3DP.%26aulast%3DMcKenzie%26aufirst%3DM.%2BJ.%26aulast%3DBeaton%26aufirst%3DH.%26aulast%3DDavey%26aufirst%3DP.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DHolenz%26aufirst%3DJ.%26aulast%3DDuggan%26aufirst%3DM.%2BE.%26aulast%3DHaeberlein%26aufirst%3DS.%2BB.%26aulast%3DB%25C3%25BCrli%26aufirst%3DR.%2BW.%26aulast%3DBurli%26aufirst%3DR.%2BW.%26atitle%3DToward%2520%25CE%25B2-Secretase-1%2520Inhibitors%2520with%2520Improved%2520Isoform%2520Selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D3491%26epage%3D3502%26doi%3D10.1021%2Facs.jmedchem.7b01716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, N.</span>; <span class="NLM_string-name">Ueda, K.</span>; <span class="NLM_string-name">Itoh, N.</span>; <span class="NLM_string-name">Suzuki, S.</span>; <span class="NLM_string-name">Sakaguchi, G.</span>; <span class="NLM_string-name">Kato, A.</span>; <span class="NLM_string-name">Yukimasa, A.</span>; <span class="NLM_string-name">Hori, A.</span>; <span class="NLM_string-name">Koriyama, Y.</span>; <span class="NLM_string-name">Haraguchi, H.</span>; <span class="NLM_string-name">Yasui, K.</span>; <span class="NLM_string-name">Kanda, Y.</span></span> <span> </span><span class="NLM_article-title">Preparation of 2-aminodihydrothiazine derivatives as β-secretase inhibitors</span>. <span class="NLM_patent">WO 2007049532 A1</span>, March 3, <span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=N.+Kobayashi&author=K.+Ueda&author=N.+Itoh&author=S.+Suzuki&author=G.+Sakaguchi&author=A.+Kato&author=A.+Yukimasa&author=A.+Hori&author=Y.+Koriyama&author=H.+Haraguchi&author=K.+Yasui&author=Y.+Kanda&title=Preparation+of+2-aminodihydrothiazine+derivatives+as+%CE%B2-secretase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DN.%26atitle%3DPreparation%2520of%25202-aminodihydrothiazine%2520derivatives%2520as%2520%25CE%25B2-secretase%2520inhibitors%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit27b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchino, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsuoka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masui, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurose, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unemura, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosono, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakaguchi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ando, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohnishi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kido, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukushima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyajima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiroyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyabu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhuyvetter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borghys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, Harrie J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iso, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusakabe, K.-I.</span></span> <span> </span><span class="NLM_article-title">Rational design of novel 1,3-oxazine based β-secretase (BACE1) inhibitors: Incorporation of a double bond to reduce P-gp efflux leading to robust Aβ reduction in the brain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5122</span>– <span class="NLM_lpage">5137</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00002</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC1cXptVWhsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5122-5137&author=K.+Fuchinoauthor=Y.+Mitsuokaauthor=M.+Masuiauthor=N.+Kuroseauthor=S.+Yoshidaauthor=K.+Komanoauthor=T.+Yamamotoauthor=M.+Ogawaauthor=C.+Unemuraauthor=M.+Hosonoauthor=H.+Itoauthor=G.+Sakaguchiauthor=S.+Andoauthor=S.+Ohnishiauthor=Y.+Kidoauthor=T.+Fukushimaauthor=H.+Miyajimaauthor=S.+Hiroyamaauthor=K.+Koyabuauthor=D.+Dhuyvetterauthor=H.+Borghysauthor=Harrie+J.+M.+Gijsenauthor=Y.+Yamanoauthor=Y.+Isoauthor=K.-I.+Kusakabe&title=Rational+design+of+novel+1%2C3-oxazine+based+%CE%B2-secretase+%28BACE1%29+inhibitors%3A+Incorporation+of+a+double+bond+to+reduce+P-gp+efflux+leading+to+robust+A%CE%B2+reduction+in+the+brain&doi=10.1021%2Facs.jmedchem.8b00002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27bR"><div class="casContent"><span class="casTitleNuber">27b</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Design of Novel 1,3-Oxazine Based β-Secretase (BACE1) Inhibitors: Incorporation of a Double Bond To Reduce P-gp Efflux Leading to Robust Aβ Reduction in the Brain</span></div><div class="casAuthors">Fuchino, Kouki; Mitsuoka, Yasunori; Masui, Moriyasu; Kurose, Noriyuki; Yoshida, Shuhei; Komano, Kazuo; Yamamoto, Takahiko; Ogawa, Masayoshi; Unemura, Chie; Hosono, Motoko; Ito, Hisanori; Sakaguchi, Gaku; Ando, Shigeru; Ohnishi, Shuichi; Kido, Yasuto; Fukushima, Tamio; Miyajima, Hirofumi; Hiroyama, Shuichi; Koyabu, Kiyotaka; Dhuyvetter, Deborah; Borghys, Herman; Gijsen, Harrie J. M.; Yamano, Yoshinori; Iso, Yasuyoshi; Kusakabe, Ken-ichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5122-5137</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Accumulation of Aβ peptides is a hallmark of Alzheimer's disease (AD) and is considered a causal factor in the pathogenesis of AD.  β-Secretase (BACE1) is a key enzyme responsible for producing Aβ peptides, and thus agents that inhibit BACE1 should be beneficial for disease-modifying treatment of AD.  Here we describe the discovery and optimization of novel oxazine-based BACE1 inhibitors by lowering amidine basicity with the incorporation of a double bond to improve brain penetration.  Starting from a 1,3-dihydrooxazine lead I identified by a hit-to-lead SAR following HTS, we adopted a pKa lowering strategy to reduce the P-gp efflux and the high hERG potential leading to the discovery of II that produced significant Aβ redn. with long duration in pharmacodynamic models and exhibited wide safety margins in cardiovascular safety models.  This compd. II improved the brain-to-plasma ratio relative to I by reducing P-gp recognition, which was demonstrated by a P-gp knockout mouse model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGPZsGRa22ZLVg90H21EOLACvtfcHk0ljm7WVa8HOCqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXptVWhsLo%253D&md5=ac366bddfe3492a0a47ce02918b5ea41</span></div><a href="/servlet/linkout?suffix=cit27b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00002%26sid%3Dliteratum%253Aachs%26aulast%3DFuchino%26aufirst%3DK.%26aulast%3DMitsuoka%26aufirst%3DY.%26aulast%3DMasui%26aufirst%3DM.%26aulast%3DKurose%26aufirst%3DN.%26aulast%3DYoshida%26aufirst%3DS.%26aulast%3DKomano%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DOgawa%26aufirst%3DM.%26aulast%3DUnemura%26aufirst%3DC.%26aulast%3DHosono%26aufirst%3DM.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DSakaguchi%26aufirst%3DG.%26aulast%3DAndo%26aufirst%3DS.%26aulast%3DOhnishi%26aufirst%3DS.%26aulast%3DKido%26aufirst%3DY.%26aulast%3DFukushima%26aufirst%3DT.%26aulast%3DMiyajima%26aufirst%3DH.%26aulast%3DHiroyama%26aufirst%3DS.%26aulast%3DKoyabu%26aufirst%3DK.%26aulast%3DDhuyvetter%26aufirst%3DD.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DGijsen%26aufirst%3DHarrie%2BJ.%2BM.%26aulast%3DYamano%26aufirst%3DY.%26aulast%3DIso%26aufirst%3DY.%26aulast%3DKusakabe%26aufirst%3DK.-I.%26atitle%3DRational%2520design%2520of%2520novel%25201%252C3-oxazine%2520based%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%253A%2520Incorporation%2520of%2520a%2520double%2520bond%2520to%2520reduce%2520P-gp%2520efflux%2520leading%2520to%2520robust%2520A%25CE%25B2%2520reduction%2520in%2520the%2520brain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5122%26epage%3D5137%26doi%3D10.1021%2Facs.jmedchem.8b00002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit27c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Nakahara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchino, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asada, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tadano, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sako, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unemura, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosono, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakaguchi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ando, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohnishi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kido, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukushima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhuyvetter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borghys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, Harrie J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iso, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusakabe, K.-I.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent and centrally active 6-substituted 5-fluoro-1,3-dihydro-oxazine β-secretase (BACE1) inhibitors via active conformation stabilization</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5525</span>– <span class="NLM_lpage">5546</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00011</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpvVarsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5525-5546&author=K.+Nakaharaauthor=K.+Fuchinoauthor=K.+Komanoauthor=N.+Asadaauthor=G.+Tadanoauthor=T.+Hasegawaauthor=T.+Yamamotoauthor=Y.+Sakoauthor=M.+Ogawaauthor=C.+Unemuraauthor=M.+Hosonoauthor=H.+Itoauthor=G.+Sakaguchiauthor=S.+Andoauthor=S.+Ohnishiauthor=Y.+Kidoauthor=T.+Fukushimaauthor=D.+Dhuyvetterauthor=H.+Borghysauthor=Harrie+J.+M.+Gijsenauthor=Y.+Yamanoauthor=Y.+Isoauthor=K.-I.+Kusakabe&title=Discovery+of+potent+and+centrally+active+6-substituted+5-fluoro-1%2C3-dihydro-oxazine+%CE%B2-secretase+%28BACE1%29+inhibitors+via+active+conformation+stabilization&doi=10.1021%2Facs.jmedchem.8b00011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27cR"><div class="casContent"><span class="casTitleNuber">27c</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent and Centrally Active 6-Substituted 5-Fluoro-1,3-dihydro-oxazine β-Secretase (BACE1) Inhibitors via Active Conformation Stabilization</span></div><div class="casAuthors">Nakahara, Kenji; Fuchino, Kouki; Komano, Kazuo; Asada, Naoya; Tadano, Genta; Hasegawa, Tsuyoshi; Yamamoto, Takahiko; Sako, Yusuke; Ogawa, Masayoshi; Unemura, Chie; Hosono, Motoko; Ito, Hisanori; Sakaguchi, Gaku; Ando, Shigeru; Ohnishi, Shuichi; Kido, Yasuto; Fukushima, Tamio; Dhuyvetter, Deborah; Borghys, Herman; Gijsen, Harrie J. M.; Yamano, Yoshinori; Iso, Yasuyoshi; Kusakabe, Ken-ichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5525-5546</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">β-Secretase (BACE1) has an essential role in the prodn. of amyloid β peptides that accumulate in patients with Alzheimer's disease (AD).  Thus, inhibition of BACE1 is considered to be a disease-modifying approach for the treatment of AD.  The authors' hit-to-lead efforts led to a cellular potent 1,3-dihydro-oxazine I, which however inhibited hERG and showed high P-gp efflux.  The close analog of 5-fluoro-oxazine II reduced P-gp efflux; further introduction of electron withdrawing groups at the 6-position improved potency and also mitigated P-gp efflux and hERG inhibition.  Changing to a pyrazine followed by optimization of substituents on both the oxazine and the pyrazine culminated in III with robust Aβ redn. in vivo at low doses as well as reduced CYP2D6 inhibition.  On the basis of the X-ray anal. and the QM calcn. of given dihydro-oxazines, it was reasoned that the substituents at the 6-position as well as the 5-fluorine on the oxazine would stabilize a bioactive conformation to increase potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBTrC8rX3RE7Vg90H21EOLACvtfcHk0lhcvmlvkSu2KA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpvVarsLs%253D&md5=e622beaca28e64ea0da30c87d0828086</span></div><a href="/servlet/linkout?suffix=cit27c&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00011%26sid%3Dliteratum%253Aachs%26aulast%3DNakahara%26aufirst%3DK.%26aulast%3DFuchino%26aufirst%3DK.%26aulast%3DKomano%26aufirst%3DK.%26aulast%3DAsada%26aufirst%3DN.%26aulast%3DTadano%26aufirst%3DG.%26aulast%3DHasegawa%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DSako%26aufirst%3DY.%26aulast%3DOgawa%26aufirst%3DM.%26aulast%3DUnemura%26aufirst%3DC.%26aulast%3DHosono%26aufirst%3DM.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DSakaguchi%26aufirst%3DG.%26aulast%3DAndo%26aufirst%3DS.%26aulast%3DOhnishi%26aufirst%3DS.%26aulast%3DKido%26aufirst%3DY.%26aulast%3DFukushima%26aufirst%3DT.%26aulast%3DDhuyvetter%26aufirst%3DD.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DGijsen%26aufirst%3DHarrie%2BJ.%2BM.%26aulast%3DYamano%26aufirst%3DY.%26aulast%3DIso%26aufirst%3DY.%26aulast%3DKusakabe%26aufirst%3DK.-I.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520centrally%2520active%25206-substituted%25205-fluoro-1%252C3-dihydro-oxazine%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%2520via%2520active%2520conformation%2520stabilization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5525%26epage%3D5546%26doi%3D10.1021%2Facs.jmedchem.8b00011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit27d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Oguma, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hisakawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takada, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusakabe, K.-I.</span></span> <span> </span><span class="NLM_article-title">Synthesis of a 6-CF<sub>3</sub>-substituted 2-amino-dihydro-1,3-thiazine b-secretase inhibitor by <i>N,N</i>-diethylsulfur trifluoride-mediated chemoselective cyclization</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">4893</span>– <span class="NLM_lpage">4897</span>, <span class="refDoi"> DOI: 10.1021/acs.joc.8b02179</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.joc.8b02179" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2019&pages=4893-4897&author=T.+Ogumaauthor=K.+Ananauthor=S.+Suzukiauthor=S.+Hisakawaauthor=A.+Takadaauthor=M.+Ogawaauthor=K.-I.+Kusakabe&title=Synthesis+of+a+6-CF3-substituted+2-amino-dihydro-1%2C3-thiazine+b-secretase+inhibitor+by+N%2CN-diethylsulfur+trifluoride-mediated+chemoselective+cyclization&doi=10.1021%2Facs.joc.8b02179"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27d&amp;dbid=16384&amp;doi=10.1021%2Facs.joc.8b02179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.joc.8b02179%26sid%3Dliteratum%253Aachs%26aulast%3DOguma%26aufirst%3DT.%26aulast%3DAnan%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DS.%26aulast%3DHisakawa%26aufirst%3DS.%26aulast%3DTakada%26aufirst%3DA.%26aulast%3DOgawa%26aufirst%3DM.%26aulast%3DKusakabe%26aufirst%3DK.-I.%26atitle%3DSynthesis%2520of%2520a%25206-CF3-substituted%25202-amino-dihydro-1%252C3-thiazine%2520b-secretase%2520inhibitor%2520by%2520N%252CN-diethylsulfur%2520trifluoride-mediated%2520chemoselective%2520cyclization%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2019%26volume%3D84%26spage%3D4893%26epage%3D4897%26doi%3D10.1021%2Facs.joc.8b02179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hilpert, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guba, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woltering, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wostl, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinard, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mauser, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayweg, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers-Evans, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humm, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krummenacher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muser, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnider, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozmen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergadano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banner, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hochstrasser, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuglstatter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David-Pierson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polara, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narquizian, R.</span></span> <span> </span><span class="NLM_article-title">β-Secretase (BACE1) inhibitors with high in vivo efficacy suitable for clinical evaluation in Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3980</span>– <span class="NLM_lpage">3995</span>, <span class="refDoi"> DOI: 10.1021/jm400225m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400225m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtVymuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3980-3995&author=H.+Hilpertauthor=W.+Gubaauthor=T.+J.+Wolteringauthor=W.+Wostlauthor=E.+Pinardauthor=H.+Mauserauthor=A.+V.+Maywegauthor=M.+Rogers-Evansauthor=R.+Hummauthor=D.+Krummenacherauthor=T.+Muserauthor=C.+Schniderauthor=H.+Jacobsenauthor=L.+Ozmenauthor=A.+Bergadanoauthor=D.+W.+Bannerauthor=R.+Hochstrasserauthor=A.+Kuglstatterauthor=P.+David-Piersonauthor=H.+Fischerauthor=A.+Polaraauthor=R.+Narquizian&title=%CE%B2-Secretase+%28BACE1%29+inhibitors+with+high+in+vivo+efficacy+suitable+for+clinical+evaluation+in+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm400225m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">β-Secretase (BACE1) Inhibitors with High in Vivo Efficacy Suitable for Clinical Evaluation in Alzheimer's Disease</span></div><div class="casAuthors">Hilpert, Hans; Guba, Wolfgang; Woltering, Thomas J.; Wostl, Wolfgang; Pinard, Emmanuel; Mauser, Harald; Mayweg, Alexander V.; Rogers-Evans, Mark; Humm, Roland; Krummenacher, Daniela; Muser, Thorsten; Schnider, Christian; Jacobsen, Helmut; Ozmen, Laurence; Bergadano, Alessandra; Banner, David W.; Hochstrasser, Remo; Kuglstatter, Andreas; David-Pierson, Pascale; Fischer, Holger; Polara, Alessandra; Narquizian, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3980-3995</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An extensive fluorine scan of 1,3-oxazines revealed the power of fluorine(s) to lower the pKa and thereby dramatically change the pharmacol. profile of this class of BACE1 inhibitors.  The CF3 substituted oxazine 89, a potent and highly brain penetrant BACE1 inhibitor, was able to reduce significantly CSF Aβ40 and 42 in rats at oral doses as low as 1 mg/kg.  The effect was long lasting, showing a significant redn. of Aβ40 and 42 even after 24 h.  In contrast to 89, compd. 1b lacking the CF3 group was virtually inactive in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmoKRrAxxHErVg90H21EOLACvtfcHk0lhcvmlvkSu2KA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtVymuro%253D&md5=e5d311d1c8fecfaed043d3a0bf16c168</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm400225m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400225m%26sid%3Dliteratum%253Aachs%26aulast%3DHilpert%26aufirst%3DH.%26aulast%3DGuba%26aufirst%3DW.%26aulast%3DWoltering%26aufirst%3DT.%2BJ.%26aulast%3DWostl%26aufirst%3DW.%26aulast%3DPinard%26aufirst%3DE.%26aulast%3DMauser%26aufirst%3DH.%26aulast%3DMayweg%26aufirst%3DA.%2BV.%26aulast%3DRogers-Evans%26aufirst%3DM.%26aulast%3DHumm%26aufirst%3DR.%26aulast%3DKrummenacher%26aufirst%3DD.%26aulast%3DMuser%26aufirst%3DT.%26aulast%3DSchnider%26aufirst%3DC.%26aulast%3DJacobsen%26aufirst%3DH.%26aulast%3DOzmen%26aufirst%3DL.%26aulast%3DBergadano%26aufirst%3DA.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DHochstrasser%26aufirst%3DR.%26aulast%3DKuglstatter%26aufirst%3DA.%26aulast%3DDavid-Pierson%26aufirst%3DP.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DPolara%26aufirst%3DA.%26aulast%3DNarquizian%26aufirst%3DR.%26atitle%3D%25CE%25B2-Secretase%2520%2528BACE1%2529%2520inhibitors%2520with%2520high%2520in%2520vivo%2520efficacy%2520suitable%2520for%2520clinical%2520evaluation%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3980%26epage%3D3995%26doi%3D10.1021%2Fjm400225m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trabanco-Suarez, A. A.</span>; <span class="NLM_string-name">Gijsen, H. J. M.</span>; <span class="NLM_string-name">Van Gool, M. L. M.</span>; <span class="NLM_string-name">Ramiro, J. A. V.</span>; <span class="NLM_string-name">Delgado-Jimenez, F.</span></span> <span> </span><span class="NLM_article-title">Preparation of Dihydropyrazolopyrazinylamine Derivatives for Use as β-Secretase Inhibitors</span>. <span class="NLM_patent">WO 2012117027 A1</span>, Sept 7, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=A.+A.+Trabanco-Suarez&author=H.+J.+M.+Gijsen&author=M.+L.+M.+Van+Gool&author=J.+A.+V.+Ramiro&author=F.+Delgado-Jimenez&title=Preparation+of+Dihydropyrazolopyrazinylamine+Derivatives+for+Use+as+%CE%B2-Secretase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTrabanco-Suarez%26aufirst%3DA.%2BA.%26atitle%3DPreparation%2520of%2520Dihydropyrazolopyrazinylamine%2520Derivatives%2520for%2520Use%2520as%2520%25CE%25B2-Secretase%2520Inhibitors%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span> </span><span class="NLM_article-title">The cocrystal structure was obtained at
Proteros</span>. <a href="http://www.proteros.de/" class="extLink">http://www.proteros.de/</a> (accessed
Sept 10, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+cocrystal+structure+was+obtained+at%0AProteros.+http%3A%2F%2Fwww.proteros.de%2F+%28accessed%0ASept+10%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DThe%2520cocrystal%2520structure%2520was%2520obtained%2520at%250AProteros%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, N.</span>; <span class="NLM_string-name">Ueda, K.</span>; <span class="NLM_string-name">Itoh, N.</span>; <span class="NLM_string-name">Suzuki, S.</span>; <span class="NLM_string-name">Sakaguchi, G.</span>; <span class="NLM_string-name">Kato, A.</span>; <span class="NLM_string-name">Yukimasa, A.</span>; <span class="NLM_string-name">Hori, A.</span>; <span class="NLM_string-name">Kooriyama, Y.</span>; <span class="NLM_string-name">Haraguchi, H.</span>; <span class="NLM_string-name">Yasui, K.</span>; <span class="NLM_string-name">Kanda, Y.</span></span> <span> </span><span class="NLM_article-title">Preparation of 2-Amino-4-phenyl-4,5-dihydro-5<i>H</i>-1,3-thiazine Derivatives and Related Compounds for Treatment of Alzheimer’s Disease</span>. <span class="NLM_patent">WO 2008133273 A1</span>, Nov 6, <span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=N.+Kobayashi&author=K.+Ueda&author=N.+Itoh&author=S.+Suzuki&author=G.+Sakaguchi&author=A.+Kato&author=A.+Yukimasa&author=A.+Hori&author=Y.+Kooriyama&author=H.+Haraguchi&author=K.+Yasui&author=Y.+Kanda&title=Preparation+of+2-Amino-4-phenyl-4%2C5-dihydro-5H-1%2C3-thiazine+Derivatives+and+Related+Compounds+for+Treatment+of+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DN.%26atitle%3DPreparation%2520of%25202-Amino-4-phenyl-4%252C5-dihydro-5H-1%252C3-thiazine%2520Derivatives%2520and%2520Related%2520Compounds%2520for%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ellard, J. M.</span>; <span class="NLM_string-name">Farthing, C. N.</span>; <span class="NLM_string-name">Hall, A.</span></span> <span> </span><span class="NLM_article-title">Preparation of Fused Aminodihydrooxazine Derivatives as β-Amyloid Inhibitors and Useful in the Treatment of Neurodegenerative Disease Caused by Aβ in Particular Alzheimer-type Dementia</span>. <span class="NLM_patent">WO 2011009898 A1</span>, Jan 27, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=J.+M.+Ellard&author=C.+N.+Farthing&author=A.+Hall&title=Preparation+of+Fused+Aminodihydrooxazine+Derivatives+as+%CE%B2-Amyloid+Inhibitors+and+Useful+in+the+Treatment+of+Neurodegenerative+Disease+Caused+by+A%CE%B2+in+Particular+Alzheimer-type+Dementia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DEllard%26aufirst%3DJ.%2BM.%26atitle%3DPreparation%2520of%2520Fused%2520Aminodihydrooxazine%2520Derivatives%2520as%2520%25CE%25B2-Amyloid%2520Inhibitors%2520and%2520Useful%2520in%2520the%2520Treatment%2520of%2520Neurodegenerative%2520Disease%2520Caused%2520by%2520A%25CE%25B2%2520in%2520Particular%2520Alzheimer-type%2520Dementia%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robak, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herbage, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellman, J. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Applications oftert-Butanesulfinamide</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">3600</span>– <span class="NLM_lpage">3740</span>, <span class="refDoi"> DOI: 10.1021/cr900382t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr900382t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2010&pages=3600-3740&author=M.+T.+Robakauthor=M.+A.+Herbageauthor=J.+A.+Ellman&title=Synthesis+and+Applications+oftert-Butanesulfinamide&doi=10.1021%2Fcr900382t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fcr900382t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr900382t%26sid%3Dliteratum%253Aachs%26aulast%3DRobak%26aufirst%3DM.%2BT.%26aulast%3DHerbage%26aufirst%3DM.%2BA.%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26atitle%3DSynthesis%2520and%2520Applications%2520oftert-Butanesulfinamide%26jtitle%3DChem.%2520Rev.%26date%3D2010%26volume%3D110%26spage%3D3600%26epage%3D3740%26doi%3D10.1021%2Fcr900382t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haveaux, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dekoker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rens, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sidani, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toye, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosez, L.</span></span> <span> </span><span class="NLM_article-title">α-Chloro enamines, reactive intermediates for synthesis: 1-chloro-<i>N,N</i>,2-trimethylpropenylamine</span>. <i>Org. Synth.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">26</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1002/0471264180.os059.05</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=10.1002%2F0471264180.os059.05" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2003&pages=26-34&author=B.+Haveauxauthor=A.+Dekokerauthor=M.+Rensauthor=A.+R.+Sidaniauthor=J.+Toyeauthor=L.+Ghosez&title=%CE%B1-Chloro+enamines%2C+reactive+intermediates+for+synthesis%3A+1-chloro-N%2CN%2C2-trimethylpropenylamine&doi=10.1002%2F0471264180.os059.05"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2F0471264180.os059.05&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F0471264180.os059.05%26sid%3Dliteratum%253Aachs%26aulast%3DHaveaux%26aufirst%3DB.%26aulast%3DDekoker%26aufirst%3DA.%26aulast%3DRens%26aufirst%3DM.%26aulast%3DSidani%26aufirst%3DA.%2BR.%26aulast%3DToye%26aufirst%3DJ.%26aulast%3DGhosez%26aufirst%3DL.%26atitle%3D%25CE%25B1-Chloro%2520enamines%252C%2520reactive%2520intermediates%2520for%2520synthesis%253A%25201-chloro-N%252CN%252C2-trimethylpropenylamine%26jtitle%3DOrg.%2520Synth.%26date%3D2003%26volume%3D59%26spage%3D26%26epage%3D34%26doi%3D10.1002%2F0471264180.os059.05" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thaisrivongs, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Z. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyons, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldman, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naber, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span> <span> </span><span class="NLM_article-title">A Next generation synthesis of BACE1 inhibitor verubecestat (MK-8931)</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1568</span>– <span class="NLM_lpage">1571</span>, <span class="refDoi"> DOI: 10.1021/acs.orglett.8b00259</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.8b00259" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjt1Smu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2018&pages=1568-1571&author=D.+A.+Thaisrivongsauthor=W.+J.+Morrisauthor=L.+Tanauthor=Z.+J.+Songauthor=T.+W.+Lyonsauthor=J.+H.+Waldmanauthor=J.+R.+Naberauthor=W.+Chenauthor=L.+Chenauthor=B.+Zhangauthor=J.+Yang&title=A+Next+generation+synthesis+of+BACE1+inhibitor+verubecestat+%28MK-8931%29&doi=10.1021%2Facs.orglett.8b00259"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">A Next Generation Synthesis of BACE1 Inhibitor Verubecestat (MK-8931)</span></div><div class="casAuthors">Thaisrivongs, David A.; Morris, William J.; Tan, Lushi; Song, Zhiguo J.; Lyons, Thomas W.; Waldman, Jacob H.; Naber, John R.; Chen, Wenyong; Chen, Lu; Zhang, Baoyun; Yang, Jun</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1568-1571</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of a com. manufg. route to verubecestat (MK-8931) is described, highlights of which include the application of a continuous processing step to outcompete fast proton transfer in a Mannich-type ketimine addn., a copper-catalyzed amidation reaction, and an optimized guanidinylation procedure to form the key iminothiadiazine dioxide core.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobgE6qFUSNV7Vg90H21EOLACvtfcHk0li4peSi0dnpJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjt1Smu7s%253D&md5=131f38cbe2ed02c9960c28e6fe4aa54d</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.8b00259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.8b00259%26sid%3Dliteratum%253Aachs%26aulast%3DThaisrivongs%26aufirst%3DD.%2BA.%26aulast%3DMorris%26aufirst%3DW.%2BJ.%26aulast%3DTan%26aufirst%3DL.%26aulast%3DSong%26aufirst%3DZ.%2BJ.%26aulast%3DLyons%26aufirst%3DT.%2BW.%26aulast%3DWaldman%26aufirst%3DJ.%2BH.%26aulast%3DNaber%26aufirst%3DJ.%2BR.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DJ.%26atitle%3DA%2520Next%2520generation%2520synthesis%2520of%2520BACE1%2520inhibitor%2520verubecestat%2520%2528MK-8931%2529%26jtitle%3DOrg.%2520Lett.%26date%3D2018%26volume%3D20%26spage%3D1568%26epage%3D1571%26doi%3D10.1021%2Facs.orglett.8b00259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1w50" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1w50','PDB','1w50'); return false;">PDB: 1w50</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3zkg" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3zkg','PDB','3zkg'); return false;">PDB: 3zkg</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i61"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00309">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_27502"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b00309">10.1021/acs.jmedchem.9b00309</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Experimental procedures and characterization data for compounds <b>15</b>, <b>18</b>, <b>19</b>, <b>20</b>, and <b>21</b>, NOE for compounds <b>44</b> and <b>45</b>, synthesis of [<sup>3</sup>H]-JNJ-962, and crystallographic data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00309/suppl_file/jm9b00309_si_001.pdf">PDF</a>)</p></li><li><p class="inline">SMILE strings, BACE1 IC<sub>50</sub>, BACE2 IC<sub>50</sub>, and cellular Aβ42 IC<sub>50</sub> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00309/suppl_file/jm9b00309_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00309/suppl_file/jm9b00309_si_001.pdf">jm9b00309_si_001.pdf (1.25 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00309/suppl_file/jm9b00309_si_002.csv">jm9b00309_si_002.csv (1.59 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last"><b>8</b> bound to BACE1: 6JSG; <b>16</b> bound to BACE1: 6JSE; <b>17</b> bound to BACE1: 6JSF; <b>22</b> bound to BACE1: 6JSN; and <b>22</b> bound to BACE2: 6JSZ.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b00309%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-10%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b00309" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799666cd82ed1df","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
